cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
7176,1-bromo-4-fluorobenzene,207-300-2,460-00-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,157.0,H319:124;H226:155;H315:106;H335:103;H317:2;H312:54;H332:141;H302:54;H336:13;Not classified:2
7177,"2,2'-[3-methyl-4-(5-nitrothiazol-2-ylazo)phenylimino]bisethanol",277-184-6,72987-42-9,Not Classified,Notified C&L,4.0,Not classified:4
7178,C.I. ACID BLUE 185,602-507-8,12234-64-9,Skin Sens. 1,Notified C&L,4.0,H317:2;Not classified:2
7179,4'-benzyloxy-2-bromopropiophenone,252-351-6,35081-45-9,Skin Sens. 1,REACH registration C&L,9.0,H317:3;H302:3;H301:1;Not classified:2;H319:1;H315:1;H335:1
7180,"Hexadecane-1,16-diol",230-030-1,6920-24-7,Not Classified,Notified C&L,1.0,Not classified:1
7182,1-bromo-2-methylpropyl propanoate,605-166-3,158894-67-8,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Carc. 2,Notified C&L,1.0,H314:1;H226:1;H351:1;H317:1
7188,2-bromo-6-nitrotoluene,259-566-4,55289-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:47;H315:47;H335:46;H312:6;H302:7;H332:2
7190,"Octane-1,8-dithiol",214-738-8,1191-62-4,Acute Tox. 4,Notified C&L,135.0,H302:135;H319:2;H315:2;H335:1
7192,"6,10-dimethylundecen-2-one",215-340-7,1322-58-3,Skin Sens. 1,Notified C&L,233.0,H317:233
7194,"1,3-BENZENEDIMETHANAMINE, N-(2-PHENYLETHYL) DERIVS.",609-828-2,404362-22-7,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;STOT RE 1,Notified C&L,56.0,H314:51;H317:51;H410:51;H373:51;H372:23;H302:51;H400:28;Not classified:5
7197,"Backhousia citriodora, ext.",283-909-7,84775-80-4,Skin Irrit. 2;Skin Sens. 1,Notified C&L,12.0,H315:12;H317:11;H411:3;H319:3;H340:1;H334:1;H302:1
7200,"α,α,α-trifluoro-p-toluidine",207-236-5,455-14-1,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,87.0,H318:6;H410:52;H331:6;H372:6;H301:54;H400:52;H319:48;Not classified:33;H341:5;H315:4;H330:2;H373:2;H311:2
7201,2-(2-ethoxyethoxy)ethyl acrylate,230-811-7,7328-17-8,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,577.0,H319:445;H315:361;H317:360;H411:96;H302:277;H311:12;H312:281;H314:56;H318:92;H412:72;H335:114;Not classified:31
7202,Amidinouronium dihydrogen phosphate,253-264-6,36897-89-9,Not Classified,Notified C&L,1.0,Not classified:1
7205,"Benzoic acid, 2,6-dichloro-3-(trifluoromethyl)-",607-829-2,25922-41-2,,Notified C&L,4.0,H319:4;H315:4;H335:4
7207,"Hydroxy(2-hydroxybenzoato-O1,O2)copper",263-506-2,62320-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:38;H315:38;H335:38;H302:4;H400:4;H410:4
7208,Benzyl 3-pyrroline-1-carboxylate,608-686-9,31970-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40
7209,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with triethylenetetramine",500-290-3,103758-99-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,7.0,H412:2;H319:2;H315:6;H317:6;H411:2;H318:4;Not classified:1;H410:2;H400:2
7211,2-Acetylnicotinic acid,618-319-4,89942-59-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
7215,"2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride",410-620-7,119154-86-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0.0,H302:0;H314:0;H317:0
7216,(Z)-hex-3-enyl phenylacetate,255-826-6,42436-07-7,Not Classified,Notified C&L,91.0,Not classified:90;H413:1
7221,Tetraamminezinc(2+) carbonate,254-099-2,38714-47-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,196.0,H319:135;H315:135;H317:134;H410:134;H400:134;Not classified:61;H335:1
7223,"Sulfuric acid, mono-C12-13-alkyl esters, sodium salts",295-101-1,91783-23-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,10.0,H318:10;H315:10;H302:1
7226,"(R*,S*)-4-[isopropylthio]-α-[1-(octylamino)ethyl]benzyl alcohol",259-332-1,54767-75-8,Acute Tox. 4,Notified C&L,38.0,H302:38
7228,4-methoxy-4-methylpentan-2-one,203-512-4,107-70-0,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0.0,H226:0;H332:0
7230,"Dichlorobis(pentane-2,4-dionato-O,O')tin",240-972-5,16919-46-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Carc. 2,Notified C&L,43.0,H312:42;H314:38;H318:38;H332:42;H351:38;H302:42;H319:5;H315:5;H335:4;H331:1;H301:1;H311:1
7231,3-acetylpyridine-adenine dinucleotide,201-649-4,86-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:40
7232,"10-methoxy-5H-dibenz[b,f]azepine",225-172-6,4698-11-7,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,4.0,H411:3;H317:3;Not classified:1
7233,"1,1-dimethoxynon-2-yne",236-249-9,13257-44-8,Skin Sens. 1,Notified C&L,1550.0,H317:1550
7235,"Imidazo[1,2-b]pyridazinium, 1-[[(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt",601-249-3,113359-04-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1.0,H334:1;H317:1
7236,"4-[bis(isopropyl)amino]-2,2-diphenylbutyronitrile",201-005-2,77-11-2,Not Classified,REACH registration C&L,2.0,Not classified:2
7239,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with fatty acids, C16-18 and C18-unsatd., branched and linear and tetraethylenepentamine",500-386-5,157707-76-1,,Notified C&L,1.0,H319:1;H315:1;H335:1;H317:1
7243,"Aromatic hydrocarbons, C9-11",274-759-3,70693-06-0,,Notified C&L,59.0,Not classified:22;H315:19;H225:19;H226:18;H304:18;H336:13
7248,1-(2-methoxyphenyl)piperazine dihydrochloride,254-167-1,38869-49-7,,Notified C&L,1.0,H302:1
7250,hydrazine bis(3-carboxy-4-hydroxybenzensulfonate),405-030-1,148434-03-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0.0,H314:0;H317:0;H350:0;H412:0;H302:0
7254,"8-hydroxy-6,7-dimethoxy-2-benzopyrone",208-370-7,525-21-3,Not Classified,Notified C&L,1.0,Not classified:1
7260,"Trisodium 5-amino-3-[[4-[[4-[(7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]phenyl]azo]phenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",257-938-0,52469-75-7,Not Classified,Notified C&L,1.0,Not classified:1
7261,"Octadecanoic acid, ester with 2,2',2''-nitrilotris[ethanol]",253-388-0,37189-41-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8.0,H319:8;H315:8
7262,Dihydrotachysterol,200-672-7,67-96-9,Acute Tox. 3,Notified C&L,40.0,H301:39;H300:1;H361:1;H330:1;H310:1;H370:1;H372:1
7263,"Decyl alcohol, propoxylated, ethoxylated",609-375-0,37251-67-5,Not Classified,Notified C&L,596.0,Not classified:553;H319:40;H315:41;H335:40;H411:26;H302:1;H318:2;H410:1
7269,Acetato-O)(12-hydroxyoctadecanoato-O1)calcium,267-980-1,67969-78-2,Not Classified,Notified C&L,1.0,Not classified:1
7271,"2,4-dioxo-1,3-diazetidine-1,3-diylbis[p-phenylenemethylene-p-phenylene] diisocyanate",241-559-2,17589-24-1,Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,6.0,H315:6;H317:6;H332:6;H351:6;H373:6;H335:6;H334:6
7273,Sennoside B,204-895-0,128-57-4,Acute Tox. 4,Notified C&L,5.0,H302:3;H334:2;H317:2
7276,"4,7-diethoxy-4,7-dimethyl-3,8-dioxa-4,7-disiladecane",241-953-4,18043-74-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22.0,H301:22;H319:22;H315:22;H335:22
7278,"2,2'-methylenebis[4,6-bis[(dimethylamino)methyl]phenol]",261-985-2,59917-57-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,1.0,H302:1;H317:1
7280,2-iodobenzoyl chloride,210-196-1,609-67-6,Skin Corr. 1B,Notified C&L,44.0,H314:44;H290:1;H318:1
7285,dichloromethane;methylene chloride,200-838-9,75-09-2,Carc. 2,Harmonised C&L,0.0,H351:0
7289,"Benzoic acid, 2-ethoxy-4-methyl-, ethyl ester",618-203-3,88709-17-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1.0,H302:1;H332:1;H312:1
7298,"Benzene, 1-(2-bromoethoxy)-2-methoxy-",610-206-8,4463-59-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,4.0,H302:4;H412:4
7299,Cholest-5-ene-3-beta-yl nonanoate,214-658-3,1182-66-7,Not Classified,Notified C&L,2.0,Not classified:2;H413:1
7302,4-hexyloxyphenol,242-713-1,18979-55-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,43.0,H318:38;H315:43;H335:42;H411:38;H302:38;H319:5
7303,Dipropyl hydrogen phosphate,217-296-4,1804-93-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,38.0,H318:38;H315:38
7306,2-methoxy-3(or5)-methylpyrazine,269-881-9,68378-13-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,146.0,H302:146;H226:144;H319:1;H315:1;H335:1
7307,N-ethylphthalimide,225-707-3,5022-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:38
7308,"2,3,5,6-tetrachloroterephthaloyl dichloride",211-947-6,719-32-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38.0,H302:38;H314:38
7310,"Ethanol, 2-(lanolin alkyloxy) derivs.",295-044-2,91782-71-7,Not Classified,Notified C&L,1.0,Not classified:1
7312,5-methylhex-3-en-2-one,225-950-5,5166-53-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3,Notified C&L,301.0,H319:258;H226:301;H331:258;H302:301;H311:301;H332:38
7314,Methyl 2-(decylideneamino)benzoate,267-495-5,67874-67-3,Not Classified,Notified C&L,233.0,Not classified:233
7315,trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate,405-860-4,121315-16-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
7321,"5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride",609-584-7,3880-88-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
7324,[(octyloxy)methyl]oxirane,222-199-5,3385-66-8,Not Classified,REACH registration C&L,2.0,Not classified:2
7325,4-cyanophenylacetic acid,226-753-7,5462-71-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,134.0,H302:134;H319:134;H315:134;H312:4;H332:4;H335:6
7332,o-(allyloxy)benzaldehyde,249-198-2,28752-82-1,,Notified C&L,5.0,H319:5;H315:5
7337,"1-[1,6-dimethyl-3-(4-methylpent-3-enyl)-3-cyclohexen-1-yl]ethan-1-one",259-173-8,54464-54-9,Not Classified,REACH registration C&L,1.0,Not classified:1
7338,Furan-2(5H)-one,207-839-3,497-23-4,Acute Tox. 4,Notified C&L,1473.0,H302:1427;H319:47;H315:47;H335:41
7341,Calcium (±)-bis[2-(3-phenoxyphenyl)propionate],252-107-9,34597-40-5,Acute Tox. 4,Notified C&L,2.0,H302:2
7346,"Reaction product of 1-Propanethiol, 3-(trimethoxysilyl)-, compd. with 5-isocyanato-1-(isocyanatomethyl) -1,3,3-trimethylcyclohexane (1:1)",700-534-0,117172-56-2,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,3.0,H334:3;H332:3;H317:3
7347,"Acetic acid, C11-14-branched alkyl esters, C13-rich",600-872-8,108419-35-8,Not Classified,REACH registration C&L,59.0,Not classified:59
7350,Linalyl cinnamate,201-110-3,78-37-5,Eye Irrit. 2,Notified C&L,1552.0,H319:1286;Not classified:266
7351,"Octadecanoic acid, reaction products with N,N-dimethyl-1,3-propanediamine",291-709-6,90459-64-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,3.0,H400:2;H319:2;H315:2;Not classified:1
7353,5-Amino-3-methyl-isothiazole-4-carbonitrile,609-957-4,41808-35-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
7356,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)]-, disodium",274-386-6,70209-87-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,90.0,H302:27;H319:61;H411:56;Not classified:29;H412:5;H315:1;H312:1
7360,Flufenamic acid,208-494-1,530-78-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,58.0,H319:55;H315:55;H335:14;H411:3;H301:54;H302:3;H317:1;H361:1;H341:1;Not classified:1
7365,Calcium hydrogen phosphonate,244-182-1,21056-98-4,Not Classified,REACH registration C&L,5.0,Not classified:4;H319:1;H315:1
7367,"3,7,11,15-tetramethylhexadec-2-en-1-ol",205-776-6,150-86-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1433.0,H400:1364;H410:1401;H315:1432;H413:25;H319:3;Not classified:1;H314:1;H304:1;H331:1;H311:1
7370,1-(vinyloxy)dodecane,212-141-7,765-14-0,Aquatic Chronic 4,REACH registration C&L,122.0,H413:84;H412:38;H319:38
7371,(2-nitroethyl)benzene,228-094-0,6125-24-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
7373,3-(dipropylamino)propiononitrile,243-999-0,20732-22-3,Acute Tox. 4,Notified C&L,38.0,H302:38
7376,Bis[(2ξ)-D-gluco-heptonato]iron,235-823-6,12786-09-3,Not Classified,Notified C&L,2.0,Not classified:2
7382,"Dodecylbenzenesulphonic acid, compound with 4,4-dimethyloxazolidine (1:1)",268-443-4,68084-53-7,,Notified C&L,2.0,Not classified:2
7384,7-Amino-2-benzoxazolinone,462-910-8,81282-60-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
7387,2-phenoxybenzoic acid,218-811-5,2243-42-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
7388,"2,6-bis(tert-butylamino)-4-methylpyridin-3-yl methyl ketone",261-189-5,58253-99-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7389,propyl (2S)-2-[(2-methylbutan-2-yl)oxy]propanoate,437-530-0,319002-92-1,Aquatic Chronic 3,REACH registration C&L,40.0,H412:40
7390,"Zirconium, chloro glycine hydroxy aluminum complexes",292-375-4,90604-80-1,Not Classified,Notified C&L,55.0,Not classified:55
7393,1-(2-hydroxyethyl)pyrrolidin-2-one,222-359-4,3445-11-2,Not Classified,REACH registration C&L,239.0,Not classified:200;H319:39;H315:38;H335:38
7397,2-(dodecylthio)ethanol,215-969-7,1462-55-1,Aquatic Chronic 4,Notified C&L,38.0,H413:38
7398,"ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate",428-030-3,67914-69-6,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H400:0;H410:0;H373:0
7403,Phenyl diamidophosphate,231-218-6,7450-69-3,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1.0,H302:1;H319:1
7404,Organosulphide,482-120-7,,Not Classified,REACH registration C&L,56.0,Not classified:56
7405,Phenoxyacetaldehyde,218-329-5,2120-70-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,291.0,H319:291;H315:291;H335:1
7408,"Licorice, Glycyrrhiza echinata, ext., hydrolyzed",309-342-8,100209-34-5,Not Classified,Notified C&L,1.0,Not classified:1
7411,tert-butyl 4-[(2-aminopyridin-3-yl)amino]piperidine-1-carboxylate,616-592-4,781649-86-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
7413,"Oils, egg",232-271-8,8001-17-0,Not Classified,Notified C&L,36.0,Not classified:36
7420,"Triethylenetetramine, propoxylated",500-055-5,26950-63-0,Eye Irrit. 2,Notified C&L,198.0,H319:107;Not classified:71;H312:17;H314:20;H412:18;H317:31;H411:13;H315:14;H318:1
7422,Diethoxydiethylsilane,225-706-8,5021-93-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40.0,H319:40;H226:40;H315:40;H335:1
7423,2-amino-5-bromobenzoic acid,227-338-3,5794-88-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H301:39;H319:49;H315:49;H335:48;H302:3;H331:1;H311:1
7426,Methyl 1-thio-β-D-galactopyranoside,205-842-4,155-30-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7427,3-methylbut-3-en-2-one,212-405-1,814-78-8,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,126.0,H319:126;H315:126;H225:126;H330:87;H335:125;H301:116;H311:77;H310:49;H300:10
7428,Diantimony tetraoxide,215-576-0,1332-81-6,Not Classified,Notified C&L,36.0,Not classified:33;H319:3;H315:3;H335:3
7429,"Poly(oxy-1,2-ethanediyl), α,α',α''-[(octadecylnitrilio)tri-2,1-ethanediyl]tris[ω-hydroxy-, phosphate (1:1)",611-618-0,58069-11-7,,Notified C&L,1.0,H400:1;H318:1;H410:1;H315:1
7430,Ethoxytriphenylsilane,216-170-6,1516-80-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
7432,"(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-pyrrolidinecarboxylic Acid",606-544-0,203866-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46
7436,(2-hydroxybenzylidene)salicylohydrazide,221-773-2,3232-36-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,131.0,H302:127;H319:131;H315:4;H335:4
7437,"4-(1,3-dioxobutyl)morpholine",240-742-4,16695-54-8,Eye Irrit. 2,Notified C&L,1.0,H319:1
7442,dimethylhexanoic acid nickel salt,301-323-2,93983-68-7,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0.0,H360:0;H341:0;H317:0;H410:0;H350:0;H372:0;H334:0;H400:0
7444,"4-trans-Methoxy-4-trans-propyl-[1,1-bicyclohexyl]",619-269-6,97398-80-6,Skin Irrit. 2,REACH registration C&L,1.0,H315:1
7454,"Iron, 5,6-diamino-1,3-naphthalenedisulfonate complexes",293-978-5,91671-76-0,Not Classified,Notified C&L,1.0,Not classified:1
7458,Buclizine dihydrochloride,204-962-4,129-74-8,Not Classified,Notified C&L,1.0,Not classified:1
7460,"Potassium sodium 7-hydroxy-8-(phenylazo)naphthalene-1,3-disulphonate",280-265-9,83232-33-1,,Notified C&L,33.0,Not classified:33
7463,Ethyl 4-aminopiperidine-1-carboxylate,261-472-3,58859-46-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46.0,H319:46;H315:46;H226:1;H332:1;H335:2;H302:1;H227:1
7464,Kanamycin sulphate,246-933-9,25389-94-0,Repr. 1B,Notified C&L,180.0,H360:175;Not classified:3;H301:2;H331:2;H361:2;H311:2;H334:4;H335:2;H319:3;H302:3;H315:2;H317:2;H371:1;H332:1;H312:1
7468,"4-(benzoylamino)-6-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-5-hydroxynaphthalene-1,7-disulphonic acid, lithium sodium salt",280-426-3,83400-11-7,Skin Sens. 1B;Resp. Sens. 1;Aquatic Chronic 2,REACH registration C&L,12.0,H334:1;H411:1;H317:12
7470,"Curcuma longa, ext.",283-882-1,84775-52-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1442.0,H412:1390;H304:1393;H317:1393;Not classified:41;H319:7;H315:5;H335:4;H226:3;H411:2;H316:1;H303:1;H320:1
7471,"Magnesium, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3α(2E,7S*,11S*),4β,21β]]]-",207-536-6,479-61-8,Asp. Tox. 1,Notified C&L,1290.0,H304:1286;Not classified:3;H302:1
7472,"2-Methyl-1,3-oxazole-4-carboxylic acid",607-188-9,23012-17-1,Eye Irrit. 2,Notified C&L,40.0,H319:40;H315:2;H335:2
7475,Dimethoxymethyloctadecylsilane,274-936-5,70851-50-2,Not Classified,REACH registration C&L,4.0,Not classified:3;H332:1;H315:1
7476,Hydrazinium bromide,237-412-7,13775-80-9,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43.0,H317:43;H410:43;H331:43;H350:42;H301:43;H400:43;H311:42;H314:1;H318:1;H361:1;H341:1;H310:1;H351:1;H370:1;H372:1
7477,Disodium zirconate,235-378-8,12201-48-8,,Notified C&L,4.0,H319:4;H315:4
7479,"Mentha cardiaca, ext.",294-809-8,91770-24-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,127.0,H304:117;H315:96;H317:117;H226:69;H411:117;H302:21;Not classified:10
7482,tetraammine platinum (II) hydrogen carbonate,426-730-3,123439-82-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H318:0;H412:0
7485,(Bromomethyl)cyclobutane,700-027-4,17247-58-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:43;H226:46;H315:43;H335:42
7487,1-(4-hydroxy-3-nitrophenyl)ethan-1-one,613-183-2,6322-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:46;H315:46;H335:45;H302:1;H314:1;H332:1;H312:1
7489,Nitro(2H5)benzene,224-014-3,4165-60-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 3,Notified C&L,47.0,H351:46;H331:40;H412:38;H372:46;H301:46;H360:38;H311:46;H361:8;H330:6;H411:8;Not classified:2
7492,"Tetrasodium 7-[[4-[[(2,3-dichloro-6-quinoxalinyl)carbonyl]amino]-5-sulphonato-1-naphthyl]azo]naphthalene-1,3,5-trisulphonate",276-752-0,72639-29-3,,Notified C&L,8.0,Not classified:8
7495,Lithium sulphamate,244-621-7,21856-68-8,Not Classified,Notified C&L,1.0,Not classified:1
7497,Mercury dicyanide,209-741-6,592-04-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41.0,H300:41;H330:41;H410:41;H310:41;H373:41;H400:38
7498,"1,1-dimethylethyl [[(2,4,6-trimethylphenyl)sulphonyl]oxy]carbamate",252-837-8,36016-39-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H302:1;H335:1
7499,diammonium hexachloroplatinate,240-973-0,16919-58-7,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0.0,H334:0;H301:0;H318:0;H317:0
7501,"5-chloro-1,3,3-trimethyl-2-methyleneindoline",229-972-6,6872-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
7504,2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate,405-350-1,54527-73-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
7506,"1,3-Benzenedicarboxylic acid, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine and hexanedioic acid",608-590-7,31214-22-9,Not Classified,Notified C&L,1.0,Not classified:1
7512,"α,α-diethoxytoluene",212-265-1,774-48-1,Acute Tox. 4,Notified C&L,1376.0,H302:1376;H315:1;H317:1
7516,"Rosin, polymer with p-tert-butylphenol, formaldehyde, maleic anhydride, pentaerythritol and soybean oil",603-655-6,132778-09-7,Not Classified,Notified C&L,69.0,Not classified:69
7517,"Sodium 4-(4-acetamidophenyl-1-amino)-1-amino-9,10-dioxoanthracene-2-sulphonate",229-190-5,6424-85-7,Not Classified,Notified C&L,77.0,Not classified:67;H318:4;H319:5;H335:4;H320:1
7522,Butyltripropylammonium bromide,262-637-2,61175-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7533,"2-chloromethyl-3,4-dimethoxypyridinium chloride",416-440-5,72830-09-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H312:0;H318:0;H315:0;H317:0;H373:0;H411:0;H302:0
7539,Sulfacarbamide,208-922-7,547-44-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,39.0,H302:39;H317:38
7545,"(E)-3,5-dimethylhex-3-en-2-one",606-014-9,18402-86-3,Flam. Liq. 3,REACH registration C&L,2.0,H226:2
7552,Methanesulphonic anhydride,230-442-1,7143-01-3,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,61.0,H314:61;H318:3
7553,Dimethyl azelate,217-060-0,1732-10-1,Not Classified,REACH registration C&L,86.0,Not classified:3;H318:83
7557,Octachlorotrisilane,237-041-0,13596-23-1,Skin Corr. 1A,REACH registration C&L,5.0,H314:5;H318:1
7562,"Lactic acid, ethyl ester, tetraester with silicic acid (H4SiO4)",606-106-9,18724-21-5,Not Classified,Notified C&L,1.0,Not classified:1
7565,"Butanedioic acid, 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-3-hydroxy-, (2R,3R)-",614-155-2,67879-58-7,Not Classified,Notified C&L,2.0,Not classified:2
7566,"Poly(oxy-1,2-ethanediyl), alpha-tridecyl-omega-hydroxy-, phosphate, sodium salt",614-351-8,68186-29-8,Not Classified,Notified C&L,88.0,Not classified:65;H318:22;H315:23;H411:21;H412:1;H319:1
7567,"Aloe ferox, ext.",283-462-8,84649-82-1,Not Classified,Notified C&L,3.0,Not classified:1;H226:2
7569,"Benzonitrile, 3-(dodecylsulfonyl)-",618-173-1,885050-35-1,Not Classified,Notified C&L,31.0,Not classified:31
7571,Steatite (Mg3H2(SiO3)4),604-380-4,14378-12-2,Not Classified,Notified C&L,1.0,Not classified:1
7573,2-(dimethylamino)ethyl dodecanoate,609-033-0,34839-10-6,Not Classified,REACH registration C&L,4.0,Not classified:4
7578,"(4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)",240-442-3,16391-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
7579,"4,8-diamino-2-(4-ethoxyphenyl)-1,5-dihydroxyanthraquinone",239-167-1,15114-15-5,Not Classified,Notified C&L,21.0,Not classified:21
7580,"Terminalia chebula, ext.",290-359-1,90131-48-9,Not Classified,Notified C&L,3.0,Not classified:3
7581,4-mercaptobutyric acid,236-013-5,13095-73-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38.0,H319:38;H315:38
7585,"Androstan-17-one, 3-[(methylsulfonyl)oxy]-, (3β,5α)-",606-350-6,19646-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Repr. 2,Notified C&L,1.0,H319:1;H315:1;H361:1;H341:1;H351:1;H335:1
7588,"1-Propanone, 1-[4-(phenylmethoxy)phenyl]-2-[[2-[4-(phenylmethoxy)phenyl]ethyl]amino]-",616-487-3,776998-89-1,,Notified C&L,1.0,Not classified:1
7589,4-Amino-3-chlorophenol Hydrochloride,610-882-4,52671-64-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
7593,"6alpha, 9alpha-difluoro-11beta,17alpha-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylic acid",608-206-8,28416-82-2,Not Classified,Notified C&L,6.0,Not classified:2;H302:1;H341:1;H411:1;H373:2;H361:2
7594,"(3,4-dihydroxyphenyl)(phenyl)methanone",600-547-0,10425-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
7595,"2,4-dinitrocumene",201-880-0,89-07-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 2;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1.0,H361:1;H341:1;H351:1;H331:1;H373:1;H412:1;H301:1;H311:1
7599,Isonicotinaldehyde oxime,211-796-6,696-54-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43.0,H319:39;H315:39;H332:38;H335:38;H302:43
7600,6-methyl-3-(1-methylethyl)-7-oxabicyclo[4.1.0]heptan-2-one,226-125-2,5286-38-4,Not Classified,Notified C&L,1.0,Not classified:1
7601,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]-, disodium",281-013-0,83833-37-8,Aquatic Chronic 2,REACH registration C&L,183.0,H411:63;Not classified:116;H412:4
7602,"1,3-bis(hydroxymethyl)-4,5-dimethoxyimidazolidin-2-one",224-138-8,4211-44-3,Not Classified,Notified C&L,1.0,Not classified:1
7605,"2H-2,4a-Methanonaphthalen-1(5H)-one, hexahydro-5,5-dimethyl-",616-578-8,77923-74-1,,Notified C&L,1.0,Not classified:1
7606,"Alcohols, C20-24",307-145-1,97552-92-6,Not Classified,Notified C&L,446.0,Not classified:446
7614,4'-aminoacetanilide,204-576-6,122-80-5,Not Classified,REACH registration C&L,73.0,Not classified:10;H334:52;H319:65;H317:52;H315:5;H335:5;H302:1
7615,N-methyl-1-(1-naphthyl)methanamine hydrochloride (1:1),613-801-0,65473-13-4,Not Classified,REACH registration C&L,51.0,Not classified:2;H319:48;H315:48;H335:47;H302:1;H361:1
7619,5-cyclohexylsalicylic acid,217-453-7,1855-23-8,Eye Irrit. 2,Notified C&L,38.0,H319:38
7627,Lauramide,214-298-7,1120-16-7,Aquatic Chronic 4,Notified C&L,39.0,H413:38;Not classified:1
7633,"Tetrasodium 4-[[3,5-bis[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]-2,4(or 2,6)-dihydroxyphenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",304-762-8,94279-16-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,6.0,H412:3;H319:3;Not classified:2;H411:1
7635,"Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;petroleum gas;[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",273-175-6,68952-81-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
7641,"1,1-dichlorodifluoroethylene",201-198-3,79-35-6,Press. Gas (Liq.);Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H280:1;H332:1;H335:1;H302:1
7642,"Fatty acids, tall oil,polymers with bisphenol A and epichlorhydrin",613-882-2,66070-75-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 1,Notified C&L,22.0,H319:22;H315:22;H317:22;H335:22;H372:22
7647,N-(aminoiminomethyl)acetamide,227-180-5,5699-40-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H319:3;H315:3;H335:3
7649,(4-nitrophenyl)methanesulfonyl chloride,609-806-2,4025-75-6,,Notified C&L,7.0,H314:6;H261:1;Not classified:1
7650,4'-formylacetanilide,204-579-2,122-85-0,,Notified C&L,3.0,H319:3;H315:3;H332:2;H335:3;H302:2
7653,"1,4-dichloro-5,8-dihydroxyanthraquinone",220-599-4,2832-30-6,Not Classified,REACH registration C&L,40.0,Not classified:2;H319:38;H315:38;H335:38
7655,"N,N'-bis[3-(triethoxysilyl)propyl]ethylenediamine",250-359-4,30858-91-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H318:1;H315:1
7658,phenolphthalein,201-004-7,77-09-8,Muta. 2;Carc. 1B;Repr. 2,Harmonised C&L,0.0,H350:0;H361:0;H341:0
7666,Sodium 8-phenylamino-5-(4-(3-sulphonatophenylazo)-1-naphthylazo)naphthalenesulphonate,222-111-5,3351-05-1,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,187.0,H412:79;H319:131;H317:104;Not classified:46;H411:38;H318:1
7667,Carbenicillin,225-171-0,4697-36-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38.0,H334:38;H317:38
7675,"Decane-1,10-dithiol",214-739-3,1191-67-9,,Notified C&L,6.0,H319:5;H315:5;Not classified:1
7677,L-cysteine,200-158-2,52-90-4,Acute Tox. 4,REACH registration C&L,412.0,H302:263;Not classified:95;H319:59;H315:59;H335:59;H301:1;H303:1
7678,Cresol red,217-064-2,1733-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:42;H315:42;H335:42;Not classified:3;H411:1
7679,"Stannane, dibutyl-, bis(C8-18 and C18-unsatd. fatty acyloxy) derivs.",287-424-1,85508-00-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,68.0,H312:68;H319:68;H315:68;H373:68;H412:55;H302:68;H410:13
7685,"D-Valine, 3-mercapto-, lead complex",611-005-8,53513-80-7,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Repr. 1A;STOT RE 2;Aquatic Chronic 3,Notified C&L,1.0,H317:1;H332:1;H373:1;H412:1;H334:1;H302:1;H360:1
7688,Diethyl adipate,205-477-0,141-28-6,Not Classified,REACH registration C&L,92.0,Not classified:92
7693,"Phenol, 4-(trans-4-pentylcyclohexyl)-",617-360-5,82575-69-7,Not Classified,Notified C&L,2.0,Not classified:1;H413:1;H317:1
7694,2-bromo-3-fluorotoluene,261-982-6,59907-13-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
7698,5-phenyl-1H-tetrazole,241-950-8,18039-42-4,Acute Tox. 4,REACH registration C&L,56.0,H302:56;H319:6;H315:6;H335:6;H228:6;Not classified:1;H332:1
7699,(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide,423-260-0,100988-63-4,Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H341:0;H411:0;H317:0
7703,9-methyl-9-azabicyclo[3.3.1]nonan-3-one,209-021-1,552-70-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:41
7705,Isopentyl α-(2-diethylaminoethylamino)phenylacetate dihydrochloride,227-571-0,5892-41-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1
7706,"5-(4-methyl-1,3-dioxolan-2-yl)-1,3-benzodioxole",262-897-7,61683-99-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
7708,"3,4-dichlorobenzyl alcohol",217-299-0,1805-32-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46.0,H302:44;H318:38;H315:43;H335:43;H319:5;H311:7;H411:1;H301:1;H331:1
7709,m-toluenesulphonamide,217-596-5,1899-94-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Carc. 2,Notified C&L,1.0,H319:1;H315:1;H351:1;H335:1;H302:1
7712,"Protein hydrolyzates, wheat germ, [3-(dodecyldimethylammonio)-2- hydroxypropyl], chlorides",603-410-3,130381-06-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,88.0,H319:88;H315:71;H411:71
7713,"Rubus fruticosus, ext.",284-110-6,84787-69-9,Flam. Liq. 2,Notified C&L,1377.0,H225:1287;Not classified:48;H226:41;H319:1
7714,"1-tert-butyl 2-methyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate",616-143-2,74844-91-0,Not Classified,Notified C&L,4.0,Not classified:2;H319:2;H315:2;H335:2
7716,"(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-,",611-380-8,56341-37-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,75.0,H302:75;H317:73;H410:29;H312:2;H319:1;H315:1;H332:2;H335:1
7718,"Phosphatidic acids, C12-24 and C12-24-unsatd.",295-465-1,92061-53-5,Not Classified,Notified C&L,1.0,Not classified:1
7719,"5-methylthio-1H-1,2,4-triazol-3-ylamine",256-242-4,45534-08-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H302:3;H319:3;H315:3;H335:2
7720,Dimethyl succinate,203-419-9,106-65-0,Not Classified,REACH registration C&L,1144.0,Not classified:734;H319:389;H335:20;H412:1;H302:1;H371:1;H373:1
7722,"Methyl 3,3-dimethylbicyclo[2.2.1]heptane-2-carboxylate",258-005-0,52557-97-8,Not Classified,Notified C&L,1552.0,Not classified:1374;H315:178
7726,Homatropine hydrochloride,211-280-0,637-21-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2.0,H301:1;H331:1;H311:1;H302:1
7728,Bis(triphenylphosphinepalladium) acetate,238-628-4,14588-08-0,Not Classified,Notified C&L,1.0,Not classified:1
7732,C.I. Acid Brown 235,602-814-7,12269-90-8,Not Classified,Notified C&L,2.0,Not classified:2
7734,N-[4-(phenylamino)phenyl]methacrylamide,255-432-4,41543-92-4,Not Classified,Notified C&L,1.0,Not classified:1
7737,"3,5-diaminobenzoic acid",208-621-0,535-87-5,Not Classified,REACH registration C&L,48.0,Not classified:2;H319:46;H315:46;H335:45;H341:1
7738,3-(trifluoromethyl)phenethylic alcohol,207-233-9,455-01-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
7739,Oxirane,617-762-0,857892-58-1,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,89.0,H412:47;H318:47;H315:47;H317:47;H411:41;Not classified:1
7742,Ethyl 1-methylpiperidine-3-carboxylate,225-951-0,5166-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
7743,"Fatty acids, tall-oil, reaction products with polyethylenepolyamines",272-756-1,68910-93-0,Not Classified,Notified C&L,578.0,Not classified:531;H318:42;H315:42;H411:37;H410:9;H335:4;H400:8;H314:4;H317:4;H319:1;H302:1
7755,"2-benzo[f]quinolin-3-yl-1H-indene-1,3(2H)-dione",264-007-2,63216-89-7,Not Classified,Notified C&L,83.0,Not classified:83
7756,"Nitriles, coco",263-066-1,61789-53-5,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,34.0,H410:34;H315:34;H400:1
7759,"3,7-dimethyloctyl ethyl ether",245-237-2,22810-10-2,Not Classified,Notified C&L,36.0,Not classified:36
7761,"Benzenesulfonic acid, 2-[2-[3-[[(2-ethoxyphenyl)amino]carbonyl]-2-hydroxy-1-naphthalenyl]diazenyl]-5-methyl-, calcium salt (2:1)",600-875-4,108582-54-3,Not Classified,Notified C&L,31.0,Not classified:31
7762,N-ethylmaleimide,204-892-4,128-53-0,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,207.0,H314:206;H300:205;H311:204;H317:205;H301:42;H318:4;H312:1;H332:1
7769,"5-ethyl-5-methylimidazolidine-2,4-dione",226-402-8,5394-36-5,Acute Tox. 4,Notified C&L,38.0,H302:38
7770,Methyl methoxyacetate,228-539-9,6290-49-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,141.0,H319:5;H226:141;H315:5;H335:1
7773,Norcodeine,207-388-2,467-15-2,,Notified C&L,1.0,H302:1
7774,Tri-μ-carbonylnonacarbonyl-tetrahedro-tetrarhodium,243-171-9,19584-30-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38;H312:38
7777,Calcium thiobis[dodecylphenolate],248-159-7,26998-97-0,Not Classified,Notified C&L,1.0,Not classified:1
7782,Ferric phosphate dihydrate,603-839-6,13463-10-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7789,"Tetradecan- l-ol, ethoxylated",500-059-7,27306-79-2,Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,124.0,H412:83;H400:122;H410:83;H302:39;H318:41;H315:39
7790,"Peppermint, ext., reaction products with hydrogen sulfide",305-101-6,94334-25-5,Acute Tox. 4,Notified C&L,36.0,H302:36
7791,Methyl p-tolylacetate,245-885-6,23786-13-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
7793,"N-(1-amino-9,10-dihydro-2-methoxy-9,10-dioxoanthryl)-4-methylbenzenesulphonamide",275-411-3,71412-03-8,Not Classified,Notified C&L,2.0,Not classified:2
7797,tert-butylphenol,248-300-2,27178-34-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,76.0,H312:76;H314:76;H332:76;H411:76;H302:76
7798,Sodium 3-morpholin-4-ylpropane-1-sulfonate,428-420-3,,Not Classified,REACH registration C&L,11.0,Not classified:11
7801,1-(2-aminophenyl)ethan-1-one hydrochloride,246-930-2,25384-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7805,"Benzo-1,3-dioxole-5-acetic acid",220-679-9,2861-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
7807,"Propane-1,2,3-triyl trisheptanoate",210-647-2,620-67-7,Not Classified,REACH registration C&L,103.0,Not classified:64;H315:39;H411:38
7808,2-Amino-5-methoxy-4-phenylmethoxy-phenylmethylbenzoat,606-574-4,205259-41-2,Aquatic Chronic 4,Notified C&L,1.0,H413:1
7816,"1,2-dichloro-1,1,2-trifluoro-2-(trifluoromethoxy)ethane",219-094-1,2356-53-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H400:1;H410:1;H319:1;H315:1;H335:1
7818,Antimony triethoxide,233-914-5,10433-06-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,64.0,H302:64;H226:38;H332:64;H411:64
7821,"Quince, Cydonia oblonga, ext.",285-564-8,85117-13-1,Not Classified,Notified C&L,89.0,Not classified:88;H225:1
7822,"3-(hexylthio)-1H-1,2,4-triazole",277-967-2,74682-60-3,,Notified C&L,4.0,H319:4;H315:4;H335:4
7826,2-[(benzoyloxy)methyl]benzoic acid,261-185-3,58249-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
7829,Diantimony tetrapotassium heptaoxide,249-748-1,29638-69-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,24.0,H302:23;H332:23;H411:23;Not classified:1
7830,"Chromate(3-), bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-, ethanolamine sodium salts",284-044-8,84777-17-3,Aquatic Chronic 3,Notified C&L,86.0,H412:83;H319:2;Not classified:1
7831,"poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)",419-590-1,,Flam. Sol. 1;Skin Sens. 1,Harmonised C&L,0.0,H228:0;H317:0
7832,"Rosin, hydrogenated",266-041-3,65997-06-0,Not Classified,REACH registration C&L,597.0,Not classified:558;H319:36;H332:5;H317:5;H411:2;H316:1;H320:1;H228:1
7838,Propyl decanoate,250-283-1,30673-60-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:38;H315:38;H335:38;Not classified:2
7844,"Fatty acids, C12-18 and C12-18-unsatd., potassium salts",292-837-5,91001-65-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
7846,Praseodymium(3+) acetate,228-242-4,6192-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
7855,"Litsea cubeba, ext.",290-018-7,90063-59-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1507.0,H304:1460;H315:1482;H317:1479;H226:1317;H410:1317;H400:1315;H319:118;H411:144;Not classified:25;H318:2;H412:5
7857,"Disodium [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulphonato(3-)][2-[(2-hydroxybenzylidene)amino]-4-nitrophenolato(2-)-N2,O1,O2]chromate(2-)",280-676-3,83733-23-7,Aquatic Chronic 2,REACH registration C&L,34.0,H411:1;H412:33
7859,"Propylidynetrimethanol, ethoxylated, esters with acrylic acid, reaction products with diethylamine",500-425-6,159034-91-0,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,166.0,H319:165;H317:143;H412:48;H315:22;H335:22;Not classified:1
7861,"2-ethyl-2-[[(1-oxooleyl)oxy]methyl]-1,3-propanediyl dioleate",260-895-0,57675-44-2,Not Classified,Notified C&L,566.0,Not classified:565;H302:1
7862,Zinc yellow,609-398-6,37300-23-5,Acute Tox. 4;Skin Sens. 1;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95.0,H317:90;H410:90;H350:88;H302:90;H400:88;Not classified:5
7864,Methyl 2-methylacetoacetate,241-161-9,17094-21-2,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H227:1;H335:1;H315:1
7866,4-pentyloxyphenol,242-712-6,18979-53-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
7877,5-chloro-2-(5-chloro-7-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-7-methylbenzo[b]thiophene-3(2H)-one,226-750-0,5462-29-3,Not Classified,Notified C&L,9.0,Not classified:9
7878,Celery seed oil,616-966-7,8015-90-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,203.0,H304:129;H315:155;H317:130;H226:168;H410:130;H400:129;Not classified:10
7880,"4,4'-[(2-sulpho-1,4-phenylene)bis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulpho-3,1-phenylene)azo]]bis[4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic] acid",282-855-1,84434-55-9,Not Classified,Notified C&L,2.0,Not classified:2
7882,2-[[3-(dimethylamino)propyl]methylamino]ethanol,279-903-9,82136-26-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,22.0,H302:22;H314:22;H332:22;H312:22
7884,"Fats and Glyceridic oils, fish, Et esters",608-737-5,324020-60-2,Not Classified,Notified C&L,22.0,Not classified:22
7887,Dow Corning(R) Silicone Diffusion Pumpfluid,614-225-2,68037-71-8,Eye Irrit. 2,Notified C&L,62.0,H319:38;Not classified:22;H412:2
7888,2-carboxyphenyl o-acetylsalicylate,208-493-6,530-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53.0,H319:52;H315:52;H335:52;H302:1
7890,Diethyl (2-bromoethyl)phosphonate,226-193-3,5324-30-1,,Notified C&L,5.0,H319:5;H315:5;H335:4
7892,Cerium(3+) neodecanoate,268-440-8,68084-49-1,Aquatic Chronic 3,REACH registration C&L,3.0,H412:2;Not classified:1
7893,pyrithiobac-sodium,602-931-3,123343-16-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,52.0,H400:52;H410:52;H319:14;H413:14;H373:14;H351:14
7897,"1,4-Benzenedicarboxylic acid, 1,4-dimethyl ester, polymer with 1,2-ethanediol, α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) and 1,2-propanediol, ester with α-methyl-ω-hydroxypoly(oxy-1,2-ethanediyl)",604-850-9,152442-40-5,Not Classified,Notified C&L,39.0,Not classified:39
7898,DL-serine dihydrogen phosphate,241-834-7,17885-08-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:38;H315:38;H335:38;H314:1;H318:1
7903,C.I. Solvent Black 45,619-074-6,94765-62-5,Not Classified,Notified C&L,8.0,Not classified:8
7906,Fluoralkylalkoxylat,614-861-0,68958-61-2,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B;Lact.;STOT RE 1;Aquatic Chronic 2,Notified C&L,13.0,H332:13;H351:13;H362:13;H411:13;H372:13;H302:13;H360:13
7908,6-chloro-2-methylthiopyrimidin-4-ylamine,213-734-3,1005-38-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:41;H302:1
7913,"Maple, Acer spicatum, ext.",294-808-2,91770-23-9,Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,87.0,H302:77;H304:77;H411:77;H317:77;Not classified:10
7917,"Fatty alcohols, manuf. of, by-products from",925-037-8,,Asp. Tox. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1.0,H400:1;H319:1;H304:1
7919,"Chromate(1-), bis[2,4-dihydro-4-[2-[2-(hydroxy-κO)-5-nitrophenyl]diazenyl-κN1]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-κO3]-, sodium (1:1)",612-673-3,61901-90-4,Not Classified,Notified C&L,5.0,Not classified:5
7927,Benzyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate,606-573-9,205259-40-1,Acute Tox. 4,Notified C&L,1.0,H302:1
7929,Methoxyacetyl chloride,254-169-2,38870-89-2,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,54.0,H314:54;H226:54;H335:48;H331:12;H318:1;H290:1
7933,Dichlorotriphenylphosphorane,607-677-7,2526-64-9,Flam. Sol. 2;Skin Corr. 1B,Notified C&L,43.0,H228:38;H314:43;H335:1
7934,L-(+)-β-mercaptovaline,214-203-9,1113-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46;H302:4
7936,4-amino-2-(aminomethyl)phenol dihydrochloride,412-510-4,135043-64-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H400:0;H410:0;H317:0
7940,"(-)-3R,4R-1-Benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-piperide-L-dibenzoyl tartrate",606-460-4,201855-65-4,Flam. Sol. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2.0,H317:2;H373:2;H411:2;H228:2;H401:2
7941,Calcium bis(mercaptoacetate),212-402-5,814-71-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H302:41;H319:39;H315:39;H335:38
7946,Pentadec-1-yne,212-140-1,765-13-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:1;H315:1;H335:1;H304:1
7948,"1,2,3-Propanetriol, glycidyl ethers",292-011-4,90529-77-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,82.0,H319:80;H315:79;H317:74;H335:2;H302:3
7951,p-xylene-2-sulphonic acid,210-193-5,609-54-1,,Notified C&L,6.0,H319:6;H315:6;H335:4
7953,Decylphosphonic acid,229-975-2,6874-60-8,Skin Corr. 1B,Notified C&L,43.0,H314:43;H290:1;H318:1
7954,"Benzenepropanoic acid, 3-[2-(4-chloro-2-nitrophenyl)diazenyl]-5-(1,1-dimethylethyl)-4-hydroxy-",617-464-0,83487-94-9,Not Classified,Notified C&L,83.0,Not classified:83
7956,"O,O-diisodecyl hydrogen dithiophosphate",249-111-8,28631-44-9,Not Classified,REACH registration C&L,2.0,Not classified:2
7957,"2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:4)",601-056-4,111211-40-6,Not Classified,Notified C&L,1.0,Not classified:1
7960,2-chloro-2-butenal,258-412-3,53175-28-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,1.0,H318:1;H315:1;H226:1;H330:1;H335:1;H301:1;H400:1;H311:1
7964,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium methyl sulphate",277-232-6,73019-09-7,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4.0,H400:1;H301:1;H318:1;H410:1;H302:2;H319:2;Not classified:1
7965,"1-O-tert-butyl 2-O-methyl (2S)-5-oxopyrrolidine-1,2-dicarboxylate",600-890-6,108963-96-8,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,41.0,H319:41;H317:41
7969,Cycloheptatriene,208-866-3,544-25-2,Flam. Liq. 2;Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H304:43;H315:45;H225:45;H335:44;H301:45;H311:45;Not classified:2
7973,Propyphenazone,207-539-2,479-92-5,Acute Tox. 4,Notified C&L,127.0,H302:127
7974,(S)-1-[3-(acetylthio)-2-methyl-1-oxopropyl]-L-proline,265-250-7,64838-55-7,Skin Sens. 1;Repr. 2;STOT RE 1,REACH registration C&L,46.0,H372:7;H360:6;H361:8;H317:8;H319:38
7975,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-ol",222-197-4,3385-61-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,113.0,H412:113;H319:113;H315:113
7976,"Cumin, ext.",283-881-6,84775-51-9,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1453.0,H304:1452;H317:1453;H226:1452;H411:1451;H302:1287;H315:5;H412:2;H319:1
7978,"2-HYDROXY-1,4-DIMETHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBONITRILE",609-728-9,39621-10-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
7980,dinickel orthosilicate,237-411-1,13775-54-7,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H317:0;H410:0;H350:0;H372:0;H400:0
7981,"reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate",436-890-6,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H318:0
7982,"4,4'-[vinylenebis[(3-sulpho-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]bis[5-hydroxy-6-[(1-sulpho-2-naphthyl)azo]naphthalene-2,7-disulphonic] acid",301-568-5,94022-69-2,Not Classified,REACH registration C&L,2.0,Not classified:2
7989,"Benzene, mono-C10-12-alkyl derivs., fractionation bottoms, light ends",271-076-2,68515-35-5,Not Classified,Notified C&L,3.0,Not classified:3
7994,Ethylene sulphite,223-131-7,3741-38-6,Acute Tox. 3;Eye Irrit. 2,Notified C&L,6.0,H301:3;H319:3;H302:2;H332:2;H312:2;H341:2;Not classified:1
7995,"5,6-dihydro-4-methyl-2-phenyl-2H-pyran",262-186-1,60335-70-8,Aquatic Chronic 3,Notified C&L,1.0,H412:1
7996,5-endo-hexyl-bicyclo[2.2.1]hept-2-ene,435-000-3,22094-83-3,Skin Irrit. 2;Asp. Tox. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H413:0;H304:0;H315:0
7999,Glutaminase,618-332-5,9001-47-2,Resp. Sens. 1,Notified C&L,17.0,H334:17
8002,isofenphos (ISO);O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate,246-814-1,25311-71-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H400:0;H410:0;H311:0
8006,2-chloropyridin-4-ol,241-399-3,17368-12-6,,Notified C&L,6.0,H319:6;H315:6;H335:5
8007,"C9-11-Alkyl D-Glycopyranoside, Decyl/undecyl glucosides",603-654-0,132778-08-6,Eye Dam. 1,Notified C&L,416.0,H318:336;H315:118;H319:55;Not classified:25
8010,Not known,606-593-8,20651-57-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
8012,3-(benzyloxy)propiononitrile,228-698-4,6328-48-9,Not Classified,Notified C&L,1.0,Not classified:1
8018,4-(aminomethyl)-N-methoxy-benzenecarboximidamide hydrochloride (1:2),619-760-5,908259-43-8,Eye Dam. 1,Notified C&L,3.0,H318:3
8022,"5-amino-2,4-dihydro-3H-pyrazol-3-one",228-095-6,6126-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
8025,"3,3'-oxydipropanol",219-251-4,2396-61-4,Not Classified,REACH registration C&L,4.0,Not classified:2;H319:2;H315:2;H335:2
8026,"6-amino-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",257-334-7,51649-83-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
8027,"2,2'-(1,4-cyclohexanediylidene)bismalononitrile",216-173-2,1518-15-6,Skin Sens. 1,Notified C&L,38.0,H317:38
8029,"3,3-dimethylbicyclo[2.2.1]heptane-2-carboxylic acid",258-006-6,52557-98-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
8033,Tetraaluminium tris(pyrophosphate),238-745-0,14696-66-3,Skin Corr. 1B,Notified C&L,1.0,H314:1
8034,3-methylpent-1-en-4-yn-3-ol,221-770-6,3230-69-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,44.0,H312:2;H314:2;H225:1;H226:44;H332:2;H302:44;H319:2;H315:2;H335:1;H318:1
8035,2-isopropyl-4-methylanisole,250-712-2,31574-44-4,Not Classified,Notified C&L,89.0,Not classified:88;H302:1;H331:1;H304:1;H311:1
8041,"5-acetyl-1,3-phenylene diacetate",252-354-2,35086-59-0,Aquatic Chronic 3,REACH registration C&L,9.0,H412:6;H319:2;H315:2;H335:2;Not classified:1
8042,3-chlorosalicylic acid,217-379-5,1829-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
8046,Tin vanadium yellow cassiterite,269-055-8,68186-93-6,Not Classified,Notified C&L,8.0,Not classified:8
8048,"4,6-Diaminoresorcinol Dihydrochloride",605-395-9,16523-31-2,Skin Irrit. 2;Eye Irrit. 2;Muta. 2,Notified C&L,2.0,H319:2;H315:2;H341:1;H335:1
8051,"Rosemary, ext.",283-291-9,84604-14-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 2;Aquatic Chronic 2,REACH registration C&L,1793.0,H319:129;H304:1738;H315:133;H317:1740;H226:1743;H371:371;H411:1451;H373:1342;H332:240;Not classified:48;H410:105;H400:88;H341:5;H331:1;H335:1;H312:2;H372:1;H302:2;H412:1;H318:1;H330:1
8053,"Methyl 2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-1,3,3-trimethylindoline-5-carboxylate",227-217-5,5718-26-3,Aquatic Chronic 2,REACH registration C&L,114.0,H411:91;Not classified:23
8054,Dititanium trioxide,215-697-9,1344-54-3,Not Classified,Notified C&L,6.0,Not classified:5;H413:1
8057,"Formaldehyde, polymer with phenol and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane",609-407-3,37337-65-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,71.0,H302:71;H318:71;H317:71
8060,Gilsonite,601-660-8,12002-43-6,Not Classified,Notified C&L,108.0,Not classified:107;H319:1;H335:1
8061,"2-Propanone, reaction products with diphenylamine",270-192-0,68412-48-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,78.0,H312:6;H317:12;H332:6;H373:6;H411:24;H302:24;H413:6;Not classified:35;H400:13;H410:13
8062,4-sulphophthalic acid,201-881-6,89-08-7,Not Classified,Notified C&L,2179.0,Not classified:2122;H314:56;H319:1;H315:1;H335:1
8065,"Carboxymethyldimethyl-3-[[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)sulphonyl]amino]propylammonium hydroxide",252-046-8,34455-29-3,Aquatic Chronic 2,REACH registration C&L,53.0,H411:4;Not classified:48;H319:1;H226:1
8066,"(2E,4E,6R)-7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide",611-758-2,58880-19-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,315.0,H312:314;H319:314;H315:313;H317:312;H332:313;H335:312;H302:314;H361:1
8067,Butyl O-butyryllactate,231-326-3,7492-70-8,Not Classified,REACH registration C&L,1615.0,Not classified:1573;H319:42;H315:42;H335:40;H226:1
8071,"2-acetoxypropane-1,3-diyl bis(1,3-dihydro-1,3-dioxoisobenzofuran-5-carboxylate)",217-063-7,1732-97-4,Not Classified,Notified C&L,56.0,Not classified:55;H318:1;H317:1;H413:1;H335:1;H334:1
8073,6-nitroindan-1-one,246-366-7,24623-24-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
8075,Diyttrium trisulphate,236-844-3,13510-71-9,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H315:1;H335:1
8079,Docosane,211-121-5,629-97-0,Not Classified,REACH registration C&L,134.0,Not classified:93;H319:40;H315:40;H335:40;H304:1
8082,Cyclohexenecarbonitrile,217-454-2,1855-63-6,Acute Tox. 4,Notified C&L,44.0,H302:43;H332:5;H312:5;H319:1;H315:1;H331:1;H301:1;H311:1
8085,"Disodium 6-[[2,4-dihydroxy-3-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2-sulphonate",229-363-5,6487-05-4,,Notified C&L,49.0,Not classified:49
8090,Haloxon,206-289-1,321-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H332:38;H335:38;H302:38
8095,"(±)-2-benzamido-3-[p-[2-(diethylamino)ethoxy]phenyl]-N,N-dipropylpropionamide hydrochloride",260-634-0,57227-16-4,Acute Tox. 4,Notified C&L,1.0,H302:1
8098,"N-(3-ethoxy-3-oxopropyl)-N-(2-methylpropyl)-β-alanine, ethyl ester",618-168-4,88488-91-9,Aquatic Chronic 2,REACH registration C&L,1.0,H411:1
8099,Dihexyl adipate,203-757-7,110-33-8,Not Classified,REACH registration C&L,17.0,Not classified:17
8100,"oleylalcohol ethoxylated, phosphated, sodium salt",607-556-9,251298-11-0,Not Classified,Notified C&L,68.0,Not classified:43;H319:22;H315:25
8103,calcium cyanide,209-740-0,592-01-8,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H300:0;H410:0
8110,Dipotassium tetraborate,215-575-5,1332-77-0,Repr. 2,REACH registration C&L,82.0,H361:56;H412:14;H360:20;Not classified:8;H319:1
8111,Cyclohexyl propionate,228-303-5,6222-35-1,Not Classified,Notified C&L,89.0,Not classified:89
8112,Rhenium pentachloride,237-042-6,13596-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
8113,Cloprothiazole,229-286-7,6469-36-9,Acute Tox. 4,Notified C&L,1.0,H302:1
8116,Dithulium trisulphate,243-996-4,20731-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:1;H315:1;H335:1;Not classified:1
8117,2-methylheptan-2-ol,210-882-0,625-25-2,Eye Dam. 1,Notified C&L,39.0,H318:38;H226:1
8119,"Lipase, lipoprotein",232-669-1,9004-02-8,,Notified C&L,39.0,H334:39
8121,"Tarragon, ext.",290-356-5,90131-45-6,Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1672.0,H304:1671;H341:1667;H317:1671;H351:1667;H411:1485;H302:1608;H371:63;H332:1;H412:2;H312:1;H315:2;H401:1
8125,"Benzenaminium, 3-amino-N,N,N-trimethyl-chloride",610-694-2,51570-74-2,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H319:1;H317:1;H410:1;H331:1;H350:1;H301:1;H400:1
8126,"2,3-dichlorophenoxyacetic acid",221-022-9,2976-74-1,Not Classified,REACH registration C&L,10.0,Not classified:2;H319:5;H315:5;H335:5;H302:3;H332:3;H312:3
8127,Trimethoxyoctylsilane,221-338-7,3069-40-7,Skin Irrit. 2,REACH registration C&L,104.0,H315:86;H331:52;H332:27;Not classified:19;H319:6;H335:5
8128,Tetrahydro-2-methyl-4-methylene-6-phenyl-2H-pyran,250-124-6,30310-41-9,Not Classified,Notified C&L,91.0,Not classified:78;H412:13;H319:13
8130,"5-methoxy-4-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one",619-590-1,135302-13-5,Skin Sens. 1,REACH registration C&L,1.0,H317:1
8132,"Tetrahydro-2,5-dimethoxyfuran",211-797-1,696-59-3,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 3,REACH registration C&L,80.0,H226:80;H315:50;H331:4;H302:2;H318:1;H319:77;H335:46;H312:1;H332:2
8133,"Magnesium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]methanesulphonate",228-161-4,6150-97-6,Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H373:1;H361:1
8137,Potassium butyl 4-oxidobenzoate,254-009-1,38566-94-8,Not Classified,Notified C&L,3.0,Not classified:3
8142,2-isopropyl-5-methylanisole,214-063-9,1076-56-8,Not Classified,Notified C&L,185.0,Not classified:133;H319:49;H226:52;H315:49;H335:49
8143,"N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate",422-050-6,118612-00-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Carc. 2,Harmonised C&L,0.0,H302:0;H318:0;H315:0;H351:0
8145,"[2,3,4,5,6-2H5]aniline",224-015-9,4165-61-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H341:38;H410:38;H351:38;H331:39;H301:39;H400:38;H311:39
8151,6-hydroxyhexyl acrylate,233-227-0,10095-14-4,Flam. Liq. 4;Skin Sens. 1,Notified C&L,1.0,H227:1;H317:1
8153,isopropylammonium 2-(3-benzoylphenyl)propionate,417-970-1,,Acute Tox. 3;Acute Tox. 4;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H312:0;H318:0;H410:0;H372:0;H301:0;H400:0
8156,5-Bromo-2-chlorophenol,606-003-9,183802-98-4,,Notified C&L,7.0,H312:5;H319:7;H315:7;H335:5;H302:5;H332:1
8158,"1,2-PROPANEDIOL, 1,3-BUTANEDIOL, TRIPROPYLENE GLYCOL, DIPHENYLMETHANEDIISOCYANATE, POLYMER",642-446-4,150449-03-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,463.0,H319:463;H315:463;H317:463;H332:463;H335:454;H334:463;H351:13;H373:13;H371:9
8161,Cysteine hydrochloride,200-157-7,52-89-1,Not Classified,REACH registration C&L,1553.0,Not classified:28;H319:1500;H315:133;H335:133;H302:28;H412:1;H314:1;H318:1
8165,"Tris(pentane-2,4-dionato-O,O')ytterbium",238-198-8,14284-98-1,Acute Tox. 4,Notified C&L,59.0,H302:58;H319:1;H315:1;H335:1
8167,"3-(allyloxy)propane-1,2-diol",204-620-4,123-34-2,Eye Irrit. 2,REACH registration C&L,98.0,H319:98;H315:1;H335:1
8170,"Resin acids and Rosin acids, hydrogenated, esters with glycerol",266-042-9,65997-13-9,Not Classified,REACH registration C&L,255.0,Not classified:253;H413:2
8174,"4,4'-methylenebis[N-sec-butylaniline]",226-122-6,5285-60-9,Acute Tox. 4;Skin Sens. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,142.0,H317:21;H410:35;H373:21;H302:136;H400:35;H341:9;Not classified:6;H319:1;H315:1;H335:1
8175,Acridin-9-ylamine hydrochloride monohydrate,205-145-5,134-50-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H302:1;H319:1;H315:1;H301:1;H331:1;H311:1;H341:1
8176,"Barium bromide (BaBr2), dihydrate",616-577-2,7791-28-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,42.0,H302:42;H332:42
8180,(2-hydroxyethyl)dimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium nitrate,220-432-5,2764-13-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,140.0,H319:140;H315:139;H410:34;H412:22;H400:1
8182,Trimethylsilyl (diethoxyphosphinoyl)acetate,266-171-0,66130-90-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38;H225:38
8185,C.I. REACTIVE BLUE 227,411-350-2,,Not Classified,Notified C&L,2.0,Not classified:2
8186,"2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-, (4S,4aS,5aR,12aS)-, sulfate (1:2)",604-916-7,153621-80-8,Acute Tox. 4,Notified C&L,1.0,H302:1
8189,"4-[(3-aminobenzoyl)amino]-5-hydroxynaphthalene-1,7-disulphonic acid",274-493-8,70239-77-9,Not Classified,REACH registration C&L,2.0,Not classified:2
8192,"Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;Refinery gas;[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",273-174-0,68952-80-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
8193,"2-amino-3,5-dichlorobenzoic acid",220-520-3,2789-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
8196,"7-(4,6-dimethoxy-pyrimidin-2-ylsulfanyl)-3-methyl-3H-isobenzofuran-1-one",603-904-9,135186-78-6,STOT RE 2;Aquatic Chronic 2,Notified C&L,156.0,H373:156;H411:156
8198,"Hierochloe alpina, ext.",295-758-4,92128-62-6,Skin Sens. 1,Notified C&L,77.0,H317:77
8199,1-methylchrysene,222-112-0,3351-28-8,STOT SE 2,Notified C&L,12.0,H371:12
8200,"3,4-dihydro-2-methoxy-2-methyl-4-phenylpyrano[3,2-c]chromen-5-one",208-248-3,518-20-7,Acute Tox. 2,Notified C&L,38.0,H310:38
8202,"Ascophyllum nodosum, ext.",283-907-6,84775-78-0,Not Classified,REACH registration C&L,147.0,Not classified:147
8203,"α,α,α-trifluoro-4-iodotoluene",207-234-4,455-13-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H319:49;H315:49;H335:48
8204,ethyl trans-3-dimethylaminoacrylate,402-650-4,1117-37-9,Skin Sens. 1,Harmonised C&L,0.0,H317:0
8205,"Amines, C14-18 and C16-18-unsatd. alkyl",268-958-4,68155-38-4,Not Classified,Notified C&L,58.0,Not classified:55;H314:3;H400:3;H335:3
8212,3-bromo-o-toluidine,259-568-5,55289-36-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:41;H301:5;H311:5;H302:4;H312:4;H332:3
8218,2-(2-butoxyethoxy)ethyl methacrylate,230-813-8,7328-22-5,Not Classified,REACH registration C&L,38.0,Not classified:36;H319:2;H315:2;H335:2
8221,"5-amino-3-methylthiophene-2,4-dicarbonitrile",610-868-8,52603-48-2,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1
8223,(2R)-Oxiran-2-ylmethyl butanoate,611-977-3,60456-26-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45;H334:40;H302:45;H312:6;H332:2;H317:1
8225,3-phosphonopropionic acid,227-738-8,5962-42-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,79.0,H314:46;H318:39;Not classified:33;H290:2
8226,"1,2-dibromo-1,1,2,3,3,3-hexafluoropropane",211-550-8,661-95-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,126.0,H312:83;H319:126;H315:126;H332:35;H335:126;H302:82;H330:85;H331:1
8227,"Alpha-chloro-alpha,2-toluenesultone",247-122-2,25595-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8229,4-methoxyazobenzene,219-250-9,2396-60-3,,Notified C&L,4.0,H319:4;H315:4;H335:4
8230,"Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, chlorides, compds. with bentonite",268-875-3,68153-30-0,Not Classified,Notified C&L,90.0,Not classified:90
8238,"Rose, Rosa gallica, ext.",283-290-3,84604-13-7,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,5.0,H412:5;H318:4;H315:4;H317:5;H319:1;H341:1;H351:1;H411:1
8240,"Pentasodium 5-[[[7-[[5-[(3-carboxylato-4-hydroxyphenyl)azo]-2-sulphonatophenyl]azo]-8-hydroxy-3,6-disulphonato-1-naphthyl]amino]sulphonyl]salicylate",276-410-0,72152-56-8,Not Classified,Notified C&L,2039.0,Not classified:2039
8247,"Sandalwood, ext.",284-111-1,84787-70-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,1522.0,H400:2;H319:13;H315:13;H317:21;Not classified:1501;H335:11;H411:11;H302:1
8248,N-methyltaurine,203-510-3,107-68-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,199.0,H318:161;H315:147;H319:55;H314:52;H335:1
8250,"2,4,6-tri-sec-butylphenol",227-572-6,5892-47-7,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,40.0,H315:40;H411:39;H400:1;H410:1
8254,"2,2',3,3'-tetrahydro-3,3,3',3'-tetramethyl-1,1'-spirobi[1H-indene]-5,5',6,6'-tetrol",201-003-1,77-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
8259,Ammonium hexafluorozirconate,240-970-4,16919-31-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,69.0,H318:15;H315:54;H317:2;H412:2;H372:2;H301:17;H319:52;H335:50;H314:15;H331:15;H311:15
8260,reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N,435-880-9,,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
8261,potassium-pentacalcium-nitrate decahydrate,480-110-7,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1.0,H302:1;H318:1
8263,"2-ethylcyclopentane-1,3-dione",212-512-3,823-36-9,Eye Irrit. 2B;Aquatic Acute 3,REACH registration C&L,1.0,H402:1;H320:1
8264,methyl 3-oxo-3-(thiophen-2-yl)propanoate,603-835-4,134568-16-4,Not Classified,REACH registration C&L,35.0,Not classified:1;H411:33;H317:33;H319:1;H315:1;H335:1
8265,"3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]",226-999-5,5590-18-1,Not Classified,REACH registration C&L,391.0,Not classified:391
8269,"1,4-dihydro-6-methylquinoxaline-2,3-dione",228-628-2,6309-61-1,,Notified C&L,33.0,Not classified:33
8271,"Trisodium [μ-[4-[[4'-[[6-benzamido-1-hydroxy-3-sulpho-2-naphthyl]azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-3-hydroxynaphthalene-2,7-disulphonato(7-)]]dicuprate(3-)",289-532-4,89899-27-4,Not Classified,Notified C&L,37.0,Not classified:37
8272,"7-β-CD-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine",200-703-4,69-33-0,Acute Tox. 2,Notified C&L,195.0,H300:195
8275,Bursera Graveolens Wood Oil,619-180-2,959130-05-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4.0,H304:3;H315:4;H317:3;H226:4;H410:3;H400:3;H319:1
8277,4-(4-trans-propylcylohexyl)phenol,440-740-5,,Aquatic Chronic 4,REACH registration C&L,2.0,H413:2
8279,"pyrimethanil (ISO);N-(4,6-dimethylpyrimidin-2-yl)aniline",610-963-4,53112-28-0,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
8283,"1,3-Benzenedisulfonic acid, 4-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-6-[[4-[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-, trisodium salt",268-516-0,68110-27-0,Skin Sens. 1B,REACH registration C&L,8.0,H317:4;Not classified:4
8284,"α,α,α,4-tetrafluoro-m-toluidine",219-095-7,2357-47-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H312:41;H319:46;H315:46;H332:45;H335:40;H302:46;H311:4;H411:1
8288,2-Methyl-3-methoxy benzoyl chloride,427-440-1,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1.0,H412:1;H314:1;H318:1;H317:1
8289,1-methylpyridinio-3-carboxylate,208-620-5,535-83-1,Eye Irrit. 2,Notified C&L,3.0,H319:2;H315:1;Not classified:1
8296,6-bromohexanoyl chloride,245-236-7,22809-37-6,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,44.0,H314:44;H318:39;H335:38;H290:1
8303,"N-benzyl-3,4,5,6-tetrahydro-2H-azepin-7-amine",230-328-1,7048-72-8,,Notified C&L,33.0,Not classified:33
8307,"Lubricating oils (petroleum), base oils, paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 °F (23cSt at 40 °C).]",297-474-6,93572-43-1,Carc. 1B,Harmonised C&L,0.0,H350:0
8308,(tert-butyl)quinoline,262-927-9,61702-91-8,Not Classified,Notified C&L,88.0,Not classified:88
8313,Allyltriphenylphosphonium bromide,216-332-6,1560-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43;H312:1;H302:1
8316,"Benzoic acid, compound with morpholine (1:1)",247-413-4,26021-56-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,70.0,H319:42;H315:42;Not classified:28
8317,Trimethylphenol,248-158-1,26998-80-1,Not Classified,Notified C&L,96.0,Not classified:83;H312:13;H318:13;H315:13;H411:13;H302:13
8325,"1,3-bis[3-(dimethylamino)propyl]urea",257-861-2,52338-87-1,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,242.0,H412:10;H318:103;H317:24;Not classified:84;H319:54;H315:54;H314:2
8326,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-methyl-2-propenoate, 2-hydroxyethyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate",609-098-5,35227-05-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,26.0,H319:26;H315:26;H335:26;H317:26
8327,1-Benzyl-1-(dimethylamino)propyl 4-morpholinophenyl ketone,601-598-1,119313-12-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,304.0,H400:303;H410:304;H361:1;Not classified:1
8329,"3-bromo-1,2,4,5-tetramethylbenzene",216-707-4,1646-53-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8330,(±)-(hydroxymethyl)phenylacetic acid,209-020-6,552-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:1
8332,2-chlorobenzoyl chloride,210-194-0,609-65-4,Skin Corr. 1B,REACH registration C&L,52.0,H314:52;H290:1;H318:1
8335,4-(2-chloroacetamido)phenylarsonic acid,226-569-7,5425-62-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H301:38;H400:38;H410:38;H331:38
8339,"Octan-1-ol, ethoxylated",500-058-1,27252-75-1,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,245.0,H314:4;H318:201;H319:44;H315:40;Not classified:37;H302:6;H335:1
8342,"4,5-dimethyloxazol-2-amine",256-241-9,45529-92-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,90.0,H318:90;H315:90;H335:90
8347,"2,2,2-Trifluoroethyl Trifluoromethanesulfonate",458-390-7,6226-25-1,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,4.0,H301:3;H330:3;H314:4;H318:1;H341:1;H226:1;H332:1
8348,"2,6-bis(m-nitrobenzylidene)cyclohexan-1-one",242-711-0,18977-36-1,Skin Sens. 1,Notified C&L,38.0,H317:38
8349,Nonafluoro(trifluoromethyl)cyclopentane,217-298-5,1805-22-7,Acute Tox. 4,Notified C&L,39.0,H302:38;Not classified:1
8352,2-isocyanatoethyl methacrylate,250-284-7,30674-80-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1,REACH registration C&L,50.0,H318:5;H315:44;H317:48;H330:49;H334:49;H302:50;H319:39;H335:41;H314:5;H311:5;H312:4;H331:1
8356,"Tris(1,10-phenanthroline-N1,N10)iron diperchlorate",238-627-9,14586-54-0,,Notified C&L,4.0,H319:4;H272:4;H315:4;H335:4
8360,(vinyloxy)cyclohexane,218-561-7,2182-55-0,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;STOT SE 3;STOT SE 3,REACH registration C&L,139.0,H336:99;H315:139;H317:100;H226:139;H335:16;H319:1;H412:1
8364,"Dibenzo[b,f][1,4]thiazepine, 11-[4-[2-[2-(triphenylmethoxy)ethoxy]ethyl]-1-piperazinyl]-",617-570-7,844639-06-1,Not Classified,Notified C&L,1.0,Not classified:1
8368,(E)-1-methoxyprop-1-ene,615-927-1,7319-16-6,Flam. Liq. 2;Aquatic Chronic 3,REACH registration C&L,2.0,H412:1;H225:1;H319:1;H226:1;H315:1;H335:1
8377,dichloroacetyl chloride,201-199-9,79-36-7,Skin Corr. 1A;Aquatic Acute 1,Harmonised C&L,0.0,H314:0;H400:0
8380,Rhenium dioxide,234-839-0,12036-09-8,Not Classified,Notified C&L,86.0,Not classified:86
8386,Methyl propyl tetrasulphide,289-302-3,87148-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8393,(E)-pent-2-en-1-oic acid,237-791-9,13991-37-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,44.0,H302:39;H314:44;H290:1;H318:1
8395,2-[(benzoyloxy)methyl]benzoyl chloride,261-186-9,58249-87-9,Skin Corr. 1B,Notified C&L,38.0,H314:38
8398,"ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate",401-290-5,103112-35-2,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H350:0;H400:0;H410:0
8402,3-isopropyl-6-methylsalicylic acid,208-949-4,548-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8406,Methyl 4-methoxyphenylacetate,245-886-1,23786-14-3,Flam. Liq. 3,Notified C&L,40.0,H226:40;H319:1;H315:1;H335:1
8408,"Ethyl 2,4-dichlorophenoxyacetate",208-558-9,533-23-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41.0,H318:41;H317:38;H410:38;H302:41;H400:38
8409,(E)-4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-fluoro-phenyl-amino)-7-((S)-(tetrahydrofuran-3-yl)oxy)-quinazoline-6-yl]-amide,923-981-5,,Acute Tox. 4;Eye Irrit. 2;Repr. 2;Lact.;STOT RE 1;Aquatic Chronic 1,Notified C&L,1.0,H319:1;H361:1;H410:1;H362:1;H372:1;H301:1
8410,"Maple, Acer saccharum, ext.",294-807-7,91770-22-8,Not Classified,Notified C&L,56.0,Not classified:56
8411,"IDS, Na-Salz",429-200-1,,Not Classified,REACH registration C&L,55.0,Not classified:55
8416,N-[4-[(dimethylamino)sulphonyl]phenyl]acetamide,259-408-4,54951-54-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
8417,"Sodium 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylsulphonyl)amino]phenyl]azo]-1H-pyrazol-1-yl]benzenesulphonate",282-854-6,84434-54-8,Not Classified,Notified C&L,8.0,Not classified:8
8421,4-nitrosalicylaldehyde,219-549-4,2460-58-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
8430,"reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C",413-710-4,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
8432,Sodium ethanesulphonate,226-194-9,5324-47-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
8433,p-benzoquinone dioxime,203-271-5,105-11-3,Expl. 1.1;Flam. Sol. 2;Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 2,REACH registration C&L,157.0,H319:61;H317:71;H201:6;H341:73;H351:78;H411:72;H302:137;H228:74;H301:20;H315:36;H312:14;H332:15;H335:29;H242:14;H318:1
8438,"2,4-Dimethyl-3-nitropyridine",600-827-2,1074-76-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H332:1;H335:1;H302:1
8444,"Trisodium hydrogen [2-[[α-[[3-[[4-chloro-6-[ethyl[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulphophenyl]azo]benzyl]azo]-4-sulphobenzoato(6-)]cuprate(4-)",289-142-4,86024-59-1,Not Classified,REACH registration C&L,47.0,Not classified:36;H412:8;H334:3;H319:4
8449,"Dichloro(1,1-dimethylethyl)phenylsilane",241-835-2,17887-41-1,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H290:1;H314:1;H318:1
8451,"Lithium [2R-(2α,3(Z),5α)]-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylate",262-639-3,61177-44-4,Aquatic Chronic 3,Notified C&L,1.0,H412:1
8461,Diammonium adipate,222-196-9,3385-41-9,Not Classified,Notified C&L,10.0,Not classified:10
8464,Bis(4-nitrophenyl) disulphide,202-840-5,100-32-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38.0,H302:38;H332:38;H312:38;H351:38
8465,C.I. Solvent Orange 41,612-674-9,61901-91-5,Not Classified,Notified C&L,69.0,Not classified:69
8467,[2H7]aniline,238-580-4,14545-23-4,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1,Notified C&L,38.0,H318:38;H317:38;H341:38;H331:38;H351:38;H372:38;H301:38;H400:38;H311:38
8470,Chromium tris((2-ethylhexanoate),222-357-3,3444-17-5,Aquatic Chronic 3,REACH registration C&L,14.0,H412:3;H319:8;H315:8;H361:6;H302:5;H312:2;H317:3
8471,2-amino-5-chlorobenzophenone,211-949-7,719-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,65.0,H319:61;H315:61;H335:60;H301:2;H300:2;H401:2;H317:2;H400:1;H410:1;H302:1
8475,Diammonium oxalate,214-202-3,1113-38-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,122.0,H302:120;H319:16;H312:120;Not classified:2
8480,"N,N-bis(carboxymethyl)glycine, compound with 2-aminoethanol (1:3)",302-766-4,94134-01-7,Acute Tox. 4;Eye Irrit. 2;Carc. 2,REACH registration C&L,3.0,H302:2;H319:3;H351:1;H315:1
8482,"1,2-Benzenedicarboxylic acid, di-C11-14-branched alkyl esters, C13-rich",271-089-3,68515-47-9,Not Classified,REACH registration C&L,111.0,Not classified:110;H411:1
8487,Cinnamomum verum bark extract ceylon,616-967-2,8015-91-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,100.0,H319:86;H315:81;H335:38;H317:71;H312:17;H341:8;H226:4;H350:14;H412:10;H304:4;H411:4;H311:6
8493,"1-cyano-3,3-dimethylguanidine",605-235-8,1609-06-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H312:2;H319:2;H315:2;H332:2;H335:2;H302:2
8494,Zinc di(benzothiazol-2-yl) disulphide,205-840-3,155-04-4,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,452.0,H400:85;H410:112;H317:418;H411:28;Not classified:24;H302:1;H319:3;H413:1;H301:1;H315:2;H335:1
8495,Bicyclo[3.2.1]octan-2-one,225-704-7,5019-82-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
8496,Diethyl[2-(2-phenylbutyroyloxy)ethyl]ammonium dihydrogen citrate,237-671-6,13900-12-4,,Notified C&L,2.0,H302:2
8499,"Tetrakis(hydroxymethyl)phosphonium chloride, oligomeric reaction products with urea",500-057-6,27104-30-9,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,12.0,H314:11;H318:11;H361:11;H317:11;H410:10;H373:10;H350:7;H302:12;H313:1;H412:2;H290:1;H319:1;H312:1;H341:1
8502,"Benzene, 1-ethoxy-2,3-difluoro-4-(trans-4-pentylcyclohexyl)-",606-628-7,207598-90-1,Not Classified,Notified C&L,1.0,Not classified:1
8503,"Fatty acids, rape-oil, monoesters with propylene glycol",297-165-6,93348-24-4,Not Classified,Notified C&L,1.0,Not classified:1
8505,"Acid chlorides, coco, reaction products with protein hydrolyzates sodium salts",614-365-4,68188-38-5,Eye Irrit. 2,Notified C&L,1.0,H319:1
8506,1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium chloride,253-300-0,36986-04-6,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,6.0,H412:5;H318:5;Not classified:1
8514,"Copolymer of hexahydro-2H-azepin-2-one and 1,6- diisocyanatehexane",607-997-7,26776-30-7,STOT RE 1,REACH registration C&L,21.0,H372:5;Not classified:16
8515,"Coriander, ext.",283-880-0,84775-50-8,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1713.0,H319:1627;H304:1640;H315:1699;H317:1699;H411:1514;H226:35;Not classified:10;H412:2;H225:1;H227:1;H303:1
8517,"2-naphthalenol, sulfurized, leuco deriv.",215-458-9,1327-11-3,Not Classified,Notified C&L,37.0,Not classified:37
8519,Palmidrol,208-867-9,544-31-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,7.0,H318:4;H315:4;H411:4;Not classified:3
8520,N-[2-[(2-hydroxyethyl)amino]ethyl]stearamide monoacetate,260-759-0,57478-07-6,Not Classified,Notified C&L,49.0,Not classified:48;H360:1
8522,CLOVE TERPENES,614-795-2,68917-29-3,Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,58.0,H312:56;H304:57;H315:56;H317:56;H302:56;Not classified:1
8524,1-(thiazol-2-yl)piperazine,255-743-5,42270-37-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
8527,Phenmetrazine hydrochloride,216-950-6,1707-14-8,Acute Tox. 3,Notified C&L,1.0,H301:1
8528,trisodium hexafluoroaluminate,237-410-6,13775-53-6,Acute Tox. 4;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H332:0;H372:0
8530,Mercury(II) sulfide,215-696-3,1344-48-5,Skin Sens. 1,Notified C&L,43.0,H317:38;H300:4;H330:4;H410:4;H310:4;H373:4;H400:4;Not classified:1
8538,Triethyl orthoacetate,201-112-4,78-39-7,Flam. Liq. 3,REACH registration C&L,92.0,H226:92;H319:82;H315:76;H335:10;Not classified:1
8541,Lanthanum titanium trioxide,235-376-7,12201-04-6,Not Classified,Notified C&L,1.0,Not classified:1
8543,"2,2-dimethyl-1,3,6,9,12-pentaoxa-2-silacyclotetradecane",274-934-4,70851-49-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
8545,acetic acid (4-ethyl-3-methyl-hexyl) ester,685-472-1,108419-33-6,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,31.0,H336:24;H319:24;H304:24;H315:24;H335:24;Not classified:7
8547,N-(4-bromobutyl)phthalimide,226-401-2,5394-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:42;H317:1;H302:1;H400:1
8551,"1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one",259-175-9,54464-59-4,Not Classified,Notified C&L,51.0,Not classified:36;H411:15;H315:15;H317:15
8559,Aluminium triformate,230-898-1,7360-53-4,Eye Dam. 1,REACH registration C&L,89.0,H318:54;Not classified:34;H315:2;H319:1;H335:1;H290:1;H400:1
8562,"4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-ol",246-815-7,25312-34-9,Not Classified,Notified C&L,258.0,Not classified:258
8563,"2-(nitromethylidene)-1,3-thiazinane",611-751-4,58842-20-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
8564,Deoxyribose-5-phosphate aldolase,629-750-2,9026-97-5,Resp. Sens. 1,Notified C&L,37.0,H334:37
8565,Barium diphenolate,220-229-1,2678-41-3,Not Classified,Notified C&L,2.0,Not classified:1;H302:1;H332:1
8566,"3,6-dichloropyridazine",205-478-6,141-30-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53.0,H301:45;H319:53;H315:53;H335:52;H302:4;H331:1;H332:2
8572,"Benzene, ethenyl-, polymer with 1,3-butadiene and 2-methyl-1,3-butadiene, hydrogenated, block",603-653-5,132778-07-5,Not Classified,Notified C&L,37.0,Not classified:37
8573,N-(1-oxotetradecyl)sarcosine,258-007-1,52558-73-3,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,59.0,H314:58;H318:59;H315:1;H335:1
8575,Tetrahydro-6-methyl-2H-pyran-2-one,212-511-8,823-22-3,Eye Irrit. 2,Notified C&L,1448.0,H319:1347;Not classified:101
8577,Tetrahydro-5-methylfuran-2-methanol,228-096-1,6126-49-4,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38;H226:38
8579,"Reaction mass of 1,1,1,2,3,3‐hexafluoro‐3‐methoxy‐2‐(trifluoromethyl)propane and 1,1,1,2,2,3,3,4,4‐nonafluoro‐4‐methoxybutane",422-270-2,,Not Classified,REACH registration C&L,7.0,Not classified:6;H413:1
8583,Sodium 3-hydroxybutyrate,205-774-5,150-83-4,,Notified C&L,1.0,H319:1;H315:1;H335:1
8586,2-methylhexan-2-ol,210-881-5,625-23-0,Flam. Liq. 3,Notified C&L,39.0,H226:39
8587,"2,4-diamino-5-methoxymethylpyrimidine",410-330-0,54236-98-5,Acute Tox. 4;Eye Irrit. 2;STOT RE 2,Harmonised C&L,0.0,H302:0;H319:0;H373:0
8588,Trimethoxyoctadecylsilane,221-339-2,3069-42-9,Not Classified,REACH registration C&L,73.0,Not classified:30;H319:43;H315:43;H335:39
8594,Chrome tungsten titanium buff rutile,269-054-2,68186-92-5,Not Classified,REACH registration C&L,9.0,Not classified:9
8597,Diallyl tetrasulphide,219-485-7,2444-49-7,Acute Tox. 4,Notified C&L,1.0,H302:1
8599,"(S)-3-(tert-butylamino)propane-1,2-diol",250-125-1,30315-46-9,Not Classified,REACH registration C&L,8.0,Not classified:7;H314:1
8600,Ethyl mandelate,212-263-0,774-40-3,Eye Dam. 1,Notified C&L,43.0,H318:38;H319:5
8604,"2-Propanamine, N,N-bis(1-methylethyl)-, compd. with α-sulfo-ω-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1)",600-839-8,107600-36-2,,Notified C&L,1.0,H302:1;H319:1
8607,"3,4-Dimethyl-1H-pyrazole Phosphate",815-238-8,202842-98-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,52.0,H302:52;H318:52
8608,"2,3-dimethoxy-5-sulphamoylbenzoic acid",266-433-4,66644-80-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
8610,"1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-(1-oxopropoxy)-, chloride (1:1), (2R)-",922-939-3,119793-66-7,Not Classified,Notified C&L,1.0,Not classified:1
8614,"Grass, hay, ext.",309-340-7,100209-32-3,Skin Sens. 1,Notified C&L,118.0,H317:117;H314:2;H318:2;Not classified:1
8615,"4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with 1,1-dimethylbiguanide (1:2)",252-047-3,34461-22-8,Not Classified,Notified C&L,1.0,Not classified:1
8620,"Ethylene bis[1,3-dihydro-1,3-dioxoisobenzofuran-5-carboxylate]",217-062-1,1732-96-3,Skin Sens. 1A;Eye Dam. 1;Resp. Sens. 1,REACH registration C&L,3.0,H334:3;H318:3;H317:3
8622,"2-methoxy-1,3,2-dioxaphospholane",223-130-1,3741-36-4,Acute Tox. 4,Notified C&L,38.0,H302:38
8627,(Z)-N-octadecyldocos-13-enamide,233-226-5,10094-45-8,Not Classified,REACH registration C&L,69.0,Not classified:44;H319:25;H315:25;H335:25
8628,"Formaldehyde, reaction products with melamine",305-551-3,94645-56-4,Not Classified,Notified C&L,9.0,Not classified:6;H312:2;H332:2;H317:3;H302:1;H351:1
8629,4-nitroindan-1-one,246-367-2,24623-25-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
8630,"3-(2-carboxyethyl)-2,5-dimethylbenzoxazolium bromide",251-009-3,32353-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8631,"Phosphonium, ethyltriphenyl-, chloride (1:1)",618-289-2,896-33-3,,Notified C&L,5.0,H312:4;H319:5;H315:5;H335:4;H411:4;H302:4
8636,"Amines, C12-14-alkyldimethyl",283-464-9,84649-84-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,221.0,H302:221;H314:221;H400:221;H410:186;H318:52
8637,Isobutyl palmitate,203-758-2,110-34-9,Not Classified,Notified C&L,2.0,Not classified:2
8640,W-663,442-200-4,,Not Classified,Notified C&L,28.0,Not classified:28
8652,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate and 2-propenoic acid",607-906-0,26300-51-6,Not Classified,Notified C&L,36.0,Not classified:36
8654,Diammonium cobalt bis(sulphate),237-043-1,13596-46-8,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1,Notified C&L,1.0,H361:1;H341:1;H317:1;H410:1;H350:1;H400:1;H334:1;H302:1;H360:1
8656,Tris(triphenylphosphine)rhodium (I) chloride,238-744-5,14694-95-2,Aquatic Chronic 2,REACH registration C&L,122.0,H411:2;H302:83;H413:117;H317:83;H319:2;H315:2;H314:1;H318:1;H335:1
8657,"(R*,S*)-(±)-α-(1-aminoethyl)-4-hydroxybenzyl alcohol hydrochloride",252-353-7,35085-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8664,3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride,224-947-6,4568-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
8666,1-naphthyloxyacetic acid,221-023-4,2976-75-2,,Notified C&L,6.0,H319:6;H315:6;H335:5
8667,"Naphthenic acids, compds. with 4,5-dihydro-2-nortall-oil alkyl-1H-imidazole-1-ethanol",271-745-9,68606-76-8,Eye Irrit. 2,Notified C&L,2.0,H319:2
8669,"Benzenesulfonic acid, 2(or 4)-C10-14-alkyl derivs., compds. with isopropanolamine",289-091-8,85995-83-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,1.0,H302:1;H318:1
8679,4-iodoanisole,211-798-7,696-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46
8682,"Alkenes, C10-18, hydroformylation products, distn. lights",307-147-2,97552-94-8,Aquatic Chronic 3,Notified C&L,20.0,H412:20
8683,"4,5-dihydro-3-phenylisoxazol-5-one",214-064-4,1076-59-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
8684,2-ethylhexyl palmitate,249-862-1,29806-73-3,Not Classified,REACH registration C&L,505.0,Not classified:502;H319:3;H315:2;H335:2
8688,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium chloride",268-750-3,68134-38-3,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,16.0,H312:2;H318:11;H410:11;H331:2;H302:16;H400:2;H319:5
8689,"Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]",273-173-5,68952-79-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
8693,"Enzymes, pancreatic, swine",272-915-5,68920-08-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,2.0,H334:2;H319:2;H315:2;H335:2
8695,[2-(1-propoxyethoxy)ethyl]benzene,231-327-9,7493-57-4,Aquatic Chronic 3,REACH registration C&L,1615.0,H412:1615;H332:1
8696,3-phenylglutaric acid,224-016-4,4165-96-2,,Notified C&L,4.0,H319:4;H315:4;H335:4
8697,4-methoxyphenylacetone,204-578-7,122-84-9,Not Classified,REACH registration C&L,104.0,Not classified:101;H412:1;H315:2;H302:1;H319:1;H335:1
8699,Molecular phosphorus,601-810-2,12185-10-3,Pyr. Sol. 1;Acute Tox. 2;Skin Corr. 1A;Acute Tox. 2;Aquatic Acute 1,Notified C&L,69.0,H314:69;H300:69;H330:69;H400:69;H250:69
8700,Diantimony trilead octaoxide,236-845-9,13510-89-9,Not Classified,Notified C&L,5.0,Not classified:5
8713,"N-ethylbenzo-1,3-dioxol-5-amine",251-302-6,32953-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:39;H315:39;H335:38;H302:1;H332:1;H312:1
8717,"Fatty acids, C16-18 and C18-unsatd., mixed esters with adipic acid and trimethylolpropane",292-832-8,91001-61-5,Not Classified,REACH registration C&L,23.0,Not classified:23
8719,dimethyl octadecanedioate,604-582-2,1472-93-1,Not Classified,Notified C&L,3.0,Not classified:3
8720,"Nonane-1,3-diol monoacetate",215-332-3,1322-17-4,Not Classified,Notified C&L,3.0,Not classified:3
8724,Tetrabutylammonium Fluoride Trihydrate,618-063-3,87749-50-6,Skin Corr. 1B,Notified C&L,85.0,H314:80;H318:44;H300:4;H315:4;H301:1
8725,"2,6,7-trihydroxy-9-phenylxanthen-3-one",213-550-3,975-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
8727,"Esterification reaction of fatty acids, C16-18 and C18-unsatd.; 3,4-epoxycyclohexyl methyl-3,4-epoxycyclohexan carboxylate and neodecanoic acid, oxiranylmethyl ester",917-830-2,,Aquatic Chronic 4,REACH registration C&L,72.0,H413:1;Not classified:71
8729,2-prop-1-enyl-p-cymene,238-347-7,14374-92-6,Asp. Tox. 1;Skin Irrit. 2,Notified C&L,349.0,H304:349;H315:349;H301:1;H319:1
8730,"p-tert-butylbenzoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",262-014-5,59993-86-1,Not Classified,Notified C&L,12.0,Not classified:12
8731,"6,7-dimethoxyquinazoline-2,4(1H,3H)-dione",249-288-1,28888-44-0,Not Classified,REACH registration C&L,46.0,Not classified:2;H319:43;H315:43;H335:41;H302:1
8736,"Sodium 2(or 5)-[[9,10-dihydro-9,10-dioxo-4-[(p-tolyl)amino]-1-anthryl]amino]-5(or 2)-methylbenzenesulphonate",286-464-7,85248-91-5,Aquatic Chronic 3,Notified C&L,1.0,H412:1
8737,4-O-β-D-galactopyranosyl-D-glucitol,209-566-5,585-86-4,Not Classified,REACH registration C&L,3.0,Not classified:3
8743,"3-benzoyloxy-2,2,4-trimethylpentyl isobutyrate",245-054-8,22527-63-5,Skin Irrit. 2;Skin Sens. 1,Notified C&L,18.0,H315:18;H317:18
8747,Aminoacylase,232-732-3,9012-37-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43.0,H334:43;H319:38;H315:38;H335:38
8753,Sodium chlorodifluoroacetate,217-586-0,1895-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H319:50;H315:50;H335:49
8754,Tris(4-aminophenyl) thiophosphate,258-083-6,52664-35-4,Not Classified,REACH registration C&L,35.0,Not classified:35
8760,2'-(2-chlorophenylamino)-6'-(dibutylamino)spiro[isobenzofuran-1(3H)-9'[9H]-xanthene]-3-one,279-906-5,82137-81-3,Not Classified,Notified C&L,1.0,Not classified:1
8763,"N,N'-ethane-1,2-diylbisoleamide",203-756-1,110-31-6,Not Classified,REACH registration C&L,84.0,Not classified:84
8765,Diaminomaleonitrile,214-697-6,1187-42-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,88.0,H302:72;H332:40;H312:40;H412:33;H331:35;H301:16;H319:2;H315:2;H335:1;H311:1
8767,"3-Pyridinecarboxylic acid, 2-[1-[2-[[(3,5-difluorophenyl)amino]carbonyl]hydrazinylidene]ethyl]-",600-910-3,109293-97-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156.0,H400:156;H410:156
8770,"etoxazol (ISO);(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole",604-891-2,153233-91-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
8771,2-(1-naphthoyl)benzoic acid,225-702-6,5018-87-1,Eye Irrit. 2,Notified C&L,38.0,H319:38
8777,"Levisticum officinale, ext.",284-292-7,84837-06-9,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,1646.0,H319:1553;H304:1634;H315:1553;H341:1553;H317:1636;H351:1553;H412:1439;H226:12;H411:14;Not classified:9;H302:3
8778,Buprenorphine,257-950-6,52485-79-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 2,REACH registration C&L,89.0,H319:79;H361:10;H332:3;H373:1;H302:10;H301:78;H315:78;H335:78;H336:7;H317:7;H370:8;H362:10;H334:9;H300:1;H330:1;H310:1;H360:1
8789,(carboxylatomethyl)di(methyl)octylammonium,248-551-8,27593-14-2,Not Classified,Notified C&L,12.0,Not classified:11;H314:1
8795,"2(3H)-Furanone, 3-[2-(acetyloxy)ethyl]dihydro-",601-286-5,113844-96-5,Eye Irrit. 2,Notified C&L,83.0,H319:83
8798,"1,3,5-tris(2-methyl-2-propenyl)-1,3,5-triazin-2,4,6-(1H, 3H, 5H) -trion",613-107-8,6291-95-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H302:39;H332:39;H312:1;H319:1;H315:1;H335:1
8802,"Disodium 4-[4-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulphonate",274-499-0,70247-70-0,Skin Sens. 1B;Resp. Sens. 1B,REACH registration C&L,31.0,H334:21;H317:21;H319:8;H315:8;Not classified:2;H412:1
8804,Bis(o-nitrophenoxy)ethane,449-470-2,51661-19-9,Expl. 1.1,REACH registration C&L,38.0,H201:37;H413:6
8805,Pyrene-1-carbaldehyde,221-196-6,3029-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43;H341:2
8809,Isodecyl oleate,261-673-6,59231-34-4,Not Classified,REACH registration C&L,145.0,Not classified:145
8812,Polymer of polypropylene and maleic anhydride,607-788-0,25722-45-6,,Notified C&L,43.0,Not classified:42;H319:1
8813,Magnesium bis(dihydrogenorthophosphate),236-004-6,13092-66-5,Not Classified,REACH registration C&L,49.0,Not classified:16;H318:33
8814,"Poly(oxy-1,2-ethanediyl), α-butyl-ω-(carboxymethoxy)-",600-838-2,107600-34-0,,Notified C&L,43.0,H318:43;H315:39;H314:4
8816,BISPHENOL A POLYCARBONATE,639-891-1,103598-77-2,,Notified C&L,53.0,Not classified:33;H319:20;H315:20
8817,"dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate",407-300-4,92683-20-0,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
8819,"Cyclopentane-1,3-dione",223-372-8,3859-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H319:3;H315:3;H335:3
8820,"1,2,4-trimethylbenzene",202-436-9,95-63-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0.0,H319:0;H315:0;H226:0;H332:0;H335:0;H411:0
8821,2-Ethylhexyl-2-cyano-3-(4-methoxyphenyl)-3-phenylprop-2-enoate,700-213-5,947753-66-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,53.0,H400:52;H410:52;Not classified:1
8822,α-phenylcinnamic acid,202-069-4,91-48-5,,Notified C&L,5.0,H319:5;H315:5;H335:4
8823,"Fatty acids, C6-18, 2,2-dimethyl-1,3-propanediyl esters",292-927-4,91031-27-5,Not Classified,Notified C&L,1.0,Not classified:1
8825,5-sulphosalicylic acid,202-555-6,97-05-2,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,2179.0,H314:59;H318:49;H319:2109;H315:2118;H302:85;H335:71;H290:9;Not classified:2;H317:1
8826,"4,6-dimethyldibenzothiophene",214-894-7,1207-12-1,Acute Tox. 4,Notified C&L,1.0,H302:1
8832,2-chlorooctane,211-046-8,628-61-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H400:38;H410:38;H317:38
8836,"Soaps, stocks, corn-oil, acidulated",296-963-1,93165-75-4,Not Classified,Notified C&L,1.0,Not classified:1
8837,"Formaldehyde, polymer with benzenamine and 4,4'-methylenebis[phenol]",606-768-9,214476-06-9,Not Classified,Notified C&L,9.0,Not classified:9
8840,"tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate",440-460-3,252579-81-0,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H319:0
8841,"2-Naphthalenesulfonic acid, 6-[[2-amino-4-[(2-hydroxyethyl)amino]phenyl]azo]-3-[[4-[[4-[[7-[[2-amino-4-[(2-hydroxyethyl)amino]phenyl]azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-4-hydroxy-, trisodium salt",229-209-7,6428-38-2,Not Classified,Notified C&L,15.0,Not classified:15
8846,tert-butyl isothiocyanate,209-682-6,590-42-1,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43.0,H319:39;H226:42;H331:38;H335:39;H301:42;H311:42;H314:4;H330:4;H315:1
8847,5-methyl-5-phenylhexan-3-one,225-561-0,4927-36-0,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1541.0,H315:26;H411:26;H317:1515
8849,"Xylanase, endo-1,4-",232-800-2,9025-57-4,Resp. Sens. 1,REACH registration C&L,289.0,H334:289
8851,"Petrolatum (petroleum), hydrotreated;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C",295-459-9,92045-77-7,Carc. 1B,Harmonised C&L,0.0,H350:0
8852,Xenon,231-172-7,7440-63-3,Press. Gas (Comp.),Notified C&L,348.0,H280:243;H281:83;Not classified:22
8853,"N,N'-(ethoxymethylsilylene)bis[N-methylbenzamide]",240-354-5,16230-35-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,29.0,H302:2;H318:2;H315:2;H317:2;H319:27
8854,3-methyl-2-butenoyl chloride,222-109-4,3350-78-5,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,38.0,H314:38;H226:38;H335:38
8859,"Xanthylium, 3,6-bis(diethylamino)-9-[[]2-(methoxycarbonyl)phenyl]-, cyano cuprate ferrate complexes",600-292-5,102262-31-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83.0,H400:83;H318:83;H410:83
8868,Iron digluconate,206-076-3,299-29-6,Not Classified,REACH registration C&L,23.0,Not classified:17;H302:4;H318:2;H319:1
8871,"Alcohol graso, C12-18, etoxilado BU éter",604-522-5,146340-16-1,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,464.0,H400:454;H302:156;H318:156;H317:156;H315:308;H412:128;H410:116;H319:25
8873,Methyl triacontanate,211-113-1,629-83-4,Not Classified,Notified C&L,1.0,Not classified:1
8875,4-allylveratrole,202-223-0,93-15-2,Acute Tox. 4;Muta. 2;Carc. 2,REACH registration C&L,1707.0,H302:1700;H351:1695;H341:1656;H401:1;H317:1287;H319:43;H315:39;H335:40;Not classified:6;H411:7;H332:1;H350:1
8877,"1-methyl-N-(methyldiphenylsilyl)-1,1-diphenylsilylamine",231-227-5,7453-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8882,Phenylphosphinic acid,217-217-3,1779-48-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,129.0,H302:127;H314:126;H318:85;Not classified:2;H290:1;H315:1
8885,11-hydroxyundecanoic acid,222-932-9,3669-80-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8886,"11β,17,21-trihydroxypregn-4-ene-3,20-dione 21-hexanoate",222-737-9,3593-96-2,Repr. 1A;STOT RE 2,Notified C&L,24.0,H360:24;H373:24
8888,"Ethyl 3,3-dimethylbutyrate",226-280-6,5340-78-3,,Notified C&L,5.0,H226:5
8894,"N,N-diethylpiperazine-1-carboxamide",204-332-9,119-54-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
8895,"Fatty acids, tallow, mixed esters with dianhydro-d-glucitol, sorbitan and sorbitol",294-790-6,91770-07-9,Not Classified,Notified C&L,1.0,Not classified:1
8899,"Tallow, reaction products with diethylenetriamine, formaldehyde and urea",287-101-5,85409-32-1,Not Classified,Notified C&L,1.0,Not classified:1
8903,Calcium bis[6-chloro-4-[[2-hydroxy-3-[(2-methoxyphenyl)carbamoyl]-1-naphthyl]azo]toluene-3-sulphonate],288-245-1,85702-54-1,Not Classified,Notified C&L,68.0,Not classified:68
8913,α-(aminomethyl)-4-methoxybenzyl alcohol,259-561-7,55275-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8914,"Quassia amara, ext.",283-287-7,84604-10-4,Flam. Liq. 2,Notified C&L,1.0,H226:1;H225:1
8916,"Methyl 3,5-Dibromobenzoate",610-649-7,51329-15-8,,Notified C&L,6.0,H319:6;H315:6;H335:5
8921,Difluorophosphoric acid,237-421-6,13779-41-4,Skin Corr. 1B,Notified C&L,40.0,H314:40;H318:1;H331:1;H301:1;H311:1
8922,(8-chloro-1-naphthylthio)acetic acid,204-971-3,129-94-2,,Notified C&L,6.0,H319:6;H315:6;H335:5
8924,Methyl 2-nitroimidazole-1-acetate,245-243-5,22813-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8925,4-tert-Butyl-2-hydroxybenzaldehyde,613-912-4,66232-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
8927,"1,1'-oxybis(dodecylbenzene)",274-142-9,69834-19-1,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1.0,H315:1;H411:1
8929,"(±)-N1,N1-dimethylpropane-1,2-diamine",263-699-3,62689-51-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38.0,H314:38;H226:38
8931,"Aluminum, (2-ethylhexanoato-[?]O)oxo-, homopolymer",611-370-3,56237-74-2,Not Classified,Notified C&L,68.0,Not classified:68
8933,"Horseradish, ext.",283-891-0,84775-62-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1384.0,H319:1349;H315:1349;H226:1374;H330:1349;H310:1345;H410:1336;H301:1304;H400:1335;H302:70;H317:25;H371:25;H411:25;Not classified:10;H335:5;H311:4
8934,copper chloride;copper (I) chloride;cuprous chloride,231-842-9,7758-89-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H400:0;H410:0
8937,"2-[2,4-bis(1,1-dimethylpropyl)phenoxy]-N-(3,5-dichloro-2-hydroxy-4-methylphenyl)acetamide",243-765-8,20364-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
8942,"1,2-Benzenedicarboxylic acid, dinonyl ester, branched and linear",271-087-2,68515-45-7,Not Classified,Notified C&L,6.0,Not classified:6
8954,1-Iodoundecane,610-064-7,4282-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:38;H315:38;H335:38;H302:1;H332:1;H312:1
8955,"2,2'-oxybis[2-chloropropane]",254-554-5,39638-32-9,Acute Tox. 3;Muta. 2,Notified C&L,38.0,H301:38;H341:38
8958,1-fluoro-4-(isopropenyl)benzene,206-501-2,350-40-3,Flam. Liq. 3,Notified C&L,44.0,H226:44;H319:5;H315:5;H335:5
8959,HYDROCARBON,952-127-4,,Asp. Tox. 1,Notified C&L,1.0,H304:1
8960,"Hydrocarbons, C9-C11, isoalkanes, cyclics,",920-134-1,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2.0,H226:2;H304:2;H336:2;H411:2
8961,"N,N'-ethane-1,2-diylbis(hydroxyoctadecan-1-amide)",253-808-2,38162-95-7,Not Classified,Notified C&L,1.0,Not classified:1
8965,"9-Octadecenoic acid (Z)-, reaction products with triethanolamine, di-Me sulfate-quaternized",302-242-5,94095-35-9,Not Classified,Notified C&L,38.0,Not classified:30;H319:8;H315:8
8966,"DL-hexane-1,2-diol",230-029-6,6920-22-5,Eye Irrit. 2,REACH registration C&L,318.0,H319:253;Not classified:65;H315:93;H335:81
8971,Benzilic acid,200-993-2,76-93-7,Acute Tox. 4,Notified C&L,50.0,H302:50
8972,"Pepper (Piper), P. betle, ext.",283-910-2,84775-81-5,Muta. 2;Carc. 1B;STOT SE 2,Notified C&L,88.0,H350:88;H371:77;H341:88
8978,"2,5-dimethylpyrazine",204-618-3,123-32-0,Acute Tox. 4,Notified C&L,1754.0,H302:1754;H319:47;H315:47;H335:46;H226:7;H301:1;H411:1;H314:1
8979,"(8E,10E)-dodeca-8,10-dienyl acetate",258-834-8,53880-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:38;H315:43;H335:38
8980,"Slags, lead-zinc smelting",297-907-9,93763-87-2,Not Classified,REACH registration C&L,9.0,Not classified:9
8990,4-bromo-2-fluorobenzonitrile,600-701-7,105942-08-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48.0,H312:46;H319:46;H315:46;H332:46;H335:45;H302:46;H301:1;Not classified:1
8991,"1,3-diethyldiphenylurea",201-645-2,85-98-3,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,80.0,H302:80;H412:80;H335:2
8995,Smectite-group minerals,235-374-6,12199-37-0,Not Classified,Notified C&L,384.0,Not classified:384
8996,SOLVENT ORANGE 54,602-679-4,12237-30-8,Not Classified,Notified C&L,8.0,Not classified:6;H400:2;H410:2
9000,1-(1-oxopropyl)-1H-imidazole,223-922-7,4122-52-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H226:1;H332:1;H335:1;H302:1
9001,"3,7-dimethyloct-6-enyl isobutyrate",202-616-7,97-89-2,Not Classified,REACH registration C&L,1633.0,Not classified:1633
9002,"trisodium N,N-bis(carboxymethyl)-β-alanine",414-070-9,129050-62-0,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H314:0
9003,4-hydroxy-3-[(4-sulpho-1-naphthyl)azo]naphthalene-1-sulphonic acid,237-098-1,13613-55-3,Not Classified,Notified C&L,3.0,Not classified:3
9005,"2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol",614-869-4,68987-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,617.0,H319:529;H315:529;H335:529;Not classified:56;H302:32;H318:32;H411:32
9007,1-chloro-2-fluoro-4-nitrobenzene,206-500-7,350-31-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
9014,"Poly(oxy-1,2-ethanediyl), .alpha.-(2-ethylhexyl)-.omega.-hydroxy-, phosphate",614-479-4,68439-39-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,104.0,H318:47;H315:45;Not classified:31;H314:28;H412:1
9015,2-[N-(4-chloro-2-methylphenyl)carbamoyl]-3-naphthyl acetate,282-098-7,84100-16-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H318:38;H315:38;H410:38;H335:38;H400:38
9017,Calcium saccharate,227-334-1,5793-88-4,Not Classified,REACH registration C&L,43.0,Not classified:4;H319:39;H315:39;H335:39
9018,Sodium 1-methyl 2-sulphonatotetradecanoate,223-675-5,4016-22-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
9020,reaction mass of 5-chloro-2-methyl-2,611-341-5,55965-84-9,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1C;Eye Dam. 1;Skin Sens. 1A;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H314:0;H318:0;H317:0;H330:0;H410:0;H310:0;H301:0;H400:0
9025,"Aromatic hydrocarbons, C",292-695-4,90989-39-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H304:0;H340:0
9026,"2,5-dihydrofuran",216-957-4,1708-29-8,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,128.0,H314:85;H318:85;H225:128;H412:85;H335:85;H302:85;H341:1;H331:1;H351:1;H312:83
9027,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine,276-258-5,71989-28-1,Not Classified,Notified C&L,5.0,Not classified:4;H302:1;H332:1;H312:1;H335:1
9031,"(3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid",228-475-1,6277-14-1,Not Classified,REACH registration C&L,1.0,Not classified:1
9036,"R-1,c-2,c-3,c-4-cyclopentanetetracarboxylic acid",223-256-7,3786-91-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,44.0,H301:39;H331:39;H311:39;H314:39;H319:4;H315:4;H335:4;Not classified:1
9040,"Ethyl (9Z,12Z,15Z)-9,12,15-octadecatrienoate",214-734-6,1191-41-9,Not Classified,Notified C&L,98.0,Not classified:98
9041,Dieuropium trioxalate,221-885-1,3269-12-3,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,Notified C&L,5.0,H302:5;H318:4;H312:5
9043,"N-methyl-P,P-bis(2-methylaziridin-1-yl)phosphinamide",285-331-0,85068-72-0,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 1;STOT SE 3;Muta. 2,REACH registration C&L,2.0,H317:2;H341:2;H330:2;H335:2;H301:2;H311:2
9044,3-(fluorosulphonyl)benzoic acid,207-232-3,454-95-5,Skin Corr. 1B,Notified C&L,39.0,H314:39;H319:1;H315:1;H335:1;H302:1
9045,"3,3-Tetramethyleneglutarimide sodium salt",600-700-1,105920-64-7,Acute Tox. 2,Notified C&L,1.0,H300:1
9046,"methyl (4R)-2,2-dimethyl-1,3-dioxolane-4-carboxylate",610-831-6,52373-72-5,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H227:1;H335:1;H315:1
9049,4'-(Isopropylaminoacetyl)methanesulfonanilide,612-015-5,60735-85-5,Eye Irrit. 2,REACH registration C&L,3.0,H319:3
9051,"1-[(2,5-dimethoxyphenyl)azo]-2-naphthol",228-778-9,6358-53-8,Carc. 2,Notified C&L,38.0,H351:38
9059,"2-amino-3,4,5,6-tetrahydropyridine",240-146-4,16011-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:40;H302:2
9060,3-chloropropyltrimethoxysilane,219-787-9,2530-87-2,Not Classified,REACH registration C&L,217.0,Not classified:181;H226:25;H319:13;H315:13;H335:8
9062,"3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one",430-820-8,114341-88-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H315:0;H317:0;H410:0;H373:0;H302:0;H400:0
9066,"Pine, ext., acetylated",305-102-1,94334-26-6,Not Classified,Notified C&L,88.0,Not classified:88
9068,"1,2,3,6-tetrahydro-N-octyl-3,6-methanophthalimide",232-103-3,7786-80-3,Not Classified,Notified C&L,5.0,Not classified:5
9070,(1-ethoxyethoxy)cyclododecane,446-240-3,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,3.0,H411:3;H317:3
9072,2-amino-4-(methylselenyl)butyric acid,215-977-0,1464-42-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47.0,H410:47;H373:47;H331:47;H301:47;H400:47
9075,trichloro(methyl)silane;methyltrichlorosilane,200-902-6,75-79-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H315:0;H335:0;H225:0
9081,Convallatoxin,208-086-3,508-75-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H301:1;H331:1;H311:1
9083,"3,4-dihydro-2H-1,4-benzoxazin-6-ol",247-415-5,26021-57-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,8.0,H302:8;H319:8
9084,"reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate",427-090-8,116044-44-1,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
9089,"Pyridine-2,6-dicarbonitrile",220-766-1,2893-33-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H312:39;H319:39;H315:39;H332:39;H335:39;H302:39
9096,p-chlorocinnamic acid,216-564-8,1615-02-7,Acute Tox. 4,REACH registration C&L,45.0,H302:45;H319:5;H315:5;H335:4
9102,Lanthanum(3+) perchlorate,237-835-7,14017-46-0,,Notified C&L,4.0,H319:4;H272:4;H315:4
9103,Ammonium D-5-bromo-6-oxo-9-bornanesulphonate,238-616-9,14575-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
9104,Hex-3-enyl formate,219-017-1,2315-09-5,Flam. Liq. 3,Notified C&L,1399.0,H226:1399
9105,"reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;propylene carbonate",403-490-8,104558-95-4,Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H319:0;H410:0;H317:0
9111,sulphuric acid ... %,231-639-5,7664-93-9,Skin Corr. 1A,Harmonised C&L,0.0,H314:0
9112,2-methylpentan-2-ol,209-681-0,590-36-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H226:44;H315:40;H335:43
9114,"1,2,3,4-tetrahydroacridin-9-amine monohydrochloride",216-867-5,1684-40-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H301:38;H319:38;H315:38;H335:38
9115,"Peptones, swine",297-242-4,93384-33-9,Not Classified,Notified C&L,1.0,Not classified:1
9116,"Disodium 4,8-diamino-1,5-dihydroxy-9,10-dioxoanthracene-2,6-disulphonate",220-678-3,2861-02-1,Aquatic Chronic 3,REACH registration C&L,1380.0,H412:4;H302:1313;H319:36;Not classified:27
9117,"(tetrahydro-3-thienyl)hydrazine S,S-dioxide",222-368-3,3448-12-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
9122,4'-Bromo-2'-chloroacetanilide,609-006-3,3460-23-9,,Notified C&L,5.0,H319:5;H315:5;H335:4
9123,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate",204-727-6,125-12-2,Not Classified,REACH registration C&L,1845.0,Not classified:1833;H315:14;H320:1;H410:1;H411:1
9124,4-(4-propylcyclohexyl)phenyl 4-butylcyclohexanecarboxylate,283-128-1,84540-35-2,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
9125,Isopropylcyclohexane,211-792-4,696-29-7,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,51.0,H413:2;H226:51;H304:51
9127,"4-amino-2,2,6,6-tetramethylpiperidine 1-oxide",238-738-2,14691-88-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:40;H315:40;H335:39;H312:2;H314:1;H318:1;H332:2;H302:2
9129,"1,1-dimethylsilacyclobutane",218-939-1,2295-12-7,Flam. Liq. 2,Notified C&L,38.0,H225:38
9130,"1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one",222-896-4,3654-49-7,Not Classified,Notified C&L,9.0,Not classified:9
9134,2-chloro-6-(trifluoromethyl)aniline,207-091-8,433-94-3,,Notified C&L,7.0,H312:6;H319:7;H315:7;H332:6;H302:6;H330:1;H335:2;H301:1;H311:1;H227:1
9136,3-ethyl-2-methylpentane,210-187-2,609-26-7,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H336:0;H304:0;H315:0;H225:0;H410:0;H400:0
9138,"(4-trans-Propyl-[trans-1,1-bicyclohexyl]-4-trans-carbonic acid)-[4-(4-trans-pentylcyclohexyl)-phenylester]",603-511-2,131790-57-3,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
9140,Sodium 3-methylsulphanilate,264-172-0,63450-43-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,14.0,H319:13;H315:13;Not classified:1
9143,1-Ethynyl-4-fluorobenzene,616-372-8,766-98-3,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H228:51;H319:52;H315:41;H335:51
9154,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-((2-ethylhexyl)oxy)- (4 - 11 EO)",600-837-7,107600-33-9,,Notified C&L,98.0,H314:39;H318:59;H315:58;Not classified:33
9156,"6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)tris-hexanoic acid, compd. with 1-amino-2-propanol",926-126-4,,Not Classified,REACH registration C&L,2.0,Not classified:2
9158,"Tetramethyl ethane-1,1,2,2-tetracarboxylate",226-757-9,5464-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
9160,"Lily, Lilium candidum, ext.",283-996-1,84776-67-0,Not Classified,Notified C&L,1.0,Not classified:1
9162,"N,N'-dimethylhexane-1,6-diamine",236-005-1,13093-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:38;H315:38;H335:38;H314:1;H318:1
9163,"Methyl 3-trimethylsilyloxybuta-1,3-dien-1-yl ether",261-753-0,59414-23-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H226:1;H315:1
9164,o-ethoxyphenyl isothiocyanate,245-468-9,23163-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
9165,Bromo-o-tolylmagnesium,213-250-2,932-31-0,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,38.0,H228:38;H314:38
9168,Bismuth tris(2-ethylhexanoate),267-499-7,67874-71-9,Skin Irrit. 2;Eye Dam. 1;Repr. 2,REACH registration C&L,231.0,H318:13;H315:109;H361:74;Not classified:59;H319:23;H335:23;H413:2
9169,"8-hydroxynaphthalene-1,6-disulphonic acid",204-189-2,117-43-1,Not Classified,Notified C&L,2.0,Not classified:2
9181,"Benzo[b]thiophene, 5-chloro-3-methyl-",606-305-0,19404-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
9186,3-(benzyloxy)-4-methoxybenzyl alcohol,217-462-6,1860-60-2,Aquatic Acute 1,Notified C&L,38.0,H400:38
9194,"4,4'-dichlorobutyrophenone",255-123-4,40877-09-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H302:38;H318:38;H315:39;H335:39;H319:1
9196,"[2R[2R*(4R*,8R*)]]-3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",240-747-1,16698-35-4,Not Classified,Notified C&L,3.0,Not classified:3
9199,o-fluorostyrene,206-896-1,394-46-7,Flam. Liq. 3,Notified C&L,44.0,H226:44;H319:5;H315:5;H335:5
9201,Chloropentamethyldisilane,216-330-5,1560-28-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40.0,H314:40;H226:39;H312:1;H318:2;H290:1
9202,ethylamine,200-834-7,75-04-7,Press. Gas;Flam. Gas 1;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H220:0;H319:0;H335:0;Not classified:0
9206,Enzymatic hydrolysis products of Palmaria palmata extract,607-053-4,223751-74-4,Not Classified,REACH registration C&L,21.0,Not classified:1;H319:20;H315:20
9208,"Fatty acids, C16-18, iso-Bu esters",288-668-1,85865-69-6,Not Classified,REACH registration C&L,31.0,Not classified:30;H319:1;H315:1;H335:1
9210,"dibenzo[def,p]chry­sene; dibenzo[a,l]pyrene",205-886-4,191-30-0,Muta. 2;Carc. 1B,Harmonised C&L,0.0,H350:0;H341:0
9211,"3,4-dimethoxyphthalic acid",208-259-3,518-90-1,Eye Irrit. 2,Notified C&L,38.0,H319:38
9213,"Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-(nonylphenoxy)-, ammonium salt (1:1)",618-573-6,9051-57-4,Eye Irrit. 2,Notified C&L,995.0,H319:854;H226:204;H315:266;H411:177;H412:36;H318:86;H314:32;Not classified:27;H413:3;H317:1
9214,"Fatty acids, soya, polymers with bisphenol A and epichlorohydrin",613-883-8,66070-76-6,Not Classified,Notified C&L,55.0,Not classified:55
9219,"Poly(oxy-1,2-ethanediyl), .alpha.-phosphono-.omega.-hydroxy-, C12-14 (even numbered)-alkyl ethers, dipotassium salts",615-846-1,72828-57-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,28.0,H319:22;H315:28;H318:6
9221,Reaction products of olive oil and ozone,919-979-9,,Acute Tox. 4,REACH registration C&L,1.0,H302:1
9222,"1,4-dimethylpentylamine",248-941-8,28292-43-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43.0,H314:43;H226:43;H312:4;H332:4;H302:4
9229,"Phosphoric acid, reaction products with aluminum hydroxide and boric acid (H3BO3)",270-110-3,68411-22-3,Not Classified,Notified C&L,2.0,Not classified:2
9232,6-(isopropyl)quinoline,205-220-2,135-79-5,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,315.0,H302:314;H319:315;H310:313;H315:315;H317:1;H335:1
9243,"3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine",251-301-0,32943-25-2,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,17.0,H302:15;H400:2;H410:2;H317:2;H315:1;H335:1;Not classified:1
9252,"1,6-Octadien-3-ol, 3,7-dimethyl-, acid-isomerized",277-225-8,73018-51-6,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,1458.0,H226:1434;H304:1433;H411:1458;H319:1287;H317:1431;H315:1
9253,"Reaction mass of 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine and 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with triethylenetetramine",921-974-1,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,46.0,H302:46;H411:46;H317:46
9255,(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoic acid,616-764-9,79990-15-1,Not Classified,Notified C&L,4.0,Not classified:3;H319:1;H315:1;H335:1
9256,"Spinels, cobalt tin grey",269-066-8,68187-05-3,Not Classified,REACH registration C&L,11.0,Not classified:11
9257,Pentoxifylline,229-374-5,6493-05-6,Acute Tox. 4,Notified C&L,66.0,H302:63;Not classified:3;H332:1;H312:1
9263,Lactose,200-559-2,63-42-3,Not Classified,Notified C&L,210.0,Not classified:210
9266,"[trans(trans)]-4,4'-bis(4-pentylcyclohexyl)biphenyl",279-322-0,79832-84-1,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
9268,"1H-Isoindole-1,3(2H)-dione, 2-[4-[[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]amino]pentyl]-",600-760-9,106635-87-4,Skin Sens. 1,Notified C&L,1.0,H317:1
9269,"1-(2-PHENYLETHYL)-4-(PHENYLMETHYL)-2,6-PIPERAZINEDIONE",600-719-5,106148-27-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2,REACH registration C&L,2.0,H302:2;H332:2;H312:2;H341:2
9271,pentyl formate,252-343-2,35073-27-9,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H335:0;H225:0
9272,"Ammonium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptane-1-sulphonate",269-510-0,68259-07-4,Not Classified,Notified C&L,22.0,Not classified:22
9281,Stearic acid,200-313-4,57-11-4,Not Classified,REACH registration C&L,2045.0,Not classified:1400;H315:514;H319:148;H335:123;H412:68;H314:59;H302:3;H332:3;H228:3;H413:2
9282,Methyl 6-bromo-2-naphthoate,608-896-0,33626-98-1,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H315:1
9283,Bis[1-[4-(pyrrolidin-1-yl)but-2-ynyl]pyrrolidin-2-one] trifumarate,241-388-3,17360-35-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38.0,H330:38;H300:38;H310:38
9286,β-methyl-β-phenylphenethylamine hydrochloride,255-039-8,40691-66-5,,Notified C&L,5.0,H319:5;H315:5;H335:5;H410:1
9287,"2-amino-N,N-dimethyltoluene-4-sulphonamide",228-707-1,6331-68-6,Eye Irrit. 2,Notified C&L,38.0,H319:38
9288,"10,11-dihydro-α-methyl-10-oxodibenzo[b,f]thiepin-2-acetic acid",277-973-5,74711-43-6,Acute Tox. 4,Notified C&L,1.0,H302:1
9294,"3,5-dichlorobenzoic acid",200-092-4,51-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53.0,H319:50;H315:50;H335:49;Not classified:3
9296,"3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide",401-820-5,793710-14-2,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
9298,"N,N'-ethylenedi(stearamide)",203-755-6,110-30-5,Not Classified,Notified C&L,1875.0,Not classified:1445;H312:139;H319:205;H315:185;H335:185;H317:82;H413:13;H412:10;H411:1
9301,5-methyl-5-phenylbarbituric acid,200-994-8,76-94-8,,Notified C&L,1.0,H302:1
9312,4-tert-butylcyclohexyl acetate,250-954-9,32210-23-4,Skin Sens. 1B,REACH registration C&L,2562.0,H317:1940;H411:566;Not classified:87;H319:42;H315:42;H335:41
9314,"Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated",295-458-3,92045-76-6,Not Classified,Notified C&L,32.0,Not classified:32
9318,2-chloro-5-(fluorosulpho)benzoic acid,244-338-9,21346-66-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39.0,H314:39;H318:38
9321,"4H-Benzo[4,5]cyclohepta[1,2-b]thiophen-4-one, 10-methoxy-",611-873-8,59743-84-9,Not Classified,Notified C&L,3.0,Not classified:2;H302:1
9324,"Trihexyl benzene-1,2,4-tricarboxylate",216-208-1,1528-49-0,Aquatic Chronic 4,REACH registration C&L,112.0,H413:34;Not classified:78
9327,1-chlorohexane,208-859-5,544-10-5,Flam. Liq. 3,REACH registration C&L,74.0,H226:74;H319:1;H315:1
9332,"Isodecyl 3,5,5-trimethylhexanoate",261-674-1,59231-35-5,Not Classified,REACH registration C&L,13.0,Not classified:13
9333,2-PHENYL-2-HEXENENITRILE,618-464-3,9011-05-6,Not Classified,Notified C&L,210.0,Not classified:123;H319:73;H315:86;H335:27;H317:25
9334,Ethyl 2-(triphenylphosphoranylidene)propionate,227-215-4,5717-37-3,Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H319:4;H335:3;H312:2;H315:2;H332:2;H302:1;H413:1
9336,7-(diethylamino)-4-methyl-2-benzopyrone,202-068-9,91-44-1,Aquatic Chronic 3,REACH registration C&L,801.0,H412:6;H312:464;H319:490;H315:473;H332:464;H335:469;Not classified:202;H411:121;H302:18;H314:1;H317:1;H341:1;H331:1;H350:1;H301:1;H311:1
9338,3-hydroxy-4-[(2-hydroxynaphthyl)azo]-7-nitronaphthalene-1-sulphonic acid,240-379-1,16279-54-2,Not Classified,Notified C&L,1.0,Not classified:1
9341,"WE 941 NV/II ""Aminothiophen",609-770-8,40017-58-1,Aquatic Chronic 2,Notified C&L,1.0,H411:1
9343,"4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-[[3,9,11-trimethyl-8-[1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-, [6S-[6α(2S*,3S*),8β(R*),9β,11α]]-",258-084-1,52665-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:39;H315:39;H335:39;H302:3;H332:3;H312:3
9345,4-chlorobenzhydryl alcohol,204-333-4,119-56-2,,Notified C&L,3.0,H302:2;H412:1
9346,Hexanol acetate branched and linear,618-129-1,88230-35-7,Aquatic Chronic 2,Notified C&L,220.0,H411:220;H226:44
9350,Disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-),276-649-0,72403-66-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,114.0,H411:63;H317:58;Not classified:48;H334:1;H319:2;H412:2
9353,Oxitropium bromide,250-113-6,30286-75-0,Not Classified,Notified C&L,1.0,Not classified:1
9354,4-Methylbenzenesulfonic acid monohydrate,612-715-0,6192-52-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,924.0,H318:624;H315:856;H335:920;H314:152;H319:296;H290:41;H312:1;H302:2
9355,"Soaps, stocks, rice bran-oil, acidulated",296-964-7,93165-76-5,Not Classified,Notified C&L,1.0,Not classified:1
9356,"1,3-Diaminotoluene, propoxylated",500-774-4,63641-63-4,Eye Irrit. 2,Notified C&L,83.0,H319:83
9360,Hydrocortisone 21-(sodium succinate),204-725-5,125-04-2,Not Classified,Notified C&L,8.0,Not classified:3;H361:3;H373:1;H312:2;H319:2;H315:1;H332:1;H335:1;H302:1
9365,4-aminobenzylsuccinic acid,262-800-8,61445-53-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
9367,Magnesium dichromate,237-959-1,14104-85-9,Acute Tox. 4;Skin Sens. 1;Carc. 1A;Aquatic Chronic 1,Notified C&L,34.0,H350:34;H302:26;H410:34;H317:34;H400:8
9370,Polydimethylsiloxane with aminoalkyl groups,614-170-4,67923-07-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,269.0,H319:204;H315:241;H318:59;Not classified:6;H226:1
9371,"1H,3H-Pyrrolo[1,2-c][1,3,2]oxazaborole, tetrahydro-1-methyl-3,3-diphenyl-, (3aR)-",443-530-1,112022-83-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,83.0,H302:83;H318:83
9373,Cyclononanone,222-108-9,3350-30-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38
9374,"4-chloro-N,N-dimethylbutyramide",245-244-0,22813-58-7,,Notified C&L,2.0,H302:2;H332:2;H319:2;H312:2;H315:1;H335:1
9377,"[nitrilotris(methylene)]trisphosphonic acid, ammonium salt",251-908-0,34274-28-7,Met. Corr. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,38.0,H290:20;H319:18;H412:35;Not classified:2
9378,Diisobutyl maleate,238-102-4,14234-82-3,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1.0,H315:1;H317:1
9380,3-ethylbenzothiazolium iodide,221-495-1,3119-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
9387,Benzo[c]cinnoline,205-936-5,230-17-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H302:38;H319:38;H315:38;H335:38;Not classified:3
9389,"p,p'-oxybisphenol",217-809-1,1965-09-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,136.0,H318:135;H315:136;H317:135;H335:135;H302:135;H319:1
9390,Octadecyne,211-114-7,629-89-0,Asp. Tox. 1,Notified C&L,1.0,H304:1
9392,Guaifenesin,202-222-5,93-14-1,Acute Tox. 4,Notified C&L,727.0,H302:683;H319:43;H315:43;H335:43;Not classified:46;H361:10
9398,"3,4-xylidine",202-437-4,95-64-7,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,54.0,H373:52;H331:53;H411:53;H302:3;H311:53;H301:51;H319:2;H315:2;H335:2
9404,Isononyl propionate,265-573-3,65155-45-5,Not Classified,Notified C&L,113.0,Not classified:113
9407,"Palygorskite, calcined",302-243-0,94095-36-0,Not Classified,Notified C&L,4.0,Not classified:4
9409,"1-hydroperoxy-2,7,7-trimethylbicyclo[3,1,1]heptane",616-792-1,8002-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,631.0,H319:368;H315:498;H335:167;H318:105;H304:253;H317:215;H341:106;H226:189;H410:110;H351:106;H400:106;Not classified:82;H411:67;H412:40;H332:6
9413,"1,3-dichloro-2,2-bis(chloromethyl)propane",221-763-8,3228-99-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
9416,"2-(4-Brom-2,6-difluorphenyl)-4H-1,3-dithiin-1-iumtrifluormethansulfonat",928-514-9,,Skin Corr. 1B,REACH registration C&L,2.0,H314:2
9417,"troclosene sodium ;troclosene sodium, dihydrate",220-767-7,2893-78-9,,,0.0,H319:0;H272:0;H410:0;H335:0;H302:0;H400:0
9421,"Sage, Salvia sclarea, ext.",283-911-8,84775-83-7,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1742.0,H412:1549;H317:1738;H319:1627;H315:1704;H226:83;H411:6;H318:2;H316:1;H304:1
9423,4-Methoxy-2-methylphenylacetonitrile,607-891-0,262298-02-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 3,Notified C&L,1.0,H301:1;H331:1;H311:1;H335:1
9424,"1,4-dihydroxybenzene;hydroquinone;quinol",204-617-8,123-31-9,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Acute 1,Harmonised C&L,0.0,H318:0;H341:0;H317:0;H351:0;H302:0;H400:0
9426,"5-{[4-({2-[methyl(2-pyridinyl)amino] ethyl} oxy)phenyl]methyl}-1,3-thiazolidine-2,4-dione",924-121-1,122320-73-4,Eye Irrit. 2;Repr. 2;Aquatic Chronic 1,Notified C&L,1.0,H319:1;H410:1;H361:1
9428,1H-imidazole-1-ethanol,216-565-3,1615-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:39;H315:39;H335:39;H302:1;H332:1;H312:1
9430,Tetraethylammonium fluoride,211-559-7,665-46-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H312:38;H319:40;H315:40;H332:38;H335:39;H302:38
9431,pentyl acetate,211-047-3,628-63-7,Flam. Liq. 3,Harmonised C&L,0.0,H226:0
9432,Niobium pentaiodide,237-422-1,13779-92-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:42;H318:38
9433,Aluminium hydroxide oxide,246-368-8,24623-77-6,Not Classified,Notified C&L,262.0,Not classified:226;H341:32;H413:4
9434,Cefuroxime,259-560-1,55268-75-2,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,14.0,H334:13;H317:13;H319:1;H315:1;H335:1
9437,(hydroxyethyl)dimethylammonium toluene-p-sulphonate,263-970-6,63150-14-1,,Notified C&L,1.0,Not classified:1
9439,"1,2-Benzenedicarboxylic acid, diheptyl ester, branched and linear",271-086-7,68515-44-6,,Notified C&L,3.0,Not classified:3
9440,4-cyclohexyl-4-methylpentan-2-one,225-562-6,4927-39-3,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1539.0,H315:1538;H411:26;H332:1;Not classified:1
9441,[No public or meaningful name is available],447-210-2,,Not Classified,Notified C&L,1.0,Not classified:1
9444,2-Chloro-4-cyanopyridine,608-852-0,33252-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H319:51;H315:51;H335:50;H332:6;H302:7;H311:6;H312:3;H341:1;H331:3;H301:2;H317:1;H334:1
9445,"7-[4-[4-Chloro-6-(p-vinylsulfonylanilino)-1,3,5-triazin-2-ylamino]-2-ureidophenylazo]-1,3,6-naphthalenetrisulfonic acid trisodium salt",619-096-6,95042-29-8,Eye Dam. 1;Resp. Sens. 1,Notified C&L,1.0,H334:1;H318:1
9446,Ytterbium,231-173-2,7440-64-4,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49.0,H312:41;H319:40;H315:40;H332:41;H335:40;H302:41;H228:41;H260:4;H250:5;H252:5;Not classified:3;H413:2
9449,"2,5-xylylacetic acid",237-097-6,13612-34-5,,Notified C&L,7.0,H319:7;H315:7;H335:6
9451,"Indigofera tinctoria, ext.",283-892-6,84775-63-3,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,19.0,H319:19;H317:16
9453,Ichthammol,232-439-0,8029-68-3,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,6.0,H412:6;H319:6
9455,"Alcohols, C12-14 (even numbered)-secondary, .beta.-(2-hydroxyethoxy), ethoxylated",604-520-4,146340-15-0,Acute Tox. 4,Notified C&L,57.0,H302:57;H319:1
9458,"reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride",404-540-1,,Skin Sens. 1,Harmonised C&L,0.0,H317:0
9460,"Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, ethyl ester",609-718-4,39562-16-8,,Notified C&L,1.0,Not classified:1
9461,5-(Methoxycarbonyl)pyridine-2-carboxylic acid,672-842-2,17874-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H319:4;H315:4;H335:4;H302:1
9463,3-(4-amino-2-methylpyrimidin-5-ylmethyl)-5-(2-hydroxyethyl)-4-methylthiazole-2(3H)-thione,206-077-9,299-35-4,Eye Irrit. 2,REACH registration C&L,1.0,H319:1
9464,Iron dichloride,231-843-4,7758-94-3,Met. Corr. 1;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,233.0,H290:82;H318:212;H302:222;H317:37;H315:61;H412:38;Not classified:10;H314:9;H319:2;H335:2;H411:2;H332:1;H312:1;H341:1;H301:1
9467,"Storax (balsam), sapond.",305-798-7,95009-68-0,Flam. Liq. 3,Notified C&L,25.0,H226:25
9469,Chlorodiisobutylaluminium,217-216-8,1779-25-5,Flam. Liq. 2;Pyr. Liq. 1;Water-react. 2;Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,132.0,H314:132;H225:41;H330:41;H261:41;H250:128;H260:91;H318:83;H336:4;H304:4;H224:4;H361:4;H373:4;H411:4
9485,C.I. Acid Brown 355,611-943-8,60181-77-3,Not Classified,Notified C&L,1.0,Not classified:1
9487,Decyl diphenyl phosphite,221-939-4,3287-06-7,Aquatic Chronic 2,Notified C&L,1.0,H411:1
9496,"2-nitro-p-xylene-α,α'-diol",245-503-8,23222-97-1,Skin Sens. 1,Notified C&L,38.0,H317:38
9497,"Soaps, manuf. of, glycerol-caustic wastes from",297-908-4,93763-88-3,Not Classified,Notified C&L,1.0,Not classified:1
9499,Iron dilactate,227-608-0,5905-52-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,987.0,H302:951;H319:951;H315:951;H335:951;H301:24;Not classified:12
9500,"2-Propanol, 1,1',1'',1'''-[iminobis(2,1-ethanediylnitrilo)]tetrakis- (9CI)",616-225-8,754930-99-9,Eye Irrit. 2,Notified C&L,1.0,H319:1
9501,"Lauric acid, compound with 2,2'-iminodiethanol (1:1)",231-297-7,7487-79-8,Not Classified,Notified C&L,6.0,Not classified:5;H319:1;H315:1
9505,N-Benzylquininium Chloride [Chiral Phase-Transfer Catalyst],614-029-7,67174-25-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
9506,Cefaclor,258-909-5,53994-73-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,80.0,H334:78;H317:80;H332:2;H319:1
9509,"2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol, oligomeric reaction products with Propylene oxide and n-butyl glycidyl ether",926-564-6,,Acute Tox. 4,REACH registration C&L,1.0,H302:1
9510,Trihydro(4-phenylmorpholine-N4)boron,282-452-0,84215-46-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38.0,H314:38;H318:38
9514,C.I. Solvent Yellow 79,602-681-5,12237-31-9,Not Classified,Notified C&L,69.0,Not classified:69
9516,Hydrogen bis[N-[7-hydroxy-8-[[2-hydroxy-5-[(methylamino)sulphonyl]phenyl]azo]-1-naphthyl]acetamidato(2-)]chromate(1-),235-404-8,12218-95-0,Eye Irrit. 2,Notified C&L,34.0,H319:30;H317:10;Not classified:4
9520,1-Eicosanethiol,603-761-2,13373-97-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:1;H315:1;Not classified:1
9521,Isopropylammonium chloride,239-629-2,15572-56-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:3;H315:3;H312:1;H332:1;H335:1;H302:1
9523,p-chlorophenoxyacetyl chloride,223-923-2,4122-68-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43.0,H314:43;H318:39;H290:1
9525,ethylene dimethacrylate,202-617-2,97-90-5,Skin Sens. 1;STOT SE 3,Harmonised C&L,0.0,H335:0;H317:0
9526,"androsta-1,4,9(11)-triene-3,17-dione",433-560-3,15375-21-0,Repr. 2,Harmonised C&L,0.0,H361:0
9527,C.I. Basic Blue 3,611-321-6,55840-82-9,Not Classified,Notified C&L,1.0,Not classified:1
9528,Isooctyl oleate,247-981-3,26761-50-2,Not Classified,Notified C&L,1.0,Not classified:1
9531,"6,8-dianilinonaphthalene-1-sulphonic acid",204-970-8,129-93-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,37.0,H412:37;H319:37
9535,acetonitrile;cyanomethane,200-835-2,75-05-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Harmonised C&L,0.0,H312:0;H319:0;H225:0;H332:0;H302:0
9537,"Formaldehyde, reaction products with hexahydro-1,3-isobenzofurandione and triethylenetetramine",614-531-6,68478-68-2,Not Classified,Notified C&L,10.0,Not classified:9;H319:1;H315:1;H317:1
9538,"Aromatic hydrocarbons, C",292-694-9,90989-38-1,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0
9543,3-chloropropylamine hydrochloride,228-474-6,6276-54-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,61.0,H319:61;H315:61;H335:59;H317:12;H334:12
9548,Cobalt(2+) disulphamate,237-834-1,14017-41-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,47.0,H315:41;H341:6;H317:47;H350:2;H400:42;H411:2;H302:42;H360:2;H319:39;H351:40;H335:39;H334:40;H361:1;H410:1
9549,Isobutylcyclopentane,223-257-2,3788-32-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,42.0,H302:38;H400:38;H226:4
9551,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and methylenediphenol",609-794-9,40216-08-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,295.0,H411:294;H319:295;H315:295;H317:295
9554,"3-(dimethylamino)-N,N-dimethylpropionamide",241-304-5,17268-47-2,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1;Eye Irrit. 2,REACH registration C&L,3.0,H302:3;H314:3;H319:2;H225:2;H312:1
9556,Tri[oxalato(2-)]diholmium,221-886-7,3269-15-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H312:1
9557,Bis(nonanoyloxy)dioctylstannane,288-877-8,85938-43-8,STOT RE 2;Aquatic Chronic 4,Notified C&L,56.0,H413:56;H373:56
9558,4-bromoveratrole,220-677-8,2859-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:1
9562,"1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole",411-650-3,110895-43-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H400:0;H410:0;H331:0
9563,"Reaction product of 2,3-epoxypropyl neodecanoate and Benzenesulfonic acid, C10-13-sec-alkyl derivatives",920-724-9,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2.0,H319:2;H315:2;H411:2
9565,"Rose, Rosa centifolia, ext.",283-289-8,84604-12-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2,Notified C&L,200.0,H319:140;H315:157;H341:150;H317:163;H351:150;Not classified:37;H318:22;H412:7;H411:2
9569,"9-[2-(2-methoxyethoxy)ethoxy]-9-[3-(oxiranylmethoxy)propyl]-2,5,8,10,13,16-hexaoxa-9-silaheptadecane",289-390-3,88127-84-8,Muta. 2;STOT RE 2,REACH registration C&L,57.0,H373:2;H341:2;Not classified:55
9572,Benzothiazol-6-amine,208-559-4,533-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
9581,"Amines, C16-18 and C18-unsatd. alkyl",268-219-6,68037-95-6,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,86.0,H314:86;H304:55;H410:55;H373:56;H302:86;H400:86;H318:30;H335:1
9584,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with hexamethylenediamine",500-134-4,56727-50-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H319:1;H315:1;H317:1
9586,"(5α)-7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one",208-085-8,508-54-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39.0,H330:38;H300:38;H310:38;H301:1;H331:1;H317:1
9588,"Acetic acid ethenyl ester, homopolymer",618-358-7,9003-20-7,Not Classified,Notified C&L,334.0,Not classified:332;H302:2;H332:2;H319:2;H315:2
9597,nickel sulfate,232-104-9,7786-81-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0.0,H360:0;H315:0;H317:0;H341:0;H410:0;H332:0;H350:0;H372:0;H334:0;H302:0;H400:0
9600,dimethyldichlorosilane,200-901-0,75-78-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H315:0;H335:0;H225:0
9602,"2,4,6-triisopropyl-m-phenylene diisocyanate",218-485-4,2162-73-4,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 1;Resp. Sens. 1;STOT SE 3;Carc. 2;Aquatic Chronic 1,REACH registration C&L,27.0,H315:27;H317:1;H330:2;H410:1;H351:1;H335:27;H334:27;H332:25;H319:1
9606,"1-(9H-fluoren-9-ylmethyl) hydrogen (S)-pyrrolidine-1,2-dicarboxylate",276-259-0,71989-31-6,Not Classified,Notified C&L,8.0,Not classified:6;H302:2;H332:2;H312:1;H319:1;H315:1;H335:1
9608,2-methylthio-2-imidazoline hydroiodide,226-756-3,5464-11-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
9610,4-(methylthio)-m-cresol,221-496-7,3120-74-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,44.0,H412:1;H319:6;H315:44;H311:1;H318:38;H335:42
9612,3-[3-(5-nitro-2-furyl)-1-[2-(5-nitro-2-furyl)vinyl]allylidene]carbazamidine monohydrochloride,219-018-7,2315-20-0,Not Classified,Notified C&L,4.0,Not classified:3;H341:1
9613,Indium trinitrate,237-393-5,13770-61-1,Eye Irrit. 2;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,45.0,H412:4;H319:43;H372:2;H272:41;H315:41;H335:39
9614,Ethyl 2-(4-vinylphenoxy)isobutyrate,257-707-4,52179-09-6,Not Classified,REACH registration C&L,1.0,Not classified:1
9616,"2,2-dimethylpentane",209-680-5,590-35-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H336:0;H304:0;H315:0;H225:0;H410:0;H400:0
9617,"Watermelon, ext.",290-802-9,90244-99-8,Flam. Liq. 3,Notified C&L,1297.0,H226:1287;Not classified:10
9619,"(1-hydroxyethylidene)bisphosphonic acid, ammonium salt",251-909-6,34274-29-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1
9622,"Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite",308-361-9,97952-68-6,Not Classified,Notified C&L,139.0,Not classified:126;H411:13
9623,Opopanax (resin),297-241-9,93384-32-8,Asp. Tox. 1,Notified C&L,112.0,H304:112
9625,3-(fluorosulphonyl)benzoyl chloride,207-231-8,454-93-3,Skin Corr. 1B,Notified C&L,1.0,H314:1
9626,Amodiaquine hydrochloride,200-706-0,69-44-3,Acute Tox. 4,Notified C&L,18.0,H302:18
9628,Galactaric acid,208-404-0,526-99-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:1;H315:1;Not classified:1
9629,2-(ethylnitroamino)ethyl nitrate,285-332-6,85068-73-1,Expl. 1.3;Acute Tox. 4,REACH registration C&L,4.0,H302:2;H203:4
9631,2-(2-piperazin-1-ylethoxy)ethanol,603-746-0,13349-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:45;H315:45;H335:44;Not classified:1
9632,Prednisone 21-acetate,204-726-0,125-10-0,Repr. 2;STOT RE 2,REACH registration C&L,3.0,H373:2;H361:2;H302:1
9633,MCPA,222-895-9,3653-48-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,212.0,H312:212;H410:212;H332:212;H302:212;H400:212
9635,"2,4-dinitroaniline",202-553-5,97-02-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H300:0;H330:0;H310:0;H373:0;H411:0
9636,"1,3,5-tris(2-methyl-2-propenyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione",421-120-3,6291-95-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,42.0,H302:9;H412:5;Not classified:32
9637,"Tetrasodium [3-[[8-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-1-hydroxy-3,6-disulpho-2-naphthyl]azo]-4-hydroxynaphthalene-1,5-disulphonato(6-)]cuprate(4-)",238-739-8,14692-76-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,59.0,H411:1;H317:56;Not classified:2;H412:1
9638,"4-Bromo-2,8-bis(trifluoromethyl)quinoline",609-183-7,35853-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
9639,"D-Glucopyranose, oligomeric, C10-16-alkyl glycosides, carboxymethyl ethers, sodium salts",609-542-8,383178-66-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,268.0,H319:268;H315:185
9642,"N,N-dimethyl-3-(trimethoxysilyl)propylamine",219-786-3,2530-86-1,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,91.0,H318:53;H317:4;H314:40;Not classified:36;H335:11;H319:1;H315:1
9644,Ethyl oct-2-enoate,219-087-3,2351-90-8,Not Classified,Notified C&L,88.0,Not classified:88
9647,xx,601-136-9,111905-50-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
9648,"2-ethyl-N,N-bis(2-ethylhexyl)hexylamine",217-461-0,1860-26-0,Repr. 2;STOT RE 2,REACH registration C&L,964.0,H373:589;H361:589;H400:290;H410:268;Not classified:72;H412:10;H319:11;H315:11;H314:1;H318:1;H413:1
9651,"2,4,6-triiodophenol",210-186-7,609-23-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H312:39;H319:45;H315:45;H332:39;H335:43;H302:6;Not classified:1
9658,"Calcium, carbonate hydroxy aluminum complexes",307-546-1,97660-35-0,Eye Irrit. 2,Notified C&L,2.0,H319:2
9669,Ytterbium trichloride,233-800-5,10361-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94.0,H319:93;H315:93;H335:93;Not classified:1
9670,Methylammonium bromide,229-981-5,6876-37-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H302:41;H319:42;H315:42;H335:41
9671,"1,3,5-Triazine-2,4,6-triamine, N,N',N''-tris[4-[(1,4-dimethylpentyl)amino]phenyl]-",601-761-7,121246-28-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16.0,H400:16;H410:16;H317:16
9672,"1-Propanaminium, 3-((9,10-dihydro-4-(methylamino)-9,10-dioxo-1-anthracenyl)amino)-N,N-dimethyl-N-propyl-, bromide",481-170-7,502453-61-4,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,4.0,H302:4;H412:4
9673,"3,4-dinitrobenzyl alcohol",279-178-9,79544-31-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H302:2;H332:2;H312:2
9675,Methyl 3β-hydroxyurs-12-en-28-oate,250-953-3,32208-45-0,Not Classified,Notified C&L,1.0,Not classified:1
9679,"Alkanes, C11-15-iso-",292-460-6,90622-58-5,Asp. Tox. 1,Notified C&L,1114.0,H304:1059;H413:100;H362:83;H312:55;H314:55;H318:72;H317:72;H302:55;H412:14;H226:13;H336:1
9686,"2-Propenoic acid, 2-methyl-, polymer with methyl 2-methyl-2-propenoate",607-538-0,25086-15-1,Not Classified,Notified C&L,128.0,Not classified:128
9687,N-benzylaniline,203-100-4,103-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:43
9690,"1,3-dichloro-5-isocyanatobenzene",252-276-9,34893-92-0,Skin Sens. 1A;Acute Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,132.0,H330:92;H411:3;H335:132;H317:3;H319:125;H315:129;H334:89;H331:40;H301:40;H311:40;H318:4;H300:1;H302:1
9693,"Sodium 4-[[3-[(2,4-dimethylphenyl)azo]-2,4-dihydroxyphenyl]azo]benzenesulphonate",228-900-0,6371-84-2,Not Classified,Notified C&L,13.0,Not classified:9;H334:4;H319:4;H317:4
9694,"O,O-diisooctyl hydrogen dithiophosphate",248-161-8,26999-29-1,,Notified C&L,2.0,Not classified:1;H314:1;H318:1
9696,dihexyl phthalate,201-559-5,84-75-3,Repr. 1B,Harmonised C&L,0.0,H360:0
9697,4-phenylcyclohexylamine,243-453-1,19992-45-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1.0,H302:1;H314:1;H332:1;H312:1
9698,"Formaldehyde, polymer with 1-phenylethanone",607-723-6,25398-55-4,Not Classified,Notified C&L,139.0,Not classified:139
9707,"Diethyl oxaloacetate, monosodium salt",255-122-9,40876-98-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,76.0,H302:74;H319:43;H315:41;H412:33;H311:33;H312:1;H332:1
9709,2-fluorobenzonitrile,206-897-7,394-47-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46.0,H302:46;H318:38;H315:46;H335:44;H312:6;H319:8;H332:2
9710,"Fatty acids, tall-oil, 2-ethylhexyl esters",269-811-7,68334-13-4,Not Classified,Notified C&L,12.0,Not classified:10;H413:2
9711,Potassium azide,244-013-1,20762-60-1,Acute Tox. 2,Notified C&L,38.0,H300:38
9714,"2-methylcyclohexane-1,3-diamine",237-667-4,13897-56-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,116.0,H302:83;H314:83;H318:83;Not classified:33
9719,"R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate",404-390-7,,Flam. Sol. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H228:0;H317:0
9724,3-(1-cyanoethyl)benzoyl chloride,255-980-4,42872-29-7,Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1.0,H412:1;H318:1;H335:1;H317:1
9728,(S)-2-(1-BOC-2-pyrrolidinyl)acetic acid,611-392-3,56502-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
9729,"Fatty acids, C16-18, isohexadecyl esters",288-669-7,85865-70-9,Not Classified,Notified C&L,2.0,Not classified:2
9730,"2-Chloromethyl-3,4-dimethoxypyridinium chloride",615-850-3,72830-09-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,43.0,H312:41;H318:42;H315:42;H317:41;H373:41;H411:42;H302:42;H319:1;H335:1
9731,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-phosphinicobis[.omega.-hydroxy-, di-C12-14 (even numbered)-alkyl ethers, potassium salts",615-845-6,72828-56-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28.0,H318:28;H315:28
9732,"8-aminonaphthalene-1,3,6-trisulphonic acid",204-188-7,117-42-0,Not Classified,Notified C&L,32.0,Not classified:32
9735,"4-acetyl-2,6-dimethoxyphenyl acetate",248-942-3,28294-47-5,Acute Tox. 4,Notified C&L,38.0,H302:38
9738,"Paraffin waxes (petroleum), low-melting, hydrotreated",295-457-8,92045-75-5,Not Classified,Notified C&L,2.0,Not classified:2
9742,4-Fluorobenzenesulfinic acid sodium salt,700-029-5,824-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H319:3;H315:3;H335:3;H302:1
9749,uranium,231-170-6,7440-61-1,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0.0,H330:0;H300:0;H413:0;H373:0
9750,2-methylundecan-4-one,243-176-6,19594-40-2,Aquatic Chronic 2,Notified C&L,38.0,H411:38
9753,"indoxacarb (ISO);methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate",605-683-4,173584-44-6,Acute Tox. 3;Skin Sens. 1B;Acute Tox. 4;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H410:0;H332:0;H372:0;H301:0;H400:0
9754,"1-Ethoxy-2,3-difluoro-4-[trans-4-(trans-4-propylcyclohexyl)-cyclohexyl]-benzene",602-941-8,123560-48-5,STOT RE 2,REACH registration C&L,1.0,H373:1
9756,Bamethan sulphate,227-214-9,5716-20-1,Acute Tox. 4,Notified C&L,38.0,H302:38
9760,Melibiose,209-568-6,585-99-9,Not Classified,Notified C&L,3.0,Not classified:3
9762,Ethylhexyl acrylate,215-330-2,1322-13-0,Not Classified,Notified C&L,2.0,Not classified:2
9764,Ethyl 2-methylbutyrate,231-225-4,7452-79-1,Flam. Liq. 3,REACH registration C&L,1859.0,H226:1858;H302:1;H411:1
9766,chlorothalonil (ISO);tetrachloroisophthalonitrile,217-588-1,1897-45-6,Eye Dam. 1;Skin Sens. 1;Acute Tox. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H317:0;H330:0;H410:0;H351:0;H335:0;H400:0
9772,2-Methylpropane-2-sulphinamide,619-964-4,146374-27-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6.0,H301:3;H319:5;H336:3;H315:5;H335:2;Not classified:1
9774,"reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)",414-770-4,140698-96-0,Self-react. C;Carc. 2,Harmonised C&L,0.0,H242:0;H351:0
9777,Cyclohexyl cinnamate,231-921-8,7779-17-1,Not Classified,Notified C&L,88.0,Not classified:88
9778,5-(phenylazo)salicylic acid,221-569-3,3147-53-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H302:39;H319:38
9780,"Benzenamine, reaction products with aniline hydrochloride and nitrobenzene",309-912-6,101357-15-7,Self-heat. 2,REACH registration C&L,329.0,H252:162;Not classified:130;H312:33;H361:27;H317:27;H332:33;H351:27;H370:27;H373:34;H411:27;H372:27;H302:33;H413:1;H412:1
9784,"5-(1H-1,2,4-Triazol-1ylmethyl)-1H-indole-3-ethanol",620-292-9,160194-39-8,Acute Tox. 4,REACH registration C&L,2.0,H302:2;H305:2
9788,6-chloro-5-methoxypyrimidin-4-amine,225-700-5,5018-41-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
9793,N-methylpropionamide,214-699-7,1187-58-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
9795,dinickel boride,234-494-6,12007-01-1,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H317:0;H410:0;H350:0;H372:0;H400:0
9797,Scandium triiodide,238-469-0,14474-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,47.0,H360:38;H319:47;H315:47;H335:47
9801,"1,8-dimethylnaphthalene",209-314-4,569-41-5,Not Classified,Notified C&L,3.0,Not classified:3
9808,[2-(dimethylamino)ethyl]triphenylphosphonium bromide,244-335-2,21331-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42
9809,"Glycerides, wheat germ-oil mono-, di- and tri-",614-884-6,68990-07-8,Not Classified,Notified C&L,1.0,Not classified:1
9810,2-bromo-2-nitropropanol,407-030-7,24403-04-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H314:0;H317:0;H410:0;H373:0;H302:0;H400:0;H311:0
9816,6-HYDROXY-1-(2-PHENYLETHYL)-4-(PHENYLMETHYL)-2-PIPERAZINONE,600-720-0,106148-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H315:2;H335:2
9817,4-isopropylbenzyl acetate,261-671-5,59230-57-8,Acute Tox. 4,Notified C&L,1549.0,H302:1549
9818,4-ethylamino-3-nitrobenzoic acid,412-090-2,2788-74-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H412:0;H317:0
9820,Chlorthal-dimethyl,217-464-7,1861-32-1,Not Classified,Notified C&L,4.0,Not classified:4
9823,"Quaternary ammonium compounds, benzyl-C16-18-alkyldimethyl, chlorides",271-754-8,68607-20-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,66.0,H302:66;H318:64;H315:64;H400:5;H314:2
9827,"1,4-bis(pentylamino)anthraquinone",220-161-2,2646-15-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39.0,H319:38;H315:38;Not classified:1
9828,Ammonium perfluorohexane-1-sulphonate,269-511-6,68259-08-5,Not Classified,Notified C&L,22.0,Not classified:22
9831,"3,8-diamino-5-methyl-6-phenylphenanthridinium bromide",208-256-7,518-67-2,Not Classified,Notified C&L,115.0,Not classified:41;H319:74;H315:74;H335:73;H302:2;H332:2;H312:2
9832,"5-[(1E)-2-bromoethenyl]-2'-deoxy-, 3',5'-bis(4-chlorobenzoate) uridine",618-029-8,87531-10-0,Not Classified,REACH registration C&L,1.0,Not classified:1
9835,5-phenyl-2-(2-phenylpropan-2-yl)-2H-tetrazole,700-215-6,165670-57-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1
9839,Dimethyltetradecylammonium acetate,246-123-5,24287-35-2,,Notified C&L,39.0,H314:39
9842,"Chromate(5-), bis[4-(hydroxy-κO)-7-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-3-[2-[2-(hydroxy-κO)- 3-nitro-5-sulfophenyl]diazenyl]-2-naphthalenesulfonato(4-)]-, sodium (1:5)",415-070-1,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,33.0,H412:33;H318:33;H317:33
9844,DRIMAREN ORANGE X-3LGN CONC.,400-800-3,,Not Classified,Notified C&L,37.0,Not classified:37
9850,azobenzene,203-102-5,103-33-3,Acute Tox. 4;Acute Tox. 4;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H341:0;H410:0;H332:0;H373:0;H350:0;H302:0;H400:0
9856,Trisodium hydrogen diphosphate,238-735-6,14691-80-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,66.0,H302:64;H318:64;Not classified:2
9858,2-methyloctan-2-ol,211-044-7,628-44-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41.0,H318:40;H226:40;H315:41;H335:41;H302:1;H319:1
9865,(carboxymethyl)trimethylammonium hydroxide,209-684-7,590-47-6,,Notified C&L,40.0,Not classified:40
9868,Lead bis(4-cyclohexylbutyrate),263-663-7,62637-99-4,,Notified C&L,5.0,H360:5;H410:4;H332:4;H373:5;H302:5;H400:4
9870,(3-hydroxy-1-adamantyl)(oxo)acetic acid,615-199-5,709031-28-7,,Notified C&L,5.0,H314:4;H318:3;H335:4;H319:1;H315:1
9871,"Nona-2,4-dien-1-al",229-810-4,6750-03-4,Skin Sens. 1,Notified C&L,185.0,H317:138;Not classified:47
9876,5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide;potassium,610-790-4,52169-36-5,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,4.0,H302:4;H413:4
9877,3-ethoxy-4-hydroxy-benzeneacetic acid,616-789-5,80018-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3.0,H319:3;H315:3;H335:3
9881,"3,4-dimethoxyphenylacetonitrile",202-225-1,93-17-4,Acute Tox. 3,REACH registration C&L,185.0,H301:88;H302:97;H312:5;H331:1;H311:1
9883,Hexadecanal,211-111-0,629-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
9886,"2-Norpinene, 2,6-dimethyl-6-(4-methyl-3-pentenyl)-, trans-(-)",603-860-0,13474-59-4,Asp. Tox. 1,Notified C&L,26.0,H304:25;Not classified:1
9895,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-isoleucine,276-255-9,71989-23-6,Not Classified,Notified C&L,7.0,Not classified:5;H302:2;H332:2;H312:2
9897,trifluoroiodomethane;trifluoromethyl iodide,219-014-5,2314-97-8,Muta. 2,Harmonised C&L,0.0,H341:0
9899,"Silicic acid (H4SiO4), tetraethyl ester, hydrolyzed",270-184-7,68412-37-3,Not Classified,Notified C&L,69.0,Not classified:50;H226:19
9902,cellulase,232-734-4,9012-54-8,Resp. Sens. 1,Harmonised C&L,0.0,H334:0
9905,"Cyclohexanebutanoic acid, 2-propen-1-yl ester",616-169-4,7493-65-4,Not Classified,Notified C&L,88.0,Not classified:88
9906,"Naphthalenesulfonic acid, bis(tripropylene)-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",617-628-1,84798-64-1,,Notified C&L,1.0,Not classified:1
9911,3-hydroxy-2-hydroxymethyl-6-methylpyridine,255-657-8,42097-42-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
9912,Magnesium adipate,231-294-0,7486-39-7,Not Classified,Notified C&L,2.0,Not classified:2
9913,"Eucalyptus smithii, ext.",294-962-0,91771-68-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,11.0,H319:5;H304:11;H315:7;H317:11;H226:11;H411:11
9918,"1,4-dimercaptobutane-2,3-diol",231-563-2,7634-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H302:38;H319:38;H315:38;H335:38
9919,Sodium gluconate,208-407-7,527-07-1,Not Classified,Notified C&L,1151.0,Not classified:1138;H302:11;H319:1;H312:1
9923,1-Amino-1-cyclopropanecarboxylic acid,606-917-8,22059-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42
9926,"Oils, fish, sulfonated, potassium salts",293-736-9,91082-25-6,Not Classified,Notified C&L,3.0,Not classified:2;H319:1
9928,"Trinonyl benzene-1,2,4-tricarboxylate",252-552-9,35415-27-1,Not Classified,Notified C&L,2.0,Not classified:2
9929,"(1R)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane",227-336-2,5794-03-6,Flam. Sol. 1,Notified C&L,55.0,H228:52;H400:13;H319:13;H410:13;Not classified:3
9941,Disodium sebacate,241-300-3,17265-14-4,Eye Irrit. 2,REACH registration C&L,633.0,H319:118;Not classified:515
9942,"1,2-dibromo-1,1-dichloroethane",200-904-7,75-81-0,,Notified C&L,4.0,H319:4;H315:4;H335:4;H301:4;H311:4
9943,"1-Propene, 1,3,3,3-tetrafluoro-, (1E)-",471-480-0,1645-83-6,Press. Gas (Liq.),REACH registration C&L,5.0,H280:5
9944,"reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]",422-040-1,426218-78-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H319:0;H315:0;H411:0
9945,Sodium anilinomethanesulphonate,247-417-6,26021-90-9,Not Classified,Notified C&L,1.0,Not classified:1
9947,[2H]hydrogen iodide,237-958-6,14104-45-1,Skin Corr. 1A,Notified C&L,38.0,H314:38
9948,"4,6-dichloro-5-nitro-pyridine",224-340-6,4316-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129.0,H319:129;H315:129;H335:129
9951,1-(4-Methoxybenzoyl)-2-pyrrolidinone,615-758-3,72432-10-1,Repr. 2,Notified C&L,3.0,H361:2;Not classified:1
9956,"1,4-bis(isopropylamino)anthraquinone",238-101-9,14233-37-5,Acute Tox. 4,REACH registration C&L,214.0,H302:3;Not classified:202;H319:8;H315:8;H335:8;H341:1;H317:1
9957,Vanadium zirconium yellow baddeleyite,269-063-1,68187-01-9,Not Classified,REACH registration C&L,15.0,Not classified:15
9958,Sodium dicaprolactamato-bis(2-methoxyethoxo)aluminate,454-350-8,,Flam. Liq. 2;Skin Corr. 1B;Skin Sens. 1;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,2.0,H314:2;H361:2;H317:2;H225:2;H373:2;H412:2
9962,"1,8-diphenylocta-1,3,5,7-tetraene",221-198-7,3029-40-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
9965,(3-Chloro-2-hydroxypropyl)cocoalkyldimethyl ammonium chloride,440-100-5,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H312:1;H318:1;H315:1;H410:1;H373:1;H302:1;H400:1;Not classified:1
9966,"Lavender, Lavandula latifolia, ext.",284-290-6,84837-04-7,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,1594.0,H319:22;H304:12;H315:1558;H317:1557;H412:11;H371:270;H226:1546;H373:899;H411:1362;H332:228;Not classified:36;H341:3
9967,"2,5-Diamino-4,6-dichloropyrimidine",611-284-6,55583-59-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:3;H315:3;H335:1;H302:1
9968,"Copper, [29H,31H-phthalocyaninetetrasulfonamidato(2-)-N29,N30,N31,N32]-, N-(2-ethylhexyl and 3-methoxypropyl) derivs.",277-222-1,73018-43-6,Not Classified,Notified C&L,36.0,Not classified:36
9971,3-ethyl-2-methylbenzothiazolium iodide,221-494-6,3119-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
9973,Dimethylgallium chloride,230-027-5,6917-81-3,Skin Corr. 1B,Notified C&L,38.0,H314:38
9974,"D-Glucitol, ethoxylated and propoxylated",500-132-3,56449-05-9,Not Classified,Notified C&L,105.0,Not classified:105
9976,"Rosin, fumarated, reaction products with formaldehyde",305-795-0,95009-65-7,Not Classified,Notified C&L,3.0,Not classified:3
9977,"Amides, coco, N-[3-(dimethylamino)propyl], alkylation products with sodium 3-chloro-2-hydroxypropanesulfonate",274-925-5,70851-08-0,Eye Dam. 1,Notified C&L,58.0,H318:52;Not classified:6
9980,4-cyanobenzoyl chloride,228-005-5,6068-72-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,50.0,H314:50;H318:42;H312:1;H302:1;H332:1;H290:1
9985,C.I. Reactive Blue 203,604-606-1,147826-71-9,Not Classified,Notified C&L,1.0,Not classified:1
9986,"dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)",407-230-4,126637-70-5,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0.0,H302:0;H317:0
9988,"N,N-dimethylhydrazine",200-316-0,57-14-7,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0.0,H314:0;H225:0;H331:0;H350:0;H411:0;H301:0
9990,"2,6-dibromo-4-cyanophenyl butyrate",223-374-9,3861-41-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,3.0,H312:2;H319:2;H315:2;H317:3;H332:3;H412:2;H335:2;H302:2;H361:1;H410:1;H301:1;H400:1
9997,10-methyl-10H-phenothiazine,214-896-8,1207-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
9998,"Residues (petroleum), steam-cracked heat-soaked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 °C to 350 °C (302 °F to 662 °F).]",297-905-8,93763-85-0,Carc. 1B,Harmonised C&L,0.0,H350:0
10000,"Sodium 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate S,S-dioxide",250-059-3,30123-17-2,Not Classified,Notified C&L,4.0,Not classified:1;H302:2;H332:1;H312:1;H301:1;H373:1;H361:1;H362:1
10002,5-isopropyl-m-cresol,221-762-2,3228-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71.0,H319:71;H315:71;H335:71
10004,"dichlone (ISO);2,3-dichloro-1,4-naphthoquinone",204-210-5,117-80-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H319:0;H315:0;H410:0;H302:0;H400:0
10005,Tetralithium pentatitanium dodecaoxide,619-916-2,12031-95-7,Not Classified,REACH registration C&L,78.0,Not classified:4;H302:38;H319:38;H315:38;H335:38;H412:35;H413:1
10007,"(-)-1-Benzyl-4-(-4-fluor-phenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine-L-dibenzoyl-tartaric salt",606-459-9,201855-57-4,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2.0,H315:2;H317:2;H373:2;H411:2;H401:2
10008,Tylosin tartrate,616-119-1,74610-55-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,92.0,H334:92;H317:92
10011,"Lanthanum, compound with nickel (1:5)",235-372-5,12196-72-4,,Notified C&L,4.0,H350:4;H228:4;H317:4
10013,Bis[2-(diphenylphosphino)ethyl]phenylphosphine,245-753-8,23582-02-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:40
10014,Mitotane,200-166-6,53-19-0,Carc. 2,Notified C&L,44.0,H351:41;Not classified:4;H361:1;H372:2;H410:1;H312:1;H360:1
10022,"Phenol, ethoxylated, esters with acrylic acid",500-133-9,56641-05-5,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,192.0,H411:60;H317:46;Not classified:73;H319:73;H315:72;H335:52;H361:32
10023,"Oxirane, 2-(chloromethyl)-, homopolymer, ether with 1,4-butanediol (2:1)",619-069-9,947328-72-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,55.0,H312:55;H319:55;H315:55;H317:55;H332:55
10027,"4-amino-2,6-dibromophenol",210-185-1,609-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
10031,Diamminedichloroplatinum,238-980-9,14913-33-8,Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,44.0,H334:43;H318:39;H317:43;H319:4;H315:4;H341:4;H335:4;H330:1;H373:1;H311:1;H340:1;H350:1;H360:1
10033,"3-(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione",240-352-4,16228-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,96.0,H319:60;H315:60;H335:38;Not classified:36;H302:22
10036,Butylnaphthalenesulphonic acid,247-982-9,26761-78-4,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,2.0,H290:2;H314:2;H318:2
10037,Butyl isobutyrate,202-614-6,97-87-0,Flam. Liq. 3,Notified C&L,1639.0,H226:1639;H319:39;H315:39;H335:38
10038,"1,3,5-triazin-2-amine",223-920-6,4122-04-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
10044,2-methyldecan-3-one,226-755-8,5463-82-1,Aquatic Chronic 2,Notified C&L,38.0,H411:38
10048,"Naphthenic acids, compds. with diethanolamine",283-998-2,84776-69-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
10050,Iron oxide brown,257-870-1,52357-70-7,Not Classified,Notified C&L,45.0,Not classified:45
10055,"Fatty acids, mixed tallow and vegetable-oil, distn. residues",274-513-5,70248-31-6,Not Classified,Notified C&L,10.0,Not classified:10
10057,Dipotassium fluorophosphate,237-957-0,14104-28-0,Not Classified,Notified C&L,3.0,Not classified:3
10059,Ethalfluralin,259-564-3,55283-68-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,101.0,H319:56;H315:56;H317:56;H410:59;H351:56;H400:101;H332:42
10060,"Residues (coal tar), creosote oil distn.;Wash Oil Redistillate;[The residue from the fractional distillation of wash oil boiling in the approximate range of 270°C to 330°C (518°F to 626°F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]",295-506-3,92061-93-3,Carc. 1B,Harmonised C&L,0.0,H350:0
10063,"α,α,α-trifluoro-m-toluic acid",207-230-2,454-92-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46
10064,"[1,1'-Bicyclohexyl]-4-ol, 4'-pentyl-, (trans,trans)-",617-361-0,82575-70-0,Not Classified,Notified C&L,1.0,Not classified:1
10065,Thulium(3+) oxalate,221-887-2,3269-17-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H312:1
10066,Dibutylmagnesium,214-736-7,1191-47-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,39.0,H260:39;H314:39;H250:39
10067,Potassium diisotridecyl phosphate,278-036-3,74937-56-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
10072,nickel phosphinate,252-840-4,36026-88-7,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H317:0;H410:0;H350:0;H372:0;H334:0;H400:0
10079,(R)-(β-D-glucopyranosyloxy)phenylacetonitrile,202-738-0,99-18-3,Acute Tox. 3;Repr. 1B,Notified C&L,38.0,H301:38;H360:38
10080,"Castor oil, sulfated, compd. with ethanolamine",281-965-7,84082-13-3,Not Classified,Notified C&L,1.0,Not classified:1
10081,"1,2-Benzenedicarboxylic acid, di-C9-11-branched and linear alkyl esters",271-085-1,68515-43-5,Not Classified,REACH registration C&L,91.0,Not classified:90;H300:1
10082,Sodium 1-carboxylatoethyl stearate,242-090-6,18200-72-1,Not Classified,Notified C&L,37.0,Not classified:36;H319:1;H315:1
10100,acetaldehyde; ethanal,200-836-8,75-07-0,Flam. Liq. 1;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 1B,Harmonised C&L,0.0,H319:0;H224:0;H341:0;H350:0;H335:0
10104,"Dibenzo[def,mno]chrysene",205-884-3,191-26-4,Skin Irrit. 2,Notified C&L,53.0,H315:38;H350:12;Not classified:3
10105,(+/-)-1-[4-Chloro-2-(1-hydroxy-1-phenylethyl)phenyl]-3-ethylthiourea,924-673-3,,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H332:1;H335:1
10107,Ethyl 2-naphthyl ether,202-226-7,93-18-5,Eye Irrit. 2A;Aquatic Chronic 2,REACH registration C&L,1830.0,H319:483;H411:1786;H315:1788;H335:4;Not classified:1
10109,"2,5-diphenyl-p-benzoquinone",212-680-8,844-51-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H317:38;H335:42;H334:38
10110,"D-Glucose, 2-deoxy-2-(sulfoamino)-, monopotassium salt",608-599-6,31284-96-5,Not Classified,Notified C&L,3.0,Not classified:3
10111,Dichlorodiphenylgermane,216-562-7,1613-66-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43.0,H312:38;H319:38;H315:38;H332:38;H335:38;H302:38;H314:5;H290:1;H318:1
10112,Iron(2+) disulphamate,237-833-6,14017-39-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
10117,"2-[2-(2,4-difluorophenyl)prop-2-en-1-yl]propane-1,3-diol",605-390-1,165115-73-1,,Notified C&L,44.0,Not classified:33;H302:11;H319:11;H412:10;H402:1
10121,"Diisononylnaphthalenedisulphonic acid, compound with triethylamine (1:2)",264-319-9,63568-33-2,,Notified C&L,1.0,Not classified:1
10122,Dextranase,232-803-9,9025-70-1,Resp. Sens. 1,Notified C&L,12.0,H334:12
10129,3-(2-pyridyl)propan-1-ol,220-676-2,2859-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
10130,"2,5-bis(3-chlorophenylamino)terephthalic acid",248-943-9,28294-55-5,Not Classified,Notified C&L,33.0,Not classified:33
10131,1-(4-chlorophenyl)piperazine dihydrochloride,254-165-0,38869-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42;H302:4
10135,"N2,N2-dimethylpyridine-2,5-diamine",225-564-7,4928-43-2,,Notified C&L,2.0,H319:1;H315:2;H335:2;H302:1;H318:1
10136,"Phospholipids, spinal cord",297-244-5,93384-34-0,Not Classified,Notified C&L,1.0,Not classified:1
10137,"α,α,α-trifluoro-o-toluic acid",207-093-9,433-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:48;H315:48;H335:47;H302:1
10140,Didysprosium trisulphate,238-345-6,14373-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:1;H315:1;H335:1;Not classified:1
10141,Methyl prop-1-enyl disulphide,227-605-4,5905-47-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1374.0,H302:1374;H315:1374;H317:1374;H226:88;H319:10
10144,"Glycoproteins, blood plasma",308-281-4,97926-63-1,Not Classified,Notified C&L,1.0,Not classified:1
10145,"phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate",406-600-2,89392-03-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
10155,"Benzoic acid, C12-15-alkyl esters",270-112-4,68411-27-8,Not Classified,REACH registration C&L,315.0,Not classified:314;H319:1;H315:1
10161,4-isopropylpyridine,211-794-5,696-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
10166,Aldacide,608-494-5,30525-89-4,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1067.0,H318:722;H315:943;H317:911;H332:1034;H334:516;H302:1025;H228:739;H312:177;H319:257;H351:378;H335:433;H341:56;H350:37;H314:25;H336:19;H371:16;H331:5;H301:5;H311:6;H330:1;H370:1;H412:2
10170,"Lactic acid, compound with N-benzyl-1-methyl-N-phenylpiperidin-4-amine (1:1)",262-887-2,61670-09-5,,Notified C&L,1.0,H302:1
10181,Cerium tetranitrate,236-007-2,13093-17-9,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,92.0,H314:6;H318:85;H410:85;H290:2;H400:85;H272:90;H315:86;H319:3;H335:3
10182,L-4-hydroxyproline,200-091-9,51-35-4,Not Classified,REACH registration C&L,23.0,Not classified:21;H319:2;H315:2;H335:2
10184,"Ethene, 1,1-dichloro-, polymer with chloroethene",619-223-5,96511-18-1,Not Classified,Notified C&L,1.0,Not classified:1
10186,Sodium 7-benzamido-4-hydroxynaphthalene-2-sulphonate,234-104-4,10534-92-6,Not Classified,Notified C&L,1.0,Not classified:1
10189,"2,7-Naphthalenedisulfonic acid, 4-amino-3-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]carbonyl]phenyl]diazenyl]-5-hydroxy-6-(2-phenyldiazenyl)-, sodium salt (1:2)",611-472-8,57131-19-8,Not Classified,Notified C&L,1.0,Not classified:1
10192,"Fatty acids, coco, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) esters",273-950-9,69278-77-9,Acute Tox. 5;Skin Mild Irrit. 3;Eye Irrit. 2,Notified C&L,10.0,H316:10;H303:10;H320:10
10193,[No public or meaningful name is available],467-870-5,,Not Classified,Notified C&L,32.0,Not classified:32
10195,4-BROMO-3-FLUOROANISOLE,610-274-9,458-50-4,,Notified C&L,8.0,H319:8;H315:8;H335:7
10200,"Carbonic acid, aluminum magnesium salt, basic",287-796-5,85585-93-9,Not Classified,Notified C&L,4.0,Not classified:4
10204,Monomethyl Suberate,609-687-7,3946-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
10206,"Tagetes erecta, ext.",290-353-9,90131-43-4,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,66.0,H315:39;H317:63;H304:61;H226:62;H411:61;Not classified:2;H410:1
10210,5-bromosalicylamide,228-704-5,6329-74-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,38.0,H302:38;H317:38
10214,"2-[(2-nitrophenyl)azo]-4-(1,1,3,3-tetramethylbutyl)phenol",257-338-9,51656-57-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1.0,H302:1;H413:1
10215,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulpho-2-naphthyl)azo]naphthalene-2-sulphonic] acid, sodium salt, compound with 2,2',2''-nitrilotriethanol",279-255-7,79770-29-9,Not Classified,REACH registration C&L,7.0,Not classified:7
10217,"Schinus molle, ext.",305-104-2,94334-31-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1424.0,H304:1399;H315:1410;H317:1399;H226:1398;H411:11;H410:1388;H400:1352;H319:3
10221,disodium heptahydrate hydrogen phosphate,616-512-8,7782-85-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,195.0,H319:103;H315:103;Not classified:92;H335:5;H318:1
10222,3-trimethoxysilylpropyl methacrylate,219-785-8,2530-85-0,Not Classified,REACH registration C&L,617.0,Not classified:524;H319:99;H315:99;H335:76;H373:8;H302:1;H370:1;H372:1
10227,Tellurium tetrabromide,233-090-7,10031-27-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:42;H318:38;H301:4
10229,"1-naphthalenesulfonic acid, 5-[(4-hydroxyphenyl)amino]-8-(phenylamino)-, reaction products with sodium sulfide (Na2(Sx)), leuco derivatives",235-521-4,12262-32-7,Not Classified,REACH registration C&L,38.0,Not classified:38
10230,2-methoxy-4-vinylphenol,232-101-2,7786-61-0,Skin Corr. 1B,Notified C&L,1594.0,H314:1312;Not classified:91;H319:192;H315:192;H335:187
10231,"2,2,4-trimethylpentane-1,3-diol",205-619-1,144-19-4,Eye Irrit. 2,REACH registration C&L,209.0,H319:193;H335:121;H302:42;H315:39;H332:7;Not classified:5
10232,Methyl 2-fluorobenzoate,206-894-0,394-35-4,,Notified C&L,5.0,H319:5;H315:5
10233,Tris[1-(methylphenyl)ethyl]phenol,280-923-5,83804-01-7,Not Classified,Notified C&L,9.0,Not classified:9
10234,"reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)",414-520-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H318:0;H410:0;H315:0
10235,Butyl decanoate,250-280-5,30673-36-0,Not Classified,Notified C&L,7.0,Not classified:7
10239,"1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)-N-methylbutane-1-sulphonamide",252-043-1,34454-97-2,Repr. 2;STOT SE 2;STOT RE 2,REACH registration C&L,103.0,H371:24;H373:24;H361:47;Not classified:56;H411:40
10240,"Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;Distillate aromatic extract (treated);[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]",272-175-3,68783-00-6,Carc. 1B,Harmonised C&L,0.0,H350:0
10250,di-n-octylaluminium iodide,408-190-0,7585-14-0,Pyr. Liq. 1;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H314:0;H400:0;H250:0
10256,"Porphyra umbilicalis, ext.",607-056-0,223751-76-6,Flam. Liq. 3,Notified C&L,1.0,H226:1
10261,"[2-[bis(2-hydroxypropyl)amino]ethyl]bis(2-hydroxypropyl)(methyl)ammonium methyl sulphate, dioleate (ester)",265-339-0,65059-61-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,1.0,H318:1;H413:1;H315:1
10264,Octyl mercaptoacetate,231-637-4,7664-80-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H301:1;H331:1;H311:1
10265,Perfluorohexane-1-sulphonic acid,206-587-1,355-46-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1.0,H302:1;H314:1;H332:1;H312:1
10269,"1-chloro-2,5-diethoxy-4-nitrobenzene",202-067-3,91-43-0,Eye Irrit. 2,Notified C&L,38.0,H319:38
10270,"Carbamic acid, N-(chlorocarbonyl)-N-[4-(trifluoromethoxy)phenyl]-, methyl ester",605-700-5,173903-15-6,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,33.0,H412:33;H318:33;H317:33
10274,Aluminium magnesium silicate(2:3:8),308-996-1,99670-23-2,Not Classified,Notified C&L,2.0,Not classified:2
10279,"Decanoic acid, mixed esters with dipentaerythritol, heptanoic acid, isononanoic acid, and octanoic acid",453-490-7,,Not Classified,REACH registration C&L,4.0,Not classified:4
10286,4-O-α-D-glucopyranosyl-D-glucitol,209-567-0,585-88-6,Not Classified,REACH registration C&L,71.0,Not classified:65;H319:6;H315:6;H335:6
10287,Calcium diundec-10-enoate,215-331-8,1322-14-1,Not Classified,Notified C&L,3.0,Not classified:3
10290,"ethyl 5-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-1-methylpyrazole-4-carboxylate",618-964-1,93697-74-6,Acute Tox. 4,Notified C&L,16.0,H332:16
10294,"4-aminonaphthalene-1,8-dicarboxylic anhydride",229-372-4,6492-86-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,38.0,H312:38;H319:38;H315:38;H332:38;H350:38;H335:38;H302:38
10296,"Pyridinium, 1,1'-[(6,13-dichloro-4,11-disulfo-3,10-triphenodioxazinediyl)bis[imino-2,1-ethanediylimino[6-[(2,5-disulfophenyl)amino]-1,3,5-triazine-4,2-diyl]]]bis[3-carboxy-, dihydroxide, bis(inner salt), hexasodium salt",279-256-2,79771-28-1,Not Classified,REACH registration C&L,7.0,Not classified:7
10299,"Naphthalene-1,4-dicarbonitrile",221-197-1,3029-30-9,Not Classified,REACH registration C&L,8.0,Not classified:3;H302:4;H319:1;H315:1;H331:1;H301:1;H311:1
10302,"Spinels, iron titanium brown",269-064-7,68187-02-0,Not Classified,Notified C&L,30.0,Not classified:30
10304,"3,4-Diaminoanisole",600-319-0,102-51-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H312:37;H319:39;H315:39;H332:37;H335:39;H302:37;H331:1;H301:2;H311:2;H330:1
10306,"Amides, from 2-[(2-aminoethyl)amino]ethanol and C14-18 fatty acids",274-926-0,70851-09-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:1;H315:1;H412:1;H360:1;H317:1
10310,"Disodium p,p'-sulphonylbis(phenolate)",222-738-4,3594-55-6,,Notified C&L,33.0,Not classified:33
10316,trans-4-phenylbut-3-en-2-one,217-587-6,1896-62-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:40;H315:40;H335:39;H317:40;H334:1;H302:1
10317,"[4-[[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium acetate",282-846-2,84434-47-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134.0,H302:121;H400:118;H410:118;H319:115;Not classified:13;H314:3;H351:3;H411:3;H318:1
10323,9-chloroacridine,214-895-2,1207-69-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
10325,"(trans,trans)-4-{(4'-Propyl[1,1'-bicyclohexyl]-4-yl)-difluor methoxy}-1,2-difluorbenzen",606-657-5,208531-64-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
10338,"1,1'-oxybis[2-methylpropane]",211-045-2,628-55-7,Flam. Liq. 2,Notified C&L,1.0,H225:1
10340,Methadone,200-996-9,76-99-3,Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,3.0,H412:3;H300:3;H336:3
10346,"reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;1-(sec-butylphenyl-1-phenylethane, mixed isomers",431-100-6,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
10347,"Paraffin waxes (petroleum), low-melting",295-456-2,92045-74-4,Not Classified,Notified C&L,1.0,Not classified:1
10352,N-Butylpyridinium chloride,620-019-3,1124-64-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44.0,H319:43;H315:43;H335:4;Not classified:1
10353,"Cymbopogon martini, ext.",283-461-2,84649-81-0,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1511.0,H412:1479;H318:1484;H317:1485;H315:221;H411:2;H401:1;H226:1;H304:2;H413:1;H302:1;H410:1;H400:1
10355,Isodecyl palmitate,261-672-0,59231-33-3,Not Classified,Notified C&L,3.0,Not classified:3
10356,6-pentyl-2H-pyran-2-one,248-552-3,27593-23-3,Not Classified,Notified C&L,130.0,Not classified:88;H319:42;H315:42;H335:41
10359,Isopropyldiphenylphosphine,228-902-1,6372-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42;H312:1;H332:1;H302:1
10364,"Reaction product of 4,4'-methylenediphenyl diisocyanate (202--966-0), ethylenediamine (203-468-6) and dodecylamine (204-690-6)",924-043-8,,Not Classified,REACH registration C&L,2.0,Not classified:2
10368,"3,4-dihydro-8-hydroxy-3,4,5-trimethyl-6H-6-oxobenzo(c)pyran-7-carboxylic acid",208-257-2,518-75-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,41.0,H351:40;H301:41;H331:41;H311:41;H319:1;H315:1;H335:1
10371,Octyl chloroformate,231-224-9,7452-59-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,40.0,H301:38;H331:38;H311:38;H314:40;H302:1;H332:1;H312:1;H318:1;H300:1;H330:1;H310:1;H290:1
10372,Cumenesulphonic acid,253-730-9,37953-05-2,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H290:1;H314:1;H318:1
10374,1-[(2-methylphenyl)azo]-2-naphthol,220-162-8,2646-17-5,Carc. 2,Notified C&L,41.0,H351:41;H341:2
10376,"Eucalyptus staigeriana, ext.",294-963-6,91771-69-6,Not Classified,Notified C&L,32.0,Not classified:25;H319:6;H304:7;H315:6;H317:7;H226:7;H411:5;H410:2;H318:1;H400:1
10379,"4,4'-bis(dimethylamino)benzhydryl alcohol",204-335-5,119-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:41;H315:41;H335:40;Not classified:2
10381,N-(3-acetyl-4-hydroxyphenyl)acetamide,230-735-4,7298-67-1,Not Classified,REACH registration C&L,42.0,Not classified:2;H302:39;H319:39;H315:39;H335:38
10385,"2,2'-[[4-[(4-aminophenyl)azo]phenyl]imino]bisethanol",243-987-5,20721-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101.0,H319:56;H315:56;H335:92;H302:58;H410:1;H400:1;Not classified:1
10388,Di(morpholin-4-yl) disulphide,203-103-0,103-34-4,Skin Sens. 1A;STOT SE 3;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,178.0,H401:9;H411:172;H335:46;H317:175;H319:19;H315:19;H400:1
10390,"(2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide",618-303-7,89786-04-9,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,42.0,H334:41;H317:6;H400:35;H373:35;H411:35;H302:1
10391,"Soaps, stocks, cod-liver-oil, acidulated",296-962-6,93165-74-3,Not Classified,Notified C&L,1.0,Not classified:1
10394,"5,6-dimethoxypyrimidin-4-amine",225-701-0,5018-45-1,Not Classified,Notified C&L,1.0,Not classified:1
10399,(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[1-(triphenylmethyl)-1H-imidazol-4-yl]propanoic acid,600-919-2,109425-51-6,Not Classified,Notified C&L,5.0,Not classified:3;H302:1;H332:1;H312:1;H335:2;H319:1;H315:1
10403,1-(4-chlorophenyl)cyclobutanecarbonitrile,248-799-7,28049-61-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46.0,H302:45;H332:44;H312:44;H319:5;H315:5;Not classified:1
10404,"Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",273-170-9,68952-77-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
10405,dodecyl 3-amino-4-chlorobenzoate,428-020-9,6195-20-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H413:0;H317:0
10407,"Bis(N,N-diethylbenzene-p-diamine) oxalate",263-662-1,62637-92-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H312:39;H319:39;H315:39;H332:39;H335:39;H302:39
10409,"Sulfurous acid, lead salt, dibasic",263-467-1,62229-08-7,Acute Tox. 4;Acute Tox. 4;Repr. 1A,Notified C&L,1.0,H360:1;H410:1;H332:1;H373:1;H302:1;H400:1
10412,4-prop-1-enylveratrole,202-224-6,93-16-3,Not Classified,Notified C&L,1708.0,Not classified:1634;H317:72;H411:1;H302:1;H319:1;H315:1;H335:1
10416,Calcium adipate,231-295-6,7486-40-0,Not Classified,Notified C&L,2.0,Not classified:2
10418,"Fatty acids, montan-wax, monoesters with 1,3-butanediol",269-641-3,68308-29-2,Not Classified,Notified C&L,3.0,Not classified:3
10420,"Diethyl [[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate",213-551-9,976-56-7,Not Classified,REACH registration C&L,86.0,Not classified:86
10421,Phenanthridine,205-934-4,229-87-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H301:39;H318:39;H315:39;H335:39;H302:3;H332:3;H312:3
10422,Dioctyl ether,211-112-6,629-82-3,Not Classified,REACH registration C&L,147.0,Not classified:147
10425,"Ammonium 1,1,2,2,3,3,4,4,5,5,5-undecafluoropentane-1-sulphonate",269-512-1,68259-09-6,Not Classified,Notified C&L,22.0,Not classified:22
10426,N6-(tert-butoxycarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine,276-256-4,71989-26-9,Not Classified,Notified C&L,6.0,Not classified:4;H302:2;H332:2;H312:2
10428,"(6R)-3-(Acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;N,N'-dibenzylethane-1,2-diamine",619-270-1,97468-37-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1.0,H334:1;H317:1
10431,(2R)-pyrrolidin-2-ylmethanamine,615-751-5,72300-69-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H302:38;H318:38;H315:38;H335:38;H314:1;H226:1
10435,"3-amino-2,4,6-triiodobenzoic acid",221-493-0,3119-15-1,Eye Irrit. 2,REACH registration C&L,68.0,H319:68;H312:38;H315:42;H332:38;H335:42;H302:42
10441,"Poly(oxy-1,2-ethanediyl), α-(2-methyl-1-oxo-2-propen-1-yl)-ω-[2,4,6-tris(1-phenylethyl)phenoxy]-",605-714-1,174200-85-2,Not Classified,Notified C&L,5.0,Not classified:5
10449,"3,4-xylenol",202-439-5,95-65-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0.0,H301:0;H411:0;H311:0;H314:0
10450,1-fluoro-4-nitrobenzene,206-502-8,350-46-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 3;STOT RE 2,Notified C&L,95.0,H302:51;H373:84;H312:82;H331:86;H317:34;H412:34;H301:36;H319:9;H315:8;H335:1;H311:3;H332:3;Not classified:1;H372:1
10451,Urea,200-315-5,57-13-6,Not Classified,REACH registration C&L,4115.0,Not classified:3940;H319:165;H315:137;H351:65;H371:60;H335:73;H413:6;H302:4;H312:1;H317:1;H332:1;H334:1
10452,"ioxynil octanoate (ISO);4-cyano-2,6-diiodophenyl octanoate",223-375-4,3861-47-0,Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H319:0;H361:0;H317:0;H410:0;H301:0;H400:0
10455,"Pyridazine-3,6-diol",204-619-9,123-33-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,76.0,H319:44;H315:44;H335:43;H341:43;Not classified:32
10456,NEOFLON TM EFEP,448-400-8,,Not Classified,Notified C&L,1.0,Not classified:1
10457,Acetamidoxime,606-918-3,22059-22-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,74.0,H302:40;H319:43;H315:43;H335:42;Not classified:31;H312:2;H332:2
10463,Calcium bis(2-(1-carboxylatoethoxy)-1-methyl-2-oxoethyl) distearate,227-335-7,5793-94-2,Not Classified,Notified C&L,68.0,Not classified:68
10465,"4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol",428-970-4,13595-25-0,Skin Sens. 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0.0,H411:0;H361:0;H317:0
10467,4-isopropyl-m-cresol,221-761-7,3228-02-2,Eye Dam. 1,REACH registration C&L,154.0,H318:68;H319:48;H315:48;H335:47;Not classified:37;H317:3;H411:4;H314:1
10468,"3,5-Dibromo-4-methylbenzoic acid",614-190-3,67973-32-4,,Notified C&L,6.0,H319:6;H315:6;H335:6
10471,Scheelite (Ca(WO4)),238-981-4,14913-80-5,Not Classified,Notified C&L,1.0,Not classified:1
10473,"3,20-bis(ethylenedioxy)pregna-5,7-diene",243-175-0,19592-55-3,Aquatic Chronic 1,REACH registration C&L,3.0,H410:2;H312:1;H319:1;H315:1;H413:1;H332:1;H335:1;H302:1
10476,"2,3-diphenylquinoxaline",216-865-4,1684-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,195.0,H319:195;H315:195;H335:194
10477,"poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]",427-480-8,176429-22-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H315:0;H410:0;H335:0;H400:0
10478,Betaine hydrochloride,209-683-1,590-46-5,Eye Dam. 1,REACH registration C&L,123.0,H318:3;H319:111;Not classified:8;H302:1;H315:1
10479,"2,2,2-tribromoethanol",200-903-1,75-80-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H302:48;H319:48;H315:48;H335:46;H332:1
10480,"Primrose, Primula veris, ext.",284-109-0,84787-68-8,Flam. Liq. 3,Notified C&L,2.0,H226:2
10483,Dimercaprol,200-433-7,59-52-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H301:46;H319:48;H315:48;H335:40;H317:5;Not classified:2;H225:1;H350:1
10484,"6-chloropyrimidine-4,5-diamine",224-341-1,4316-98-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39.0,H302:38;H319:39;H317:38;H315:1
10492,Lead dichloride,231-845-5,7758-95-4,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,57.0,H410:57;H332:56;H351:5;H362:2;H400:52;H372:6;H302:56;H360:57;H373:52;Not classified:2;H318:1;H331:1;H370:1;H350:1;H301:1
10494,Oxymetazoline hydrochloride,219-015-0,2315-02-8,Acute Tox. 1;Eye Dam. 1;Acute Tox. 1;STOT RE 1;Aquatic Chronic 3,Notified C&L,235.0,H318:194;H300:198;H330:158;H412:194;H372:152;H319:1;H315:1;H301:1;H314:1
10495,"N,N-diphenyl-N'-picrylhydrazine",216-953-2,1707-75-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H302:39;H332:39;H312:39;H228:1
10498,3-Methoxy-2-nitropyridine,606-480-3,20265-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40
10501,Methyl 2-[[(4-hydroxy-3-methoxyphenyl)methylene]amino]benzoate,277-026-6,72927-84-5,Not Classified,Notified C&L,88.0,Not classified:88
10502,"α-D-Glucopyranose, 4-O-β-D-galactopyranosyl-, hydrate (1:1)",611-913-4,5989-81-1,,Notified C&L,63.0,Not classified:63
10505,Diisopentyl ether,208-857-4,544-01-4,Flam. Liq. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,121.0,H226:121;H411:79;H331:79;H317:79
10507,"Adipic acid, polymer with hexane-1,6-diol and propylidynetrimethanol",500-131-8,56266-32-1,,Notified C&L,36.0,Not classified:36
10508,"2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)",429-600-4,1026988-42-0,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H318:0;H411:0
10510,Sodium 4-[[5-methoxy-4-[(4-methoxyphenyl)azo]-2-methylphenyl]azo]benzenesulphonate,271-462-0,68555-86-2,Acute Tox. 3;Acute Tox. 2;STOT SE 2,Notified C&L,35.0,H371:32;H301:32;H330:32;Not classified:3
10512,Methyltriphenylphosphonium bromide,217-218-9,1779-49-3,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,94.0,H301:14;H411:15;H302:57;H332:55;H312:56;H300:17;Not classified:6;H319:9;H315:9;H335:7;H331:1;H311:1
10517,"D-Glucose, 4-O-β-D-galactopyranosyl-, hydrate (1:1)",600-087-0,10039-26-6,Not Classified,Notified C&L,74.0,Not classified:74
10520,"Sodium [2S-[2α,5α,6β(S*)]]-6-(aminophenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",200-708-1,69-52-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,311.0,H334:309;H317:308;H302:1;H319:3;H315:3;H335:3;Not classified:1
10528,trinickel boride,234-495-1,12007-02-2,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H317:0;H410:0;H350:0;H372:0;H400:0
10529,"Disodium carbonate, compound with hydrogen peroxide (2:3)",239-707-6,15630-89-4,Ox. Sol. 2;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,1164.0,H302:1134;H318:1103;H272:551;H271:91;H319:54;H315:53;H411:10;Not classified:8;H335:5;H316:1;H332:1;H401:1;H270:1
10532,"Trichloro[3-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethoxy]propyl]silane",239-589-6,15538-93-9,Skin Corr. 1B,Notified C&L,40.0,H314:40
10533,Cyclohexyl anthranilate,231-920-2,7779-16-0,Not Classified,Notified C&L,89.0,Not classified:88;H319:1;H315:1;H335:1
10535,"Disodium 4-amino-3,6-bis[[4-[(2,4-diaminophenyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",229-208-1,6428-31-5,Not Classified,REACH registration C&L,279.0,Not classified:240;H319:39;H315:39;H335:38
10536,bis(2-ethylhexyl) phthalate;di-(2-ethylhexyl) phthalate;DEHP,204-211-0,117-81-7,Repr. 1B,Harmonised C&L,0.0,H360:0
10538,Vanadium,231-171-1,7440-62-2,Not Classified,REACH registration C&L,408.0,Not classified:400;H228:4;H319:4;H315:4;H335:4;H413:4
10540,Copper diperchlorate,237-391-4,13770-18-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,13.0,H319:13;H272:13;H315:13;H335:13
10542,"2,5,6-triaminopyrimidin-4-ol",213-725-4,1004-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
10544,2-nitrobiphenyl,201-646-8,86-00-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39.0,H302:39;H332:38;H312:38;H351:38
10545,Sodium 4-[4-[[2-methyl-4-[[(p-tolyl)sulphonyl]oxy]phenyl]azo]anilino]-3-nitrobenzenesulphonate,235-406-9,12220-06-3,Not Classified,REACH registration C&L,92.0,Not classified:82;H412:10
10548,Gliquidone,251-463-2,33342-05-1,Not Classified,Notified C&L,1.0,Not classified:1
10549,"(±)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane",209-275-3,565-00-4,Flam. Liq. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H400:1;H319:1;H226:1;H410:1
10553,Cocaine hydrochloride,200-167-1,53-21-4,Acute Tox. 3;Skin Sens. 1;Repr. 1B,Notified C&L,49.0,H301:45;H360:44;H317:42;H319:8;H331:3;H372:3;H336:1;H315:1;H341:1;H362:1;H370:1;H373:1;H334:1;H311:1;H330:1
10554,Trimebutine,254-309-2,39133-31-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,13.0,H312:4;H413:2;H332:4;Not classified:8;H302:3;H412:1
10561,"2,6-dichlorobenzene-1,4-diamine",210-184-6,609-20-1,Acute Tox. 4;Eye Irrit. 2;Resp. Sens. 1;Carc. 2,Notified C&L,39.0,H334:38;H302:39;H319:39;H351:38;H312:1;H315:1;H332:1;H335:1
10562,N-butyltriphenylphosphonium chloride,217-219-4,1779-51-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,225.0,H319:186;H315:186;H330:177;H412:177;H335:184;H301:185;H311:178;H302:40;H312:40;Not classified:1;H331:1;H411:1
10563,"Benzoic acid, 2-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-5-[2-[6(or 7)-sulfo-1-naphthalenyl]diazenyl]-, sodium salt (1:2)",616-813-4,8003-58-5,Eye Irrit. 2,Notified C&L,1.0,H319:1
10573,8-hydroxy-5-methylquinolinium decyl sulphate,245-246-1,22816-64-4,Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H335:1
10574,1-phenyltetrazole-5-thiol,201-710-5,86-93-1,Flam. Sol. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,54.0,H228:51;H319:6;H413:5;H317:5;H302:49;H411:1;H315:2;Not classified:1;H335:1
10575,"Silicic acid, lithium magnesium sodium salt",258-476-2,53320-86-8,Not Classified,REACH registration C&L,402.0,Not classified:402
10576,n-butyl methacrylate,202-615-1,97-88-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0.0,H319:0;H315:0;H317:0;H226:0;H335:0
10578,ethanethiol;ethyl mercaptan,200-837-3,75-08-1,Flam. Liq. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H332:0;H225:0
10580,Dithallium selenide,239-627-1,15572-25-5,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H300:42;H330:42;H410:38;H373:42;H400:38;H411:4
10581,Fluorene-1-carboxylic acid,228-472-5,6276-03-5,,Notified C&L,4.0,H319:4;H315:4;H335:4
10585,Ethyl 2-(ethoxymethylene)acetoacetate,223-259-3,3788-94-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2;H302:1
10586,"Potassium [2R-(2α,3Z,5α)]-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate",262-640-9,61177-45-5,Flam. Sol. 2;Self-heat. 2;Skin Sens. 1;Resp. Sens. 1,Notified C&L,57.0,H334:40;H228:57;H252:43;H317:40;H319:13;H361:8;H315:2;H335:2;H251:2;H412:1
10591,"Mallotus philippinensis, ext.",283-997-7,84776-68-1,Flam. Liq. 3,Notified C&L,2.0,H226:2
10600,Silver (I) tetrafluoroborate,237-956-5,14104-20-2,Skin Corr. 1B,Notified C&L,51.0,H314:51;H400:4;H302:4;H318:4;Not classified:1
10602,Inulinase,232-802-3,9025-67-6,Resp. Sens. 1,REACH registration C&L,3.0,H334:3
10605,"4-amino-5-hydroxynaphthalene-2,7-disulphonic acid, sodium salt",241-302-4,17265-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
10606,"Hexane-1,6-dithiol",214-735-1,1191-43-1,Not Classified,Notified C&L,96.0,Not classified:66;H302:30;H332:30;H312:30;H319:2;H315:2;H335:1
10608,"Diaminoanthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione",261-073-4,58019-27-5,Not Classified,Notified C&L,1.0,Not classified:1
10609,salts of 2-naphthylamine,209-030-0,553-00-4,Acute Tox. 4;Carc. 1A;Aquatic Chronic 2,Harmonised C&L,0.0,H350:0;H302:0;H411:0
10613,"1,2-benzenedicarboxylic acid;di-C",271-084-6,68515-42-4,Repr. 1B,Harmonised C&L,0.0,H360:0
10615,"[7(S)-(1α,.2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate",225-139-6,4684-28-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H301:1;H331:1;H311:1
10623,"Aluminoxanes, Me octyl, branched, cyclic and linear",606-592-2,206451-54-9,Flam. Sol. 1;Pyr. Sol. 1;Self-heat. 2;Water-react. 1,Notified C&L,3.0,H260:3;H228:3;H250:3;H252:3
10624,Vanadium tetrachloride,231-561-1,7632-51-1,Skin Corr. 1A;Aquatic Chronic 3,REACH registration C&L,81.0,H412:2;H314:81;H301:79;H331:74;H311:74;H318:1;H312:1;H226:1
10625,"1-Ethoxy-2,3-difluoro-4-[4-(trans-4-pentylcyclohexyl)-1-cyclohexene-1-yl]-benzene",611-450-8,570384-43-9,Not Classified,REACH registration C&L,2.0,Not classified:2
10626,1-benzyl-1 H-indazole-3-carboxylic acid isobutyl ester,924-122-7,,Not Classified,REACH registration C&L,1.0,Not classified:1
10629,ethyl (2R)-2-hydroxy-4-phenylbutanoate,618-525-4,90315-82-5,Not Classified,Notified C&L,5.0,Not classified:4;H319:1;H315:1;H335:1
10632,Mercury bis(trifluoroacetate),236-250-4,13257-51-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H300:42;H330:42;H410:42;H310:42;H373:42;H400:42
10633,Oxyresveratrol,608-401-8,29700-22-9,Eye Irrit. 2,Notified C&L,40.0,H319:40;H315:1
10635,"Acetic acid ethenyl ester, Polymer mit Chloroethene",618-359-2,9003-22-9,Not Classified,Notified C&L,549.0,Not classified:547;H412:1;H350:1
10636,"[4S-(4α,4aα,5aα,12aα)]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride",237-099-7,13614-98-7,Eye Irrit. 2;Lact.,REACH registration C&L,50.0,H319:47;H362:7;H315:46;H335:46;H361:5;H373:3;H334:1;H317:2;H360:2
10637,"Fuel gases, refinery",269-640-8,68308-27-0,Flam. Gas 1;Press. Gas (Liq.);STOT SE 3,REACH registration C&L,105.0,H280:105;H336:9;H220:105;H340:60;H350:60;H360:60;H332:45;H373:30
10638,2-chloro-N-mesitylacetamide,609-612-8,3910-51-8,Eye Irrit. 2,Notified C&L,39.0,H319:39;H315:1;H335:1
10641,1-(chloromethyl)-3-phenoxybenzene,258-831-1,53874-66-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,43.0,H302:43;H314:43
10642,"Bis(2,6-diisopropylphenyl)carbodiimide",218-487-5,2162-74-5,Acute Tox. 4;Repr. 1B;STOT RE 1,REACH registration C&L,594.0,H302:581;H360:484;H372:484;H373:89;H319:10;H315:10;H335:10;H301:2;H332:1;H310:1;Not classified:1
10643,C.I. Solvent Yellow 62,612-679-6,61901-95-9,Not Classified,Notified C&L,70.0,Not classified:70
10645,"Fatty acids, linseed-oil, polymers with bisphenol A, epichlorohydrin and soya fatty acids",613-885-9,66070-79-9,Not Classified,Notified C&L,56.0,Not classified:55;H411:1;H319:1;H315:1;H317:1
10646,"Propanoic acid, 3,3'-[(dioctylstannylene)bis(thio)]bis-, di-C12-22-alkyl esters",292-020-3,90529-85-4,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,1.0,H413:1;H361:1;H372:1
10648,"4,4'-bis[(4-amino-1-naphthyl)azo]stilbene-2,2'-disulphonic acid",226-754-2,5463-64-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
10649,"2-(2-Oxobutyl)-1,3-cyclohexanedione",607-447-6,24836-98-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H302:1;H312:1
10650,Sodium 1-methoxy-1-oxohexadecane-2-sulphonate,223-676-0,4016-24-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,28.0,H302:21;H400:20;H412:21;H319:6;H304:6;Not classified:1;H318:1
10652,"isopentyl 4-{}{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}}benzoate",418-930-4,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
10654,Lead hydrogenorthophosphate,239-952-9,15845-52-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H360:38;H410:38;H332:38;H373:38;H302:38;H400:38
10656,"Magnesium, hydroxy sulfate aluminum complexes",287-797-0,85585-94-0,Not Classified,Notified C&L,1.0,Not classified:1
10657,"4,5,6,7-tetrabromo-3H-2,1-benzoxathiol-3-one 1,1-dioxide",270-624-8,68460-01-5,Skin Corr. 1B,Notified C&L,41.0,H314:41;H318:1
10659,"2(3H)-Benzofuranone, hexahydro-3,6-dimethyl-",618-807-7,92015-65-1,Not Classified,Notified C&L,89.0,Not classified:89
10662,"3-[[4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile",259-563-8,55281-26-0,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,74.0,H302:13;H412:13;H317:13;Not classified:61
10667,2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methylbenzothiazolium thiocyanate,279-908-6,82142-16-3,Eye Irrit. 2,Notified C&L,2.0,H319:2
10668,"(6alpha,11beta,16alpha,17alpha)-6,9-difluoro-11,17-dihydroxy-16methyl-3oxoandrosta-1,4diene-17-carboxylicacid",434-320-0,,Aquatic Chronic 2,Notified C&L,3.0,H411:3;H401:1
10669,"[1,1'-biphenyl]-4,4'-dicarbonyl dichloride",219-085-2,2351-37-3,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H290:1;H314:1;H318:1
10670,(6R-trans)-7-amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,258-907-4,53994-69-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1.0,H334:1;H317:1
10672,Trehalose,202-739-6,99-20-7,Not Classified,REACH registration C&L,402.0,Not classified:402
10676,"[3-(2,3-epoxypropoxy)propyl]trimethoxysilane",219-784-2,2530-83-8,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1909.0,H412:206;H318:923;H341:554;Not classified:282;H302:148;H319:222;H226:45;H301:45;H411:38;H315:80;H335:27;H331:4;H332:1;H312:1;H361:1;H304:1;H317:1
10678,Ethylenebis[phenylphosphine],242-649-4,18899-64-4,Pyr. Liq. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H250:38;H315:38;H335:38
10679,"Glycerides, C14-18 and C16-18-unsatd. mono-, di- and tri-",293-187-5,91052-28-7,Not Classified,REACH registration C&L,113.0,Not classified:113
10685,"Alcohols, C16-22",283-460-7,84649-80-9,,Notified C&L,1.0,Not classified:1
10686,"1-chloro-2,4-dinitrobenzene",202-551-4,97-00-7,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,109.0,H318:93;H315:94;H317:89;H410:107;H310:90;H302:50;H400:96;H331:58;H373:57;H301:57;H311:18;Not classified:4;H341:1;H370:1;H372:1;H319:1;H240:1
10688,hydroxyphosphonoacetic acid,405-710-8,23783-26-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2,Harmonised C&L,0.0,H302:0;H314:0;H373:0;H317:0
10690,3-benzyl-1-dodecyl-2-methyl-1H-imidazolium chloride,244-179-5,21054-72-8,,Notified C&L,2.0,H312:1;H301:1;H332:1;Not classified:1
10691,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with [(dimethylamino)methyl]phenol and piperazine",500-429-8,159034-96-5,Aquatic Chronic 4,REACH registration C&L,16.0,H413:2;H319:14;H341:1
10697,N-[2-[[5-[(dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitrovinylidenediamine monohydrochloride,275-207-4,71130-06-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,54.0,H319:54;H315:54;H317:54;H335:54;H334:52
10699,Zinc selenate,237-051-5,13597-54-1,,Notified C&L,4.0,H410:4;H373:4;H331:4;H301:4;H400:4
10700,"4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid",413-120-7,107144-30-9,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H411:0
10705,Cadmium disulphamate,237-832-0,14017-36-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H312:1;H410:1;H332:1;H302:1;H400:1
10707,"1,3,8-trihydroxy-6-methylanthraquinone",208-258-8,518-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H319:48;H315:48;H335:47;H302:2;H341:1
10709,"Chromate(2-), [4-[4-[(5-chloro-2-hydroxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)][4-[(5-chloro-2-hydroxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, sodium",290-920-0,90294-36-3,Not Classified,REACH registration C&L,473.0,Not classified:8;H319:465;H411:462
10713,2-Bromo-4-fluorobenzoyl chloride,619-124-7,95383-36-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2.0,H302:1;H314:2;H332:1;H312:1
10715,1-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]-N-tridecylnaphthalen-2-amine,260-913-7,57712-94-4,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,112.0,H413:8;H315:91;H373:8;H317:8;H351:18;Not classified:3
10719,Hexaamminecobalt trichloride,234-103-9,10534-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:41;H315:41;H335:40;H351:4;H317:4;H302:2;H332:2;H410:1;H312:2;H331:1;H301:1;H311:1
10720,2'-(oxiranylmethoxy)-3-phenylpropiophenone,245-052-7,22525-95-7,Not Classified,REACH registration C&L,48.0,Not classified:5;H302:43
10722,Europium(2+) sulphate,233-091-2,10031-54-6,Not Classified,Notified C&L,1.0,Not classified:1
10728,3-(3-pyridyl)propan-1-ol,220-675-7,2859-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:40;H315:40;H335:39;H312:2;H332:2;H302:3
10730,"(2S,4S,5R)-2-Aminomethyl-5-ethylquinuclidine",610-356-4,475160-59-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,38.0,H302:38;H318:38;H315:38
10731,p-(1-piperazinyl)phenol dihydrobromide,254-164-5,38869-37-3,Skin Irrit. 2;Eye Irrit. 2A,Notified C&L,1.0,H319:1;H315:1
10732,Pyrrolidine-1-propylamine,245-465-2,23159-07-1,,Notified C&L,6.0,H314:6;H318:1
10735,"(2,2-dimethoxyethoxy)benzene",267-496-0,67874-68-4,Not Classified,REACH registration C&L,2.0,Not classified:2
10738,hyoscine,200-090-3,51-34-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Harmonised C&L,0.0,H330:0;H300:0;H310:0
10740,2-cyano-N-methylacetamide,228-705-0,6330-25-2,Acute Tox. 4,REACH registration C&L,86.0,H302:85;H301:1;H331:1;H311:1
10744,Methane Disulfonic Acid disodium Salt,406-440-3,,Not Classified,REACH registration C&L,3.0,Not classified:3
10745,"Thuya plicata, ext.",305-105-8,94334-32-4,Flam. Liq. 3;Acute Tox. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,17.0,H304:7;H315:6;H317:7;H226:7;H411:7;H301:6;Not classified:10;H302:1
10747,"4,4-dimethyl-3-oxovaleronitrile",262-017-1,59997-51-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,92.0,H312:43;H319:7;H315:7;H332:39;H335:6;H302:6;H301:85;H412:33;H331:2;H311:2
10749,"2-Chloro-4-(methylsulfonyl)-3-((2,2,2-trifluoroethoxy)methyl) benzoic acid",480-290-7,,Skin Sens. 1,REACH registration C&L,2.0,H317:2
10753,"1,2-bis(trifluoromethyl)benzene",207-092-3,433-95-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H226:39;H315:39;H335:38
10757,"Epoxides C12-16, reaction product with ethylene glycol",925-701-7,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,84.0,H400:84;H315:84;H411:84
10758,"2-ethyl-2-[[(1-oxododecyl)oxy]methyl]propane-1,3-diyl dilaurate",246-777-1,25268-73-9,Not Classified,Notified C&L,8.0,Not classified:8
10760,5-methyl-2-(1-methylvinyl)cyclohexan-1-ol,232-102-8,7786-67-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,104.0,H302:104;H319:90;H315:103;H335:4
10761,(chloromethyl)bis(4-fluorophenyl)methylsilane,401-200-4,85491-26-5,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
10763,"2,5-dihydro-2-isobutyl-4,5-dimethylthiazole",265-969-6,65894-83-9,Not Classified,Notified C&L,89.0,Not classified:89
10765,"Balsams, copaiba, sulfurized, mixed with turpentine, gold salts",273-589-7,68990-27-2,Flam. Sol. 1,REACH registration C&L,3.0,H228:3
10769,"2,8-dimethylquinoline",215-974-4,1463-17-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H302:38;H318:38;H315:39;H335:39;H319:1
10772,4-Ethynyltoluene,616-371-2,766-97-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H226:46;H315:42;H335:46;H304:5;H228:1;H312:1;H332:1;H302:1
10774,"1,7,7-trimethyltricyclo[2.2.1.02,6]heptane",208-083-7,508-32-7,Not Classified,Notified C&L,119.0,Not classified:88;H304:18;H400:13;H410:13
10779,3-fluoro-4-nitrophenol,206-895-6,394-41-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48.0,H302:48;H318:40;H315:47;H335:46;H319:7;H312:2;H332:2
10788,2-(4-acetylphenoxy)-2-methylpropionic acid,257-705-3,52179-07-4,Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H335:2
10789,"N,N'-diethylhexamethylenediamine",236-006-7,13093-05-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H314:1;H318:1
10793,2-heptadecyl-1H-imidazole,245-589-7,23328-87-2,Not Classified,REACH registration C&L,72.0,Not classified:34;H319:25;H318:13;H315:2
10794,Perfluorohexadecane,206-588-7,355-49-7,,Notified C&L,2.0,H319:1;H315:1;H335:1;H413:1
10796,"Residues (coal tar), pitch distn.;Pitch Redistillate;[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 °C to 470 °C (752 °F to 846 °F). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]",295-507-9,92061-94-4,Carc. 1B,Harmonised C&L,0.0,H350:0
10798,p-cyclopentylbenzaldehyde,254-923-0,40452-70-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
10801,N-phenylanthranilic acid,202-066-8,91-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
10808,[No public or meaningful name is available],686-220-3,51267-48-2,Acute Tox. 4,Notified C&L,25.0,H302:25
10809,5-tert-butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-aminoglutarate,276-253-8,71989-18-9,Not Classified,Notified C&L,6.0,Not classified:5;H302:1;H332:1;H312:1;H335:1
10811,Dipraseodymium tricarbonate,227-578-9,5895-45-4,Not Classified,REACH registration C&L,11.0,Not classified:7;H413:4
10813,"Hexamethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]",252-346-9,35074-77-2,Not Classified,REACH registration C&L,319.0,Not classified:273;H413:46
10817,"ethyl N,N-dimethyl-β-alaninate",243-524-7,20120-21-2,Flam. Liq. 3,Notified C&L,42.0,H226:42;H319:4;H315:4;H335:4
10822,Canrenone,213-554-5,976-71-6,Carc. 2;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,69.0,H373:4;H361:13;H351:42;H411:42;H312:16;H332:16;H412:9;H302:1;H341:1;Not classified:1
10823,Methoxyphenamine hydrochloride,226-993-2,5588-10-3,Acute Tox. 4,Notified C&L,40.0,H302:40
10824,"Ethyl 2-(Ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate",611-474-9,571-55-1,,Notified C&L,8.0,H319:8;H315:8;H335:3;H312:1;H332:1;H302:1
10826,"Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 4-hydroxy-, 4-oxide, (11bS)-",609-088-0,35193-64-7,,Notified C&L,5.0,H319:5;H315:5;H335:5
10832,"3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline",441-190-9,121451-05-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H400:0;H410:0;H317:0
10833,1-amino-2-(1-methyl-1-phenoxycarbonylamino-ethyl)-oxime,610-731-2,518047-98-8,Acute Tox. 3,REACH registration C&L,1.0,H301:1
10837,2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine,604-859-8,152460-10-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4.0,H319:3;H315:3;Not classified:1
10838,"(5α)-4,5-epoxy-14-hydroxy-3-methoxymorphinan-6-one",260-887-7,57664-96-7,Not Classified,REACH registration C&L,2.0,Not classified:2
10844,Isobutyl isobutyrate,202-612-5,97-85-8,Flam. Liq. 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1923.0,H412:196;H226:1918;H336:12;H319:56;H315:57;H335:67;H332:11;Not classified:5
10847,1-N-Boc-2-piperidone,617-775-1,85908-96-9,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,40.0,H400:40;H319:40;H315:1;H335:1
10849,"1-(trimethylsilyl)-1H-1,2,3-triazole",236-253-0,13257-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
10851,Allyl nonan-1-oate,231-334-7,7493-72-3,Skin Irrit. 2,Notified C&L,184.0,H315:184;H319:65;H335:64;H302:10;H311:10
10853,"Trisodium 5-[[4-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]benzoyl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",276-403-2,72152-49-9,Skin Sens. 1,Notified C&L,12.0,H317:12
10855,"(2,4-dichlorophenyl)acetonitrile",228-621-4,6306-60-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,168.0,H319:168;H315:135;H331:95;H335:133;H301:95;H311:95;H412:33;H312:1;H332:1;H302:1
10856,6-glycidyloxynapht-1-yl oxymethyloxirane,429-960-2,27610-48-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H312:0;H315:0;H341:0;H317:0;H412:0
10858,"2,4-dichloro-3-ethyl-6-aminophenol",700-377-8,99817-37-5,Not Classified,Notified C&L,1.0,Not classified:1
10859,"Sulfonic acids, C10-18-alkane, sodium salts",268-213-3,68037-49-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,221.0,H302:152;H314:85;H318:172;H312:85;Not classified:36;H315:97;H319:10
10866,Epinephrine hydrogen tartrate,200-097-1,51-42-3,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H319:42;H300:51;H315:42;H335:41;H330:8;H310:8;H317:3;H360:2;H311:2;H412:2;H301:1;H341:1;H373:1
10867,2-bromo-5-nitroaniline,233-874-9,10403-47-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:38;H312:6;H332:6;H302:6
10868,Disodium 4-octyl 2-sulphonatosuccinate,230-971-8,7389-41-5,Not Classified,Notified C&L,2.0,Not classified:1;H318:1
10872,3-methyl-2-butenyl acetate,214-730-4,1191-16-8,Flam. Liq. 3,REACH registration C&L,1873.0,H226:1872;H411:1
10873,"α,2-dichlorotoluene",210-258-8,611-19-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 1,REACH registration C&L,168.0,H312:127;H319:39;H315:122;H317:77;H410:128;H332:124;H335:122;H302:128;H400:123;H314:44;H330:39;H331:4;Not classified:1;H336:1;H318:1;H227:1
10879,"2,4,6-triiodo-5-[[[2-(1-methylethyl)-1,3-dioxan-5-yl]carbonyl]amino]-1,3-Benzenedicarbonyl dichloride",603-266-1,128286-13-5,Not Classified,REACH registration C&L,1.0,Not classified:1
10882,9-oxofluorene-4-carboxylic acid,228-311-9,6223-83-2,,Notified C&L,4.0,H319:4;H315:4;H335:4
10883,Cobalt magnesium red-blue borate,271-811-7,68608-93-5,Not Classified,Notified C&L,2.0,Not classified:2
10885,"Fatty acids, montan-wax, stearyl esters",269-642-9,68308-30-5,Not Classified,REACH registration C&L,32.0,Not classified:32
10886,"Phosphoric acid, lanthanum salt, cerium terbium-doped",619-176-0,95823-34-0,Not Classified,Notified C&L,2.0,Not classified:2
10887,"reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate",423-180-6,,STOT RE 2,Harmonised C&L,0.0,H373:0
10891,Aluminium magnesium silicate(2:1:2),235-682-0,12511-31-8,Not Classified,Notified C&L,9.0,Not classified:9
10895,"Fatty acids, rape-oil, reaction products with diethanolamine",293-104-2,91051-51-3,Not Classified,Notified C&L,1.0,Not classified:1
10900,Manganese alumina pink corundum,269-061-0,68186-99-2,Not Classified,REACH registration C&L,11.0,Not classified:11
10904,DL-methionine,200-432-1,59-51-8,Not Classified,Notified C&L,193.0,Not classified:192;H319:1
10907,"1,1-dimethyl-N,N'-bis(1-methylpropyl)silanediamine",298-130-8,93777-98-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,3.0,H318:2;H302:2;H314:2;H226:3;H319:1;H315:1;H335:1
10910,(1S-exo)-2-methyl-3-methylene-2-(4-methyl-3-pentenyl)bicyclo[2.2.1]heptane,208-130-1,511-59-1,Not Classified,Notified C&L,88.0,Not classified:88
10912,"2,2-dimethylbutane",200-906-8,75-83-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0.0,H336:0;H304:0;H315:0;H225:0;H411:0
10913,"1,3,3-trimethylnorbornan-2-one",232-107-5,7787-20-4,Aquatic Chronic 2,REACH registration C&L,332.0,H411:2;Not classified:284;H226:46
10917,"1,2-Ethanediamine, N1-[3-(trimethoxysilyl)propyl]-, N-[(ethenylphenyl)methyl] derivs., hydrochlorides, hydrolyzed",605-621-6,171869-90-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,22.0,H319:22;H317:22
10920,"2,3-dihydro-4-methyl-2-thioxothiazol-5-acetic acid",251-905-4,34272-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
10923,"Tricyclo[5.2.1.02,6]dec-4-en-8-yl acetate",219-700-4,2500-83-6,Aquatic Chronic 3,Notified C&L,828.0,H412:438;Not classified:390;H411:1
10930,4-chloro-3-nitrobenzenesulphonamide,202-559-8,97-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56.0,H319:56;H315:56;H335:56;H361:1;H373:1
10932,Dichlorodihexylsilane,242-093-2,18204-93-8,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,1.0,H312:1;H314:1;H318:1;H302:1;H332:1;H290:1
10935,β-methoxyphenethyl alcohol,221-030-2,2979-22-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H312:38;H319:38;H315:38;H332:38;H335:38;H302:38
10937,"2,3,4-trihydroxybenzaldehyde",218-404-2,2144-08-3,Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,117.0,H302:70;H412:70;H315:117;H335:116;H319:56
10938,Dodecyl α-D-glucopyranoside,249-988-7,29980-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
10939,"15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)",600-627-5,104987-12-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41.0,H302:41;H332:41;H312:41
10942,Ampicillin,200-709-7,69-53-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,196.0,H334:194;H317:192;H319:41;H315:41;H335:41;H302:1;H351:1;Not classified:1
10946,C.I. Disperse Yellow 119,611-499-5,57308-41-5,Not Classified,Notified C&L,1.0,Not classified:1
10947,11-bromoundecanoic acid,220-602-9,2834-05-1,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,7.0,H302:3;H315:6;H319:4;H411:1;H317:1;H335:1
10948,"Poly[imino(1,2-ethanediyl)]",608-018-6,26913-06-4,,Notified C&L,1.0,Not classified:1
10952,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, esters with acrylic acid",500-130-2,55818-57-0,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3163.0,H411:23;H317:3106;H319:650;H315:210;Not classified:35;H335:23;H413:22;H318:1
10953,"Lithium hydroxide (Li(OH)), monohydrate",603-454-3,1310-66-3,Acute Tox. 4;Skin Corr. 1A,Notified C&L,547.0,H302:441;H314:518;H301:64;H318:91;H331:62;H360:29;H290:22;H332:13;H370:4;H372:4;H335:3;H412:1
10954,1-chloropentan-3-one,251-247-8,32830-97-0,Flam. Liq. 3,Notified C&L,38.0,H226:38
10972,2-bromo-4-fluorobenzonitrile,252-949-7,36282-26-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H312:45;H319:47;H315:46;H332:44;H335:46;H302:45;H331:2;H301:1;H311:1
10975,2-methyl-5-tert-butylthiophenol,444-970-7,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Asp. Tox. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H319:0;H304:0;H315:0;H336:0;H317:0;H361:0;H226:0;H410:0;H373:0;H400:0
10977,"Sodium O,O-diisobutyl phosphorothioate",610-992-2,53378-52-2,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,72.0,H314:71;H410:71;H400:14;H318:15;H290:1;H412:1
10979,"7,8-epoxyoctene",243-178-7,19600-63-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H226:42;H315:42;H335:42
10982,Oct-3-yn-1-ol,238-986-1,14916-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
10984,"Benzaldehyde, 4-hydroxy-, sodium salt, compd. with sulfurous acid (1:1:1)",618-827-6,92203-22-0,Not Classified,Notified C&L,1.0,Not classified:1
10989,"(20ξ)-3β-[(6-deoxy-α-L-mannopyranosyl)oxy]-1β,5β,11α,14,19-pentahydroxycardanolide",214-663-0,1183-35-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39.0,H301:38;H331:38;H311:38;H330:1;H300:1;H373:1
10993,"Phosphoric acid, octadecyl ester, compd. with 2,2',2''-nitrilotris[ethanol]",270-358-2,68425-56-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H319:1;H318:1;H315:1
10994,Ethisterone,207-096-5,434-03-7,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 1,REACH registration C&L,42.0,H360:41;H410:3;H351:4;H362:3;Not classified:38;H361:1
10995,"1-[(difluoromethyl)sulfonyl]-3-(4,6-dimethoxy-1,3,5-triazin-2-yl)-7-fluoro-1H-indol-2-ol",930-430-2,1383692-20-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35.0,H400:35;H410:35;H317:35
10996,methyl (2E)-[2-(chloromethyl)phenyl](methoxyimino)acetate,464-520-3,189813-45-4,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,84.0,H319:83;H411:84;H317:84;H320:1
10998,"C10-16 alcohols, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with acrylic acid",500-771-8,270923-16-5,Not Classified,Notified C&L,3.0,Not classified:2;H412:1;H319:1;H315:1;H317:1
11000,Sodium [2-[(2-amino-1-naphthyl)azo]-5-nitrophenolato(2-)][5-[(5-chloro-2-hydroxyphenyl)azo]-6-hydroxynaphthalene-2-sulphonamidato(2-)]cobaltate(1-),299-762-7,93894-62-3,Not Classified,Notified C&L,1.0,Not classified:1
11002,"Citric acid, magnesium salt",231-923-9,7779-25-1,Not Classified,Notified C&L,8.0,Not classified:8
11003,Prednisolone 21-(disodium phosphate),204-722-9,125-02-0,Repr. 2;STOT RE 2,Notified C&L,113.0,H373:78;H361:81;H302:29;H332:28;H360:25;Not classified:3;H312:2;H341:1
11006,Bis(3-methoxyphenyl)ethanedione,254-793-5,40101-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
11009,1-[4-(methylthio)phenyl]ethan-1-one,217-213-1,1778-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44.0,H319:44;H315:44;H335:44
11015,"Bismuth tris(2,4,6-tribromophenoxide)",225-958-9,5175-83-7,Not Classified,Notified C&L,56.0,Not classified:55;H317:1
11017,Dicyclohexyl ketone,204-336-0,119-60-8,Eye Irrit. 2,REACH registration C&L,4.0,H319:2;Not classified:2;H302:1;H202:1
11019,boron trifluoride,231-569-5,7637-07-2,Press. Gas;Skin Corr. 1A;Acute Tox. 2,Harmonised C&L,0.0,H314:0;H330:0;Not classified:0
11023,lead chromate,231-846-0,7758-97-6,Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0.0,H360:0;H410:0;H373:0;H350:0;H400:0
11025,Streptozocin,242-646-8,18883-66-4,Carc. 1B,Notified C&L,41.0,H350:40;H341:1;Not classified:1
11026,"2,3-dibromopropionic acid",209-981-1,600-05-5,Skin Corr. 1B,Notified C&L,44.0,H314:41;H319:3;H315:3;H335:3;H290:1;H318:2;H341:1
11029,"Pyroligneous acids, aq. phase",300-268-1,93924-72-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,99.0,H319:89;H315:89;H302:10;H312:10;H314:10
11030,"Alcohols, C13-15-branched and linear, butoxylated ethoxylated",601-137-4,111905-53-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,319.0,H319:319;H315:223;H400:83;H302:13;H412:13
11037,"Gasoline, pyrolysis, hydrogenated;Low boiling point naphtha-unspecified;[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20°C to 200°C (68°F to 392°F).]",302-639-3,94114-03-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H304:0;H340:0
11039,Ruthenium triiodide,237-664-8,13896-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,42.0,H360:38;H319:42;H315:42;H335:42
11042,"Primrose, Primula vulgaris, ext.",283-283-5,84604-06-8,Not Classified,Notified C&L,1.0,Not classified:1
11044,"2-Naphthalenecarboxylic acid, 4-[[]2-(4-chloro-3-sulfophenyl)diazenyl]-3-hydroxy-, manganese(2+) salt (1:1)",615-974-8,73385-04-3,Not Classified,Notified C&L,83.0,Not classified:83
11047,Tetrahydrothiophene 1-oxide,216-493-2,1600-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
11053,"1,3-Butadiene, 2-methyl-, polymer with 2-methyl-1-propene, chlorinated",614-265-0,68081-82-3,,Notified C&L,34.0,Not classified:34
11059,Aprobarbital,200-997-4,77-02-1,Acute Tox. 3,Notified C&L,39.0,H301:39
11060,"1-bromo-3,6-dioxaheptane",259-000-6,54149-17-6,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H227:1;H335:1;H315:1
11063,"N,N-diethyl-5-fluoro-2,4-dinitroaniline",230-025-4,6917-48-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38.0,H301:38;H331:38;H311:38
11066,FA C16-18/C18-unsatd. ethanediyl esters~,604-706-5,149821-07-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13.0,H319:13;H315:13
11067,Acexamic acid,200-310-8,57-08-9,Not Classified,REACH registration C&L,4.0,Not classified:2;H318:2;H315:2;H335:2
11073,"[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-, chloride, mixt. with 1,2-dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride",601-152-6,112025-60-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1
11074,"(1,1,2,2-tetrafluoroethoxy)benzene",206-505-4,350-57-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H226:38;H315:38;H335:38
11075,Sodium triaqua[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(1-),257-930-7,52455-30-8,Not Classified,Notified C&L,5.0,Not classified:5
11077,Bis(pentamethylene)urea,226-407-5,5395-04-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42.0,H302:38;H319:42;H315:4;H335:4
11078,"2-sec-butyl-4,5-dimethyl-2,5-dihydrothiazole",265-968-0,65894-82-8,Not Classified,Notified C&L,91.0,Not classified:91
11079,"Quaternary ammonium compounds, C12-20-alkylethyldimethyl, Et sulfates",282-022-2,84082-76-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,3.0,H302:3;H314:3;H400:3
11085,"Cyclohexanone, 4-methoxy-",480-410-8,,Eye Irrit. 2,REACH registration C&L,3.0,H319:3
11086,"[1S-(1α,4aα,5α,7aα)]-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl-β-D-glucopyranoside",207-540-8,479-98-1,Acute Tox. 4,Notified C&L,3.0,H302:3
11090,N-phenyl-3-(phosphonooxy)naphthalene-2-carboxamide,237-789-8,13989-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
11091,2-nitro-4-(trifluoromethyl)benzenethiol,238-343-5,14371-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:40
11092,3-(bromomethyl)pentane,223-302-6,3814-34-4,Flam. Liq. 3,REACH registration C&L,51.0,H226:51;H302:2;H319:2;H315:2;H335:2
11094,Hydroxyphosphonoacetic acid,607-269-9,23783-26-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2,Notified C&L,47.0,H302:47;H314:47;H373:47;H317:47
11095,Potassium sodium diniobate,235-370-4,12196-68-8,Not Classified,Notified C&L,1.0,Not classified:1
11100,"2-[[3-hydroxy-2,2-bis[[(1-oxoallyl)oxy]methyl]propoxy]methyl]-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate",262-270-8,60506-81-2,Eye Irrit. 2,Notified C&L,464.0,H319:330;Not classified:134;H315:75;H317:96;H412:36;H335:16;H413:1
11104,"2-methylbutane-1,2,4-triol",263-746-8,62875-07-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H302:2;H319:2;H315:2;H335:2
11112,Decahydroisoquinoline,228-702-4,6329-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39;H227:1
11114,Sodium C-(2-ethylhexyl) C-methyl hydrogen 2-sulphonatosuccinate,300-033-3,93919-49-4,,Notified C&L,34.0,Not classified:34
11115,"Methyl hydrogen 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate",278-034-2,74936-72-4,Not Classified,Notified C&L,3.0,Not classified:1;H302:2
11120,Tripotassium hydrogen diphosphate,240-374-4,16270-76-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,1.0,H302:1;H318:1
11123,Trichloro(trimethylamine)boron,216-166-4,1516-55-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;STOT SE 3,REACH registration C&L,11.0,H319:2;H315:2;H335:2;Not classified:9
11129,[No public or meaningful name is available],478-380-6,1013116-84-1,Skin Sens. 1B,Notified C&L,25.0,H317:25
11131,"2,4-dihydroxybenzamide",221-567-2,3147-45-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,4.0,H319:3;H315:3;H302:1
11141,2-[(4-chloro-2-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutyramide,236-852-7,13515-40-7,Not Classified,REACH registration C&L,55.0,Not classified:55
11146,"[6R-[6α,7β(R*)]]-7-[[amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, compound with propane-1,2-diol",260-642-4,57235-40-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1.0,H334:1;H317:1
11147,Barium isodecanoate,300-972-9,93965-23-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1
11152,"Naphthalene-1,8-diol",209-316-5,569-42-6,Eye Dam. 1,Notified C&L,39.0,H318:38;H302:1;H319:1
11153,"α,α-dimethylphenethyl acetate",205-781-3,151-05-3,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1853.0,H412:468;H315:58;Not classified:1343;H319:39;H411:1
11154,1-Ethyl-2-iodobenzene,605-979-3,18282-40-1,,Notified C&L,7.0,H319:7;H315:7;H335:2
11155,"reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene",412-460-3,89079-92-5,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H315:0;H411:0
11159,"Tris(2-ethylhexyl) 2-(acetyloxy)propane-1,2,3-tricarboxylate",205-617-0,144-15-0,Not Classified,Notified C&L,1.0,Not classified:1
11163,"Fatty acids, castor-oil, hydrogenated, zinc salts",294-969-9,91771-75-4,Not Classified,Notified C&L,1.0,Not classified:1
11164,"(dicyclopropylmethyl)(4,5-dihydro-2-oxazolyl)ammonium dihydrogen phosphate",287-106-2,85409-38-7,Acute Tox. 3,Notified C&L,5.0,H301:2;Not classified:1;H302:2;H332:2;H373:1;H400:1;H410:1;H362:1
11165,1-(2-chloroethyl)piperidinium chloride,217-920-5,2008-75-5,Acute Tox. 2;Skin Corr. 1B;Muta. 2,REACH registration C&L,78.0,H314:77;H300:77;H341:31;H301:1;H318:2;H315:1;H330:1
11167,2-aminophenol,202-431-1,95-55-6,Acute Tox. 4;Acute Tox. 4;Muta. 2,Harmonised C&L,0.0,H302:0;H332:0;H341:0
11168,3-anilinopropionitrile,214-057-6,1075-76-9,Not Classified,REACH registration C&L,2.0,Not classified:1;H319:1;H315:1
11169,Hexaboron silicide,234-535-8,12008-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:38;H315:38;H335:38;Not classified:1
11171,Biotin,200-399-3,58-85-5,Not Classified,Notified C&L,162.0,Not classified:161;H319:1;H315:1;H335:1
11172,5-methyluridine,215-973-9,1463-10-1,Not Classified,REACH registration C&L,2.0,Not classified:2
11177,2-isopropylcyclohexan-1-one,213-728-0,1004-77-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H226:1;H315:1;H335:1
11181,"(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one",616-668-7,79200-56-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,42.0,H302:42;H318:42;H317:42
11182,Orthotelluric acid,232-267-6,7803-68-1,Acute Tox. 4,Notified C&L,56.0,H332:55;H319:1;H315:1;H331:1;H301:1;H311:1
11185,"Bis(pentane-2,4-dionato)tin",240-142-2,16009-86-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H302:39;H319:39;H315:39;H335:39
11190,"2,4-dichloro-2-butenal",247-651-9,26394-31-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,1.0,H318:1;H315:1;H330:1;H335:1;H301:1;H400:1;H311:1
11194,Indan-4-amine,250-950-7,32202-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
11196,"ammonia, anhydrous",231-635-3,7664-41-7,Press. Gas;Flam. Gas 2;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0.0,H314:0;H331:0;Not classified:0;H221:0;H400:0
11199,"Zinc bis(O,O-diisooctyl) bis(dithiophosphate)",249-109-7,28629-66-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,493.0,H318:472;H315:472;H411:472;Not classified:21
11201,Zinc adipate,222-364-1,3446-35-3,Not Classified,Notified C&L,4.0,Not classified:4
11203,"2-(3,5-dichloro-2-hydroxyphenyl)quinazolin-4(3H)-one",600-418-9,1033-16-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H400:2;H410:2
11204,"(5α,6α)-7,8-didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan",220-674-1,2859-16-7,,Notified C&L,1.0,H334:1;H302:1
11214,"3,6-bis[(4-chloro-2-phosphonophenyl)azo]-4,5-dihydroxynaphthalene-2,7-disulphonic acid",217-628-8,1914-99-4,Carc. 2,Notified C&L,1.0,H351:1
11215,Hexahydro-1H-azepine-1-ethanol,243-915-2,20603-00-3,Eye Irrit. 2,Notified C&L,42.0,H319:38;H314:4
11216,3-(4-methylpiperazin-1-yl)propylamine,224-954-4,4572-03-6,,Notified C&L,6.0,H314:6
11217,"2-Propenoic acid, 2-methyl-, C12-15-alkyl esters",292-093-1,90551-75-0,Not Classified,Notified C&L,84.0,Not classified:83;H319:1;H315:1;H335:1
11219,Quinoline 1-oxide,216-560-6,1613-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
11221,"5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)[4-(diethylamino)phenyl]methyl]-3-methylsalicylic acid",231-222-8,7452-51-9,Not Classified,Notified C&L,9.0,Not classified:9
11227,"2,2-dibutyl-1,3,2-dioxastannolane",222-732-1,3590-59-8,Acute Tox. 2,Notified C&L,38.0,H300:38
11229,"3,5-bis(tert-butyl)benzoic acid",240-350-3,16225-26-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43.0,H302:39;H332:39;H312:39;H319:4;H315:4;H335:4
11233,"3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide",431-030-6,163269-30-5,Eye Dam. 1;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H373:0;H331:0;H400:0
11236,p-isocyanatobenzenesulphonyl chloride,229-812-5,6752-38-1,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,39.0,H334:39;H314:39;H335:39;H317:39
11238,"N,N'-ethane-1,2-diylbis(12-hydroxyoctadecan-1-amide)",204-613-6,123-26-2,Not Classified,REACH registration C&L,154.0,Not classified:58;H412:44;H317:71;H319:25;H315:25;H335:25;H413:13
11239,Estrone,200-164-5,53-16-7,Carc. 2;Repr. 1A;Lact.,REACH registration C&L,133.0,H360:105;H351:75;H362:48;H350:54;H312:27;H361:27;H332:27;H412:26;H302:28;H317:1;H334:1;H341:1;H410:1;H413:1
11241,1-iodooctadecane,211-117-3,629-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
11244,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,1'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[3-[bis(2-hydroxyethyl)amino]-2-propanol] (6:1), tetracoco alkyl ethers",618-554-2,90438-81-6,Not Classified,Notified C&L,38.0,Not classified:38
11246,2-chloro-1-methylpyridinium iodide,238-288-7,14338-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
11247,Dirubidium molybdate,237-271-1,13718-22-4,,Notified C&L,4.0,H319:4;H373:4;H335:4
11252,Diphenylacetic acid,204-185-0,117-34-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,23.0,H302:12;H319:14;H412:3;H315:19;H332:8;H331:8;Not classified:10;H400:8;H311:8;H335:6
11254,"[2-[[4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium hydrogen sulphate",281-594-0,83969-16-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2.0,H302:2;H319:2;H411:2
11257,D-gluconic acid,208-401-4,526-95-4,Not Classified,REACH registration C&L,780.0,Not classified:227;H319:553;H315:472;H335:30
11258,"Dihydrogen bis[L-aspartato(2-)-N,O1]zincate(2-)",253-012-5,36393-20-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,2.0,H302:1;H318:1;H319:1
11260,"1,1-diethoxyoct-2-yne",240-438-1,16387-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
11267,"N-(4-chloro-9,10-dihydro-9,10-dioxo-1-anthryl)benzamide",201-350-9,81-45-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H400:38;H319:38;H410:38
11268,"2,3,5-triphenyltetrazolium chloride",206-071-6,298-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58.0,H319:58;H315:58;H335:57;H301:1
11277,methyl 2-(3-nitrobenzylidene)acetoacetate,405-270-7,39562-17-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H317:0
11282,(+)-Tubocurarine chloride pentahydrate,615-023-7,6989-98-6,Acute Tox. 3,Notified C&L,55.0,H301:39;H330:16;H300:16;H310:16
11284,"2-Naphthalenesulfonic acid, 5(or 8)-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-8(or 5)-[[4-(phenylazo)-6(or 7)-sulfo-1-naphthalenyl]azo]-, trisodium salt",616-812-9,8003-57-4,Not Classified,Notified C&L,1.0,Not classified:1
11285,Bicyclo[2.2.1]hept-5-en-2-yltriethoxysilane,242-278-8,18401-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
11292,"1,2-Benzenedicarboxylic acid, di-C7-9-branched and linear alkyl esters",271-083-0,68515-41-3,Not Classified,Notified C&L,10.0,Not classified:10
11293,Pin-2-ene-1-carbaldehyde,209-274-8,564-94-3,Skin Irrit. 2,Notified C&L,1374.0,H315:1287;Not classified:87
11295,Thymidine 5'-(trisodium hydrogen triphosphate),248-679-4,27821-54-1,Not Classified,Notified C&L,1.0,Not classified:1
11297,"Hydrogen 3-(2,6-dimethylanilino)-6-(2,6-dimethylsulphonatoanilino)-9-(2-sulphonatophenyl)xanthylium, monosodium salt",235-407-4,12220-28-9,Not Classified,Notified C&L,14.0,Not classified:13;H351:1
11300,Benorilate,225-674-5,5003-48-5,Acute Tox. 4,Notified C&L,1.0,H302:1
11303,"2,6-bis(4-ethylphenyl)perhydro-1,3,5,7-tetraoxanaphth-4-ylethane-1,2-diol",406-176-9,79072-96-1,Not Classified,REACH registration C&L,5.0,Not classified:5
11304,Dierbium tricarbonate,228-003-4,6067-35-2,Not Classified,Notified C&L,6.0,Not classified:6
11306,2-hydrazinopyridine,225-566-8,4930-98-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40;H312:2;H332:2;H302:2;H361:1;H351:1
11312,"1-(2,5-dimethyl-3-furyl)ethan-1-one",234-216-3,10599-70-9,Not Classified,Notified C&L,992.0,Not classified:986;H302:6;H319:4;H317:4
11315,4'-ethoxy-2-benzimidazoleanilide,407-600-5,120187-29-3,Muta. 2;Aquatic Chronic 4,Harmonised C&L,0.0,H413:0;H341:0
11317,"3,6,9,12,15,18-Hexaoxahexacosan-1-ol",610-181-3,4440-54-4,Not Classified,Notified C&L,1.0,Not classified:1
11318,"1-(2,4-dichlorophenyl)ethan-1-one",218-780-8,2234-16-4,Skin Sens. 1B,REACH registration C&L,243.0,H412:170;H317:6;H302:204;H318:39;Not classified:33;H319:5;H315:5;H335:4;H312:1;H341:2;H332:1
11320,"4,4'-methylenebis[N,N-diethylaniline]",205-224-4,135-91-1,Aquatic Chronic 4,Notified C&L,83.0,H413:83
11321,4'-BROMO-O-ACETOTOLUIDIDE,607-322-6,24106-05-6,Acute Tox. 4,Notified C&L,38.0,H302:38
11322,Tris[4-(diethylamino)phenyl]methylium acetate,263-974-8,63157-72-2,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,91.0,H314:90;H318:88;H317:88;H410:89;H372:88;H301:89;H400:91;H302:2;H319:1;H315:1
11326,"dichloro[1,1'bis(diphenylphosphino)ferronece]palladium (II) acetone adduct",617-677-9,851232-71-8,,Notified C&L,5.0,H319:4;H315:4;H335:4;H317:1
11329,"2H-Benzimidazole-2-thione, 1,3-dihydro-, sodium salt (1:1)",604-756-8,15091-69-7,Acute Tox. 4;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,33.0,H361:33;H410:33;H332:33;H373:33;H302:33
11331,Medrogestone,213-555-0,977-79-7,Repr. 2,Notified C&L,43.0,H361:42;H302:1
11332,C.I. Acid Red 407,604-506-8,146103-68-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:1;H315:1;Not classified:1
11334,2-(2-naphthyloxy)ethanol,202-228-8,93-20-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2.0,H319:2;H411:2
11339,3-(dimethylamino)-3'-methoxypropiophenone,252-347-4,35076-32-5,Not Classified,Notified C&L,1.0,Not classified:1
11346,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamine,276-254-3,71989-20-3,Not Classified,Notified C&L,3.0,Not classified:3
11347,"Uridine 5'-(trihydrogen diphosphate), disodium salt",248-678-9,27821-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
11351,"Bone meal, mixed with meat meal, poultry",272-921-8,68920-45-6,Not Classified,Notified C&L,10.0,Not classified:10
11352,Methyl formylphenylacetate,227-577-3,5894-79-1,Acute Tox. 4,Notified C&L,1.0,H302:1
11354,Titanium vanadium antimony gray rutile,269-062-6,68187-00-8,Not Classified,Notified C&L,2.0,Not classified:2
11361,m-methylcinnamic acid,221-199-2,3029-79-6,,Notified C&L,6.0,H319:6;H315:6;H335:5
11362,"11β,21-dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate",221-250-9,3044-42-6,Repr. 2;Aquatic Chronic 3,REACH registration C&L,3.0,H412:2;H361:3
11363,"2-(3,3-dimethyltriazen-1-yl)benzoic acid",243-523-1,20119-28-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,38.0,H302:38;H317:38
11364,Decynyl methyl carbonate,215-337-0,1322-34-5,Not Classified,Notified C&L,1.0,Not classified:1
11366,"Polyphosphoric acids, compds. with triethanolamine",269-643-4,68308-31-6,Not Classified,Notified C&L,3.0,Not classified:3
11367,"Aromatic hydrocarbons, C7-8, ethylene-manuf.-by-product",292-699-6,90989-43-8,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1A,REACH registration C&L,103.0,H336:89;H304:89;H340:89;H315:89;H225:4;H350:89;H373:91;H361:97;H411:93;H226:2;H312:8;H319:10;H332:89;H335:8;H372:6;H302:4;H317:4;H410:4;H331:4;H400:4;H301:2;H311:2
11370,sodium; 5-benzoyl-α-methyl-2-thiopheneacetic acid,923-143-9,,Acute Tox. 3;Repr. 2,REACH registration C&L,2.0,H301:2;H361:2
11371,isobutyl methacrylate,202-613-0,97-86-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;STOT SE 3,Harmonised C&L,0.0,H226:0;H315:0;H335:0;H317:0
11372,"2-chloro-5-(1-chloro-1,3-dihydro-3-oxo-1-isobenzofuranyl)benzenesulphonyl chloride",271-615-1,68592-11-0,Not Classified,REACH registration C&L,2.0,Not classified:2
11376,"Disodium 4,4'-[3-(pyridin-2-yl)-1,2,4-triazine-5,6-diyl]bis(benzenesulphonate)",248-797-6,28048-33-1,,Notified C&L,5.0,H319:5;H315:5;H335:4
11377,"5,5-dibromobarbituric acid",208-131-7,511-67-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,40.0,H314:40;H318:40
11378,Octadecenylsuccinic acid,248-947-0,28299-29-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21.0,H302:18;H319:18;H315:18;Not classified:3
11379,"Amides, rape-oil, N,N-bis(hydroxyethyl)",292-531-1,90640-15-6,,Notified C&L,3.0,H319:3;H315:2;H318:1
11381,Manganese antimony titanium buff rutile,270-185-2,68412-38-4,Not Classified,REACH registration C&L,128.0,Not classified:45;H302:83;H332:83;H411:83
11386,"Amines, C14-18-alkyl",268-214-9,68037-91-2,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1,Notified C&L,2.0,H314:2;H318:2;H373:2;H335:1;H302:2;H400:2;H304:1;H410:1
11388,"Isobutyl (Z,Z)-10,10-dibutyl-2-methyl-5,8,12-trioxo-4,9,11-trioxa-10-stannapentadeca-6,13-dien-15-oate",261-812-0,59571-08-3,Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,12.0,H302:11;H314:10;H373:10;H411:10;Not classified:1;H319:1;H315:1;H341:1;H410:1;H400:1;H372:1;H360:1
11389,Allyl 2-methylcrotonate,231-333-1,7493-71-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,126.0,H312:78;H319:88;H315:88;H335:88;H302:88;H226:38;H311:10
11391,"3-(2-hydroxyethyl)-1H,3H-quinazoline-2,4-dione",214-897-3,1207-75-6,Not Classified,REACH registration C&L,1.0,Not classified:1
11393,Fluphenazine O-decanoate,225-672-4,5002-47-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,28.0,H312:16;H317:17;H332:16;H334:16;H302:17;H300:11;H315:10;H361:9;H362:2;H372:2;H360:1;H413:1;H330:1;H310:1
11394,Norepinephrine,200-096-6,51-41-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,45.0,H330:40;H300:44;H310:40;H301:1
11397,Methyl 3-hydroxyhexanoate,244-261-0,21188-58-9,Not Classified,Notified C&L,152.0,Not classified:102;H318:50
11398,"Prunus serotina, ext.",283-284-0,84604-07-9,Flam. Liq. 3,Notified C&L,1413.0,H226:1286;Not classified:89;H302:38;H315:38
11401,3-fluorostyrene,206-504-9,350-51-6,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,44.0,H319:43;H226:44;H315:5;H335:4
11402,"Sulfuric acid, mono-C8-14-alkyl esters, compds. with triethanolamine",288-134-8,85665-45-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,189.0,H318:167;H315:189;H332:83;H412:166;H335:83;H302:166;H319:22
11405,Salicylonitrile,210-259-3,611-20-1,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,85.0,H302:51;H318:4;H317:6;H319:46;H315:46;H335:45;H314:35;H412:1;H312:2;H332:1
11408,4-aza-5α-androsta-1-en-3-one-17β-carboxylic acid,600-542-3,104239-97-6,Acute Tox. 4;Repr. 2,Notified C&L,3.0,H302:2;H361:2;H319:1;H315:1;H335:1
11412,3-(methylthio)propionaldehyde,221-882-5,3268-49-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,1658.0,H318:1609;H315:1619;H317:1613;H332:1372;H302:1653;H311:1613;H412:1368;H226:232;H314:39;H331:43;H335:61;H319:10;H312:2;Not classified:2;H370:2;H373:1;H400:1
11415,"2,6-difluorobenzonitrile",217-589-7,1897-52-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,98.0,H312:79;H319:47;H315:47;H332:78;H335:45;H302:95;Not classified:1;H331:2;H301:2;H311:2
11418,Flutriafol,616-367-0,76674-21-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,290.0,H302:290;H411:161;H332:84;H412:84;H312:84;H301:1;H361:2
11419,2-Methoxy-6-methyl-benzoic acid ethyl ester,613-756-7,6520-83-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
11421,Desipramine,200-040-0,50-47-5,Acute Tox. 4;STOT SE 3;STOT SE 1,REACH registration C&L,3.0,H302:2;H336:2;H370:2;H400:1
11423,"3-[[(dimethylamino)methylene]amino]-3-(2,4,6-triiodophenyl)propionic acid",226-992-7,5587-89-3,Eye Dam. 1,Notified C&L,24.0,H318:24
11429,"Alcohols, C9-11, ethoxylated propoxylated",600-492-2,103818-93-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,178.0,H302:176;H318:90;H319:88
11434,"1,2-bis[4-fluoro-6-{}{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245",417-610-1,155522-09-1,Skin Sens. 1,Harmonised C&L,0.0,H317:0
11436,"Hexanedinitrile, hydrogenated, high-boiling fraction, phosphonomethylated",273-287-5,68955-64-6,Skin Corr. 1B,Notified C&L,1.0,H314:1
11437,chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol,200-431-6,59-50-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Skin Sens. 1B;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 3,Harmonised C&L,0.0,H314:0;H318:0;H317:0;H412:0;H335:0;H302:0;H400:0
11439,4-[(trimethylsilyl)oxy]pent-3-en-2-one,236-252-5,13257-81-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H226:39;H315:39;H335:38
11442,"1,2-dibromo-1,1-difluoroethane",200-905-2,75-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Ozone 1,Notified C&L,38.0,H319:38;H315:38;H335:38;H420:38
11444,Barium fluoride,232-108-0,7787-32-8,Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,268.0,H319:11;H332:266;H302:255;H301:4;H312:1;H315:1;H335:1;H331:1;H311:1;Not classified:2
11445,HSY-2570,434-260-5,,Not Classified,Notified C&L,4.0,Not classified:4
11446,Diborane(6),242-940-6,19287-45-7,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 1,Notified C&L,271.0,H280:245;H330:271;H220:271
11448,4-chloro-3-nitrobenzenesulphonyl chloride,202-558-2,97-08-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46.0,H314:46;H318:40;H290:1
11449,Coagulant 110C,414-480-8,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H317:1
11450,"4,4'-methylenediphenololigomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with acrylic acid",500-770-2,64448-68-6,Skin Sens. 1,Notified C&L,5.0,H317:3;Not classified:2
11452,Ethylenediammonium diiodide,227-186-8,5700-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H302:45;H319:46;H315:46;H335:45;H317:3;H312:1;H332:1
11454,Scillaren A,204-721-3,124-99-2,Acute Tox. 3,Notified C&L,38.0,H301:38
11455,"D-Mannitol, 1,4:3,6-dianhydro-, 2,5-bis[3-methoxy-4-[[4-[(1-oxo-2-propen-1-yl)oxy]benzoyl]oxy]benzoate]",700-376-2,1015689-48-1,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,2.0,H413:2;H317:2
11460,"1H-Imidazole, polymer with (chloromethyl)oxirane",614-729-2,68797-57-9,Aquatic Chronic 2,Notified C&L,194.0,H411:192;H312:56;H302:1;H319:1;H315:2;H400:1;H410:1
11463,"9-Octadecenoic acid (Z)-, isooctyl ester, sulfurized",281-511-8,83968-33-6,Not Classified,Notified C&L,33.0,Not classified:33
11464,"Fatty acids, tall-oil, maleated, compds. with triethanolamine",309-692-1,100684-20-6,Not Classified,Notified C&L,84.0,Not classified:83;H317:1
11465,"2,5-dichloro-2,5-dimethylhexane",228-310-3,6223-78-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H312:2;H319:2;H315:2;H332:2;H335:2;H302:2
11466,"4-[bis(2-tert-butyl-4-hydroxy-6-methylphenyl)methyl]phenyl 6-diazo-5-oxo-5,6-dihydronaphthalene-1-sulfonate",451-040-4,,Flam. Sol. 2,Notified C&L,1.0,H228:1
11467,2-(trichlorosilyl)ethyl acetate,242-092-7,18204-80-3,Skin Corr. 1B,Notified C&L,38.0,H314:38
11472,"Cholest-5-en-3β-yl 2,4-dichlorobenzoate",251-248-3,32832-01-2,Aquatic Chronic 4,Notified C&L,38.0,H413:38
11474,"(Z)-penta-1,3-diene",216-401-0,1574-41-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,66.0,H304:39;H225:66;H319:23;H315:23
11475,Direct Yellow 107,612-513-2,61815-04-1,Aquatic Chronic 3,Notified C&L,70.0,H412:70
11476,Chlorodifluoroacetic anhydride,220-603-4,2834-23-3,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,54.0,H312:46;H301:46;H314:53;H290:1;H318:1;Not classified:1
11483,2-Bromo-4-chloro-6-fluoroaniline,606-332-8,195191-47-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40;H312:1;H332:1;H302:1
11484,"Benzenesulfonic acid, 2-methyl-5-nitro-, alk. cond. products, reduced, lithium salts",297-511-6,93572-80-6,Not Classified,Notified C&L,38.0,Not classified:38
11485,"Alcohols, C13-15-branched and linear, ethoxylated propoxylated",601-139-5,111905-54-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,37.0,H400:36;H318:36;H315:37;H319:1;H335:1
11487,"(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid",618-046-0,87679-37-6,Repr. 2;STOT RE 2,Notified C&L,50.0,H373:49;H361:48;H312:1;H332:1
11488,"2,2-dimethylpropanehydrazide",610-065-2,42826-42-6,Acute Tox. 3,Notified C&L,43.0,H301:40;H319:3;H315:3;H335:2;H312:1;H332:1;H302:1;H228:1
11489,"Diammonium [[N,N'-ethylenebis[N-(carboxylatomethyl)glycinato]](4-)-N,N',O,O',ON,ON']zincate(2-)",267-400-7,67859-51-2,Not Classified,REACH registration C&L,76.0,Not classified:76
11490,(±)-2-methylbutyric acid,209-982-7,600-07-7,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,89.0,H312:89;H314:89;H318:89;H302:89;H290:89
11493,"3-chloro-2,4-difluoronitrobenzene",411-980-8,3847-58-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H314:0;H317:0;H410:0;H302:0;H400:0
11494,"Chromate(1-), bis[[]2-[[]2-[[]4,5-dihydro-3-methyl-5-(oxo-[?]O)-1-phenyl-1H-pyrazol-4-yl]diazenyl-[?]N1]benzoato(2-)-[?]O]-, hydrogen, compd. with 1-tridecanamine (1:1:1)",615-953-3,73297-13-9,,Notified C&L,88.0,H400:83;H410:83;Not classified:5
11495,Disodium N-(carboxylatomethyl)-N-[(2-hydroxyphenyl)methyl]glycinate,251-904-9,34270-33-2,Skin Sens. 1,Notified C&L,1.0,H317:1
11504,"Tuberose, ext.",305-108-4,94334-35-7,Skin Sens. 1;Acute Tox. 4;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,1485.0,H341:1346;H317:1470;H332:1287;H351:1347;H412:1359;H302:172;H400:11;H410:11;H371:1;H319:2;H226:1;H225:1
11507,"Cyclohexa-1,4-diene",211-043-1,628-41-1,Flam. Liq. 2,Notified C&L,44.0,H225:44;H350:4;H304:4;H373:4
11508,"Amides, tallow, hydrogenated, N-[2-[(2-hydroxyethyl)amino]ethyl], acetates (salts)",270-357-7,68425-52-5,Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,Notified C&L,61.0,H360:25;H318:59;H411:50;Not classified:2
11511,"(1β,3β,5β)-3-[(6-deoxy-3-O-methyl-α-L-talopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide",211-555-5,663-95-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38.0,H301:38;H331:38;H311:38
11515,Anthraquinone acid dye,,,Not Classified,Notified C&L,1.0,Not classified:1
11516,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., ammonium salts",286-680-1,85338-08-5,Not Classified,Notified C&L,1.0,Not classified:1
11517,"Sulphuric acid, compound with graphite",235-819-4,12777-87-6,Not Classified,REACH registration C&L,75.0,Not classified:75
11523,Tris(methylphenyl) phosphite,247-119-6,25586-42-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,36.0,H302:36;H315:36;H317:36;H312:1;H319:1;H290:1
11525,Fosfomycin,245-463-1,23155-02-4,Not Classified,Notified C&L,4.0,Not classified:4
11526,2-chlorophenol,202-433-2,95-57-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H332:0;H312:0;H411:0
11533,"Senna, Cassia angustifolia, ext.",286-092-5,85187-05-9,Not Classified,Notified C&L,2.0,Not classified:1;H226:1
11534,DL-borneol,208-080-0,507-70-0,Flam. Sol. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 2,REACH registration C&L,1828.0,H318:4;H315:16;H332:4;H371:4;H228:1810;H225:17;H411:11;H302:1;H319:1;Not classified:1
11537,"Urea, polymer with N-cyanoguanidine and formaldehyde",608-156-7,27968-41-8,,Notified C&L,42.0,Not classified:42
11544,"A mixture of: alpha necrodyl acetate 1-acetoxymethyl-2,2,3,4-tetramethyl-4-cyclopentene; alpha necrodol 1-hydroxymethyl-2,2,3,4-tetramethyl-4-cyclopentene; cineole 1,8 eucalyptol 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane",448-190-8,,Flam. Liq. 3;Skin Sens. 1,Notified C&L,1.0,H226:1;H317:1
11545,copper sulphate;copper sulphate pentahydrate,231-847-6,7758-98-7,,,0.0,H319:0;H315:0;H410:0;H302:0;H400:0
11546,"Acetic acid, 2-bromo-, 4-nitrophenyl ester",919-989-3,19199-82-7,,Notified C&L,4.0,H318:4;H315:4;H335:4
11547,"Tar, wood, ext.",300-269-7,93924-73-3,Not Classified,Notified C&L,55.0,Not classified:53;H312:2;H319:2;H315:2;H226:2;H335:2
11549,"Triisodecyl benzene-1,2,4-tricarboxylate",253-138-0,36631-30-8,Not Classified,REACH registration C&L,540.0,Not classified:496;H319:38;H315:38;H335:38;H413:6
11553,"(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;N,N-diethylethanamine",926-346-0,,Not Classified,REACH registration C&L,2.0,Not classified:2
11554,"1-Ethoxy-2,3-difluor-4-[4-(trans-4-propylcyclohexyl)-1-cyclohexen-1-yl]-benzene",603-006-7,124728-62-7,Not Classified,REACH registration C&L,1.0,Not classified:1
11556,Lithium triazide,243-177-1,19597-69-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39.0,H330:38;H300:39;H310:38
11561,"[N-[3-(dimethylamino)propyl]-29H,31H-phthalocyaninesulphonamidato(2-)-N29,N30,N31,N32]copper",269-767-9,68324-29-8,Not Classified,Notified C&L,7.0,Not classified:7
11563,Methyl (E)-hex-2-enoate,237-663-2,13894-63-8,Flam. Liq. 3,Notified C&L,1405.0,H226:1405
11565,Acetone thiosemicarbazone,217-137-9,1752-30-3,Acute Tox. 2;Acute Tox. 4;Acute Tox. 1,Notified C&L,1.0,H312:1;H330:1;H300:1
11566,"5-(o-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridinium chloride",258-837-4,53885-35-1,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,134.0,H400:85;H302:134;H318:86;H410:86;H361:7;H319:2;H315:2;H335:2;H332:2;H312:1;H373:3;H372:1
11567,"1,5-dimethyl-1-vinylhex-4-enyl hexanoate",231-922-3,7779-23-9,Not Classified,Notified C&L,234.0,Not classified:234
11569,"2,6-dihydroxybenzamide",221-568-8,3147-50-0,,Notified C&L,4.0,H319:4;H315:4;H335:4
11570,1-ethyl-4-iodobenzene,607-691-3,25309-64-2,Eye Irrit. 2,Notified C&L,44.0,H319:44;H315:6;H335:1
11578,"Cyclohexene, 1-(1-methylethoxy)-",611-589-4,57899-54-4,Flam. Liq. 3,Notified C&L,1.0,H226:1
11580,"Ethanol, 2,2'-iminobis-, polymer with methyloxirane and oxirane",608-978-6,34354-45-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,17.0,H319:17;H315:17
11588,"Cinchona pubescens, ext.",306-882-6,97435-02-4,Flam. Liq. 3,Notified C&L,1.0,H226:1
11589,"(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone",418-650-2,104872-06-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
11590,Inositol,230-024-9,6917-35-7,Not Classified,Notified C&L,2.0,Not classified:2
11592,Dipotassium azelate,257-931-2,52457-54-2,Not Classified,Notified C&L,83.0,Not classified:83
11593,Pregnenolone acetate,217-212-6,1778-02-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,17.0,H312:17;H361:17;H332:17;H351:17;H302:17
11595,chloroethane,200-830-5,75-00-3,Press. Gas;Flam. Gas 1;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H220:0;H412:0;H351:0;Not classified:0
11596,4-isocyanatosulphonyltoluene;tosyl isocyanate,223-810-8,4083-64-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0.0,H334:0;H319:0;H315:0;H335:0
11600,"Benzene-1,2,3-tricarboxylic acid",209-317-0,569-51-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71.0,H319:71;H315:39;H335:38
11601,C.I. Reactive Blue 72,612-911-6,61968-93-2,Resp. Sens. 1,Notified C&L,3.0,H334:2;H319:1;H315:1;H335:1;H317:1
11603,"3,5,7-trihydroxy-2-(2-hydroxyphenyl)-4-benzopyrone",207-541-3,480-15-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
11605,"Calcium (R*,R*)-5,5'-bis(β-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo[9,9'-bianthracene]-2,2'-dicarboxylate",263-461-9,62211-03-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,78.0,H334:78;H317:78
11608,"N,N,N-Trimethyl-3-(octadecyloxy)propan-1-ammonium chloride",700-414-8,23328-71-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H400:1;H302:1;H318:1;H410:1
11609,vinyl chloride;chloroethylene,200-831-0,75-01-4,Press. Gas;Flam. Gas 1;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;Not classified:0
11614,"4-(dimethylamino)-3,5-xylenol",228-089-3,6120-10-1,Not Classified,Notified C&L,2.0,Not classified:1;H302:1;H319:1;H315:1;H335:1
11619,Orciprenaline,209-569-1,586-06-1,Not Classified,Notified C&L,1.0,Not classified:1
11620,1-Hydroxycyclopentanecarboxylic acid ethyl ester,457-730-1,,Aquatic Chronic 3,REACH registration C&L,57.0,H412:57
11621,"(8α)-12'-hydroxy-2',5'α-diisopropylergotaman-3',6',18-trione",209-273-2,564-37-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1.0,H302:1;H332:1;H312:1;H361:1
11623,"Reaction product of benzene-1,2:4,5-tetracarboxylic dianhydride, Octadecylamine, (Z)-Octadec-9-enylamine, hexamethylenediamine and 4-methyl-m-phenylenediamine",921-582-0,,Not Classified,Notified C&L,2.0,Not classified:2
11624,"8,9,10-trinorborn-5-ene-2,3-dicarboxylic acid",223-301-0,3813-52-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H312:38;H319:39;H315:39;H332:38;H335:38;H302:38
11628,Tetrahydrogen dihydroxyoxobis[phosphato(3-)-O]wolframate(4-),263-745-2,62862-66-2,Not Classified,Notified C&L,1.0,Not classified:1
11632,"3,3-diethylpiperidine-2,4-dione",200-999-5,77-03-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
11633,"(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]manganese (III) chloride",604-063-0,138124-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40
11639,Terpineol,232-268-1,8000-41-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2752.0,H319:2251;H315:2723;H341:156;H317:190;H351:156;H411:190;Not classified:29;H304:19;H335:6;H302:2;H226:1
11644,N-aminophthalimide,217-505-9,1875-48-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H317:39;H335:42;H334:39
11647,[No public or meaningful name is available],454-410-3,,Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1286.0,H412:1286;H332:1286;H317:1286
11649,Dipotassium isotridecyl phosphate,278-035-8,74937-55-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
11651,"disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate",606-452-0,201792-73-6,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1.0,H412:1;H318:1
11659,"2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate",414-260-1,88938-37-8,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
11669,"Tar acids, cresylic, sodium salts, caustic solns.;Alkaline Extract",272-361-4,68815-21-4,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0
11673,Isopropyl myristate,203-751-4,110-27-0,Not Classified,REACH registration C&L,3004.0,Not classified:2530;H315:473;H319:6;H335:6;H412:1
11674,"Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione",226-408-0,5395-50-6,Skin Sens. 1;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,355.0,H350:3;H411:86;H317:317;H400:58;Not classified:38
11680,5-Bromo-2-methoxybenzonitrile,604-428-4,144649-99-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H302:44;H332:44;H312:44;H319:6;H315:6;H335:5;H331:1;H301:1;H311:1
11683,"Fatty acids, C11-19, reaction products with o-phenylenediamine, chloromethane-quaternized, sulfonated, sodium salts",309-172-4,100085-32-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H400:1;H410:1
11684,C.I. Pigment Yellow 127,615-667-9,71872-67-8,Not Classified,Notified C&L,7.0,Not classified:7
11685,3β-hydroxyolean-12-en-28-oic acid,208-081-6,508-02-1,,Notified C&L,70.0,Not classified:67;H319:3;H315:3;H335:3;H302:1
11690,2-bromophenol,202-432-7,95-56-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,56.0,H319:52;H315:52;H226:49;H335:51;H302:55;H400:50;H312:9;H332:4;H330:1;H314:1
11691,4-(2-chloroethyl)morpholine,221-810-2,3240-94-6,Not Classified,Notified C&L,3.0,Not classified:1;H301:2;H318:1;H314:1
11693,4-METHYL-2-(PHENYLAZO)PHENOL,619-117-9,952-47-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38.0,H318:38;H315:38;H335:38;H411:38;H302:38
11696,O-(ethoxycarbonyl)-N-(1-methyl-2-oxo-2-phenylethylidene)hydroxylamine,265-967-5,65894-76-0,,REACH registration C&L,36.0,H400:34;H411:34;H317:34;H410:32;Not classified:1;H319:1;H315:1;H335:1
11703,N-butyl-N-(3-chloropropyl)butan-1-amine hydrochloride (1:1),601-371-7,115555-77-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3.0,H319:3;H315:3;H410:2;H302:3;H400:2
11709,"(±)-1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazolium nitrate",272-295-6,68797-31-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4.0,H302:4;H319:4;H315:4
11714,Diethyl diselenide,211-042-6,628-39-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H319:1;H315:1;H410:1;H331:2;H373:2;H301:2;H400:1;H311:2
11715,2-nitrobenzenesulphonyl fluoride,207-094-4,433-98-7,Skin Corr. 1B,Notified C&L,39.0,H314:39
11716,"Amides, tallow, N-[3-(dimethylamino)propyl]",270-356-1,68425-50-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,28.0,H400:23;H302:23;H314:26;H318:23;H319:2;H315:2
11717,N-(2-hydroxyethyl)-N-[2-(stearoylamino)ethyl]stearamide monoacetate,266-781-7,67633-78-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31.0,H412:31;H319:31;H315:31;H411:31
11718,Sodium hydrogen tartrate,208-400-9,526-94-3,Not Classified,Notified C&L,2.0,Not classified:2
11729,Benzophenone,204-337-6,119-61-9,STOT RE 2;Aquatic Chronic 3,REACH registration C&L,4649.0,H412:371;H373:1712;H411:3584;H400:352;H319:337;H410:318;H315:336;H335:255;Not classified:85;H351:40;H372:5;H302:13;H317:1
11731,3-methoxy-2-methylpyridine,247-652-4,26395-26-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
11734,(2R)-(-)-Glycidyl p-Toluenesulfonate,601-283-9,113826-06-5,Eye Dam. 1;Resp. Sens. 1;Carc. 1B,Notified C&L,40.0,H334:38;H318:39;H350:39;H341:2;H317:1;H411:1;H312:1;H319:1;H315:1;H332:1;H302:1
11735,4-isopropoxyaniline,231-636-9,7664-66-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3.0,H312:1;H319:3;H315:3;H332:1;H302:1;H335:1;H331:1;H301:1;H311:1
11739,"(4S)-1-methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohexene",610-461-5,495-61-4,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,293.0,H304:293;H315:293;H317:293;H332:35;H411:35
11740,lead(II) methanesulphonate,401-750-5,17570-76-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT RE 2;Repr. 1A,Harmonised C&L,0.0,H318:0;H315:0;H332:0;H373:0;H302:0;H360:0
11741,Nickel dinitrate hexahydrate,603-868-4,13478-00-7,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,174.0,H318:173;H272:173;H315:173;H317:174;H341:173;H410:173;H332:173;H350:173;H400:173;H372:174;H334:173;H302:173;H360:173;H351:1
11742,"Methyl 3,4,5-trimethoxybenzoate",217-629-3,1916-07-0,Not Classified,REACH registration C&L,12.0,Not classified:12
11745,C.I. Acid Brown 98,602-812-6,12269-88-4,Not Classified,Notified C&L,1.0,Not classified:1
11748,"1,10-dichlorodecane",218-489-6,2162-98-3,Aquatic Acute 1,REACH registration C&L,48.0,H400:5;H411:2;H319:41;H315:41;H335:40;Not classified:2;H410:2
11751,Zinc isodecanoate,250-117-8,30304-30-4,Not Classified,Notified C&L,1.0,Not classified:1
11754,"D-glucopyranose, oligomers, xylityl glycosides and 1,4 anhydro D-xylitol and D-xylitol",446-990-1,,Not Classified,REACH registration C&L,2.0,Not classified:2
11759,"Hydrogen bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-) , compound with dicyclohexylamine (1:1)",277-864-2,74421-71-9,Repr. 1B,Notified C&L,92.0,H360:83;Not classified:9
11763,Tiemonium iodide,205-616-5,144-12-7,Acute Tox. 4,Notified C&L,2.0,H302:2
11764,"(E)-beta-((Dichlorophenyl)methylen)-alpha-(1,1-dimethyl-ethyl)-1H-1,2,4-triazol-1-ethanol",617-485-5,83657-24-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,208.0,H302:208;H400:208;H410:208
11766,2-Chloro-N-(2-methylpropyl)-3-nitro-4-quinol,603-769-6,133860-75-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H302:2;H319:2;H315:2;H335:2
11769,"Protein hydrolyzates, corn",309-349-6,100209-41-4,Not Classified,Notified C&L,38.0,Not classified:38
11780,Pivalamidine hydrochloride,242-091-1,18202-73-8,,Notified C&L,7.0,H319:7;H315:7;H335:5;H312:1;H332:1;H302:1
11785,3-(hydroxymethyl)pyrocatechol,238-106-6,14235-77-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
11786,Disodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate,222-899-0,3655-00-3,Skin Corr. 1B,Notified C&L,18.0,H314:18
11788,Diethyl succinate,204-612-0,123-25-1,Not Classified,REACH registration C&L,400.0,Not classified:398;H302:1;H319:2;H335:2;H315:1
11790,"Triethoxy(2,4,4-trimethylpentyl)silane",252-558-1,35435-21-3,Flam. Liq. 3,REACH registration C&L,177.0,H226:172;H412:21;H413:14;Not classified:5
11791,"Strychnos ignatii, ext.",290-350-2,90131-39-8,,Notified C&L,1.0,H225:1
11792,Henicosane,211-118-9,629-94-7,Not Classified,Notified C&L,95.0,Not classified:93;H304:2
11795,"A mixture of tetralithium cis-2-[3-tert-butyl-4-cyano-5-({2-[(2,6-diethyl-4-methyl-3-sulfonatophenyl)amino]-6-[(2,6-diethyl-4-methyl-3-sulfonatophenyl)(6-sulfonato-2,7a-dihydro-1,3-benzothiazol-2-yl)amino]-4-methylpyridin-3-yl}diazenyl)-1H-pyrazol-1-yl]-2,7a-dihydro-1,3-benzothiazole-6-sulfonate and tetralithium trans-2-[3-tert-butyl-4-cyano-5-({2-[(2,6-diethyl-4-methyl-3-sulfonatophenyl)amino]-6-[(2,6-diethyl-4-methyl-3-sulfonatophenyl)(6-sulfonato-2,7a-dihydro-1,3-benzothiazol-2-yl)amino]-4-methylpyridin-3-yl}diazenyl)-1H-pyrazol-1-yl]-2,7a-dihydro-1,3-benzothiazole-6-sulfonate",472-030-6,,Aquatic Chronic 2,Notified C&L,2.0,H411:2
11798,Sodium metavanadate,237-272-7,13718-26-8,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,61.0,H319:57;H361:5;H332:11;H411:9;H372:5;H301:59;H315:52;H335:52;H340:2;H317:2;H331:2;H350:2;H412:2;H334:2;H360:2;Not classified:2
11803,Tannase,232-804-4,9025-71-2,Resp. Sens. 1,Notified C&L,42.0,H334:42;H319:1;H315:1;H335:1
11804,4-(methylthio)benzaldehyde,222-365-7,3446-89-7,Acute Tox. 4,REACH registration C&L,6.0,H302:4;H301:2;H319:1;H315:1;H335:2;H331:1;H311:1
11806,Chloramide,234-217-9,10599-90-3,Not Classified,REACH registration C&L,5.0,Not classified:2;H314:2;H412:2;H335:2;H372:2;H290:2;H319:1;H315:1
11810,2-ethylhexyl pivalate,240-437-6,16387-18-1,Not Classified,Notified C&L,1.0,Not classified:1
11817,Thiane,216-561-1,1613-51-0,Flam. Liq. 2,Notified C&L,46.0,H225:46
11818,"perboric acid (H3BO2(O2)), monosodium salt trihydrate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate;sodium perborate;[containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]",239-172-9,15120-21-5,,,0.0,H318:0;H272:0;H335:0;H302:0;H360:0
11819,2-isobutylquinoline,202-227-2,93-19-6,Not Classified,Notified C&L,1411.0,Not classified:1384;H302:27
11820,tert-butyl propionate,606-566-0,20487-40-5,Flam. Liq. 2,Harmonised C&L,0.0,H225:0
11821,3-(4-hydroxyphenyl)-2-phenylpropionic acid,201-888-4,89-23-6,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38.0,H400:38;H301:38;H319:38
11822,5-methylphenazinium methyl sulphate,206-072-1,299-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46;H341:3
11824,2-(2-hydroxyethoxy)ethyl formate,611-115-6,54229-31-1,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H315:1;H335:1
11826,"2,2'-[(4-nitrosophenyl)imino]bisethanol",222-731-6,3590-52-1,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H312:1;H301:1;H332:1
11827,1-(5-fluoro-2-hydroxyphenyl)ethan-1-one,206-893-5,394-32-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H302:41;H319:47;H315:47;H335:46
11830,"Fatty acids, tall-oil, tetraesters with pentaerythritol",269-815-9,68334-18-9,Not Classified,Notified C&L,4.0,Not classified:4
11835,2-bromo-2-methylpropionyl bromide,244-017-3,20769-85-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Muta. 1B;Aquatic Acute 3,REACH registration C&L,51.0,H314:51;H340:3;H317:6;H402:3;H302:44;H290:1;H318:2;H335:1;Not classified:1
11837,"1,2-Benzenedicarboxylic acid, benzyl C7-9-branched and linear alkyl esters",271-082-5,68515-40-2,Not Classified,Notified C&L,153.0,Not classified:116;H400:33;H411:4
11838,Allyl 2-ethylbutyrate,231-332-6,7493-69-8,Not Classified,Notified C&L,126.0,Not classified:88;H226:38
11839,2-amino-5-bromo-6-methylpyrimidin-4(1H)-one,228-623-5,6307-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
11842,"Bis((1,2,3,4,5,6-eta)-isopropylbenzene)chromium",234-410-8,12001-89-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38.0,H319:38;H315:38
11844,"Benzoic acid, 2-hydroxy-, reaction products with formaldehyde, coupled with diazotized 5-amino-8-[[4-[(4-nitro-2-sulfophenyl)amino]phenyl]azo]-2-naphthalenesulfonic acid disodium salt",276-521-4,72245-24-0,Skin Sens. 1,REACH registration C&L,39.0,H317:6;Not classified:33
11846,4-vinyl-m-xylene,218-781-3,2234-20-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52.0,H319:52;H226:52;H315:52;H335:52
11848,"Residues (coal tar), anthracene oil distn.;Anthracene Oil Fraction;[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340°C to 400°C (644°F to 752°F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]",295-505-8,92061-92-2,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0
11855,Methyl 5-oxo-L-prolinate,225-567-3,4931-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
11857,Dibutyl methylenedithiodi(acetate),238-289-2,14338-82-0,Aquatic Chronic 2,REACH registration C&L,34.0,H411:34
11862,N-(2-benzoyl-4-chlorophenyl)-2-chloroacetamide,223-678-1,4016-85-7,Skin Corr. 1B,Notified C&L,39.0,H314:39
11865,Reaction Mass of 4-tert-butyl-2-hydroxycyclohexyl methacrylate and 5-tert-butyl-2-hydroxycyclohexyl methacrylate,418-420-1,,Skin Irrit. 2;Skin Sens. 1B;STOT SE 3;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H315:1;H335:1;H317:1
11869,"1,3,5-Triazine-2,4,6-triamine, polymer with formaldehyde, butylated methylated",614-213-7,68036-97-5,Aquatic Chronic 4,Notified C&L,104.0,H413:58;H319:38;H315:38;H335:38;H317:38;Not classified:6;H412:2
11872,TKP 50059,442-970-1,,Not Classified,Notified C&L,83.0,Not classified:83
11873,"(trans,trans)-5-{(4-Propyl[1,1-bicyclohexyl]-4-yl)-difluormethoxy}-1,2,3-trifluorbenzene",606-647-0,208338-50-5,Not Classified,REACH registration C&L,2.0,Not classified:2
11875,4-tert-butylcyclohex-1-ene,606-973-3,2228-98-0,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40.0,H400:40;H410:40;H315:40
11881,7-hydroxycitronellal,203-518-7,107-75-5,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2012.0,H319:2012;H317:2012;H315:43;Not classified:1
11885,"2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane",411-280-2,74091-64-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H314:0;H317:0;H330:0;H412:0;H334:0;H302:0
11890,"Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper",238-984-0,14915-37-8,Not Classified,Notified C&L,133.0,Not classified:85;H318:48;H315:42;H330:48;H302:48;H400:48;H335:2;H410:1
11891,"cobaltate(3-), bis(6-(amino-kN)-5-(2-(2-9hydroxy-kO)-3,5-dinitrophenyl)diazenyl-kN1)-1-naphthalenesulfonate(3-))-,sodium hydrogen (1:1:2)",615-952-8,73297-10-6,Aquatic Chronic 3,Notified C&L,1.0,H412:1
11893,2-amino-3-chlorobenzoic acid,228-996-4,6388-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:42;H315:42;H335:41;Not classified:1;H302:1
11895,"N,N,N',N',1-pentamethyltrimethylenediamine",202-610-4,97-84-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,44.0,H314:43;H226:43;H331:38;H302:43;H311:43;H332:5;Not classified:1;H318:1
11897,2-[4-chloro-3-(chlorosulphonyl)benzoyl]benzoic acid,271-616-7,68592-12-1,Skin Corr. 1B,REACH registration C&L,6.0,H314:6
11898,"3,3'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[2,5-bis(p-nitrophenyl)-2H-tetrazolium] dichloride",214-665-1,1184-43-6,Carc. 1B,Notified C&L,39.0,H350:38;H302:1;H228:1;H332:1;H312:1
11902,(3H)phosphoric acid,238-285-0,14335-33-2,Skin Corr. 1B,Notified C&L,39.0,H314:39
11905,Methyl L-histidinate dihydrochloride,230-973-9,7389-87-9,,Notified C&L,9.0,H319:8;H315:8;H335:7;Not classified:1
11907,"2-ethyl-2-(3-chloro-propyl)-malonic acid-1,3-diethyl ester",608-788-3,32821-60-6,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2.0,H315:2;H317:2;H373:2;H411:2;H401:2
11908,Methyl N-methylanthranilate,201-642-6,85-91-6,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1723.0,H412:21;H319:51;Not classified:1659;H315:44;H335:41
11909,"Amines, C16-22-alkyl",268-215-4,68037-92-3,Skin Corr. 1B;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,42.0,H314:4;H318:41;H410:4;H372:4;H400:41;H315:37;H373:33;Not classified:1
11910,Tungsten boride,234-498-8,12007-09-9,Not Classified,Notified C&L,1.0,Not classified:1
11912,4-(2-hydroxyethyl)morpholin-3-one,609-886-9,41036-01-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
11913,"2,2-difluorosuccinic acid",211-558-1,665-31-6,,Notified C&L,6.0,H314:6
11914,Furfuryl acrylate,234-078-4,10525-17-4,,Notified C&L,1.0,H319:1;H315:1;H335:1
11920,"(2S-trans)-18-carboxy-20-(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionic acid",243-209-4,19660-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
11927,Chloromethyl thiocyanate,221-883-0,3268-79-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H302:40;H332:40;H312:40;H319:5;H315:5;H330:4;H335:5;H301:5;H311:4;H331:1
11930,"Fatty acids, C18-unsaturated, dimers, compounds with polyethylenepolyamine-tall-oil fatty acid reaction products (AMIDOAMINE RESIN)",613-690-9,64754-99-0,Eye Dam. 1,Notified C&L,77.0,H318:49;H319:24;H315:24;H317:24;H314:4
11931,Methandriol dipropionate,222-735-8,3593-85-9,Carc. 2,Notified C&L,38.0,H351:38
11932,"acrylic acid, monoester with propane-1,2-diol",247-118-0,25584-83-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0.0,H314:0;H317:0;H331:0;H301:0;H311:0
11933,"Imidazolium compounds, 1-(carboxymethyl)-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, hydroxides, inner salts",269-819-0,68334-21-4,Eye Irrit. 2,Notified C&L,8.0,H319:8
11936,2-ethoxybutane,220-234-9,2679-87-0,Not Classified,Notified C&L,89.0,Not classified:64;H224:24;H225:1
11939,5-Bromo-2-chlorotoluene,611-212-3,54932-72-8,,Notified C&L,8.0,H319:7;H315:7;H335:2;H314:1;H226:1
11941,"Aromatic hydrocarbons, C",292-698-0,90989-42-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H304:0;H340:0
11943,"Phenol, 2-bromo-5-methoxy-",613-281-5,63604-94-4,Not Classified,Notified C&L,1.0,Not classified:1
11945,"2-(3,6-dihydroxyxanthen-9-yl)benzoic acid",208-252-5,518-44-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
11948,"Disodium 2-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]naphthalene-1-sulphonate",235-409-5,12220-64-3,Not Classified,Notified C&L,5.0,Not classified:4;H334:1;H317:1
11951,"bis(3,5-di-tert-butylsalicylato-O",403-360-0,42405-40-3,Flam. Sol. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H228:0;H400:0;H410:0
11953,Ditolyl ether,248-948-6,28299-41-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,42.0,H302:13;H400:12;H410:18;Not classified:24
11954,"4-ethoxy-4'-(trans-4-ethylcyclohexyl)-2,3-difluoro-1,1'-biphenyl",608-727-0,323178-01-4,Not Classified,REACH registration C&L,2.0,Not classified:2
11957,"Formaldehyde, polymer with 3-chloro-1-propene and phenol",608-216-2,28470-78-2,Not Classified,Notified C&L,2.0,Not classified:2
11958,N-methyl-4-nitrophenethylamine hydrochloride,425-800-0,166943-39-1,Skin Sens. 1,Notified C&L,29.0,H317:29
11959,"2,8-Dimethylphenoxathiin",606-832-6,21797-73-9,Not Classified,Notified C&L,1.0,Not classified:1
11961,"2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)",418-280-1,18600-59-4,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H413:0;H317:0
11963,"A mixture of: 1,6-bis((3aR,4S,5S (or R),7S,7aR)-1-(octahydro-4,7-methano-1H-inden-5-yl)methyl) hexan-1,6-dioate; 1,6-bis((3aS,4S,5S (or R),7S,7aS)-1-(octahydro-4,7-methano-1H-inden-5-yl)methyl) hexan-1,6-dioate",430-080-6,195371-10-9,Skin Irrit. 2,Notified C&L,1.0,H315:1
11966,"Silicic acid, aluminum zinc salt",257-956-9,52488-90-1,Eye Dam. 1,Notified C&L,1.0,H318:1
11967,Gliclazide,244-260-5,21187-98-4,Not Classified,Notified C&L,83.0,Not classified:54;H302:21;H361:9;H319:7;H315:7;H335:7;H402:1;H412:2;H413:1;H362:1
11968,4-aminophenol,204-616-2,123-30-8,Acute Tox. 4;Acute Tox. 4;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H341:0;H410:0;H332:0;H302:0;H400:0
11972,2-iodopyridin-3-ol,254-864-0,40263-57-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44.0,H302:38;H318:38;H315:44;H335:43;H319:6
11973,Conalbumin,215-727-0,1391-06-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38.0,H334:38;H317:38
11974,"1,1',1''-(1,3,5,5-tetramethylpent-1-ene-1,3,5-triyl)tribenzene",242-951-6,19303-34-5,Not Classified,Notified C&L,1.0,Not classified:1
11980,"Anethum sowa, ext.",283-912-3,84775-84-8,Not Classified,Notified C&L,185.0,Not classified:184;H304:1;H315:1;H317:1;H226:1;H411:1
11981,Dioctadecyl disulphide,219-702-5,2500-88-1,Not Classified,REACH registration C&L,43.0,Not classified:43
11991,C.I. Disperse Yellow 3;N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide,220-600-8,2832-40-8,Skin Sens. 1;Carc. 2,Harmonised C&L,0.0,H351:0;H317:0
11992,"1-chloro-N,N,1,1-tetramethylsilylamine",242-095-3,18209-60-4,,Notified C&L,1.0,H314:1;H225:1
11993,"2-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)methyl]-1-methyl-1-(p-tolyl)diazonium chloride",253-806-1,38151-74-5,,Notified C&L,2.0,H302:1;H314:1;H318:1;H411:1;Not classified:1
11994,"trans-2,3-dimethyloxirane",244-406-8,21490-63-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60.0,H319:60;H315:60;H335:60;H225:60;H341:20;H312:1;H332:1;H351:2;H302:1;H412:1
11995,"reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid",421-280-4,,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
11996,"Diindolo[3,2-b:3',2'-m]triphenodioxazine, 8,18-dichloro-5,15-diethyl-5,15-dihydro-, (4-methyl-1H-imidazolyl)methyl derivs., acetates",286-002-4,85186-19-2,,Notified C&L,83.0,Not classified:83
11998,"2-Propenoic acid, polymer with ethenylbenzene and ethyl 2-propenoate",607-750-3,25585-77-7,Not Classified,Notified C&L,68.0,Not classified:68
11999,HD6662,442-360-5,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H318:1;H317:1;H410:1;H302:1;H400:1
12001,Desmophen 1150,611-045-6,53795-85-0,Not Classified,Notified C&L,1.0,Not classified:1
12002,4-tert-butyl hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-aspartate,276-251-7,71989-14-5,Not Classified,Notified C&L,6.0,Not classified:3;H302:3;H332:3;H312:3
12003,"Oxidase, hexose",618-521-2,9028-75-5,Resp. Sens. 1,Notified C&L,5.0,H334:5
12004,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with resorcinol, reaction products with formaldehyde",288-599-7,85828-72-4,Eye Irrit. 2,REACH registration C&L,9.0,H319:6;Not classified:3
12008,"Hypnea musciformis, ext.",607-050-8,223751-71-1,Not Classified,Notified C&L,52.0,Not classified:52
12009,Etoxazene hydrochloride,219-010-3,2313-87-3,Not Classified,Notified C&L,3.0,Not classified:2;H319:1;H315:1
12010,4-acetylpiperidinium chloride,289-528-2,89895-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
12014,"5,6-dimethyl-1,2,4-triazin-3-ylamine",241-552-4,17584-12-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H302:39;H319:45;H315:45;H335:44
12017,N-phenyl-N-(p-tolyl)-p-toluidine,243-822-7,20440-95-3,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39.0,H302:38;H400:38;H319:1;H315:1
12021,Cyclopentanemethylamine,227-965-2,6053-81-2,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,39.0,H302:38;H314:39;H226:38
12024,"Glucanase, endo-1,3(4)-β-",263-462-4,62213-14-3,Resp. Sens. 1,REACH registration C&L,45.0,H334:45
12027,"2,5-dioxo-1,3-diazolidin-4-ylacetic acid",226-574-4,5427-26-9,,Notified C&L,5.0,H319:5;H315:5;H335:5;H302:1
12033,"Peanut oil, sulfated, sodium salt",263-071-9,61789-58-0,Not Classified,Notified C&L,1.0,Not classified:1
12036,Ethyl p-tolyl carbonate,245-175-6,22719-81-9,Not Classified,Notified C&L,88.0,Not classified:88
12037,(p-phenylenedivinylene)bisbenzonitrile,301-710-6,94031-05-7,Not Classified,Notified C&L,37.0,Not classified:37
12045,"9-Octadecenoic acid (Z)-, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol",235-816-8,12772-47-3,Not Classified,Notified C&L,3.0,Not classified:3
12046,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., compds. with diethanolamine",286-681-7,85338-09-6,Not Classified,Notified C&L,5.0,Not classified:3;H302:2;H318:2;H315:2
12048,Oxymetholone,207-098-6,434-07-1,Carc. 2;Repr. 2,Notified C&L,41.0,H361:39;H351:39;H312:1;H332:1;H373:1;H302:1;H350:1
12049,2-chloro-1-(3-ethoxy-4-nitrophenoxy)-4-(trifluoromethyl)benzene,255-983-0,42874-03-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,415.0,H400:408;H410:408;H319:4;H315:4;H351:5;H335:4;Not classified:3;H302:5;H332:3;H312:3;H314:1;H318:1
12055,Tetraammonium cerium tetrakis(sulphate),231-567-4,7637-03-8,Not Classified,Notified C&L,1.0,Not classified:1
12059,2-methylstyrene;2-vinyltoluene,210-256-7,611-15-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H332:0;H411:0
12061,Norepinephrine hydrogen tartrate,200-095-0,51-40-1,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Repr. 1B,Notified C&L,42.0,H360:38;H330:38;H300:40;H310:39;H301:2;H315:1;H331:1;H311:1
12064,Virginiamycin S1,245-462-6,23152-29-6,Not Classified,Notified C&L,1.0,Not classified:1
12070,"epoxiconazole (ISO);(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane",406-850-2,133855-98-8,Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0.0,H360:0;H351:0;H411:0
12071,"4-hydroxy-3,5-dimethoxycinnamic acid",208-487-3,530-59-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,169.0,H319:168;H315:168;H335:167;H302:1;H332:1;H312:1
12072,"Hierochloe odorata, ext.",294-796-9,91770-13-7,Skin Sens. 1,Notified C&L,25.0,H317:25
12073,(Z)-Tetracos-15-enoic acid,610-549-3,506-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:41;H315:41;H335:40;Not classified:1
12074,"Octadecanoic acid, reaction products with diethylenetriamine, di-Et sulfate-quaternized",271-548-8,68585-05-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
12076,Tris(2-chloro-1-methylethyl) phosphate,237-158-7,13674-84-5,Acute Tox. 4,Notified C&L,715.0,H302:708;H412:15;H319:6;Not classified:6;H413:1;H315:1
12077,Sodium 3-[[(dimethylamino)thioxomethyl]thio]propanesulphonate,242-644-7,18880-36-9,Not Classified,REACH registration C&L,2.0,Not classified:2
12078,"3-(3,4-Dimethoxyphenyl)propanenitrile",610-465-7,49621-56-9,Acute Tox. 4,REACH registration C&L,1.0,H302:1
12080,Tricobalt dicitrate,212-751-3,866-81-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,19.0,H318:18;H341:19;H317:19;H350:18;H411:18;H334:18;H302:18;H360:18;H373:14
12082,Dihydrogen sodium bis[2-[[[4-hydroxy-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]phenyl]sulphonyl]amino]benzoato(3-)]cobaltate(3-),277-226-3,73018-84-5,Aquatic Chronic 2,Notified C&L,2.0,H411:2
12089,"9-Octadecenoic acid (Z)-, compd. with N-coco alkyl-1,1'-iminobis[2-propanol]",287-418-9,85507-95-5,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,33.0,H315:33;H411:33
12091,Glycylvaline,217-806-5,1963-21-9,Eye Dam. 1,Notified C&L,38.0,H318:38
12093,"Fatty acids, safflower-oil, Et esters",293-106-3,91051-53-5,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,85.0,H412:84;H400:84;H315:84;H411:1;H317:1
12096,"Aluminum, benzoate iso-Pr alc. stearate complexes",272-365-6,68815-27-0,Not Classified,Notified C&L,40.0,Not classified:40
12098,Ethyl 5-methylsalicylate,251-903-3,34265-58-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H312:38;H319:38;H315:38;H226:38;H332:38;H335:38;H302:38
12101,N-phenylnicotinamide,217-138-4,1752-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12105,"4-methylcyclohexane-1,3-diamine",237-666-9,13897-55-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,116.0,H302:116;H314:83;H318:83;H312:33
12106,3-aminopyridine-2-carboxylic acid,215-971-8,1462-86-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,55.0,H319:54;H317:53;H315:2;H335:2
12109,2-(propylthio)ethanol,245-241-4,22812-90-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,43.0,H302:39;H318:38;H314:4;H332:1;H312:1
12110,"Dibutyl hydrogen phosphate, compound with 2,2'-iminodiethanol (1:1)",224-344-8,4318-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:3;H315:3
12112,"2-ethylhexanoic acid, compound with 2-aminoethanol (1:1)",278-031-6,74931-55-8,Skin Corr. 1B;Eye Dam. 1;Repr. 2,REACH registration C&L,2.0,H314:1;H318:1;H361:1;H319:1;H315:1
12114,2-methylbutan-2-ol;tert-pentanol,200-908-9,75-85-4,Flam. Liq. 2;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0.0,H332:0;H315:0;H335:0;H225:0
12115,"Alcohols, C14-15",616-261-4,75782-87-5,Aquatic Chronic 1,REACH registration C&L,470.0,H410:448;Not classified:22
12117,"Thyme, Thymus mastichina, ext.",284-294-8,84837-14-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1400.0,H319:104;H304:1390;H315:104;H317:104;H226:1390;H412:1292;H411:99;Not classified:10
12121,"tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene",408-210-8,124605-82-9,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0
12123,Mercury di(acetate),216-491-1,1600-27-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,71.0,H300:71;H330:71;H410:71;H310:71;H373:71;H400:71;Not classified:1
12124,4-(dimethylamino)benzaldehyde [[4-(dimethylamino)phenyl]methylene]hydrazone,218-402-1,2143-98-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38.0,H319:38;H315:38;H317:38;H413:38;H335:38;H302:38
12126,1-chloro-4-(methylsulphonyl)-2-nitrobenzene,202-557-7,97-07-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,43.0,H302:4;H319:43;H312:4;H315:5;H335:1
12129,"phosphoric acid ... %, orthophosphoric acid ... %",231-633-2,7664-38-2,Skin Corr. 1B,Harmonised C&L,0.0,H314:0
12131,N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide,411-590-8,70693-57-1,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H314:0
12134,p-aminobenzamidine,223-370-7,3858-83-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12137,2-chloro-3-methylpyrazine,202-434-8,95-58-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
12139,"Tetrasodium α,α'.-(ethylenediimino)bis[(2-hydroxy-5-sulphonatophenyl)acetate]",290-809-7,90247-45-3,Not Classified,REACH registration C&L,7.0,Not classified:6;H412:1;H319:1
12140,Tris(trifluoroacetoxy)borane,206-507-5,350-70-9,Acute Tox. 3,Notified C&L,38.0,H301:38
12143,AMORPHOUS SILICA,614-122-2,67762-90-7,Not Classified,Notified C&L,606.0,Not classified:602;H332:3;H303:1
12145,Palmitic acid,200-312-9,57-10-3,Not Classified,REACH registration C&L,1840.0,Not classified:1218;H319:546;H315:525;H335:517;H412:69;H413:1
12147,Calcium propan-2-olate,239-621-9,15571-51-4,Self-heat. 2;Skin Corr. 1B,Notified C&L,38.0,H314:38;H252:38
12148,Tetrasodium bis[2-[[[3-[[1-[(2-chloroanilino)carbonyl]-2-oxopropyl]azo]-4-hydroxyphenyl]sulphonyl]amino]benzoato(3-)]cobaltate(4-),274-929-7,70851-34-2,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,359.0,H400:296;H319:313;H410:297;H317:308;H318:18;H315:18;H320:15;Not classified:12;H411:17
12152,"Fatty acids, C8-10, lauryl esters",292-929-5,91031-28-6,Not Classified,Notified C&L,1.0,Not classified:1
12153,Bibrocathol,230-023-3,6915-57-7,Not Classified,Notified C&L,1.0,Not classified:1
12154,Disodium octenylsuccinate,259-003-2,54163-66-5,Not Classified,Notified C&L,1.0,Not classified:1
12159,"2',3,4',5,7-pentahydroxyflavone",207-542-9,480-16-0,Aquatic Chronic 2,REACH registration C&L,116.0,H411:15;H319:59;H315:59;H341:55;H335:58;H302:58;H301:38;Not classified:2
12160,"1,2-bis(ethylthio)ethane",226-409-6,5395-75-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H301:1;H319:1;H315:1;H335:1
12161,DL-proline,210-189-3,609-36-9,Not Classified,Notified C&L,21.0,Not classified:21
12162,"Slags, chromium-manufg.",286-094-6,85187-07-1,Not Classified,Notified C&L,1.0,Not classified:1
12163,"Amides, soya, N,N-bis(hydroxyethyl)",270-355-6,68425-47-8,Eye Irrit. 2,Notified C&L,603.0,H319:447;H318:118;H315:124;Not classified:26;H411:19;H316:12;H303:12;H320:12
12164,"1,4-dioxane-2,5-diol",607-202-3,23147-58-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
12169,"1-(2,6,6-trimethyl-2-cyclohexen-1-yl)pent-1-en-3-one",231-926-5,7779-30-8,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,281.0,H411:243;H317:189;Not classified:39;H315:112;H319:45
12170,Trichlorobenzene,234-413-4,12002-48-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H319:33;H315:33;H410:33;H302:33;H400:33;Not classified:5
12171,2-cyanophenyl acetate,227-210-7,5715-02-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H302:1
12173,3-chlorophenylglycolic acid,240-376-5,16273-37-3,,Notified C&L,5.0,H319:5;H315:5;H335:4
12176,"3,3',4',5,7-pentahydroxyflavone",204-187-1,117-39-5,Acute Tox. 3,Notified C&L,260.0,H301:165;H302:92;Not classified:3
12179,4-Methoxyphenyl 4-Hydroxybenzoate,610-562-4,50687-62-2,Not Classified,Notified C&L,2.0,Not classified:1;H319:1;H315:1
12182,Dioctylbis(palmitoyloxy)stannane,288-876-2,85938-42-7,STOT RE 2;Aquatic Chronic 4,Notified C&L,56.0,H413:56;H373:56
12184,Hemin,240-140-1,16009-13-5,Not Classified,Notified C&L,4.0,Not classified:2;H319:2;H315:2;H317:1;H335:2;H334:1
12185,"Sodium 4-hydroxy-3,5-diiodophenylcyanide",220-995-7,2961-62-8,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33.0,H312:33;H319:33;H361:33;H410:33;H331:33;H373:33;H301:33;H400:33
12186,"1H-Isoindole-1,3(2H)-dione, 2-(4-bromo-3-oxobutyl)-",610-614-6,51132-00-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H317:38
12188,"Fatty acids, C8-10, esters with 3,3'-oxybis[1,2-propanediol]",608-062-6,272449-93-1,Not Classified,Notified C&L,1.0,Not classified:1
12192,"2-hexyl-1,3-dioxolane",216-959-5,1708-34-5,Skin Sens. 1,Notified C&L,263.0,H317:263;H315:1;H335:1
12193,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide",617-230-8,81403-80-7,STOT RE 2,REACH registration C&L,4.0,H373:4
12195,N-(3-Amino-4-(methylamino)benzoyl)-N-2-pyridinyl-beta-alaninethylester,606-728-0,212322-56-0,Not Classified,REACH registration C&L,3.0,Not classified:3
12196,"Potassium 1,1,2,2,3,3,4,4-octafluorobutane-1-sulphonate",274-517-7,70259-85-7,Not Classified,Notified C&L,33.0,Not classified:33
12197,"Alkanes, C16-20-iso-",292-461-1,90622-59-6,Aquatic Chronic 4,Notified C&L,119.0,H413:83;Not classified:36
12200,Lemon Oil Terpenes,614-796-8,68917-33-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,254.0,H304:139;H315:164;H317:120;H226:139;H411:113;Not classified:90;H410:26;H400:23
12201,C.I. Acid Brown 58,602-811-0,12269-87-3,Not Classified,Notified C&L,3.0,Not classified:3
12208,Methoxymethyl isocyanate,229-197-3,6427-21-0,Acute Tox. 4,Notified C&L,38.0,H302:38
12211,Fluoroethylene,200-832-6,75-02-5,Flam. Gas 1;Press. Gas (Liq.);Muta. 2;Carc. 1B;STOT RE 2,REACH registration C&L,145.0,H341:83;H280:145;H373:83;H350:83;H220:145
12212,"2,2,6,6-tetramethylpiperidin-4-one hydrochloride",251-769-6,33973-59-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
12215,Decyl β-D-glucopyranoside,261-469-7,58846-77-8,Not Classified,Notified C&L,4.0,Not classified:4
12216,(E)-1-benzhydryl-4-cinnamylpiperazine,240-749-2,16699-20-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1
12220,(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline maleate,278-375-7,76095-16-4,Eye Dam. 1,Notified C&L,182.0,H318:93;H361:73;H360:48;H302:38;H319:46;H372:36;H362:30;Not classified:2;H312:2;H315:5;H335:5;H373:1;H317:1;H334:1
12223,Calcium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]toluene-4-sulphonate],268-057-6,67990-35-6,Not Classified,Notified C&L,1.0,Not classified:1
12228,"1,3-dihydro-4(or 5)-methyl-2H-benzimidazole-2-thione",258-904-8,53988-10-6,Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,87.0,H410:52;H332:52;H373:52;H302:86;H360:5;H361:47;H412:18;Not classified:1
12231,"Petroleum products, refinery gases;Refinery gas;[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]",271-750-6,68607-11-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
12233,"1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin",600-447-7,1035218-79-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1;H315:1;H317:1
12235,Isooctadecyl palmitate,276-719-0,72576-80-8,Not Classified,REACH registration C&L,12.0,Not classified:12
12236,"Corn oil, sulfated, sodium salt",281-969-9,84082-17-7,Not Classified,Notified C&L,1.0,Not classified:1
12237,"Residues, steam cracked, thermally treated;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 °C (356 °F).]",308-733-0,98219-64-8,Carc. 1B,Harmonised C&L,0.0,H350:0
12238,N-(2-Bromo-5-hydroxy-4-methoxybenzyl)-N-[2-(4-hydroxyphenyl)ethyl]formamide,602-791-3,122584-18-3,Muta. 2,REACH registration C&L,2.0,H341:1;H319:1;H315:1
12243,Methyl isobutyrate,208-929-5,547-63-7,Flam. Liq. 2,Notified C&L,1643.0,H225:1642;H332:42;H302:1;H226:1;H315:1;H317:1
12244,"Disodium 4-amino-3-[[4-[(2-amino-4-hydroxyphenyl)azo]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",270-629-5,68460-07-1,Not Classified,Notified C&L,2047.0,Not classified:2046;H412:1
12245,Butyl 5-oxo-L-prolinate,225-568-9,4931-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12249,Bromotrimethylsilane,220-672-0,2857-97-8,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,52.0,H314:52;H318:6;H335:4;H225:9;H226:43
12250,"4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxoanthryl)amino]propyl]-4-methylmorpholinium methyl sulphate",254-161-9,38866-20-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,39.0,H302:39;H317:39;H412:1
12252,"3,3'-formyliminodipropiononitrile",222-362-0,3445-84-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1.0,H319:1;H315:1;H331:1;H301:1;H311:1
12253,"1,1,2,3-tetrachloropropene",233-920-8,10436-39-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55.0,H319:55;H315:55;H410:55;H302:55;H400:55
12254,4'-hydroxy-2-methylpropiophenone,252-287-9,34917-91-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1.0,H319:1;H315:1;H412:1;H335:1;H302:1
12255,(2-hydroxyethyl)methylbis[2-[(1-oxooctadecyl)oxy]ethyl]ammonium methyl sulphate,250-952-8,32208-04-1,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,61.0,H412:59;H318:60;Not classified:1
12257,"Esterase, pectin",232-807-0,9025-98-3,Resp. Sens. 1,Notified C&L,16.0,H334:16
12258,"α-d-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-d-glucopyranuronosyl-, dipotassium salt",272-296-1,68797-35-3,Not Classified,REACH registration C&L,101.0,Not classified:101
12259,Nonadecanenitrile,249-107-6,28623-46-3,Acute Tox. 4,Notified C&L,39.0,H302:38;H301:1;H331:1;H311:1
12261,"2-Propenoic acid, 2-methyl-, C12-18-alkyl esters",292-095-2,90551-77-2,Not Classified,Notified C&L,524.0,Not classified:441;H319:83;H315:83;H335:83
12265,5-methyl-1-phenylhex-1-en-3-one,220-760-9,2892-18-4,Aquatic Chronic 2,Notified C&L,42.0,H411:42
12268,Tomatine,241-429-5,17406-45-0,Acute Tox. 4,Notified C&L,4.0,H302:4
12269,Benzoxazol-2-amine,224-952-3,4570-41-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H302:43;H319:42;H315:42;H335:41;H332:1
12270,"Adenosine 5'-(trihydrogen diphosphate), 5'→5'-ester with 3-carbamoyl-1-α-D-ribofuranosylpyridinium--ate",230-738-0,7298-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12274,Palladium monoxide,215-218-3,1314-08-5,Ox. Sol. 1,REACH registration C&L,258.0,H271:92;Not classified:115;H319:50;H315:50;H335:50;H272:2
12278,"o-(1,1,3,3-tetramethylbutyl)phenol",223-420-8,3884-95-5,Not Classified,Notified C&L,2.0,Not classified:1;H318:1;H315:1;H335:1
12282,"2-Chloro-N4-(2-methylpropyl)-3,4-quinolinediamine",603-770-1,133860-76-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H302:2;H319:2;H315:2;H335:2
12283,Magnesium dihydrogenpyrophosphate,244-016-8,20768-12-1,Eye Dam. 1,Notified C&L,2.0,H318:2
12287,2-methyl-4-nitroimidazole,211-790-3,696-23-1,Acute Tox. 4,REACH registration C&L,57.0,H302:56;H319:1;H315:1;H341:1
12288,4-Hydroxy-3-nitro-2(1H)-quinolinone,604-801-1,15151-57-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3.0,H319:3;H315:3;H335:3
12290,Allyl anthranilate,231-331-0,7493-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12292,"2-Propenoic acid, reaction products with pentaerythritol and TDI",270-188-9,68412-43-1,Eye Irrit. 2,Notified C&L,145.0,H319:116;H318:28;H315:44;H317:33;H411:28;H302:28;H335:1;Not classified:1
12293,Ethyl nonanoate,204-615-7,123-29-5,Not Classified,Notified C&L,1678.0,Not classified:1634;H319:44;H315:44;H335:38
12296,Heptadecanal,211-115-2,629-90-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
12300,Perhydroazepin-1-ylamine,227-609-6,5906-35-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:38;H226:39;H315:38;H335:38;H318:1;H314:1
12302,Magnesium sulphate,231-298-2,7487-88-9,Not Classified,REACH registration C&L,2475.0,Not classified:1012;H302:1430;H332:1426;H312:1286;H317:22;H319:7;H315:7;H335:7;H371:4
12304,L-xylo-hex-2-ulosonic acid,208-403-5,526-98-7,Eye Irrit. 2,REACH registration C&L,2.0,H320:1;H319:1;Not classified:1
12306,"(+)-2'-Deoxy-2',2'-difluorocytidine hydrochloride",601-823-3,122111-03-9,Repr. 1B,Notified C&L,60.0,H360:51;H312:16;H319:19;H340:15;H315:8;H411:5;H351:3;H372:3;H302:7;H361:8;H341:2;H311:1;H332:1;H335:1
12310,"25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydroavermectin A1a",604-305-5,142680-85-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H302:1;H400:1;H410:1
12318,"Diammonium dihydroxybis[lactato(2-)-O1,O2]titanate(2-)",265-409-0,65104-06-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,326.0,H319:279;H315:20;H226:93;H335:1
12322,"Urea, reaction products with formaldehyde and methanol",305-547-1,94645-52-0,Not Classified,Notified C&L,32.0,Not classified:31;H317:1
12323,"N,N'-methylenediacrylamide",203-750-9,110-26-9,Acute Tox. 3;Acute Tox. 4;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 1,REACH registration C&L,461.0,H312:151;H340:235;H361:158;H332:246;H350:150;H372:234;H301:234;H302:227;H318:83;H317:83;H351:84;H360:83;H373:20;Not classified:2;H319:4;H335:3;H315:3;H341:1
12325,DL-3-(2-aminopropyl)indole,206-073-7,299-26-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,40.0,H330:40;H300:40;H310:40
12327,2-methoxy-alpha-methylbenzyl alcohol,236-850-6,13513-82-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
12329,"Aromatic hydrocarbons, C",292-697-5,90989-41-6,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H350:0;H340:0
12330,α-ethoxy-p-cresol,260-918-4,57726-26-8,Not Classified,Notified C&L,88.0,Not classified:88
12332,Imidocarb,248-711-7,27885-92-3,Acute Tox. 4;Repr. 2;STOT SE 1;STOT RE 1,Notified C&L,36.0,H302:36;H370:35;H361:35;H372:35
12335,Calcium phthalate,227-332-0,5793-85-1,Not Classified,Notified C&L,2.0,Not classified:2
12338,4-fluoro-2-nitrobenzoic acid,206-890-9,394-01-4,,Notified C&L,10.0,H319:10;H315:10;H335:9
12340,"Propolis, ext.",288-130-6,85665-41-4,Not Classified,Notified C&L,13.0,Not classified:11;H225:1;H317:1
12341,2(3H)-benzoxazolone,200-430-0,59-49-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46.0,H302:46;H332:46;H312:40;H319:1;H315:1;H335:1
12351,papaverine,200-397-2,58-74-2,Acute Tox. 4,Harmonised C&L,0.0,H302:0
12353,4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid,427-680-5,188907-52-0,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H318:0;H317:0
12354,"3,7-dimethyloct-6-enyl 2-methylbutyrate",287-104-1,85409-36-5,Not Classified,Notified C&L,1.0,Not classified:1
12359,Cadusafos,619-129-4,95465-99-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Aquatic Acute 1,Notified C&L,213.0,H300:210;H330:210;H310:210;H331:156;H301:156;H400:210;H311:156;H410:16;Not classified:3
12364,Emsorb 6907,618-424-5,9005-71-4,Not Classified,Notified C&L,74.0,Not classified:74
12367,"Hydrogen bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzene-1-sulphonamidato(2-)]chromate(1-)",250-054-6,30112-70-0,Aquatic Chronic 2,REACH registration C&L,10.0,H411:6;Not classified:3;H410:2;H317:2;H412:1
12368,4-(1-pyrrolidinyl)piperidine,225-676-6,5004-07-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:40;H315:40;H335:39;H314:5;H312:1;H332:1;H302:1
12369,2-[benzyl(2-hydroxyethyl)amino]-1-phenylethanol,607-206-5,23175-18-0,Not Classified,Notified C&L,1.0,Not classified:1
12371,2-[[(3-amino-4-hydroxyphenyl)sulphonyl]amino]benzoic acid,202-063-1,91-35-0,Skin Irrit. 2;Aquatic Chronic 4,REACH registration C&L,42.0,H413:2;H315:2;H302:38;H319:38;Not classified:1;H317:1
12372,Zinc oxide (ZnO),617-101-6,8051-03-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H400:38;H410:38
12373,N-hydroxysuccinimide,228-001-3,6066-82-6,Not Classified,REACH registration C&L,68.0,Not classified:16;H319:52;H315:52;H335:52
12377,"1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]piperidinium chloride",205-222-3,135-87-5,Acute Tox. 4,Notified C&L,38.0,H302:38
12381,p-tert-butylphenetole,241-305-0,17269-94-2,Aquatic Chronic 2,Notified C&L,38.0,H411:38
12384,"2,7,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane",216-869-6,1686-14-2,Acute Tox. 4,REACH registration C&L,96.0,H302:93;H331:1;H226:2;H315:1;Not classified:1
12386,O-benzyl-L-tyrosine toluene-p-sulphonate,258-650-8,53587-11-4,Not Classified,Notified C&L,1.0,Not classified:1
12388,"Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-, polymer with formaldehyde, butylated",614-214-2,68036-98-6,Aquatic Chronic 2,Notified C&L,146.0,H411:146
12389,2-methoxyethyl acry­late,221-499-3,3121-61-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Muta. 2;Repr. 1B,Harmonised C&L,0.0,H314:0;H318:0;H317:0;H341:0;H226:0;H331:0;H302:0;H360:0
12393,4-ethylpiperidine,221-766-4,3230-23-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2.0,H302:2;H319:2;H315:2;H335:2
12394,Ricinoleic acid,205-470-2,141-22-0,Not Classified,Notified C&L,123.0,Not classified:81;H319:42;H315:42;H335:40;H317:2
12395,4-tritylphenol,213-557-1,978-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42
12396,"1,2-dichloro-4-(dichloromethyl)benzene",260-477-8,56961-84-3,Acute Tox. 4;Skin Corr. 1B;STOT SE 3;Aquatic Chronic 2,Notified C&L,3.0,H302:3;H314:3;H335:3;H411:3
12400,Methyl chlorosulphate,212-380-7,812-01-1,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1.0,H302:1;H314:1;H332:1;H225:1
12401,Iron cobalt chromite black spinel,269-060-5,68186-97-0,Not Classified,REACH registration C&L,183.0,Not classified:158;H334:23;H317:23;H412:1;H319:1
12403,4-isopropyl-m-phenylenediamine,238-104-5,14235-45-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H312:2;H319:2;H315:2;H332:2;H335:2;H302:2
12405,4-methoxycinnamaldehyde,217-807-0,1963-36-6,Not Classified,Notified C&L,234.0,Not classified:234
12407,12-Methyltridecanoic acid,608-066-8,2724-57-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12408,"3,7-dimethyloctane-1,7-diol",203-517-1,107-74-4,Eye Irrit. 2,REACH registration C&L,1551.0,H319:7;Not classified:1544
12410,Dineodymium tricarbonate,227-579-4,5895-46-5,Not Classified,REACH registration C&L,14.0,Not classified:14
12413,Tris(2-hydroxyethyl)ammonium octyl sulphate,250-364-1,30862-34-1,,Notified C&L,1.0,H318:1;H315:1
12417,methyl tetrahydro-2-furancarboxylate,420-670-1,37443-42-8,Eye Dam. 1,Harmonised C&L,0.0,H318:0
12423,5-diethylamino-2-(5-bromo-2-pyridylazo)phenol,238-286-6,14337-53-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
12427,Cortisone,200-162-4,53-06-5,Repr. 2,Notified C&L,48.0,H361:48
12432,"Pulmonaria officinalis, ext.",283-286-1,84604-09-1,Flam. Liq. 3,Notified C&L,1.0,H226:1
12433,3-(isodecyloxy)propylamine,250-056-7,30113-45-2,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85.0,H302:77;H314:80;H400:70;H410:76;H318:9;H411:1;H335:7;Not classified:5;H371:3
12436,2-amino-N-2-naphthylacetamide monohydrochloride,214-899-4,1208-12-4,Carc. 2,Notified C&L,39.0,H351:38;H350:1
12437,Methyl valinate hydrochloride,228-620-9,6306-52-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
12439,2-phenylpropyl acetate,233-871-2,10402-52-5,Not Classified,Notified C&L,88.0,Not classified:88
12440,"tert-butyl (4R)-cis-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate",425-780-3,125971-94-0,Aquatic Chronic 4,REACH registration C&L,2.0,H413:1;H312:1;H319:1;H315:1;H332:1;H302:1
12442,Titanium nitride,247-117-5,25583-20-4,Not Classified,REACH registration C&L,50.0,Not classified:15;H228:35;H319:11;H315:11
12445,"(1R)-2-(benzyl{(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl}amino)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol hydrochloride (1:1)",927-046-2,1180001-17-5,Not Classified,REACH registration C&L,2.0,Not classified:1;H360:1;H302:1;H318:1;H373:1
12446,Tris[oxalato(2-)]dipraseodymium,221-884-6,3269-10-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H312:1
12447,(2E)-2-methoxyimino-N-methyl-2-(2-phenoxyphenyl)acetamide,603-742-9,133408-50-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,90.0,H302:90;H332:90;H411:90
12448,"1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]distannoxane",222-931-3,3669-02-1,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,303.0,H360:276;H341:258;H410:276;H373:199;H400:276;H372:77;Not classified:27;H319:1;H315:2;H302:2;H317:1;H371:1
12452,Ethyl-(3-hydroxypropyl)propanedioic acid,610-813-8,52250-47-2,Acute Tox. 4;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1.0,H302:1;H412:1;H402:1;H373:1
12453,2-[-N-(2-cyanoethyl)-4-[(p-nitrophenyl)azo]anilino]ethyl benzoate,255-037-7,40690-89-9,Not Classified,REACH registration C&L,61.0,Not classified:61
12456,"[N,N',N'',N'''-tetrakis[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetetrasulphonamidato(2-)-N29,N30,N31,N32]copper",266-906-5,67689-49-0,Not Classified,Notified C&L,7.0,Not classified:7
12465,"1,4,5,8-Napthalenetetracarboxylic acid, 1,4-monoanhydride",619-817-4,52671-72-4,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,72.0,H400:38;H319:72;H317:34
12466,Calcium gluconate,206-075-8,299-28-5,Not Classified,REACH registration C&L,69.0,Not classified:68;H302:1
12467,Disodium 2-(3-oxo-6-oxidoxanthen-9-yl)benzoate,208-253-0,518-47-8,Not Classified,REACH registration C&L,306.0,Not classified:268;H319:32;H315:30;H312:2;H332:2;H340:2;H317:1
12468,"Nickel chloride (NiCl2), hexahydrate",616-576-7,7791-20-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1A;Acute Tox. 3;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,246.0,H315:246;H317:244;H341:242;H410:244;H331:242;H350:226;H400:245;H372:242;H334:245;H301:246;H360:242;H351:20;H370:20;H319:4;H340:1;H335:1
12477,1-chloroethyl pivalate,254-863-5,40258-80-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H226:1;H315:1;H335:1
12482,Methylchromone,201-641-0,85-90-5,Acute Tox. 4,Notified C&L,38.0,H302:38
12485,Dimethyldiphenylthioperoxydicarbamic acid,258-835-3,53880-86-7,STOT RE 2,Notified C&L,37.0,H373:34;Not classified:2;H350:1;H302:1;H412:1
12486,Sulbutiamine,221-937-3,3286-46-2,Aquatic Chronic 4,Notified C&L,1.0,H413:1
12487,monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate,429-570-2,,Skin Sens. 1,Harmonised C&L,0.0,H317:0
12489,2-Methoxy-6-methylbenzoic acid,612-182-4,6161-65-5,Eye Dam. 1,REACH registration C&L,4.0,H318:3;H315:3;H302:1;H319:1;H335:1
12490,tert-butyl 5-oxo-L-prolinate,252-555-5,35418-16-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39.0,H319:39;H315:39
12492,1-hydroxy-4-(p-toluidino)anthraquinone,201-353-5,81-48-1,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,2713.0,H413:251;H317:284;Not classified:2428
12494,"Sodium hexane-1-sulphonate, monohydrate",220-601-3,2832-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58.0,H319:56;H315:56;H335:54;Not classified:2;H334:1;H317:1
12498,2-[(3-hydroxy-3-oxo-propanoyl)amino]benzoic acid,917-483-7,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,REACH registration C&L,2.0,H319:2;H315:2;H226:2;H335:2;H360:2
12500,"1-Propanone, 1-[4-(phenylmethoxy)phenyl]-2-[[2-[4-(phenylmethoxy)phenyl]ethyl]amino]-, hydrochloride (1:1)",610-838-4,52446-86-3,,Notified C&L,1.0,Not classified:1
12504,N-[2-[[2-(dodecylamino)ethyl]amino]ethyl]glycine monohydrochloride,242-094-8,18205-85-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7.0,H302:7;H319:7;H315:7
12506,"5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone",253-805-6,38150-27-5,Not Classified,REACH registration C&L,1.0,Not classified:1
12508,"Aloe, ext.",284-293-2,84837-08-1,Flam. Liq. 2,Notified C&L,115.0,H225:80;Not classified:35
12510,"[1S-(1α,2β,5α)]-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol",242-645-2,18881-04-4,Not Classified,Notified C&L,122.0,Not classified:84;H319:38;H315:38;H335:38
12511,Ethyl 2-bromo-2-methylpropionate,209-980-6,600-00-0,Flam. Liq. 3;Skin Mild Irrit. 3;Skin Sens. 1;Eye Dam. 1;Muta. 1A;Aquatic Acute 3,REACH registration C&L,140.0,H316:2;H318:134;H340:93;H317:93;H402:2;H226:138;H302:40;H314:5;H319:2;H315:2;H410:1;H335:2;Not classified:2;H400:1
12514,"4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one",219-089-4,2353-33-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Repr. 1B,Notified C&L,45.0,H319:42;H315:42;H341:42;H335:42;H302:42;H360:42;H340:1;H351:1;H372:1
12517,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-asparagine,276-252-2,71989-16-7,Not Classified,Notified C&L,2.0,Not classified:2
12519,"Dimethylsiloxane, polymer, (((3-((2-aminoethyl)amino)propyl)-dimethoxysilyl)oxy)-terminated",615-337-4,71750-80-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,312.0,H319:293;H315:268;H302:11;H318:8
12521,Benz[c]acridine,205-930-2,225-51-4,Aquatic Acute 1,Notified C&L,12.0,H400:12
12523,Methyltriphenoxyphosphonium iodide,241-551-9,17579-99-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H319:2;H315:2;H335:2
12524,"1-Propene, 1,1,3,3,3-pentafluoro-2-(trifluoromethyl)-",609-533-9,382-21-8,Acute Tox. 1;STOT SE 1,Notified C&L,47.0,H330:47;H370:47
12525,"1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonic anhydride",253-270-9,36913-91-4,Skin Corr. 1B,Notified C&L,38.0,H314:38
12526,"A mixture of: trimagnesium bis[(5R)-5-((1S)-1,2-dihydroxyethyl)-4-oxido-2-oxo-2,5-dihydrofuran-3-yl]phosphate hexahydrate; magnesium bis[(5R)-5-((1S)-1,2-dihydroxyethyl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl]phosphate hexahydrate",427-790-3,,Not Classified,Notified C&L,1.0,Not classified:1
12529,"cyclopentane-1,2,3,4-tetracarboxylic dianhydride",227-964-7,6053-68-5,Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H335:0
12540,"Sodium 4-[[(3-chloro-1,2,4-benzotriazin-7-yl)carbonyl]amino]-2-[[1-(6-chloro-o-tolyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonate N4-oxide",235-817-3,12777-30-9,Not Classified,Notified C&L,2.0,Not classified:2
12541,2-Phenylthioaniline,601-258-2,1134-94-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,71.0,H411:71;H317:71;H400:33
12544,Neryl formate,218-401-6,2142-94-1,Not Classified,Notified C&L,114.0,Not classified:79;H400:35;H411:35;H317:35
12545,Zinc bis(isononanoate),258-902-7,53988-06-0,Not Classified,Notified C&L,4.0,Not classified:3;H411:1
12546,"Ononis spinosa, ext.",283-913-9,84775-89-3,Not Classified,Notified C&L,1.0,Not classified:1
12547,17β-hydroxy-1-methyl-5α-androst-1-en-3-one acetate,207-097-0,434-05-9,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,Notified C&L,24.0,H302:24;H360:24;H351:24;H362:24
12548,"Butyl 4-hydroxy-3,5-diiodobenzoate",200-094-5,51-38-7,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38.0,H301:38;H413:38
12549,"Phenol, 4-amino-, reaction products with 4-(2-naphthalenylamino)phenol and sodium sulfide (Na2(Sx))",291-833-0,90480-94-7,Not Classified,REACH registration C&L,39.0,Not classified:39
12551,1-(bromomethyl)-2-chlorobenzene,210-257-2,611-17-6,Skin Corr. 1B;STOT SE 3,Notified C&L,46.0,H314:46;H335:38;H290:1;H318:1
12554,2-diethylaminoethyl 4-amino-2-chlorobenzoate hydrochloride,223-371-2,3858-89-7,Acute Tox. 3,Notified C&L,3.0,H301:3
12555,Cetrimonium bromide,200-311-3,57-09-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,658.0,H318:592;H315:210;H410:57;H373:127;H335:156;H302:633;H400:619;H319:62;Not classified:6;H361:4;H317:3;H370:4;H341:1;H312:1;H314:1;H336:2;H411:1;H332:1
12556,"(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-[(1R)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol",600-864-4,108321-42-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,54.0,H334:43;H317:49;H360:8;H373:5;H319:5;H315:5;H335:5;H302:2;H332:2;H312:1;H361:2
12557,C.I. Acid Blue 72,601-946-2,12219-17-9,Not Classified,Notified C&L,1.0,Not classified:1
12560,Polyisobutylene,618-360-8,9003-27-4,Not Classified,Notified C&L,552.0,Not classified:530;H413:15;H228:4;H319:3;H315:2;H335:1;H304:1
12564,"Potassium sodium 4,4'-bis(4-phenyl-2H-1,2,3-triazol-2-yl)stilbene-2,2'-disulphonate",268-332-0,68057-99-8,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,31.0,H318:31;H411:31
12565,Agarose,232-731-8,9012-36-6,Not Classified,Notified C&L,133.0,Not classified:129;H226:4
12567,"1,1'-carbonylbis-1H-imidazole",208-488-9,530-62-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,211.0,H302:175;H314:173;H318:52;H360:30;H319:37;H315:37;Not classified:2;H317:1;H332:2;H312:2
12572,5-methyl-2-phenylpyridine,248-163-9,27012-22-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
12574,Lead tungsten tetraoxide,231-849-7,7759-01-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H360:38;H410:38;H332:38;H373:38;H302:38;H400:38
12577,Diethyltin dichloride,212-750-8,866-55-7,,Notified C&L,4.0,H301:4;H330:4;H311:4;H314:4
12580,tris[2-chloro-1-(chloromethyl)ethyl] phosphate,237-159-2,13674-87-8,Carc. 2,Harmonised C&L,0.0,H351:0
12583,"reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)",430-750-8,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
12587,"3,4-dimethoxy-N-methylphenethylamine hydrochloride",235-981-6,13078-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:39;H315:39;H335:39;H302:2
12588,"Fatty acids, rape-oil, sulfurized",293-105-8,91051-52-4,Not Classified,Notified C&L,33.0,Not classified:33
12595,"2,3,6-trimethylpyridine",215-970-2,1462-84-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H315:38;H226:38;H335:38;H302:38
12601,1-isopropylpiperazine,224-345-3,4318-42-7,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:41;H315:42;H226:46;H335:41;H311:41;H312:5;H314:4;H318:1
12602,"Octahydro-4,7-methano-1H-indenemethanol",250-561-2,31308-55-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,115.0,H319:115;H315:88
12606,"2,2-dimethylpropanol",200-907-3,75-84-3,Flam. Sol. 1;Acute Tox. 4;STOT SE 3,Notified C&L,194.0,H228:89;H332:127;H335:127;Not classified:61;H319:38;H226:44
12610,tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate,444-440-5,220689-12-3,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H412:0
12611,"Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, monosodium salt",214-664-6,1184-16-3,,Notified C&L,39.0,Not classified:34;H319:5;H315:5;H335:5
12612,[No public or meaningful name is available],481-080-8,,Not Classified,Notified C&L,1.0,Not classified:1
12613,"Hexahydro-1,3,5-triethyl-1,3,5-triazine",231-924-4,7779-27-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,65.0,H312:65;H319:39;H315:39;H332:39;H335:39;H302:65;H318:1
12616,"Polyaddition product of 1,6-Hexanediamine and Neodecanoic acid oxiranylmethyl ester",923-789-1,,Not Classified,Notified C&L,71.0,Not classified:71
12620,"2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol]",245-509-0,23235-61-2,Not Classified,REACH registration C&L,163.0,Not classified:163
12621,Ammonium hydrogensulphate,232-265-5,7803-63-6,Skin Corr. 1B,Notified C&L,59.0,H314:51;Not classified:8;H318:1
12622,Docos-1-ene,216-490-6,1599-67-3,Asp. Tox. 1,Notified C&L,3.0,H304:2;H319:1;H315:1;H335:1
12626,2-(m-benzoylphenyl)propionitrile,255-982-5,42872-30-0,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,61.0,H302:61;H411:18;H319:41;H315:41;H335:40
12627,Arsenic triiodide,232-068-4,7784-45-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43.0,H301:43;H400:39;H410:43;H331:43;H373:4
12631,[(p-chlorophenyl)amine]trifluoroboron,223-812-9,4084-48-4,Eye Dam. 1,Notified C&L,22.0,H318:22
12636,"4,7-dibromo-3-hydroxy-2-naphthoic acid",217-214-7,1779-10-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44.0,H302:39;H319:44;H315:6;H335:5;H332:1
12637,"2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",239-622-4,15571-58-1,STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H400:0;H410:0;H372:0
12638,"Octadecanoic acid, reaction products with acetic acid and tetraethylenepentamine",271-547-2,68585-02-4,Eye Irrit. 2,REACH registration C&L,2.0,H319:2
12639,"Guava, Psidium guajava, ext.",294-795-3,91770-12-6,Not Classified,Notified C&L,76.0,Not classified:26;H226:25;H224:25
12642,hydrofluoric acid ... %;hydrogen fluoride,231-634-8,7664-39-3,,,0.0,H330:0;H314:0;H300:0;H310:0
12646,Malic acid,230-022-8,6915-15-7,Eye Irrit. 2,REACH registration C&L,1982.0,H319:1774;H315:1567;H318:201;H335:145;H302:154;Not classified:8;H303:1;H317:1
12648,"Fatty acids, C18-unsatd., trimers, oligomeric reaction products with tall-oil fatty acids and triethylenetetramine",925-388-7,,Not Classified,Notified C&L,9.0,Not classified:9
12654,"(2R-trans)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4-benzopyrone",207-543-4,480-18-2,Acute Tox. 4,Notified C&L,3.0,H302:3
12655,Dodecyldimethylamine oxide,216-700-6,1643-20-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1137.0,H318:836;H315:1012;H411:112;H302:242;H400:696;H412:448;H319:217;H331:107;H314:85;Not classified:34;H410:26;H332:2;H312:2
12658,Tetramisole hydrochloride,225-799-5,5086-74-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,242.0,H302:241;H319:237;H315:237;H335:237;Not classified:1;H332:1;H312:1
12663,Iodoethane,200-833-1,75-03-6,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Muta. 2,REACH registration C&L,122.0,H319:106;H227:6;H315:111;H317:108;H341:6;H335:110;H334:103;H302:121;H332:17;H226:17;H312:11;H318:5;H311:5;H371:1
12664,3-[(8-methylnonyl)oxy]propan-1-amine,606-838-9,218141-16-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,41.0,H302:41;H314:41;H410:41
12667,N-(2-carboxyethyl)-N-octyl-β-alanine,258-081-5,52663-87-3,Not Classified,REACH registration C&L,1.0,Not classified:1
12668,Ammonium phosphinate,232-266-0,7803-65-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,67.0,H319:67;H315:67;H335:63
12673,(isobutoxymethyl)oxirane,223-303-1,3814-55-9,Not Classified,REACH registration C&L,41.0,Not classified:2;H319:39;H226:39;H315:39;H335:39
12674,"Diisotridecyl 3,3'-[(dibutylstannylene)bis(thio)]dipropionate",284-461-5,84896-44-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Repr. 1B;STOT SE 1;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,2.0,H319:2;H315:2;H341:2;H317:2;H410:2;H370:2;H372:2;H360:2;H311:2;H400:1;H302:1
12675,8-methylisoquinoline,263-747-3,62882-00-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
12677,Doxycycline,209-271-1,564-25-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,96.0,H312:52;H319:55;H315:55;H332:52;H335:55;H302:93;Not classified:3
12682,Bis(myristoyloxy)dioctylstannane,288-875-7,85938-41-6,STOT RE 2;Aquatic Chronic 4,Notified C&L,56.0,H413:56;H373:56
12689,"Alkenes, C>10 α-, oxidized",270-354-0,68425-39-8,Not Classified,Notified C&L,41.0,Not classified:40;H228:1;H319:1;H315:1
12693,Phosphodiesterase,232-806-5,9025-82-5,Resp. Sens. 1,Notified C&L,6.0,H334:6
12696,"3,4-dihydroxy-3-cyclobutene-1,2-dione",220-761-4,2892-51-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,58.0,H319:42;H315:42;H335:41;H317:51;H314:4
12697,o-chlorophenethylamine,235-982-1,13078-80-3,Skin Corr. 1B,Notified C&L,41.0,H314:39;H319:2;H315:2;H335:1;H302:1;H332:1;H312:1
12698,"2-Propenoic acid, 2-methyl-, C12-16-alkyl esters",292-094-7,90551-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,163.0,H319:156;H315:156;H335:156;Not classified:7
12700,"9β,11β-epoxy-6α-fluoro-17,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-acetate",224-953-9,4571-51-1,Skin Sens. 1;Resp. Sens. 1;Repr. 1B,REACH registration C&L,1.0,H334:1;H360:1;H317:1
12701,"4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid",429-790-9,137281-39-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H319:2;H315:2;H335:1;Not classified:1
12704,"1,2,3,3a,4,5,6,8a-Octahydro-2-isopropylidene-4,8-dimethylazulen-6-yl acetate",614-797-3,68917-34-0,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,158.0,H411:133;H317:158;H304:25
12706,"Isooctyl dihydrogen phosphate, compound with 2-ethylhexylamine (1:2)",262-644-0,61188-13-4,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,125.0,H318:125;H411:125
12715,Quinolinium chloride,208-489-4,530-64-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Carc. 1B;Aquatic Chronic 2,Notified C&L,16.0,H319:16;H315:16;H341:16;H350:16;H411:16;H301:16;H311:16
12717,"9-hydroxy-7H-furo[3,2-g][1]benzopyran-7-one",217-923-1,2009-24-7,Acute Tox. 4,Notified C&L,2.0,H302:2
12726,"Fatty acids, C14-18 and C14-18-unsatd., oleic acid-rich, ammonium salts",294-968-3,91771-74-3,Eye Irrit. 2,Notified C&L,3.0,H319:3
12727,"1,2-Benzenedicarboxylic acid, tridecyl ester, manuf. of, by-products from",271-080-4,68515-39-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H400:2;H410:2
12728,Hydrazodicarbaldehyde,211-040-5,628-36-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
12731,"Silicic acid, methyl ester",234-412-9,12002-26-5,Not Classified,Notified C&L,7.0,Not classified:5;H319:2
12737,4-(dimethylamino)butyronitrile,237-788-2,13989-82-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H302:39;H319:39;H312:1;H315:1;H226:1;H332:1
12742,"3-[3-(4'-bromo[1,1'-biphenyl]-4-yl)-3-oxo-1-phenylpropyl]-4-hydroxy-2-benzopyrone",249-106-0,28614-07-5,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;Repr. 1A;Aquatic Chronic 1,Notified C&L,1.0,H300:1;H330:1;H410:1;H310:1;H360:1
12744,4'-amino-N-methylacetanilide,204-339-7,119-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12748,"Ferrate(3-), bis[4-chloro-3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, sodium",294-142-2,91673-27-7,Eye Irrit. 2,Notified C&L,442.0,H319:442
12749,Methyl 6-hydroxy-m-toluate,245-173-5,22717-57-3,Acute Tox. 4,Notified C&L,1561.0,H302:1520;H319:41;H315:41;H335:40
12752,"poly(oxy-1,2-ethanedily),a-sulfo-w-[(1,1,2,3-tetramethylbutyl)phenoxy]-,sodium salt",611-257-9,55348-40-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,139.0,H318:78;H315:100;Not classified:38;H319:22;H411:1;H361:1;H226:1;H370:1;H335:1;H372:1
12763,"α,α-dimethyl-4-methylenecyclohexanemethanol",230-739-6,7299-42-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3.0,H319:3;H315:3;H335:2
12765,Methoxydiethylborane,616-038-1,7397-46-8,Flam. Liq. 2;Pyr. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Notified C&L,43.0,H312:39;H314:43;H225:43;H317:39;H413:39;H332:39;H373:39;H302:39;H250:38;H301:4;H251:1
12766,Quinolin-2-ol,274-516-1,70254-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
12769,"Methyl 2,4,6-trihydroxybenzoate",221-566-7,3147-39-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42;H317:38
12770,"(trans,trans)-5-{(4-Pentyl[1,1-bicyclohexyl]-4-yl)-difluormethoxy}-1,2,3-trifluorbenzene",606-648-6,208338-52-7,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
12774,"3,3-bis(bromomethyl)pentane",267-985-9,67969-84-0,,Notified C&L,4.0,H319:4;H315:4;H335:4
12776,"1,3-dioxolan-4-ylmethanol",226-758-4,5464-28-8,Eye Irrit. 2,Notified C&L,39.0,H319:39
12778,"4-amino-3,5,6-trichloropyridine-2-carboxylic acid, compound with 1,1',1''-nitrilotripropan-2-ol (1:1)",229-815-1,6753-47-5,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,88.0,H400:55;H410:55;H317:55;H412:33
12779,(3-methylphenyl)boronic acid,605-855-9,17933-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:46;H315:46;H335:45;H301:1;H331:1;H311:1;H302:2;H332:1;H312:1
12781,4-azidobenzoic acid,229-198-9,6427-66-3,Self-react. B;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 1,Notified C&L,40.0,H319:38;H315:38;H241:38;H335:38;H372:38;H228:1;H301:1;H373:1;H314:1
12782,"Triammonium 5,5'-(3-carboxylato-4-oxocyclohexa-2,5-dienylidenemethylene)disalicylate",209-319-1,569-58-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,50.0,H319:49;H315:49;Not classified:1
12794,"(1E)-1-(4-Chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-ol",617-483-4,83657-22-1,Acute Tox. 4,Notified C&L,194.0,H302:194
12799,Trihexyphenidyl,205-614-4,144-11-6,Acute Tox. 3,REACH registration C&L,2.0,H301:2
12801,Sodium 4-morpholin-1-ylethylsulphonate,275-203-2,71119-23-8,Not Classified,REACH registration C&L,47.0,Not classified:46;H319:1;H315:1;H335:1
12804,Sodium hexanoate,233-179-0,10051-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39
12808,hexahydro-1-methylphthalic anhydride,256-356-4,48122-14-1,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0.0,H334:0;H318:0;H317:0
12809,Nonadecane,211-116-8,629-92-5,Not Classified,Notified C&L,157.0,Not classified:94;H304:63
12810,"(3,4-dimethoxyphenyl)acetaldehyde",227-189-4,5703-21-9,Eye Irrit. 2,Notified C&L,38.0,H319:38
12814,"Terpolymer of Methacrylamidopropylttrimethylammoniumchloride, Ethylacrylate and Acrylic acid (3:2:8)",606-258-6,192003-74-0,Aquatic Chronic 2,Notified C&L,106.0,H411:106
12815,Emsorb 6903,618-422-4,9005-70-3,Aquatic Chronic 3,Notified C&L,301.0,H412:158;Not classified:123;H319:20
12816,"Didodecyl 3,3'-thiodipropionate",204-614-1,123-28-4,Not Classified,REACH registration C&L,526.0,Not classified:258;H412:218;H413:33;H410:16;H315:2;H411:3;H319:1
12822,mercury dichloride;mercuric chloride,231-299-8,7487-94-7,Acute Tox. 2;Skin Corr. 1B;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H314:0;H300:0;H361:0;H341:0;H410:0;H372:0;H400:0
12825,Barium pentafluorobenzenesulphonate,275-943-6,71735-31-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38
12826,"1-(4-butoxy-1-naphthyl)tetrahydrothiophenium 2-(bicyclo[2.2.1]heptan-2-yl)-1,1,2,2-tetrafluoroethanesulfonate",468-790-3,,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,1.0,H318:1;H413:1
12827,"3-ethoxypropane-1,2-diol",217-503-8,1874-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:41
12832,1-(5-methyl-2-furyl)propan-1-one,234-215-8,10599-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
12834,N-2-naphthylaniline;N-phenyl-2-naphthylamine,205-223-9,135-88-6,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H319:0;H315:0;H317:0;H351:0;H411:0
12837,Diterbium tricarbonate,228-002-9,6067-34-1,Not Classified,Notified C&L,6.0,Not classified:6
12839,Magnesium potassium orthophosphate,237-274-8,13718-30-4,Not Classified,Notified C&L,1.0,Not classified:1
12840,Potassium gluconate,206-074-2,299-27-4,Not Classified,REACH registration C&L,115.0,Not classified:114;H302:1
12844,1-ethyl-2-[(1-ethyl-2(1H)-quinolylidene)methyl]quinolinium iodide,213-556-6,977-96-8,Acute Tox. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,40.0,H312:40;H319:40;H300:40;H315:40;H330:40;H335:39
12845,(2-naphthylthio)acetic acid,202-229-3,93-21-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
12851,"Pentasiloxane, 1,1,9,9-tetramethyl-3,3,5,5,7,7-hexaphenyl-",605-880-5,180073-46-5,Not Classified,Notified C&L,22.0,Not classified:22
12853,"N-[1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]piperidin-4-yl]benzene-1,4-diamine",260-917-9,57718-48-6,Flam. Sol. 1,Notified C&L,1.0,H228:1
12855,Allyl Propyl Ether,604-560-2,1471-03-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38;H225:39
12858,Tetraoctyltin,222-733-7,3590-84-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,33.0,H319:21;H315:21;H317:32;H410:33;H373:32;H335:21;H400:33;H361:10;H371:10
12862,Strontium oxide,215-219-9,1314-11-0,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,129.0,H314:105;H318:15;Not classified:18;H412:6
12866,2-nitro-4-trifluoromethylanisole,206-891-4,394-25-2,Skin Corr. 1B,Notified C&L,44.0,H314:42;H312:1;H319:2;H315:2;H332:1;H335:1;H302:1
12867,"3,7-dihydro-3-methyl-1H-purine-2,6-dione",214-058-1,1076-22-8,Acute Tox. 4,REACH registration C&L,53.0,H302:52;H373:1;H332:1;H312:1
12875,3-bromopropylamine hydrobromide,225-675-0,5003-71-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
12879,Sodium 1-octadecyl sulphonatoacetate,266-783-8,67633-83-4,Not Classified,Notified C&L,1.0,Not classified:1
12880,"N,N-dimethyl-2-[3-(4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl]-4-formylaminobenzamide, sodium salt",605-667-7,173159-72-3,Aquatic Chronic 3,Notified C&L,1.0,H412:1
12888,2-(4-methylphenoxy)-1-(2-phenylethoxy)ethanol,277-189-3,72987-59-8,Not Classified,Notified C&L,89.0,Not classified:89
12889,2-(methylamino)toluene-4-sulphonic acid,238-287-1,14338-01-3,Skin Sens. 1,Notified C&L,38.0,H317:38
12891,"Disodium 3-[[2,2'-dimethyl-4'-[[4-[[(p-tolyl)sulphonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonate",228-779-4,6358-57-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,49.0,H400:2;H410:2;H317:2;H412:42;Not classified:5
12892,sabadilla (ISO);veratrine,617-100-0,8051-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H319:0;H315:0;H335:0
12894,2-[3-nitro-4-(phenylmethoxy)phenyl]-oxirane,610-702-4,51582-41-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,3.0,H334:3;H317:3
12898,Tetrapropylgermanium,213-620-3,994-65-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H312:38;H332:38
12900,"Orthoboric acid, compound with 1,3,5-triazine-2,4,6-triamine",258-651-3,53587-44-3,Not Classified,Notified C&L,11.0,Not classified:11
12902,Anisindione,204-186-6,117-37-3,Acute Tox. 4,Notified C&L,1.0,H302:1
12906,5-Hexenyl Acetate,610-535-7,5048-26-0,,Notified C&L,5.0,H226:5
12908,"Ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionate",257-709-5,52179-28-9,Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H335:2
12909,"Formaldehyde, reaction products with melamine and methanol",305-548-7,94645-53-1,Not Classified,Notified C&L,137.0,Not classified:133;H302:3;H332:3;H312:3;H317:4
12912,4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide,601-578-2,119018-29-0,Not Classified,Notified C&L,2.0,Not classified:1;H412:1
12914,"Bis[5-benzyl-2,3,4,5-tetrahydro-2-methyl-1H-pyrido[4,3-b]indole] sulphate",279-612-7,80879-62-5,Not Classified,REACH registration C&L,2.0,Not classified:2
12917,"1-bromo-2,3-dichlorobenzene",260-476-2,56961-77-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,202.0,H302:158;H411:156;H319:45;H315:45;H335:44;H312:2;H332:2
12918,Chromium diboride,234-499-3,12007-16-8,Not Classified,REACH registration C&L,47.0,Not classified:2;H350:44;H400:44;H410:44;H317:44;H318:6;H319:1;H370:1;H335:1
12919,dimethyl ether,204-065-8,115-10-6,Press. Gas;Flam. Gas 1,Harmonised C&L,0.0,H220:0;Not classified:0
12924,Benzyl(3-hydroxyphenacyl)methylammonium chloride,276-017-4,71786-67-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41.0,H302:39;H400:38;H410:38;H317:38;H412:2;H318:2;H413:2
12925,"Soybean oil, epoxidized, reaction products with diethylene glycol, glycerol and trimethylolpropane",285-104-6,85029-79-4,Not Classified,Notified C&L,1.0,Not classified:1
12926,"1-(2,6-difluorophenyl)ethan-1-one",237-151-9,13670-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H315:47;H335:46;H302:1
12927,3-ethyloxetane-3-methanol,221-254-0,3047-32-3,Eye Irrit. 2,REACH registration C&L,322.0,H319:144;H412:178;H317:178;H302:1;H315:1;H335:1
12929,3-hydroxy-4-(6-hydroxy-m-tolylazo)naphthalene-1-sulphonic acid,221-563-0,3147-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,67.0,H319:64;H315:64;H335:43;Not classified:2;H314:1;H318:1
12931,"(-)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl][2-(3,4-dimethoxyphenyl)ethyl]methylammonium chloride",253-132-8,36622-28-3,Acute Tox. 3,Notified C&L,38.0,H301:38
12932,N-purin-6-ylaniline,214-914-4,1210-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,194.0,H319:194;H315:194;H335:194
12935,"1-(2,3-dichlorophenyl)ethan-1-one",259-954-3,56041-57-7,,Notified C&L,5.0,H319:5;H315:5;H335:5
12940,Ammonium L-5-bromo-6-oxo-9-bornanesulphonate,259-871-2,55870-50-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
12944,"Alcohols, C6 and C8-iso-, distn. residues",271-228-8,68526-80-7,Skin Irrit. 2,Notified C&L,29.0,H315:29;H318:4
12946,METHYL (3-OXO-2-PENTYLCYCLOPENT-1-EN-1-YL)ACETATE,431-410-1,,Not Classified,REACH registration C&L,2.0,Not classified:2;H313:1;H303:1
12949,"1-(2,2,3,3,3-pentafluoro-1-oxopropyl)-1H-imidazole",275-944-1,71735-32-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,39.0,H302:39;H314:39
12952,"N-[dimethyl(3,3,3-trifluoropropyl)silyl]-1,1-dimethyl-1-(3,3,3-trifluoropropyl)silylamine",254-470-9,39482-87-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
12953,"Fatty acids, C18-22",292-772-2,90990-11-7,Not Classified,REACH registration C&L,17.0,Not classified:17
12957,7-amino-4-(trifluoromethyl)-2-benzopyrone,258-599-1,53518-15-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:44
12960,"2,1,3-Benzoxadiazole",608-080-4,273-09-6,Acute Tox. 4,Notified C&L,39.0,H302:38;H319:1;H315:1;H335:1
12968,"[N,N'-bis(3-ethoxypropyl)-29H,31H-phthalocyaninedisulphonamidato(2-)-N29,N30,N31,N32]copper",287-191-6,85410-17-9,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,1.0,H314:1;H318:1;H331:1;H335:1;H301:1
12970,Thioridazine,200-044-2,50-52-2,Acute Tox. 4;Skin Mild Irrit. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,197.0,H302:196;H316:2;H400:197;H410:196
12972,Tetrazol-5-ylamine,224-581-7,4418-61-5,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,116.0,H412:59;H318:53;H302:53;H319:53;H315:53;H335:52;H228:5;H332:3;H312:3;Not classified:1
12973,Dodecanal,203-983-6,112-54-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2102.0,H319:1615;H315:2102;H317:1610;H411:501;H335:4;Not classified:2;H330:1
12975,1-bromo-2-methylpropyl propionate,422-900-6,158894-67-8,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Carc. 2,Harmonised C&L,0.0,H314:0;H226:0;H351:0;H317:0
12980,C.I. Reactive Blue 89,612-913-7,61968-98-7,Not Classified,Notified C&L,1.0,Not classified:1
12982,Diphenyl-p-tolylphosphine,213-848-3,1031-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
12984,"Trilithium, 7-amino-2-[4-(3,5-dicarbonylphenylazo)-2,5-di(2-hydroxyethoxy)phenylazo] -1-hydroxy-3-napthalenesulfonate",432-370-8,,Not Classified,Notified C&L,1.0,Not classified:1
12987,Bis(n-butylcyclopentadienyl)zirconium dichloride,416-980-1,73364-10-0,Skin Corr. 1B,Notified C&L,6.0,H314:5;H312:1;H332:1;H252:1;H302:1;H319:1;H315:1
12992,1-allyl-6-aminouracil,225-446-5,4852-21-5,Eye Irrit. 2,Notified C&L,38.0,H319:38
12996,"Gases (petroleum), benzene unit hydrodesulfurizer off;Refinery gas;[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]",270-747-7,68477-66-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
13000,"(4-(5-Oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-phenylamino)-acetic acid ethyl ester",927-587-4,872728-83-1,Not Classified,REACH registration C&L,2.0,Not classified:2
13002,Molybdenum hydroxide oxide phosphate,234-336-6,11104-88-4,Not Classified,Notified C&L,34.0,Not classified:32;H413:2
13006,"Tetrasodium [μ-[7-[[4'-[[6-anilino-1-hydroxy-3-sulpho-2-naphthyl]azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-8-hydroxynaphthalene-1,3,6-trisulphonato(8-)]]dicuprate(4-)",277-020-3,72927-72-1,Not Classified,REACH registration C&L,64.0,Not classified:10;H412:38;H335:15;H320:13;H319:3;H302:1
13010,Methyl non-3-enoate,236-786-9,13481-87-3,Not Classified,Notified C&L,92.0,Not classified:92
13018,"8-ethoxy-2,6-dimethyloct-2-ene",274-222-3,69929-16-4,Not Classified,Notified C&L,89.0,Not classified:89
13021,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, manuf. of, by-products from, distn. lights",281-516-5,83968-37-0,Eye Dam. 1,Notified C&L,1.0,H318:1
13024,"2,5-Oxazolidinedione, 4-(1-methylethyl)-, (4S)-",607-408-3,24601-74-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,2.0,H318:2;H315:2;H335:2
13033,Potassium dihexadecyl phosphate,241-098-7,17026-47-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,17.0,H318:17;H315:17
13035,4-nitrobenzoyl azide,220-351-5,2733-41-7,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38;H302:38;H228:38
13038,"α,3,4-trichlorotoluene",203-033-0,102-47-6,Skin Corr. 1B;STOT SE 3,Notified C&L,50.0,H314:47;H335:44;H319:3;H315:3;H411:3;H302:5;H312:1;H318:1;H332:1;Not classified:1
13041,3-methoxybenzonitrile,216-201-3,1527-89-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45.0,H312:44;H319:45;H315:45;H332:44;H335:39;H302:44;H331:1;H301:1;H311:1
13042,"N,N-diethyl-2-aminoethylcarbamoylacetanilide",251-831-2,34118-92-8,Acute Tox. 4,Notified C&L,1.0,H302:1
13044,p-(chlorodiphenylmethyl)anisole,238-463-8,14470-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:45;H315:45;H335:44;H314:1;H318:1
13049,"N,N-diethylguanidinium sulphate (2:1)",278-660-6,77297-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
13051,fenson (ISO);4-chlorophenyl benzenesulphonate,201-274-6,80-38-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H302:0;H319:0;H411:0
13053,Lanthanum hexaboride,234-531-6,12008-21-8,Not Classified,Notified C&L,3.0,Not classified:3
13054,"cyclohexanone, peroxide;cyclohexanone, peroxide",235-527-7,12262-58-7,,,0.0,H302:0;H314:0;H242:0
13055,N-cyclohexyl-N-methylcyclohexylamine,231-453-4,7560-83-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,70.0,H314:70;H318:7;H411:5;H301:27;H311:27;H302:43;H332:1;H312:1
13056,"reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)",428-260-4,,Eye Dam. 1,Harmonised C&L,0.0,H318:0
13057,"Dimethyl 3,7,12,17-tetramethyl-21H,23H-porphine-2,18-dipropionate",234-195-0,10589-94-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
13062,3-(5-chlorobenzoxazol-2-yl)-7-(diethylamino)-2-benzopyrone,252-722-2,35773-43-4,Not Classified,REACH registration C&L,96.0,Not classified:94;H318:2
13065,"1,2,3-Propanetriol, homopolymer, monooctadecanoate",609-412-0,37349-34-1,Not Classified,Notified C&L,11.0,Not classified:11
13066,Tris(undecafluoropentyl)amine,206-421-8,338-84-1,,Notified C&L,46.0,Not classified:38;H319:7;H315:7;H335:2;H413:1
13070,[2-(diethoxymethyl)-1-octenyl]benzene,267-331-2,67845-59-4,Skin Sens. 1,Notified C&L,25.0,H317:25
13075,Ammonium sulfate suspension,920-762-6,,Not Classified,Notified C&L,1.0,Not classified:1
13078,4-(1-butylpentyl)pyridine,220-993-6,2961-47-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
13082,"2,2' -oxybisethanol;diethylene glycol",203-872-2,111-46-6,Acute Tox. 4,Harmonised C&L,0.0,H302:0
13084,4-Chloro-3-nitrophenol,612-076-8,610-78-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H312:40;H319:44;H315:44;H332:40;H335:43;H302:44
13086,"Eicosane, branched",296-584-1,92797-48-3,Not Classified,Notified C&L,4.0,Not classified:3;H304:1;H332:1
13092,(E)-2-phenylpropenyl acetate,253-735-6,37973-51-6,Not Classified,Notified C&L,88.0,Not classified:88
13094,"D-Alloisoleucine, methyl ester",601-571-4,118878-53-8,Not Classified,Notified C&L,11.0,Not classified:11
13096,"1,1-dimethoxydecane",231-928-6,7779-41-1,Not Classified,Notified C&L,151.0,Not classified:113;H315:38;H411:38
13098,"3,3'-[(2,5-dichloro-1,4-phenylene)diimino]bis[1H-isoindol-1-one]",256-914-7,51016-63-8,Not Classified,Notified C&L,31.0,Not classified:31
13101,"P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine",413-430-2,116163-96-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
13102,2-methylfluorene,215-853-6,1430-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H319:1;H315:1;H335:1
13103,Tris[(2-hydroxyethyl)ammonium] orthoborate,272-298-2,68797-44-4,Not Classified,REACH registration C&L,2.0,Not classified:2
13106,Quinidine,200-279-0,56-54-2,Acute Tox. 3;Skin Sens. 1A,REACH registration C&L,205.0,H301:204;H317:2;H319:4;H315:4;H335:4;H302:1;H332:1;H312:1
13107,"Propanoic acid, 2-methyl-, 2-ethoxy-4-formylphenyl ester",606-142-5,188417-26-7,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,113.0,H412:88;H317:113
13111,"2,4,6-trichlorophenoxyacetic acid",209-394-0,575-89-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H302:38;H319:38;H301:1;H331:1;H311:1
13122,"Dihydrogen [29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cobaltate(2-)",249-591-9,29383-29-7,Eye Dam. 1,Notified C&L,2.0,H318:2
13125,"2,2'-[vinylenebis[(3-sulpho-p-phenylene)imino[6-morpholino-1,3,5-triazine-4,2-diyl]imino]]bis[benzene-1,4-disulphonic] acid, sodium salt",300-461-0,93940-63-7,Eye Irrit. 2,Notified C&L,1.0,H319:1
13127,Farnesal,242-957-9,19317-11-4,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,1437.0,H315:1335;H317:1296;Not classified:102;H319:39;H335:39
13128,(±)-(3-amino-3-carboxypropyl)dimethylsulphonium chloride,222-484-4,3493-12-7,Not Classified,Notified C&L,2.0,Not classified:2
13130,"Disodium 2-[[5-carbamoyl-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridyl]azo]-4-[[4-[(2-chloro-5-sulphonatophenyl)amino]-6-fluoro-1,3,5-triazin-2-yl]amino]benzenesulphonate",278-154-5,75268-65-4,Skin Sens. 1B,REACH registration C&L,6.0,H317:6
13131,Tetramethylammonium tribromide,239-700-8,15625-56-6,Skin Corr. 1B,Notified C&L,42.0,H314:42
13136,Pentamethylenebis(triphenylphosphonium) bromide,245-292-2,22884-31-7,,Notified C&L,4.0,H319:4;H315:4;H335:4
13139,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,2,3-propanetriol mono(16-methylheptadecanoate) (2:1)",614-860-5,68958-58-7,Not Classified,Notified C&L,1.0,Not classified:1
13140,nickel tungsten tetraoxide,238-032-4,14177-51-6,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0.0,H350:0;H372:0;H317:0
13142,"Tetrahydro[3,3'-bifuran]-2,2',5,5'-tetraone",224-877-6,4534-73-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2.0,H302:2;H319:2;H312:1;H315:1;H332:1;H335:1
13145,"Benzeneacetic acid, .alpha.-hydroxy-, monoammonium salt, (.alpha.R)-",606-826-3,217308-07-1,Eye Irrit. 2,REACH registration C&L,84.0,H319:84
13146,DL-malic acid,210-514-9,617-48-1,Eye Irrit. 2,REACH registration C&L,322.0,H319:267;H315:186;H302:42;H318:55;H335:43
13153,Quinoxalin-2(1H)-one,214-815-6,1196-57-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H319:48;H315:48;H335:47
13154,m-chlorostyrene,218-024-7,2039-85-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,44.0,H302:39;H332:39;H319:5;H315:5;H335:4;H312:1
13155,Benzyl 4-hydroxybenzoate,202-311-9,94-18-8,Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,341.0,H400:1;H410:1;H335:334;H317:2;H319:334;H315:334;Not classified:6;H411:1
13156,"Alcohols, lanolin",232-430-1,8027-33-6,Not Classified,REACH registration C&L,100.0,Not classified:100
13158,(±)-2-hydroxybutyric acid,209-985-3,600-15-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
13161,"Butane-1,2,3-triol",224-643-3,4435-50-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H302:38;H319:39;H315:39;H335:38
13164,Methylhydrazinium sulphate,206-115-4,302-15-8,Acute Tox. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2,Notified C&L,43.0,H319:38;H300:38;H315:38;H330:42;H351:42;H335:38;H311:43;H301:5;H331:1
13166,1-(2-thienyl)ethanone oxime,217-800-2,1956-45-2,Acute Tox. 3,Notified C&L,38.0,H301:38
13173,"Fatty acids, C14-18 and C16-18-unsatd., compds. with diethanolamine",270-278-8,68424-17-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,30.0,H318:29;H315:29;Not classified:1
13175,C8-16 fatty alcohol glucoside,604-232-9,141464-42-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,220.0,H319:142;H315:219;H318:77;Not classified:1
13177,"polysodium 2-[(E)-{8-[(4-{[3-({[(2-alkenylsulfonyl) ethyl]amino}carbonyl)phenyl] amino}-6-fluoroheterocyclyl) amino]-1-hydroxy-polysulfonato-2-naphthalenyl}diazenyl]-1,5-naphthalene, polysulfonate",403-880-8,,Not Classified,REACH registration C&L,1.0,Not classified:1
13179,"Coffee, Coffea canephora, ext.",307-315-5,97593-13-0,Flam. Liq. 3,Notified C&L,1316.0,H226:1286;H319:25;H317:25;H225:5
13180,"Fatty acids, C14-18, sodium salts",293-020-6,91032-13-2,Not Classified,Notified C&L,4.0,Not classified:4
13182,4-formylbenzonitrile,203-267-3,105-07-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H302:45;H332:41;H312:40;H319:7;H315:7;H335:6
13185,"3-(2-{4-[(Z)-(2,4-DIFLUOROPHENYL)(HYDROXYIMINO)METHYL]PIPERIDIN-1-YL}ETHYL)-2-METHYL-6,7,8,9-TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE",603-689-1,132961-05-8,Acute Tox. 3;Skin Sens. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,3.0,H412:2;H301:2;H373:2;H317:2;H302:1
13188,"2,4,8-trichlorodibenzofuran",259-248-5,54589-71-8,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38.0,H301:38;H319:38
13189,Isouron,611-325-8,55861-78-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,195.0,H302:195;H332:195;H319:1;H315:1;H335:1
13192,Carbon black,215-609-9,1333-86-4,Not Classified,REACH registration C&L,3934.0,Not classified:2747;H351:1120;H335:180;H373:63;H319:49;H413:16;H372:53;H251:14;H228:5;H252:7;H315:2;H370:2;H410:1;H332:1;H411:1
13196,Pyrithione sodium,240-062-8,15922-78-8,Not Classified,Notified C&L,1.0,Not classified:1
13198,"(S)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone",207-173-3,446-71-9,Not Classified,Notified C&L,1.0,Not classified:1
13199,m-cymene,208-617-9,535-77-3,Flam. Liq. 3,Notified C&L,44.0,H226:44;H319:1;H315:1
13202,Sulfaethidole,202-312-4,94-19-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H319:1;H315:1;H335:1
13205,Calcium isononanoate,258-901-1,53988-05-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,84.0,H302:74;H319:75;Not classified:4;H315:4;H413:2
13206,Methyl 4-bromo-2-hydroxybenzoate,607-144-9,22717-56-2,Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H335:1
13208,5-methoxyindan-1-one,225-838-6,5111-70-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3.0,H302:3;H332:3;H312:3
13209,Tantalum pentachloride,231-755-6,7721-01-9,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,49.0,H302:49;H314:49;H335:1;H290:1;H318:1
13210,3-sulphophthalic acid,267-576-5,67892-43-7,Skin Corr. 1B,Notified C&L,2078.0,H314:2078
13211,"Tripotassium [5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-4-sulpho-1-naphthyl)azo]naphthalene-2,7-disulphonato(5-)]cuprate(3-)",304-149-5,94246-75-0,Not Classified,REACH registration C&L,11.0,Not classified:11
13212,"2,5-dimethyl-1H-indole",214-816-1,1196-79-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H318:38;H315:42;H335:42;H319:4;H312:2;H332:2;H302:2
13213,"Proteinase, Myxobacter AL-1, II",276-716-4,72561-05-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H317:38;H335:39;H334:39
13214,"1,1-dimethylethyl 4(or 5)-chloro-2-methylcyclohexanecarboxylate",234-416-0,12002-53-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
13216,Diisopropylbenzene hydroperoxide,247-988-1,26762-93-6,Org. Perox. F;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,19.0,H314:18;H318:12;H304:12;H317:18;H332:12;H242:18;H411:18;H331:6;H302:1;H319:1;H315:1
13220,3-(4-pyridyl)propan-1-ol,220-107-8,2629-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:41;H315:41;H335:40
13223,"Formaldehyde, polymer with 1,3-dimethylbenzene",607-871-1,26139-75-3,Not Classified,Notified C&L,83.0,Not classified:83
13225,Lutetium,231-103-0,7439-94-3,Flam. Sol. 1,Notified C&L,50.0,H228:44;Not classified:4;H260:4;H319:2;H315:2;H335:2
13228,"Methyl 2,6,6-trimethylcyclohex-2-ene-1-carboxylate",248-792-9,28043-10-9,Aquatic Chronic 3,REACH registration C&L,164.0,H412:45;Not classified:119
13230,"Levisticum officinale, ext.",616-978-2,8016-31-7,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,105.0,H412:67;H304:67;H317:67;H319:48;H315:48;H341:2;H351:2
13231,"Tungstate(3-), tetracosa-µ-oxododecaoxo[[]µ12-[[]phosphato(3-)-[?]O:[?]O:[?]O:[?]O':[?]O':[?]O':[?]O'':[?]O'':[?]O'':[?]O''':[?]O''':[?]O''']]dodeca-, hydrogen, hydrate (1:3:[?])",603-020-3,12501-23-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,155.0,H302:88;H314:131;H318:91;H411:88;Not classified:24
13232,6-O-palmitoylascorbic acid,205-305-4,137-66-6,Eye Irrit. 2,REACH registration C&L,412.0,H319:114;H412:178;Not classified:147
13233,7-chloroquinolin-4-ol,201-715-2,86-99-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
13242,11-oxahexadecan-16-olide,222-225-5,3391-83-1,Aquatic Chronic 3,REACH registration C&L,1555.0,H412:14;Not classified:1541
13245,Dimethyl [3-[(hydroxymethyl)amino]-3-oxopropyl]phosphonate,243-528-9,20120-33-6,Carc. 1B,REACH registration C&L,40.0,H350:3;H332:31;H317:35;Not classified:2
13248,"N-(3-Guanidino-4-methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide, dihydrochloride",611-624-3,581076-67-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1;H317:1
13251,"Trideca-1,1,1,2,2,3,3,4,4,5,5,6,6-fluorohexane",206-581-9,355-37-3,Not Classified,REACH registration C&L,4.0,Not classified:3;H319:1;H315:1;H335:1
13252,(benzothiazol-2-ylthio)succinic acid,401-450-4,95154-01-1,Skin Sens. 1,Harmonised C&L,0.0,H317:0
13257,4-Isobutylbenzaldehyde,464-400-0,,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H302:2;H400:2;H410:2;H317:2
13259,"trans-4'-(4-pentylcyclohexyl)[1,1'-biphenyl]-4-carbonitrile",268-333-6,68065-81-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2.0,H312:1;H319:1;H315:1;H332:1;H302:1;H413:1;Not classified:1
13260,"Naphthalenesulfonic acids, branched and linear Bu derivs., sodium salts",293-346-9,91078-64-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,150.0,H302:150;H319:149;H412:149;H332:150;H315:33;H335:2;H318:1
13263,"3,5-dinitrobenzyl alcohol",275-131-1,71022-43-0,,Notified C&L,93.0,H302:93;H319:93;H315:93;H335:93
13268,HD7057,427-150-3,,Not Classified,Notified C&L,1.0,Not classified:1
13276,"1,2,4-trifluoro-5-nitrobenzene",218-281-5,2105-61-5,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:44;H300:38;H315:44;H335:38;H312:5;H332:5;H302:5;H331:2;H301:3;H311:3;H330:1;H314:1
13279,Ethyl 4-oxopiperidine-1-carboxylate,249-984-5,29976-53-2,Acute Tox. 4,REACH registration C&L,11.0,H302:5;Not classified:4;H319:3;H315:2;H335:1
13283,DL-2-aminopent-4-enoic acid,231-689-8,7685-44-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:43;H335:42;H317:39
13284,"7-[(4aS,7aS)-1,2,4a,5,7,7a-hexahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6,8-difluoro-4-oxo-3H-quinoline-3-carboxylic acid",604-776-7,151213-15-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1.0,H319:1;H411:1
13285,Boldenone,212-686-0,846-48-0,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 3,REACH registration C&L,14.0,H412:11;H360:11;H351:11;H362:11;H319:2;H315:2;H361:1;H302:2;H312:1;H341:1
13286,(4-ethylphenoxy)acetic acid,246-245-9,24431-27-4,,Notified C&L,5.0,H319:5;H315:5;H335:5
13290,"Bis(2-hydroxyethyl) (6H-dibenz[c,e][1,2]oxaphosphorin-6-ylmethyl)succinate P-oxide",264-313-6,63562-34-5,Not Classified,REACH registration C&L,1.0,Not classified:1
13293,"Fatty acids, C18-36, esters with ethylene glycol",305-673-7,94944-95-3,Not Classified,REACH registration C&L,1.0,Not classified:1
13295,"Formic acid, reaction products with boron trifluoride and [1S-(1α,3aβ,4α,8aβ)]-decahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene",272-483-8,68855-38-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,76.0,H319:66;H315:66;H226:66;H332:66;H412:66;H302:66;Not classified:10
13296,"[S-(R*,S*)]-2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one",217-924-7,2009-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
13297,2-hydroxy-5-methylacetophenone,215-915-2,1450-72-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43;H302:1
13298,"Octanoic acid, cobalt salt",229-744-6,6700-85-2,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1.0,H400:1;H410:1;H317:1
13299,"1,3-Benzenedicarboxylic acid, polymer with 2,5-furandione and 1,2-propanediol",607-908-1,26301-26-8,Not Classified,Notified C&L,20.0,Not classified:20
13300,"(20R,25R)-spirost-5-en-3β-ol",208-134-3,512-04-9,Not Classified,REACH registration C&L,2.0,Not classified:2
13304,"2,4-dimethylcyclohex-3-ene-1-methanol",266-821-3,67634-17-7,Eye Irrit. 2,Notified C&L,235.0,H319:235;H314:1;H315:1;H317:1;H332:1;H412:1;H411:1;H302:1;H301:1
13305,"Benzene, 1,4-dibromo-2-ethyl-",608-281-7,289039-53-8,,Notified C&L,4.0,H319:4;H315:4
13310,"D-pentose, oligomeric, C5 alkyl glycosides",444-850-4,1235390-87-0,Eye Irrit. 2,Notified C&L,1.0,H319:1
13321,"4-amino-2,3,5,6-tetrafluorobenzamide",216-285-1,1548-74-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
13322,[2H2]malonic [2H2]acid,212-385-4,813-56-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H302:38;H332:38;H312:38
13324,Shale oils,269-646-0,68308-34-9,Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5.0,H314:4;H318:4;H304:4;H340:4;H317:4;H410:4;H332:4;H350:4;H400:4;H335:4;H301:4;H360:4;H311:4;Not classified:1
13325,[(p-bromophenoxy)methyl]oxirane,218-656-3,2212-06-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39.0,H302:39;H319:39;H312:39;H315:39
13327,3-chloro-1-ethylpiperidinium chloride,256-592-8,50461-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
13330,1-(ethoxymethoxy)-4-methyl-benzene,609-065-5,35117-05-6,Not Classified,Notified C&L,1.0,Not classified:1
13332,"(E)-1,1-diethoxyhex-2-ene",266-989-8,67746-30-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,236.0,H319:236;H315:236;H317:236;H226:236;H302:236
13333,"Potassium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate",212-753-4,866-83-1,Not Classified,Notified C&L,7.0,Not classified:7
13334,"Aluminum chloride, hexahydrate",616-520-1,7784-13-6,Skin Corr. 1B,Notified C&L,275.0,H314:159;H319:115;H315:116;H335:95;H412:40;H290:36;H318:39;H413:35
13338,F-94,429-840-1,,Not Classified,Notified C&L,1.0,Not classified:1
13340,3-methoxy-4-nitrobenzoic acid,225-793-2,5081-36-7,,Notified C&L,8.0,H319:7;H315:7;H335:6;H302:1;H341:1
13342,"3-(1-(4-amino-3-methyl-5-sulphonatophenyl)-1-(4-amino-3-sulphonatophenyl)methylene)cyclohexa-1,4-dienesulphonic acid",221-816-5,3244-88-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,58.0,H314:2;H318:2;H319:48;H315:48;H335:47;Not classified:8
13343,"2-bromo-N,N-dibutylacetamide",254-797-7,40124-27-4,Acute Tox. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,1.0,H301:1;H335:1;H314:1
13344,"Fatty acids, C18-unsatd., dimers, reaction products with fatty acids, C14-18 and C16-18-unsatd. and propylidynetrimethanol",500-707-9,162353-70-0,Not Classified,REACH registration C&L,11.0,Not classified:11
13346,Hexahydro-1-nitroso-1H-azepine,213-258-6,932-83-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,38.0,H319:38;H315:38;H350:38;H335:38;H302:38
13349,4-bromo-4-phenylpiperidinium bromide,279-589-3,80866-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H319:38;H315:38;H335:38
13350,bis(4-tert-butylphenyl)iodonium nonafluorobutane-1-sulfonate,432-660-4,,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1.0,H318:1;H411:1
13355,"1-amino-2,4-dibromoanthraquinone",201-354-0,81-49-2,Eye Irrit. 2,Notified C&L,44.0,H319:40;H351:6
13359,"Disodium 2',2'''-(azodi-4,1-phenylene)bis[6-methyl[2,6'-bibenzothiazole]-7-sulphonate]",229-448-7,6537-66-2,Not Classified,Notified C&L,10.0,Not classified:10
13361,C.I. Direct Black 179,604-367-3,143549-91-1,Not Classified,Notified C&L,2.0,Not classified:2
13362,Magnesium hydroxide,215-170-3,1309-42-8,Not Classified,REACH registration C&L,603.0,Not classified:517;H319:64;H315:63;H335:63;H332:23;H302:23;H318:22;H372:1
13365,"Propanoyl chloride, 3,3'-dithiobis-",600-037-8,1002-18-2,Not Classified,Notified C&L,1.0,Not classified:1
13367,2-methylpyridine 1-oxide,213-230-3,931-19-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:43;H315:39;H335:38;H302:4
13370,nickel selenide,215-216-2,1314-05-2,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H317:0;H410:0;H350:0;H372:0;H400:0
13371,3-fluorophenylacetic acid,206-360-7,331-25-9,Skin Irrit. 2,Notified C&L,204.0,H315:204;H319:9;H335:8
13373,4-Cyclohexylpropiophenon,611-869-6,59721-67-4,Not Classified,Notified C&L,1.0,Not classified:1
13375,"L-Phenylalanine, 4-nitro-, methyl ester, hydrochloride (1:1)",605-624-2,17193-40-7,,Notified C&L,7.0,H319:4;H317:7
13376,"Sodium hydrogen 4-hydroxy-5-(salicylideneamino)naphthalene-2,7-disulphonate",227-698-1,5941-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H319:39;H315:39;H335:38;Not classified:2
13377,Decyl cyanoacetate,241-670-6,17686-43-0,Aquatic Chronic 4,Notified C&L,38.0,H413:38
13379,Diphenyliodonium bromide,216-050-3,1483-73-4,,Notified C&L,6.0,H301:6;H319:6;H315:6;H335:5;H331:1;H311:1
13385,Perylene Black I,479-300-2,,Not Classified,REACH registration C&L,1.0,Not classified:1
13386,1-(4-methoxyphenyl)thiourea,218-931-8,2293-07-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44.0,H301:44;H331:38;H311:38
13392,Triruthenium dodecacarbonyl,239-287-4,15243-33-1,Acute Tox. 4,Notified C&L,66.0,H332:62;H319:22;H315:22;H335:22;H302:23;H301:4;H330:4;H228:1;H312:1
13393,"2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with methyl 2-methyl-2-propenoate, pentadecyl 2-methyl-2-propenoate, tetradecyl 2-methyl-2-propenoate and tridecyl 2-methyl-2-propenoate",613-170-1,63164-09-0,Not Classified,Notified C&L,6.0,Not classified:6
13396,Sodium cyclohexanecarboxylate,205-228-6,136-01-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,31.0,H319:31;H315:31;H335:31
13399,3-chloro-4-morpholino-1-nitrobenzene,259-638-5,55435-71-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
13400,4-tert-butylphenol,202-679-0,98-54-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H318:0;H410:0;H315:0;H361:0
13403,2-C-[(galloyloxy)methyl]-D-ribose 5-gallate,207-416-3,469-32-9,Not Classified,Notified C&L,2.0,Not classified:2
13405,4-(2-aminoethyl)pyrocatechol hydrobromide,211-436-8,645-31-8,Not Classified,REACH registration C&L,40.0,Not classified:2;H319:38;H315:38;H335:38
13407,"Sodium 2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanesulphonate",248-460-3,27441-70-9,Aquatic Chronic 3,REACH registration C&L,39.0,H412:39;H317:37
13408,"Chromate(2-), [3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-, sodium",290-927-9,90294-43-2,Not Classified,Notified C&L,442.0,Not classified:441;H319:1
13410,"Sodium hydrogen 3-aminonaphthalene-1,5-disulphonate",225-133-3,4681-22-5,Eye Irrit. 2,REACH registration C&L,12.0,H319:11;Not classified:1
13411,"2,2'-dimethyl[1,1'-biphenyl]-4,4'-diamine",201-551-1,84-67-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2;H335:1
13415,(2-(tert-butoxy)-2-oxoethyl)triphenylphosphonium chloride,609-051-9,35000-37-4,Acute Tox. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,43.0,H319:43;H300:1;H411:1;H315:42;H335:42
13418,"2-Butyne-1,4-diol, reaction products with 1,2-oxathiolane 2,2-dioxide and sodium hydroxide",290-883-0,90268-78-3,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,2.0,H314:2;H318:2;H302:1;H312:1
13422,"3-[2-[4-(4-fluorobenzoyl)piperidino]ethyl]quinazoline-2,4(1H,3H)-dione [R-(R*,R*)]-tartrate",281-062-8,83846-83-7,Acute Tox. 3,Notified C&L,47.0,H301:39;H302:8
13428,(2S)-but-3-yn-2-ol,608-322-9,2914-69-4,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2,Notified C&L,46.0,H300:41;H319:46;H315:46;H317:40;H226:46;H330:41;H310:41;H335:4;H301:5;H311:4
13431,(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile,441-070-6,61826-76-4,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H317:0;H410:0;H301:0;H400:0
13436,4-(diethylamino)benzaldehyde diphenylhydrazone,269-181-3,68189-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
13441,Diphemanil metilsulfate,200-552-4,62-97-5,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2,Notified C&L,12.0,H330:10;H301:10;H318:10;H302:2;H319:1;H315:1
13443,Salicylohydrazide,213-311-3,936-02-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H319:46;H315:46;H335:45
13444,3-fluoroaniline,206-747-0,372-19-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48.0,H302:42;H318:39;H315:47;H335:41;H312:7;H319:8;H332:7;H373:5;H301:6;H331:2;H311:2
13446,"1,3,3a,4,9,9a-hexahydro-9-hydroxy-6,7-(methylenedioxy)-4-(3',4',5'-trimethoxyphenyl)benz[f]isobenzofuran-3-one",208-250-4,518-28-5,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:44;H315:44;H310:44;H335:43;H301:43;H361:1;H331:1;Not classified:1;H300:1;H330:1
13447,(R)-[3-carboxy-2-[(1-oxohexadecyl)oxy]propyl]trimethylammonium chloride,242-642-6,18877-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
13448,"3,3-diphenylacrylaldehyde",214-913-9,1210-39-5,Skin Sens. 1,Notified C&L,38.0,H317:38
13449,"N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)butan-2-amine hydrobromide (1:1)",600-477-0,1037185-08-2,Not Classified,Notified C&L,1.0,Not classified:1
13452,5-nitro-m-xylene,202-732-8,99-12-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,43.0,H301:38;H373:38;H331:38;H311:38;H302:4;H332:4;H312:4;H330:1;H300:1;H310:1
13453,(5-bromopyridin-2-yl)methanol,618-116-0,88139-91-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,51.0,H312:38;H319:41;H315:41;H332:38;H335:41;H302:49
13455,methylmercuric chloride,204-064-2,115-09-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 2;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0.0,H360:0;H300:0;H330:0;H410:0;H310:0;H351:0;H362:0;H372:0;H400:0
13457,"Alkenes, C16-20 α-, sulfurized",286-994-9,85408-34-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1
13458,"Gases (petroleum), amine system feed;Refinery gas;[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]",270-746-1,68477-65-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H350:0;H340:0;Not classified:0
13460,"1,3,5-triazine-2,4,6(1H,3H,5H)-trione, trisodium salt",221-255-6,3047-33-4,,Notified C&L,2.0,H314:1;Not classified:1
13465,2-phenyl-2-imidazoline,213-313-4,936-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,328.0,H302:120;H318:96;H410:118;H315:145;H411:178;H400:55;H319:51;H335:26;Not classified:5
13466,"C12-16 alkyl, glycerol ether",922-520-5,,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2.0,H412:2;H400:2;H413:2
13475,"Undecanal, 11-(triethoxysilyl)-",601-410-8,116047-42-8,,Notified C&L,1.0,H319:1;H315:1;H335:1
13476,"Hexanol, branched and linear",271-227-2,68526-79-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H319:2;H315:2
13478,"2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-",613-980-5,66722-44-9,Acute Tox. 4,Notified C&L,40.0,H302:40;H362:1
13488,Tris(decyl)amine,213-966-5,1070-01-5,Aquatic Chronic 2,Notified C&L,116.0,H411:115;H319:2;H315:2;H372:1;H360:1
13491,7-(dimethylamino)-4-(trifluoromethyl)-2-benzopyrone,258-598-6,53518-14-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:38
13492,Tin dioxide,242-159-0,18282-10-5,Not Classified,Notified C&L,692.0,Not classified:260;H335:309;H413:103;H319:22;H315:22
13494,17-β-hydroxyestr-4-en-3-one 17-(3-phenylpropionate),200-551-9,62-90-8,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,55.0,H302:55;H312:55;H351:55;H332:17;H360:17
13500,"2-bromo-1,1,1-trifluoroethane",207-001-7,421-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Ozone 1,Notified C&L,38.0,H319:38;H315:38;H335:38;H420:38
13501,"sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;sodium dehydracetate",224-580-1,4418-26-2,Acute Tox. 4,Harmonised C&L,0.0,H302:0
13507,"2,7-Dibromo-9-fluorenone",604-362-6,14348-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
13508,"(2S,5R,6R)- 6-{[(2R)-2-amino- 2-(4-hydroxyphenyl)- acetyl]amino}- 3,3-dimethyl- 7-oxo- 4-thia- 1-azabicyclo[3.2.0]heptane- 2-carboxylic acid trihydrate",612-127-4,61336-70-7,Skin Sens. 1;Resp. Sens. 1,Notified C&L,179.0,H334:178;H317:139;H400:35;H410:35;H412:2;H302:1
13511,1-benzyl-4-(propylamino)piperidine-4-carboxamide,213-847-8,1031-37-4,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38.0,H301:38;H319:38
13513,1-benzyl-4-hydroxypiperidine-4-carbonitrile monohydrochloride,275-713-5,71617-20-4,Acute Tox. 4,Notified C&L,1.0,H312:1
13514,Dodecan-1-ol,203-982-0,112-53-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3803.0,H400:3303;H319:3190;H411:943;H410:460;Not classified:78;H412:209;H312:69;H318:69;H336:69;H225:69;H335:107;H302:70;H315:280;H371:1
13517,Phenyl cyanate,214-364-5,1122-85-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39.0,H334:39;H317:39;H312:1;H319:1;H315:1;H332:1;H335:1;H302:1
13518,"Benzoic acid, 2-hydroxy-, reaction products with formaldehyde, coupled with 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid monosodium salt",276-641-7,72403-26-0,Aquatic Chronic 3,Notified C&L,2045.0,H412:2042;Not classified:3
13521,"4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)",423-490-1,130755-46-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0
13529,Valdipromide,257-630-6,52061-73-1,,Notified C&L,1.0,H302:1
13531,Tin dioleate,217-625-1,1912-84-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,24.0,H319:24;H413:24;H315:24
13535,"Octadecanoic acid, ester with 1,2-ethanediol",609-356-7,37221-98-0,Not Classified,Notified C&L,1.0,Not classified:1
13536,2-(allyloxy)ethanol,203-871-7,111-45-5,,REACH registration C&L,109.0,H319:59;H315:108;H335:38;H302:1;H318:50;H226:2;H303:1;H227:1
13538,"Reaction mass of Tetrasodium 4,4'-bis[2-[4,5-dihydro-3-methyl-5-oxo-1-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]-1H-pyrazol-4-yl]diazenyl]-[1,1'-biphenyl]-2,2'-disulfonic acid and Trisodium 4-[[5-hydroxy-1-[4-[(2-hydroxyethyl)sulfonyl]phenyl]-3-methyl-1H-pyrazol-4-yl]diazenyl]-4'-[[5-hydroxy-3-methyl-1-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]-1H-pyrazol-4-yl]diazenyl]-[1,1'-biphenyl]-2,2'-disulfonate",433-330-2,,Not Classified,REACH registration C&L,2.0,Not classified:2
13539,"Oxalic acid, vanadium salt",239-052-6,14974-48-2,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,96.0,H302:95;H318:92;H412:92;H312:92;H319:3;H332:3;H335:3;Not classified:1;H411:1;H290:1
13541,p-(2-methoxyethyl)phenol,260-354-9,56718-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56.0,H319:48;H315:50;H335:47;Not classified:4;H302:3
13542,"Tetra sodium 4-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-6--[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazine-2-yl-amino]-4-[[2,5-disulfo-1-phenyl]azo]-5-[3-carbamoyl-4-methyl-6-hydroxy]-N-ethyl-pyridone",926-840-6,,Resp. Sens. 1,Notified C&L,1.0,H334:1
13543,"Amines, C36-alkylenedi-",273-282-8,68955-56-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,159.0,H400:41;H318:41;H410:41;H315:41;H412:105;Not classified:13
13544,"1-(2,4-dimethyl-3-cyclohexenyl)-2,2-dimethylpropan-1-one",274-223-9,69929-17-5,Skin Irrit. 2;Skin Sens. 1,Notified C&L,112.0,H315:102;H317:102;Not classified:10
13547,"4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane",245-962-4,23978-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H319:42;H315:43;H335:41;H302:1;H318:1;Not classified:1
13549,"[1aS-(1aα,2aβ,3α,5aα,7β,7aα)]-octahydro-3,6,6,7a-tetramethyl-2H-2a,7-methanoazuleno[5,6-b]oxirene",236-971-4,13567-39-0,Not Classified,Notified C&L,303.0,Not classified:302;H304:1;H315:1;H361:1;H225:1;H373:1;H411:1
13557,(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride,415-170-5,90274-24-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Harmonised C&L,0.0,H302:0;H332:0;H317:0
13563,"Rape oil, reaction products with diethylenetriamine, di-Me sulfate-quaternized",308-732-5,98219-63-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,20.0,H400:2;H319:2;H410:2;Not classified:18
13565,4-(chloromethyl)-o-xylene,203-032-5,102-46-5,Skin Corr. 1B;STOT SE 3,Notified C&L,41.0,H314:40;H335:39;H290:1;H318:1;H319:1;H315:1
13568,"Terpene and terpenoids, sunflower (Helianthus annuus) oil",457-800-1,666723-01-9,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1286.0,H412:1286;H226:1286;H304:1286;H317:1286
13570,"[S-(R*,R*)]-2,3-bis(benzoyloxy)succinic acid",241-097-1,17026-42-5,Eye Irrit. 2,REACH registration C&L,62.0,H319:60;H315:4;H335:3;Not classified:2
13571,N-[4-[[(5-methylisoxazol-3-yl)amino]sulphonyl]phenyl]acetamide,244-330-5,21312-10-7,,Notified C&L,90.0,H302:90;H341:90
13572,"(2S)-(5α,7α)-7-(2-hydroxy-3,3-dimethylbutan-2-yl)-3,6-dimethoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-17-carbonitrile",605-429-2,16614-60-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,91.0,H334:91;H302:91;H332:91;H317:91
13573,Zirconium oxide sulphate,263-372-5,62010-10-0,Not Classified,REACH registration C&L,65.0,Not classified:65
13574,Chlorpromazine,200-045-8,50-53-3,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H317:2;H410:2;H331:2;H362:2;H301:2;H400:2
13575,4-pentylbenzoyl chloride,256-478-8,49763-65-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H314:42;H318:38
13580,N-ethyltoluene-4-sulphonamide,201-275-1,80-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80.0,H319:61;H315:61;H335:60;Not classified:18;H302:1;H412:1
13586,5-tert-butyl N-[(phenylmethoxy)carbonyl]-L-glutamate,223-421-3,3886-08-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H319:39;H315:39;H335:39;H317:39
13589,"N,N'-dimethyldiphenylthiuram disulphide",234-196-6,10591-84-1,STOT RE 2,REACH registration C&L,4.0,H373:4
13590,(p-formylphenoxy)acetic acid,244-749-3,22042-71-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H302:39;H319:44;H315:44;H335:43
13591,dinickel trioxide,215-217-8,1314-06-3,Skin Sens. 1;STOT RE 1;Aquatic Chronic 4;Carc. 1A,Harmonised C&L,0.0,H350:0;H372:0;H413:0;H317:0
13596,"Alkanes, C10-14",300-199-7,93924-07-3,Asp. Tox. 1,Notified C&L,225.0,H304:223;H302:59;Not classified:2;H226:1
13597,"Fats and Glyceridic oils, Virola sebifera",609-149-1,356065-37-7,Not Classified,Notified C&L,1.0,Not classified:1
13598,Sodium mentholate,242-958-4,19321-38-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,84.0,H314:84;H318:84
13599,"Benzenebutanoic acid, α-[[(1S)-2-chloro-1-methyl-2-oxoethyl]amino]-, ethyl ester, hydrochloride (αS)-",601-303-6,114192-42-6,Not Classified,REACH registration C&L,2.0,Not classified:2
13602,"2,4-difluorobenzaldehyde",216-287-2,1550-35-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H319:47;H226:47;H315:47;H335:46
13608,"(3'α,4'α,7'α,7'aα)-octahydrospiro[1,3-dioxolane-2,5'-[4,7]methano[5H]indene]",239-659-6,15591-90-9,Not Classified,Notified C&L,88.0,Not classified:88
13612,Disodium iminodi(acetate),213-181-8,928-72-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
13613,"Hexamethylene diisocyanate, oligomers, reaction products with 4-Hydroxybutyl acrylate",929-915-1,,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,2.0,H315:2;H317:2
13616,"Esterase, cholesterol",232-808-6,9026-00-0,Resp. Sens. 1,REACH registration C&L,12.0,H334:10;Not classified:2;H318:1;H411:1
13617,Barium iodide,237-276-9,13718-50-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,49.0,H302:48;H332:48;H312:1;H317:1;H341:1;H334:1;Not classified:1;H319:1;H315:1;H335:1;H401:1
13618,4-pentylpyridine,220-994-1,2961-50-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H315:1
13619,"1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)",414-380-4,140681-55-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H318:0;H412:0;H317:0
13632,"Formaldehyde, reaction products with 1,4-benzenediol and m-phenylenediamine, sulfurized",600-959-0,110392-46-6,Not Classified,Notified C&L,31.0,Not classified:31
13633,4-chloro-o-anisic acid,260-761-1,57479-70-6,,Notified C&L,8.0,H319:8;H315:8;H335:7
13634,2-oxobutyric acid,209-986-9,600-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1471.0,H319:1438;H315:1438;H335:1437;H314:33
13636,3-methoxybutyl acetate,224-644-9,4435-53-4,Not Classified,REACH registration C&L,575.0,Not classified:331;H336:211;H319:33;H315:1;H335:1
13637,strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate,427-930-3,250639-69-1,Skin Sens. 1,Harmonised C&L,0.0,H317:0
13639,2-(bromomethyl)-1-fluoro-3-nitrobenzene,217-801-8,1958-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:38;H315:38;H335:38;H314:6
13641,"3,3,5-trimethylcyclohexyl methacrylate",231-927-0,7779-31-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,73.0,H319:73;H315:73;H317:25;H335:73;H411:25;H400:7
13642,2-hydroxyhippuric acid,207-661-6,487-54-7,Not Classified,Notified C&L,4.0,Not classified:2;H319:2;H315:2;H335:2
13643,3-bromostyrene,218-025-2,2039-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H319:45;H315:45;H335:44
13659,"Disodium 2-[[2,6-dihydroxy-3-[(3-sulphonatophenyl)azo]phenyl]azo]benzoate",265-014-3,64683-38-1,Not Classified,Notified C&L,1.0,Not classified:1
13663,"2,2-bis(acryloyloxymethyl)butyl acrylate;trimethylolpropane triacrylate",239-701-3,15625-89-5,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0.0,H319:0;H315:0;H317:0
13665,Isobutyltriphenylphosphonium bromide,245-291-7,22884-29-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H319:42;H315:42;H335:42
13667,6-chloro-2-[4-[ethyl(2-hydroxyethyl)amino]phenyl]-1-methylbenz[cd]indolium acetate,296-673-5,92952-73-3,Aquatic Chronic 1,Notified C&L,1.0,H410:1
13670,"Butyraldehyde, 2,2-diethyl-",607-897-3,26254-89-7,Not Classified,Notified C&L,16.0,Not classified:15;H319:1;H226:1;H315:1;H335:1
13671,1-(carboxylatomethyl)methylpyridinium,288-098-3,85650-88-0,Not Classified,REACH registration C&L,67.0,Not classified:47;H319:20;H315:20
13675,"Methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide",252-600-9,35511-14-9,,Notified C&L,1.0,H302:1
13677,Chloropropylmagnesium,218-785-5,2234-82-4,Water-react. 2;Skin Corr. 1B,Notified C&L,44.0,H314:43;H261:42;H225:5;H260:1;H226:1;Not classified:1
13680,4-isopropyl-m-toluidinium chloride,224-876-0,4534-11-6,,Notified C&L,4.0,H302:4;H332:4;H312:4
13681,"N-hydroxy-3,3-diphenylpropionamidine",212-963-6,890-35-7,Not Classified,REACH registration C&L,2.0,Not classified:2
13682,1-[[3-methyl-4-[(3-methylphenyl)azo]phenyl]azo]-2-naphthol,221-647-7,3176-79-2,Not Classified,Notified C&L,98.0,Not classified:98
13687,2-Amino-3-chloro-5-(trifluoromethyl)-pyridine,616-692-8,79456-26-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39.0,H302:38;H412:38;H319:1;H315:1;H335:1
13690,"Silicic acid, sodium salt, hydrolysis products with chlorotrimethylsilane and dichloroethenylmethylsilane",271-545-1,68584-83-8,Not Classified,Notified C&L,32.0,Not classified:32
13691,α-phenylpyridine-2-acetonitrile,225-677-1,5005-36-7,Not Classified,REACH registration C&L,42.0,Not classified:3;H312:38;H318:38;H315:39;H332:38;H335:38;H301:39;H319:1;H331:1;H311:1
13694,"1-Ethyl-5-nitro-1,3-dihydrobenzimidazole-2-one",611-695-0,58533-62-3,Skin Sens. 1,Notified C&L,31.0,H317:31
13697,Phenylmalonic acid,220-044-6,2613-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H319:44;H315:44;H335:43
13705,"N2-(2,4-dinitrophenyl)-L-arginine",216-497-4,1602-42-2,Flam. Sol. 1,Notified C&L,1.0,H228:1
13707,hydrazine,206-114-9,302-01-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H314:0;H317:0;H226:0;H410:0;H331:0;H350:0;H301:0;H400:0;H311:0
13711,"N-[(6-chloro-3-pyridinyl)methyl]-1,2-ethane-diamine",600-261-6,101990-44-7,Eye Irrit. 2,Notified C&L,1.0,H319:1
13713,"Fatty acids, C16-18 and C18-unsatd., compds. with triethanolamine",270-279-3,68424-19-1,Eye Irrit. 2,REACH registration C&L,162.0,H319:63;Not classified:99;H315:52
13720,Tribenuron (aka metometuron),600-714-8,106040-48-6,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H317:38
13721,"Cyclohex-1,4-ylenedimethanol",203-268-9,105-08-8,Eye Dam. 1,REACH registration C&L,470.0,H318:270;H319:173;Not classified:27
13722,4-tert-butylcyclohexanone,202-678-5,98-53-3,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,1673.0,H302:1387;H411:1422;Not classified:212;H319:73;H315:39;H335:39;H400:24
13725,"2- [[[ 3- methyl- 4- (2,2,2 -trifluoroethoxy)- 2- piridinyl] methyl] sulfinyl]- 1Hbenzimidazole",627-144-2,103577-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,197.0,H319:192;H315:192;H335:191;H317:4;H362:1;H350:1;H373:2;H302:1;H413:1;H412:1;H351:1;Not classified:1
13729,"p-xylene-α,α'-dithiol",203-269-4,105-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H319:40;H315:40;H335:39
13732,"Calcium, acetate hydrogenated castor-oil fatty acids complexes",290-884-6,90268-79-4,Not Classified,Notified C&L,2.0,Not classified:2
13734,"6-amino-1,7-dihydro-8H-purine-8-thione",230-974-4,7390-62-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H302:38;H319:38;H315:38;H335:38
13735,"[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hydrogen [R-(R*,R*)]-succinate",222-590-0,3544-94-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,3.0,H319:2;H315:2;H332:2;H335:2;H302:2;H371:1
13742,Oxidized sulfurized aminophenols,215-462-0,1327-14-6,Not Classified,Notified C&L,37.0,Not classified:37
13743,"Carbonic acid, rare earth salts",268-210-7,68037-33-2,Not Classified,Notified C&L,2.0,Not classified:2
13745,"1-(2,6,6-trimethyl-3-cyclohexen-1-yl)ethan-1-one",247-343-4,25915-53-1,Not Classified,Notified C&L,1.0,Not classified:1
13748,6-bromo-2-naphthylmethylether,225-837-0,5111-65-9,Acute Tox. 4,Notified C&L,44.0,H302:42;H312:1;H319:3;H315:3;H332:1;H335:2
13749,"α,α,4-trimethylbenzyl alcohol",214-817-7,1197-01-9,Not Classified,Notified C&L,139.0,Not classified:139
13751,ethyl N-benzyl-β-alaninate,245-759-0,23583-21-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,43.0,H302:38;H319:43;H315:5
13752,2-ethylhexyl sulfate,615-733-7,72214-01-8,Not Classified,Notified C&L,24.0,Not classified:23;H314:1
13756,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate monosodium salt, saponified, sodium salts",287-790-2,85585-88-2,Not Classified,Notified C&L,7.0,Not classified:7
13757,"(1S-endo)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol",208-135-9,512-13-0,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,89.0,H412:89;H317:89
13759,Aminoviolanthrone,247-989-7,26763-69-9,Not Classified,Notified C&L,1.0,Not classified:1
13761,Tripropylphosphine,218-786-0,2234-97-1,Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,42.0,H314:42;H250:38
13762,lithium,231-102-5,7439-93-2,Water-react. 1;Skin Corr. 1B,Harmonised C&L,0.0,H260:0;H314:0
13763,"Aluminate(1-), bis[3,5-bis(1,1-dimethylethyl)-2-(hydroxy-κO)benzoato(2-)-κO]-, hydrogen (1:1), (T-4)-",601-524-8,118422-20-1,,Notified C&L,6.0,H400:6;H410:6
13767,N-benzylprop-2-enamide,473-370-8,,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,4.0,H319:4;H302:4
13768,"Fatty acids, C8-18 and C16-18-unsatd., sodium salts",287-032-0,85408-69-1,Not Classified,Notified C&L,37.0,Not classified:37
13769,"3,5-dimethylcyclohexene-1-methanol",266-820-8,67634-16-6,Eye Irrit. 2,Notified C&L,233.0,H319:233
13770,2-amino-5-(aminosulphonyl)benzoic acid,205-304-9,137-65-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H319:1;H335:1;H302:1;H315:1
13778,Cefoperazone,263-749-4,62893-19-0,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,40.0,H334:40;H317:40
13780,molybdenum nickel tetraoxide,238-034-5,14177-55-0,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0.0,H350:0;H372:0;H317:0
13783,"1-(bromomethyl)-4-(1,1-dimethylethyl)benzene",242-643-1,18880-00-7,Skin Corr. 1B,Notified C&L,43.0,H314:43
13787,"Shellac, ammonium salt",269-647-6,68308-35-0,Not Classified,Notified C&L,2.0,Not classified:2
13788,"1,3-difluorobenzene",206-746-5,372-18-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,55.0,H315:5;H302:2;H225:55;H411:3;H317:4;H412:2;H319:9;H332:42;H335:3;H318:1
13792,Methyl 3-oxotetradecanoate,244-929-1,22348-97-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38.0,H413:38;H302:38
13796,Magnesium dipropan-2-olate,239-620-3,15571-48-9,Flam. Sol. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2.0,H319:2;H228:2;H336:2
13797,"Jasmine, Jasminum sambac, ext.",294-797-4,91770-14-8,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 2;Aquatic Chronic 3,Notified C&L,1448.0,H412:1290;H330:1286;H317:1378;H315:1398;H410:76;H400:40;H413:32;H332:21;H304:20;H319:36;H411:30;H401:1;H227:1
13799,Rhenium hexafluoride,233-172-2,10049-17-9,Skin Corr. 1A;Eye Dam. 1,Notified C&L,38.0,H318:38;H314:38
13804,"Bisbenzimidazobenzo[lmn][3,8]phenanthrolinedione",232-340-2,8005-56-9,Not Classified,REACH registration C&L,47.0,Not classified:46;H412:1
13806,"Phosphoric acid, C8-18-alkyl esters, compds. with 2-ethyl-1-hexanamine",281-284-5,83899-28-9,Not Classified,Notified C&L,10.0,Not classified:10
13807,Perfluorohexanoyl fluoride,206-582-4,355-38-4,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2.0,H314:2;H290:2;H318:1
13810,"Dibutylbis(octadeca-9(Z),12(Z)-dienoyloxy)stannane",286-834-8,85391-79-3,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,303.0,H341:274;H360:274;H410:274;H400:274;H373:199;H372:75;H319:22;H413:22;H315:22;H302:22;H311:22;Not classified:7
13816,arsine,232-066-3,7784-42-1,Press. Gas;Flam. Gas 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H373:0;H330:0;H220:0;H410:0;H400:0;Not classified:0
13825,"N-(2,4-dinitrophenyl)-L-aspartic acid",231-688-2,7683-81-0,,Notified C&L,38.0,Not classified:38
13831,1-(5-chloro-2-hydroxyphenyl)ethan-1-one,215-916-8,1450-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H319:42;H315:42
13832,6-chlorohexan-1-ol,217-925-2,2009-83-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,57.0,H312:46;H332:47;H319:52;H315:52;H320:3;H302:10;H335:3;Not classified:1
13833,Ethyl furan-2-propionate,233-097-5,10031-90-0,Flam. Liq. 3,Notified C&L,1399.0,H226:1286;Not classified:78;H312:25;H302:35;H315:35;H311:10
13837,4-[[(4-butoxybenzylidene]amino]benzonitrile,253-018-8,36405-17-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H319:1;H302:1;H315:1
13843,Potassium isopentyl dithiocarbonate,213-180-2,928-70-1,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,4.0,H302:4;H311:4;H228:4;H314:4;H411:4;H317:4
13844,"2,2-dimethylhexane",209-689-4,590-73-8,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H336:0;H315:0;H304:0;H410:0;H225:0;H400:0
13846,3-chlorobenzoic acid,208-618-4,535-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70.0,H335:63;H319:67;H315:67;Not classified:5;H302:1;H242:1;H317:1
13850,"3,4-dihydro-6-methylnaphthalen-1(2H)-one",256-913-1,51015-29-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H319:38;H302:38
13851,"Sweet clover, Melilotus officinalis, ext.",282-028-5,84082-81-5,Flam. Liq. 2;Acute Tox. 4;Skin Sens. 1,Notified C&L,130.0,H225:77;H302:98;H317:98;Not classified:29;H373:22;H226:2
13853,(chloromethyl)diethoxymethylsilane,218-657-9,2212-10-4,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,45.0,H226:41;H412:1;H302:41;H317:1;H335:39;H315:40;H318:39;Not classified:4;H319:1
13854,Dicopper citrate,212-752-9,866-82-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,50.0,H410:41;H302:50;H400:42;H318:3;H315:4;H332:1;H319:1;H335:1;H317:1;H351:1
13857,"Pentasodium pentahydrogen [[(phosphonatomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",263-212-4,61792-09-4,Not Classified,REACH registration C&L,1.0,Not classified:1
13858,Ethyl (chloroformyl)acetate,251-390-6,33142-21-1,Acute Tox. 4,Notified C&L,38.0,H302:38
13864,cobalt nickel dioxide,261-346-8,58591-45-0,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0.0,H350:0;H372:0;H317:0
13867,3-[[3-[(dihydroxyboryl)oxy]propyl]amino]propan-1-ol,267-652-8,67905-33-3,Eye Irrit. 2,Notified C&L,2.0,H319:2
13869,Cobalt dibenzoate,213-257-0,932-69-4,,Notified C&L,5.0,H341:5;H317:5
13870,"Ethyl 2,4-dimethyl-5-(ethoxycarbonyl)-3-pyrrolepropionate",611-118-2,54278-10-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H319:38;H315:38
13876,1-ethyl-3-hydroxypyridinium bromide,279-588-8,80866-84-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40.0,H319:2;H315:2;H318:38;H314:38
13878,"Di(µ-2,2´,2´´-nitrilotris(ethanol)-diperchlorato)dinatrium",480-340-8,,Unst. Expl.;Eye Dam. 1;STOT RE 2,REACH registration C&L,4.0,H200:4;H373:4;H318:4
13886,Jervine,207-417-9,469-59-0,Acute Tox. 3,Notified C&L,39.0,H301:39;H360:1
13888,Diethyl phthalate,201-550-6,84-66-2,Not Classified,REACH registration C&L,1769.0,Not classified:1690;H319:51;H373:11;H331:16;H315:23;H302:11;H311:8;H332:18;H400:8;H335:13;H410:8;H361:6;H336:1;H317:1;H312:1
13891,"9-Octadecenoic acid (Z)-, calcium salt, basic",294-016-7,91672-11-6,Not Classified,Notified C&L,1.0,Not classified:1
13892,Glycerol tribenzoate,210-379-6,614-33-5,Not Classified,REACH registration C&L,12.0,Not classified:12
13894,"p-[[1-hydroxy-6-[[[[5-hydroxy-7-sulpho-6-[(4-sulpho-o-tolyl)azo]-2-naphthyl]amino]carbonyl]amino]-3-sulpho-2-naphthyl]azo]benzoic acid, sodium salt, compound with 2-aminoethanol",302-470-5,94109-30-5,,Notified C&L,83.0,Not classified:83
13895,"Fatty acids, fish-oil, reaction products with 2[(2-aminoethyl)amino]ethanol, 2-[(2-[(2-aminoethyl)amino]ethyl]amino]ethanol, diethanolamine, fish oil, 1-piperazineethanamine and triethylenetetramine",305-674-2,94944-96-4,Not Classified,Notified C&L,1.0,Not classified:1
13896,Lithocholic acid,207-099-1,434-13-9,Not Classified,Notified C&L,5.0,Not classified:3;H335:1;H319:2;H315:2
13900,Prednisone,200-160-3,53-03-2,Repr. 2,Notified C&L,167.0,H361:109;H372:53;H360:57;H373:33;Not classified:1;H319:1;H315:1;H335:1;H302:1;H332:1;H312:1;H412:1;H351:1
13902,"Chromate(2-), [2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-nitrobenzoato(2-)][2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]azo]benzoato(3-)]-, sodium",290-926-3,90294-42-1,Aquatic Chronic 3,Notified C&L,444.0,H412:441;Not classified:3
13903,"Phosphoric acid, C12-14-branched and linear alkyl esters, compds. with ethanolamine",306-955-2,97468-05-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2.0,H318:2;H315:2
13904,4-bromobenzylamine,223-559-4,3959-07-7,Skin Corr. 1B,Notified C&L,44.0,H314:44;H312:3;H302:3;H318:2
13908,Lithium 4-[(octadecylamino)carbonyl]benzoate,282-973-3,84501-54-2,Not Classified,Notified C&L,4.0,Not classified:4
13909,(2R-trans)-2-methyl-5-(1-methylvinyl)cyclohexan-1-one,226-872-4,5524-05-0,Not Classified,Notified C&L,1.0,Not classified:1
13911,"Propane-1,2,3-tricarboxylic acid",202-733-3,99-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,222.0,H335:215;H319:216;H315:216;Not classified:6
13919,α-cyclopropyl-4-fluoro-α-methylbenzyl alcohol,219-821-2,2542-09-8,Eye Irrit. 2,Notified C&L,38.0,H319:38
13921,"Fatty acids, coco, isotridecyl esters",292-997-6,91031-91-3,Not Classified,REACH registration C&L,11.0,Not classified:11
13923,"5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone",207-174-9,446-72-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,148.0,H319:93;H335:93;H315:93;H302:137;H410:89;H400:89;Not classified:6;H341:1;H361:1
13925,sodium bifluoride;sodium hydrogen difluoride,215-608-3,1333-83-1,Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0.0,H314:0;H301:0
13928,1-amino-4-bromo-2-methylanthraquinone,201-355-6,81-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H319:38;H315:38
13929,Lutetium(3+) acetate,242-566-3,18779-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H319:1;H315:1
13932,5-methylnicotinonitrile,255-988-8,42885-14-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44.0,H315:43;H318:39;H335:39;H301:40;H319:4;H302:4;H311:1;H331:1
13933,"2-propanol, 1-amino-3-(3,5-dimethylphenoxy)-",613-984-7,66766-07-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2.0,H312:2;H319:2;H302:2;H315:2
13938,Benzyl cinnamate,203-109-3,103-41-3,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1703.0,H400:79;H411:1694;H410:79;H317:1700;H315:1
13939,"Poly(oxy-1,2-ethanediyl), a-(tributylphenyl)-w-hydroxy- (8-11EO)",618-560-5,9046-09-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,728.0,H411:500;H315:515;H319:515;H318:194;H412:160;H302:34;Not classified:19
13942,"Poly(oxy-1,2-ethanediyl), a-(1-oxotetradecyl)-[?]-hydroxy-",618-402-5,9004-89-1,Not Classified,Notified C&L,1.0,Not classified:1
13943,1-methylpiperazine,203-639-5,109-01-3,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,345.0,H318:168;H332:185;H314:341;H226:340;H317:175;H361:4;H372:4;H312:165;H330:91;H331:44;H290:26;H311:10;H334:10;Not classified:4;H302:12
13944,"Endo-1,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-ol",249-036-0,28462-85-3,Not Classified,Notified C&L,90.0,Not classified:90
13950,"(17R)-17-hydroxy-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)-1,4,7,8,9,10,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-11(2H)-one",616-077-4,74332-34-6,,REACH registration C&L,0.0,No data
13951,5-bromo-1H-pyrimidin-2-one,253-896-2,38353-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H315:46;H335:45;H319:46;H332:1;H302:1
13954,"(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]azetidin-2-one",605-319-4,163222-32-0,Aquatic Chronic 4,Notified C&L,1.0,H413:1
13957,PGIGI-3F,412-990-5,154346-21-1,Aquatic Chronic 4,Notified C&L,1.0,Not classified:1;H413:1
13958,"5,6,6a,7-tetrahydro-2,9-dihydroxy-1,10-dimethoxy-6-methyl-4H-dibenzo[de,g]quinolinium chloride",240-675-0,16625-69-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H312:38;H332:38;H302:38
13959,Hexafluoroglutaric acid,206-813-9,376-73-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46.0,H314:45;H318:38;H315:1;H319:1;H335:1
13963,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium stearate",228-908-4,6373-07-5,,Notified C&L,2.0,H315:2;H335:2;H319:2;H302:2
13964,1-Phenyl-3-(pyrrolidin-yl)propan-1-one,619-034-8,94-39-3,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,Notified C&L,2.0,H314:2;H317:2;H318:2;H302:2
13971,1-methyl-5-nitro-1H-imidazole-2-methanol,213-312-9,936-05-0,Acute Tox. 4,Notified C&L,3.0,H302:3
13974,"(-)-1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one",252-946-0,36275-29-3,Not Classified,Notified C&L,115.0,Not classified:115
13976,1-nitro-4-propoxybenzene,230-650-2,7244-77-1,Acute Tox. 4;Carc. 2,Notified C&L,1.0,H351:1;H302:1
13978,"Cellulose, 2-hydroxyethyl methyl ether",618-528-0,9032-42-2,Not Classified,Notified C&L,168.0,Not classified:168
13981,"Benzenamine, N-methyl-2,4-dinitro-N-(2,4,6-tribromophenyl)-6-(trifluoromethyl)-",613-202-4,63333-35-7,Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H300:38;H400:38;H330:38;H410:38
13983,"2,2-dipropylvaleric acid",257-631-1,52061-75-3,,Notified C&L,1.0,H302:1
13985,Fosphenytoin sodium salt,618-823-4,92134-98-0,Acute Tox. 3,Notified C&L,39.0,H301:38;H302:1
13987,Molybdenite,215-172-4,1309-56-4,,Notified C&L,4.0,Not classified:3;H350:1
13993,"1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 4-chloro-4-deoxy-α-D-galactose",259-952-2,56038-13-2,Not Classified,REACH registration C&L,201.0,Not classified:201
13998,2-phenylglutaric anhydride,220-991-5,2959-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H315:38;H335:38;H319:38
13999,(+)-B-Chlorodiisopinocampheylborane,601-177-2,112246-73-8,Skin Corr. 1A,Notified C&L,123.0,H314:123;H318:40
14000,"6-allyl-4-methoxy-1,3-benzodioxole",210-146-9,607-91-0,Not Classified,Notified C&L,90.0,Not classified:78;H412:10;H411:2;H302:1
14001,"Alcohols, coco",270-351-4,68425-37-6,Not Classified,Notified C&L,92.0,Not classified:92
14004,"(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate",254-843-6,40220-08-4,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,222.0,H318:57;H411:10;H317:43;Not classified:101;H315:44;H335:39;H319:64
14005,bis(2-chloroethyl) ether,203-870-1,111-44-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Carc. 2,Harmonised C&L,0.0,H351:0;H300:0;H330:0;H310:0
14006,"Benzoic acid, 4-hydroxy-3,5-dimethyl-",928-921-1,4919-37-3,,Notified C&L,4.0,H315:4;H335:4;H319:4
14008,"Disodium 4-amino-3-[(4-aminophenyl)azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",227-452-3,5850-39-5,Not Classified,Notified C&L,2058.0,Not classified:2049;H312:8;H332:8;H302:8;H319:1
14018,"Alcohols, C12-14 (even numbered), ethoxylated (<=2.5 moles EO), carboxymethylated",606-920-4,220622-96-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,451.0,H318:451;H315:451;H411:446
14019,"Fatty acids, C16-22, compds. with 2-(dimethylamino)ethanol, salt with lactic acid",927-112-0,1038821-09-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,22.0,H318:22;H315:22
14022,"Zinc, 2-ethylhexanoate isononanoate complexes, basic",286-295-9,85204-03-1,Not Classified,Notified C&L,1.0,Not classified:1
14028,"Benzoic acid, 2-hydroxy-5-sulfo-, compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide",252-677-9,35689-59-9,Repr. 1A,REACH registration C&L,30.0,H360:30
14034,"2,3,4,5-Tetrafluorobenzotrifluoride",613-798-6,654-53-5,,Notified C&L,5.0,H315:5;H226:4;H319:5;H335:4;H225:1
14035,"Phosphorous acid, tri-C12-15-alkyl esters",271-870-9,68610-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H315:39;H335:38;H319:38;H317:2;H318:1
14041,"N,N-diethylsalicylamide",242-955-8,19311-91-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H315:38;H335:38;H319:38;H302:39
14042,"L-Valine, 3-methyl-",606-659-6,20859-02-3,Not Classified,Notified C&L,3.0,Not classified:3
14044,4-bromobenzaldehyde,214-365-0,1122-91-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,64.0,H315:63;H335:60;H319:63;H302:56;H334:38;H317:3;Not classified:2
14045,"Distillates (petroleum), intermediate catalytic cracked, thermally degraded;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 °C to 450 °C (428 °F to 842 °F). This stream is likely to contain organic sulfur compounds.]",295-990-6,92201-59-7,Carc. 1B,Harmonised C&L,0.0,H350:0
14046,"3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;blasticidin-s",606-640-2,2079-00-7,Acute Tox. 2,Harmonised C&L,0.0,H300:0
14049,3-(4-piperidyl)-1H-indole,241-425-3,17403-09-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4.0,H302:3;H332:3;H312:3;H319:4;H335:3;H315:4
14050,3-(propan-2-yl)aniline,611-035-1,5369-16-4,,Notified C&L,36.0,Not classified:33;H302:3;H315:2;H319:2;H412:1
14056,"[[2,2',2''-nitrilotris[ethanolato]](3-)-N,O,O',O'']boron",239-317-6,15277-97-1,Eye Dam. 1,Notified C&L,87.0,H318:38;H335:25;H315:26;H319:26;Not classified:23
14057,"2-methyl-1-(3-sulphonatopropyl)naphtho[1,2-d]thiazolium",221-646-1,3176-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
14061,"7-Oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one, 2,2,4,4-tetramethyl-, hydrochloride (1:?), reaction products with epichlorohydrin, hydrolyzed, polymd.",606-476-1,202483-55-4,Not Classified,Notified C&L,31.0,Not classified:31
14063,"1-amino-4-(3-amino-2,4,6-trimethyl-5-sulphoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",246-025-2,24124-40-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2.0,H318:1;H314:1;H335:1;H315:1;H319:1
14065,"Benzoic acid, 2-hydroxy-, 5-C>13-alkyl derivs., sodium salts",283-049-2,84539-60-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,447.0,H318:1;H410:1;H314:1;H373:1;H317:1;H302:1;H400:1;H412:446;H319:446
14068,Disodium oxalate,200-550-3,62-76-0,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,115.0,H302:113;H312:115;H301:1;H332:1;H315:1;H319:1;H335:1;Not classified:1
14070,1-(3-hydroxypropyl)pyrrolidin-2-one,263-373-0,62012-15-1,Eye Irrit. 2,Notified C&L,38.0,H319:38
14073,"6,7-diisopropylpteridine-2,4-diamine phosphate",282-331-2,84176-65-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
14074,Alprazolam,249-349-2,28981-97-7,Acute Tox. 4,Notified C&L,232.0,H302:232;H360:5;H362:7;H361:4;H336:2;H225:1
14075,Isocyanic acid,616-189-3,75-13-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,38.0,H334:38;H332:38;H314:38;H312:38;H335:38;H302:38
14076,[(tribromomethyl)sulphonyl]benzene,241-096-6,17025-47-7,Not Classified,Notified C&L,91.0,Not classified:53;H335:38;H315:38;H319:38
14077,"Pyroligneous acids, exts.",232-432-2,8028-47-5,Not Classified,Notified C&L,87.0,Not classified:87
14079,MALPIGHIA GLABRA FRUIT EXTRACT,607-012-0,223747-63-5,Not Classified,Notified C&L,2.0,Not classified:1;H319:1
14082,2-Phenyl-2-oxazoline,615-271-6,7127-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
14083,1-(trimethylsilyl)pyrrolidin-2-one,238-461-7,14468-90-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:39;H226:43;H315:43;H319:43
14085,Methyl p-chlorocinnamate,231-451-3,7560-44-3,Acute Tox. 4,Notified C&L,43.0,H302:38;H335:4;H315:5;H319:5
14087,Ethyl toluene-4-sulphonate,201-276-7,80-40-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61.0,H335:57;H315:48;H319:48;H332:9;H314:10;H317:10;H312:10;H302:13;H301:6;H341:5;H318:1;Not classified:1;H351:1
14088,"(S)-Ketoprofen trometamol; 2-Amino-2-(hydroxymethyl)-1,3-propanediol (S)-3-benzoyl-alpha-methylbenzeneacetate",605-065-4,156604-79-4,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,70.0,H331:54;H410:54;H311:54;H301:11;Not classified:2;H302:3;H361:1;H332:2;H312:2;H319:2;H335:2;H315:2;H373:1;H411:1
14090,"1,4,4-trimethyl-2,3-diazabicyclo[3.2.2]non-2-ene 2,3-dioxide",251-833-3,34122-40-2,Flam. Sol. 2;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,33.0,H228:33;H411:33;H302:33;H319:33
14091,4-methylvaleryl chloride,253-801-4,38136-29-7,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,4.0,H226:4;H314:4;H318:1;H290:1
14095,KY-WPH,414-980-6,,Not Classified,Notified C&L,1.0,Not classified:1
14096,"2,3-epoxypropyl 4'-methoxyphenyl ether",218-653-7,2211-94-1,,Notified C&L,5.0,H335:5;H341:5;H315:5;H319:5
14101,"Siloxanes and Silicones, di-Me, chlorine-terminated",614-173-0,67923-13-1,Skin Corr. 1B,Notified C&L,5.0,H314:5
14105,Belsil DM 1000,618-433-4,9006-65-9,Not Classified,Notified C&L,195.0,Not classified:128;H319:67
14106,Tribromoacetaldehyde,204-067-9,115-17-3,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B,Notified C&L,39.0,H301:39;H314:39;H310:39;H318:1
14108,Tetrapentylammonium bromide,212-756-0,866-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
14109,"4'-chloro-3-hydroxy-2',5'-dimethoxy-2-naphthanilide",224-270-6,4273-92-1,Skin Sens. 1A,REACH registration C&L,37.0,H317:4;Not classified:33
14112,Isopropylthiophene,216-288-8,1551-27-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:40;H226:45;H315:40;H319:40
14113,2-METHYLOXAZOLE-4-CARBOXYLIC ACID ETHYL ESTER,600-263-7,10200-43-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
14115,Pyridine-4-ethanol,226-286-9,5344-27-4,,Notified C&L,5.0,H335:5;H315:5;H319:5
14116,lead massive: [particle diameter ≥ 1 mm];lead powder; [particle diameter ,231-100-4,7439-92-1,,,0.0,H360:0;H362:0;H410:0;H400:0
14117,"1,3,5-Triazine, 2,4,6-tris((1,1'-biphenyl)-4-yl)-",479-950-7,31274-51-8,Not Classified,REACH registration C&L,85.0,Not classified:2;H413:83
14120,"Silane, trimethoxymethyl-, hydrolysis products with silica",271-544-6,68584-81-6,Not Classified,Notified C&L,7.0,Not classified:7
14121,"1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",226-639-7,5444-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39;H302:1;H332:1;H312:1
14123,1-(4-phenyl-4-piperidyl)propan-1-one hydrochloride,239-959-7,15847-64-0,Acute Tox. 3,Notified C&L,38.0,H301:38
14124,Propamocarb,607-406-2,24579-73-5,Acute Tox. 4,Notified C&L,127.0,H302:127
14128,"Distillates (petroleum), clay-treated light paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-138-8,64742-37-6,Carc. 1B,Harmonised C&L,0.0,H350:0
14131,"Bis[(tert-butyl)(β,3,4-trihydroxyphenethyl)ammonium] sulphate",256-916-8,51022-70-9,Skin Sens. 1;Carc. 2;Repr. 2,Notified C&L,103.0,H317:79;H361:88;H351:77;H302:22;H373:4;H332:9;H315:8;H319:4;H335:3;H372:1
14133,"Oils, peach",617-019-0,8023-98-1,Not Classified,Notified C&L,52.0,Not classified:52
14134,C.I. Reactive Yellow 22,602-429-4,12226-49-2,Not Classified,Notified C&L,3.0,Not classified:3
14135,"[ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid",215-851-5,1429-50-1,Eye Irrit. 2,REACH registration C&L,191.0,H319:184;H335:94;H315:185;H318:7;H373:6;H290:1
14140,"3,6,9,12,15-pentaoxaheptadecane-1,17-diol",220-045-1,2615-15-8,Not Classified,Notified C&L,73.0,Not classified:37;H319:36
14141,Butyl cyclohex-3-ene-1-carboxylate,253-737-7,37981-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1.0,H335:1;H413:1;H315:1;H319:1
14142,"4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, disodium salt, compound with 2,2',2''-nitrilotriethanol (1:2)",268-177-9,68025-18-3,Not Classified,Notified C&L,5.0,Not classified:5
14144,(Z)-13-octadecenal,261-349-4,58594-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133.0,H335:127;H315:127;H319:127;H332:6;H400:5
14146,Icosan-1-ol,211-119-4,629-96-9,Not Classified,REACH registration C&L,431.0,Not classified:337;H318:9;H410:18;H336:9;H225:9;H312:9;H319:76;H335:9;H302:9;H400:27;H412:18;H411:27
14152,"Amines, C14-18 Alkyl, Ethoxylated",614-342-9,68155-33-9,Skin Corr. 1B,Notified C&L,3.0,H314:2;H412:1;H319:1
14155,"Trisodium 6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoate",700-292-6,135043-68-4,Not Classified,Notified C&L,500.0,Not classified:441;H315:59;H319:59
14158,1-chlorododecane,203-981-5,112-52-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,50.0,H315:11;H410:49;H400:49;H351:39;H319:2;H336:1
14160,"3,9-bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",247-952-5,26741-53-7,Aquatic Chronic 1,Notified C&L,553.0,H410:257;H335:179;H315:237;H319:224;Not classified:33;H318:30;H314:18;H412:8;H413:1;H312:1;H332:1;H400:1
14161,N-ethyldibutylamine,224-711-2,4458-33-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38.0,H226:38;H314:38
14163,Cobalt oxide,234-334-5,11104-61-3,,Notified C&L,7.0,Not classified:7
14164,"(octahydro-4,7-methano-1H-indenediyl)bis(methylene) diacrylate",255-901-3,42594-17-2,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,269.0,H411:208;H317:80;H335:179;H315:209;H319:194;Not classified:26;H412:4;H400:1;H336:1
14165,"Alpha-bromo-2,6-dichlorotoluene",243-827-4,20443-98-5,Skin Corr. 1B;STOT SE 3,Notified C&L,46.0,H335:39;H314:46;H318:1;H290:1
14167,Methyl 4-(indol-3-yl)butyrate,239-658-0,15591-70-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
14171,"Gases (petroleum), blend oil, hydrogen-nitrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",270-749-8,68477-68-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
14174,"Nonane-1,9-dithiol",222-482-3,3489-28-9,Acute Tox. 4,Notified C&L,1415.0,H302:1367;H335:125;H315:129;H319:129;H312:4
14187,p-chlorophenethylic alcohol,217-506-4,1875-88-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:2;H319:2
14189,Butyloctylmagnesium,274-224-4,69929-18-6,Pyr. Sol. 1;Self-heat. 2;Water-react. 1;Skin Corr. 1A,Notified C&L,2.0,H252:2;H260:2;H314:2;H250:2
14192,Norbornane-2-carbonitrile,218-782-9,2234-26-6,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H228:38;H312:38;H319:38;H335:38;H315:38
14194,"Rose, Rosa rugosa, ext.",296-213-3,92347-25-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,26.0,H317:25;H315:26;H319:26;H335:1
14202,"3,5-dimethyladamantan-1-ol",615-150-8,707-37-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4.0,H335:3;H315:3;H319:3;H413:1
14206,(+)-isomenthone,214-813-5,1196-31-2,Not Classified,Notified C&L,107.0,Not classified:90;H412:13;H317:4;H315:4
14207,"2,4,6-trimethylbenzaldehyde",207-662-1,487-68-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,47.0,H411:2;H315:46;H319:46;H335:44
14210,"3,4-dichlorobenzylamine",203-035-1,102-49-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46.0,H318:40;H314:46
14211,"2,4-bis(benzyl)pyridine",247-347-6,25920-18-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
14212,Tetrazinc hexaborateoxide,234-533-7,12008-25-2,,Notified C&L,1.0,Not classified:1
14213,"Fatty acids, coco, esters with trimethylolpropane",615-916-1,73138-40-6,Not Classified,Notified C&L,31.0,Not classified:31
14219,"2,2'-[(dibutylstannylene)bis(thio)]diethanol",221-190-3,3026-81-1,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H360:1;H301:1;H332:1;H410:1;H317:1;H372:1;H341:1;H315:1;H310:1;H400:1
14220,dibutyltin dichloride;(DBTC),211-670-0,683-18-1,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H301:0;H410:0;H314:0;H330:0;H372:0;H312:0;H341:0;H400:0
14221,"Anthracene oil;[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 °C to 400 °C (572 °F to 752 °F). Composed primarily of phenanthrene, anthracene and carbazole.];[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 °C ot 400 °C (572 °F to 752 °F). Composed primarily of phenanthrene, anthracene and carbazole.]",292-602-7,90640-80-5,Carc. 1B,Harmonised C&L,0.0,H350:0
14226,2-fluorobenzaldehyde,207-171-2,446-52-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:48;H226:49;H315:49;H319:49;H302:4
14233,"(3,4-dimethoxyphenyl)hydrazine monohydrochloride",254-795-6,40119-17-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H315:1;H319:1;H335:1
14237,Chlorpropamide,202-314-5,94-20-2,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,129.0,H332:129;H312:129;H351:128;H341:1;H302:1
14241,"iron (II) sulfate;iron (II) sulfate (1:1) heptahydrate;sulfuric acid, iron(II) salt (1:1), heptahydrate;ferrous sulfate heptahydrate",231-753-5,7720-78-7,,,0.0,H302:0;H315:0;H319:0
14243,(R)-(-)-Tetrahydrofurfurylamine,615-707-5,7202-43-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H226:43;H315:39;H319:39;H314:4
14245,1-deoxy-1-(octylamino)-D-glucitol,245-582-9,23323-37-7,Not Classified,REACH registration C&L,2.0,Not classified:2
14247,"Disodium 4-[[4-(acetylmethylamino)-2-sulphonatophenyl]amino]-1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",276-409-5,72152-54-6,Not Classified,Notified C&L,2166.0,Not classified:2165;H412:1
14248,Hexadecyloxirane,230-977-0,7390-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:39;H315:44;H319:44;Not classified:4
14252,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, sulfonated",268-211-2,68037-36-5,Aquatic Chronic 3,REACH registration C&L,521.0,H412:27;Not classified:494
14254,Manganese yttrium oxide (MnYO3),601-698-5,12032-75-6,Not Classified,Notified C&L,2.0,Not classified:2
14255,Silymarin,613-830-9,65666-07-1,Repr. 2;STOT RE 2,Notified C&L,2.0,H361:2;H373:2
14256,7-(dimethylamino)-4-methyl-2-benzopyrone,201-717-3,87-01-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46.0,H335:39;H334:38;H315:40;H319:40;Not classified:6;H317:1
14257,"3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:4)",278-293-1,75701-34-7,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,117.0,H301:83;H412:83;Not classified:34
14258,Sodium 5-[[2-nitro-4-sulphamoylphenyl]amino]-2-[[4-[[2-nitro-4-sulphamoylphenyl]amino]phenyl]amino]benzenesulphonate,276-131-4,71873-58-0,Not Classified,Notified C&L,9.0,Not classified:9
14259,Marjoram oil,616-979-8,8016-33-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38.0,H334:38;H304:38;H226:38;H319:38;H315:38
14261,"Oils, lard, sulfated",273-582-9,68990-17-0,Not Classified,Notified C&L,4.0,Not classified:4
14262,3-fluoro-4-nitroaniline,219-130-6,2369-13-3,Acute Tox. 4,Notified C&L,45.0,H302:45;H332:7;H312:7;H319:7;H335:6;H315:7
14264,"2',3',4'-trichloroacetophenone",237-092-9,13608-87-2,,Notified C&L,5.0,H335:4;H315:5;H319:5
14265,"Octyl (2,4,5-trichlorophenoxy)acetate",220-109-9,2630-15-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H302:38;H410:38;H315:38;H319:38;H335:38;H400:38
14271,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, methyloxirane and oxirane",614-281-8,68123-18-2,Not Classified,Notified C&L,114.0,Not classified:59;H412:35;H411:20;H317:20;H315:20;H319:20
14275,"Nitric acid, ammonium calcium salt",239-289-5,15245-12-2,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,286.0,H318:220;H302:220;Not classified:52;H335:16;H336:16;H272:14
14276,"Phosphoric acid, ethyl ester",253-391-7,37203-76-2,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,690.0,H318:443;H314:688;H226:31;Not classified:2;H332:1;H312:1;H302:1
14280,(+)-menthone,222-227-6,3391-87-5,Aquatic Chronic 3,Notified C&L,28.0,H412:28
14281,Lithium 2-ethylhexanoate,239-657-5,15590-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:38;H315:38;H319:38;H361:5;H413:3;Not classified:1
14282,"Reseda luteola, ext.",290-237-8,90106-16-4,Not Classified,Notified C&L,1.0,Not classified:1
14287,Sodium 2-hexyloxyethanolate,700-291-0,1000701-92-7,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,84.0,H302:84;H314:84;H311:84;H318:83
14288,4-(2-chloroethyl)phenyl methyl ether,242-099-5,18217-00-0,Muta. 2,Notified C&L,1.0,H341:1
14296,"Fatty acids, C16-18-unsatd., sulfated, ammonium salts",308-585-7,98106-63-9,Not Classified,Notified C&L,1.0,Not classified:1
14300,1-Chloro-2-methylpropyl chloroformate,618-859-0,92600-11-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,40.0,H301:40;H314:40;H311:40;H331:40;H226:40
14302,"Fatty acids, C8-18 and C18-unsatd., isononyl esters",288-662-9,85865-64-1,Not Classified,Notified C&L,1.0,Not classified:1
14303,Estazolam,249-982-4,29975-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:39;H315:39;H319:39;Not classified:1;H362:1;H336:2;H302:1;H361:2
14305,reaction product of aminoacids and palmitoyl chloride,920-912-0,,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,4.0,H318:4;H314:4
14306,Temazepam,212-688-1,846-50-4,Acute Tox. 4,Notified C&L,47.0,H302:47;H362:1;H336:1;H361:2;H341:1
14308,diisobutyl phthalate,201-553-2,84-69-5,Repr. 1B,Harmonised C&L,0.0,H360:0
14311,"2-(3,4-dihydroxyphenyl)ethyl [2S-(2α,3E,4β)]-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate",251-129-6,32619-42-4,Not Classified,Notified C&L,2.0,Not classified:2
14312,"2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane",406-970-5,129228-11-1,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H315:0
14314,1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide,406-210-2,110560-22-0,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
14315,Magnesium(2+) 12-hydroxyoctadecanoate,254-868-2,40277-04-1,Not Classified,Notified C&L,3.0,Not classified:3
14317,(2S)-2-Phenylbutyric Acid,610-071-5,4286-15-1,Acute Tox. 4,Notified C&L,43.0,H302:43;H315:4;H319:4
14318,3-chloro-2-fluoroaniline,218-283-6,2106-04-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,49.0,H335:40;H318:39;H302:47;H315:45;H332:8;H373:4;H311:5;H319:6;H312:4;H331:1;H301:1
14321,"Fatty acids, C9-11-branched, calcium salts",287-033-6,85408-70-4,Not Classified,Notified C&L,1.0,Not classified:1
14328,Pyrimidine-2-ol hydrochloride,253-897-8,38353-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,7.0,H335:5;H315:6;H319:6;H318:1;H314:1
14330,"9-Octadecenoic acid (Z)-, reaction products with diethanolamine",272-485-9,68855-44-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41.0,H315:35;H319:28;H318:7;Not classified:6;H411:2
14334,4-phenylthiazol-2-amine,217-926-8,2010-06-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,53.0,H335:41;H301:53;H318:40;H315:42;H319:2
14335,Molecular sieve,613-189-5,63231-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:40;H315:40;H319:40
14336,4-(chlorocarbonyl)phenyl 3-chloropropanoate,609-280-4,366448-53-5,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2.0,H318:2;H314:2
14339,"11α,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione",278-982-7,78761-59-8,Repr. 1B;STOT RE 2,Notified C&L,16.0,H360:16;H373:16
14340,4-bromostyrene,218-022-6,2039-82-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47.0,H315:47;H319:47;H335:7;Not classified:1
14341,Soybean meal,269-648-1,68308-36-1,Not Classified,REACH registration C&L,5.0,Not classified:5
14342,"3,5-dihydroxybenzoic acid",202-730-7,99-10-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H335:49;H315:50;H319:50;H302:1
14344,2-phenoxynicotinonitrile,238-035-0,14178-15-5,,Notified C&L,4.0,H335:4;H302:4;H315:4;H319:4
14345,Sodium 4-dodecylbenzenesulphonate,218-654-2,2211-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:38;H315:40;H319:38;H318:2;H302:3;Not classified:1
14348,"L-erythro-Pentofuranosylamine, 2-deoxy-N-phenyl-",600-579-5,104578-89-4,Not Classified,Notified C&L,1.0,Not classified:1
14350,2-hydrazinobenzoic acid,226-202-0,5326-27-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
14353,Amitriptyline,200-041-6,50-48-6,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Repr. 2;Aquatic Chronic 1,REACH registration C&L,198.0,H301:159;H318:159;H410:159;H311:159;H331:159;H361:159;H302:38;H400:1
14356,chromium (VI) trioxide,215-607-8,1333-82-0,Ox. Sol. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H301:0;H271:0;H334:0;H410:0;H314:0;H330:0;H350:0;H317:0;H311:0;H372:0;H340:0;H361:0;H400:0
14357,"Orthoboric acid, compound with 2,2',2''-nitrilotriethanol",233-175-9,10049-36-2,Not Classified,REACH registration C&L,475.0,Not classified:474;H319:1
14363,"Amines, C12-14-alkyl, reaction products with hexanol, phosphorus oxide (P2O5), phosphorus sulfide (P2S5) and propylene oxide",294-716-2,91745-46-9,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,623.0,H411:603;H318:557;H317:580;H226:487;H302:557;H314:64;H228:42;Not classified:20;H225:3
14367,"1,1'-[ethylidenebis(oxy)]dibutane",212-804-0,871-22-7,Skin Irrit. 2,Notified C&L,10.0,H315:10
14369,5-[[4-[(4-sulphophenyl)azo]phenyl]azo]salicylic acid,247-238-3,25747-21-1,Not Classified,Notified C&L,2.0,Not classified:2
14374,Amianthus,603-721-4,1332-21-4,Carc. 1A,Notified C&L,43.0,H350:38;Not classified:5
14375,"Oils, vegetable, sulfated, ammonium salts",293-411-1,91079-24-2,Not Classified,Notified C&L,9.0,Not classified:9
14379,α-ethylcinnamaldehyde,249-037-6,28467-92-7,Not Classified,Notified C&L,1.0,Not classified:1
14381,Neodymium oxide,215-214-1,1313-97-9,Not Classified,REACH registration C&L,257.0,Not classified:167;H410:83;H400:83;H413:5;H370:1;H335:1;H315:1;H319:1
14388,(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid,430-900-2,192725-50-1,Eye Dam. 1,Harmonised C&L,0.0,H318:0
14391,"Oils, pennyroyal, Mentha pulegium",616-943-1,8013-99-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,83.0,H411:56;H302:57;H312:56;H315:25;H317:2;H412:1;H226:1;H410:1;H304:1
14396,2-tetradecyloxyaniline,255-510-8,41710-89-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38.0,H317:38;H319:38
14399,"6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine",403-240-8,106264-79-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H302:0;H410:0;H400:0
14403,"4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine",401-360-5,5248-39-5,Acute Tox. 4;STOT RE 2,Harmonised C&L,0.0,H302:0;H373:0
14405,C.I. Solvent Violet 37,612-929-4,61969-50-4,Not Classified,Notified C&L,2.0,Not classified:2
14407,Ethyl 4-morpholinepropionate,243-526-8,20120-24-5,,Notified C&L,5.0,H315:5;H319:5
14408,"2,2,3,3,4,4,5,5-octafluorovaleric acid",206-812-3,376-72-7,,Notified C&L,5.0,H302:4;H314:4;H335:1;H315:1;H319:1
14411,2-chloro-3-methyl-4-(methylsulfonyl)benzoic acid,600-786-0,106904-09-0,Not Classified,REACH registration C&L,5.0,Not classified:5
14413,L-histidine monohydrochloride,211-438-9,645-35-2,Not Classified,REACH registration C&L,29.0,Not classified:29
14414,"[3R-(3α,3aβ,7β,8aα)]-2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene",207-418-4,469-61-4,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1600.0,H304:1519;H410:1525;H400:1561;H226:389;H315:42;H319:42;Not classified:36;H314:1
14416,2-[(dimethylamino)methyl]cyclohexan-1-one,239-422-7,15409-60-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,41.0,H226:41;H302:41;H314:41
14420,cis-decahydroquinoline,233-752-5,10343-99-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14423,C.I. DIRECT RED 262,406-170-6,,Not Classified,Notified C&L,1.0,Not classified:1
14425,"2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6α,12aα)]-",234-198-7,10592-13-9,Acute Tox. 4,Notified C&L,15.0,H302:15;H332:6;H312:5;H361:4;H315:8;H319:8;H335:8;H311:1;H373:1;H360:3;H362:2;H317:2;H334:1;H400:1;H410:1
14431,Potassium dihydrogenarsenate,232-065-8,7784-41-0,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H301:38;H410:38;H350:38;H331:38;H400:38
14432,"Dodecanedioic acid, compound with 2,2',2''-nitrilotriethanol",285-271-5,85049-97-4,Eye Irrit. 2,Notified C&L,573.0,H319:448;H332:125;H412:125;H315:2
14436,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium methyl sulphate",281-435-5,83949-75-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31.0,H411:18;H302:21;H319:17;Not classified:10;H318:3;H314:1
14439,Dysprosium(3+) acetate,242-565-8,18779-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14444,"tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine",427-600-9,192439-46-6,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
14446,Ethyl non-2-ynoate,233-098-0,10031-92-2,Not Classified,Notified C&L,126.0,Not classified:88;H335:38;H315:38;H319:38
14451,(6-Bromo-2-pyridinyl)(4-methylphenyl)methanone,618-079-0,87848-95-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 1,Notified C&L,1.0,H302:1;H332:1;H410:1;H312:1;H319:1;H335:1;H315:1
14452,Hexaphenyldisilane,215-913-1,1450-23-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H302:39;H312:39;H332:1
14454,6-benzamidohexanoic acid,213-477-7,956-09-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H315:38
14455,"1,3-dichloro-2-(methoxymethyl)benzene",251-541-6,33486-90-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H226:1
14456,"Phenol, 2,4,6-tris[[[3-(dimethylamino)propyl]amino]methyl]-",607-115-0,225795-35-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,71.0,H302:40;H410:40;H400:40;Not classified:31
14459,"Fatty acids, C10-18 and C18-unsatd.",292-775-9,90990-14-0,Not Classified,Notified C&L,2.0,Not classified:1;H319:1
14460,"9,10-Anthracenedione, 1,4-diamino-2,3-dichloro-",615-223-4,70956-27-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1.0,H302:1;H319:1
14462,Trisodium [2-[4-[[3-hydroxy-4-[[1-hydroxy-3-sulpho-7-(3-sulphoanilino)-2-naphthyl]azo]phenyl]azo]phenyl]-6-methyl-7-benzothiazolesulphonato(5-)]cuprate(3-),282-275-9,84145-48-2,Not Classified,Notified C&L,11.0,Not classified:11
14467,"1-Pyrrolidineacetic acid, α-ethyl-2-oxo-, ethyl ester",617-924-0,86815-10-3,Not Classified,Notified C&L,1.0,Not classified:1
14469,Hexabutyldistannane,212-383-3,813-19-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46.0,H301:46;H410:45;H372:46;H312:46;H319:46;H315:46;H400:43
14471,4-(2-bromoethyl)benzoic acid,257-632-7,52062-92-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90.0,H315:90;H319:90
14474,Tetrahydro-3-pentyl-2H-pyran-4-yl acetate,242-640-5,18871-14-2,Not Classified,REACH registration C&L,1748.0,Not classified:28;H412:1719;H319:392;H411:1
14476,(E)-5-methylhept-2-en-4-one,617-270-6,81925-81-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,372.0,H317:327;H315:328;H319:328;H226:60;H302:15;Not classified:1
14481,2-bromo-2-nitroethan-1-ol,611-128-7,5437-60-5,Acute Tox. 3,Notified C&L,39.0,H301:38;H335:1;H318:1;H315:1
14489,"Soybean oil, maleated, ester with triethanolamine",285-107-2,85029-82-9,Aquatic Chronic 3,REACH registration C&L,9.0,H412:9
14490,"Gases (petroleum), benzene unit recycle, hydrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]",270-748-2,68477-67-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
14502,"(R,E)-Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]-3-hydroxy-5-oxohept-6-enoate",604-567-0,147118-39-6,Aquatic Chronic 4,Notified C&L,1.0,H413:1
14505,"Soaps, stocks, shea-fat, acidulated",296-511-3,92704-75-1,Not Classified,Notified C&L,3.0,Not classified:3
14508,2-Ethoxy-4-(methoxymethyl) phenol,611-336-8,5595-79-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,309.0,H317:308;H302:307;Not classified:1
14509,Sodium hydrogen oxalate,214-691-3,1186-49-8,,Notified C&L,8.0,H302:8;H312:8
14512,"3(2H)-Furanone, 4-(acetyloxy)-2,5-dimethyl-",435-910-0,4166-20-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,402.0,H411:402;H317:402
14514,Methyl (Z)-tetracos-15-enoate,220-352-0,2733-88-2,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
14515,Oxacycloheptadec-7-en-2-one,231-929-1,7779-50-2,Not Classified,Notified C&L,324.0,Not classified:283;H319:41
14518,Benzylphenol,215-339-1,1322-51-6,Not Classified,Notified C&L,1.0,Not classified:1
14519,"Zinc, 2-ethylhexanoate isodecanoate complexes, basic",286-294-3,85204-02-0,Not Classified,Notified C&L,1.0,Not classified:1
14526,"3-(2-chloroethyl)(1H,3H)quinazoline-2,4-dione",225-795-3,5081-87-8,Aquatic Chronic 2,REACH registration C&L,41.0,H411:1;H302:40;H332:1;H315:1;H319:1;H335:1
14529,"4-[(4-aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]aniline mononitrate",262-806-0,61467-64-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
14531,Diphenyl(4-(phenylthio)phenyl)sulfonium hexafluoroantimonate,680-227-5,71449-78-0,Acute Tox. 4;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,61.0,H317:39;H302:19;H410:4;H400:39;H411:16;H332:16;Not classified:5
14538,1-benzylpiperidine-4-acetonitrile,278-822-6,78056-67-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
14541,"1-(2-Chloro-acetyl)-3-[1-methoxy-1-phenyl-meth-(E)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester",919-003-1,1174335-83-1,Not Classified,REACH registration C&L,2.0,Not classified:2
14545,"2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione",406-295-6,128344-23-0,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
14548,2-bromo-5-isothiocyanatotoluene,275-823-3,71672-88-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
14557,Propyl salicylate,210-145-3,607-90-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
14563,"1,3,5-tris[6-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]hexyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",299-988-6,93919-05-2,Not Classified,Notified C&L,71.0,Not classified:71
14564,"Distillates (petroleum), clay-treated middle;Gasoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-139-3,64742-38-7,Carc. 1B,Harmonised C&L,0.0,H350:0
14565,"Benzenesulfonic acid, dimethyl-, mono-C11-16-alkyl derivs., sodium salts",283-048-7,84539-59-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,8.0,H318:8;H302:8;H315:8
14566,Sodium formaldehydesulfoxylate dihydrate,611-965-8,6035-47-8,Muta. 2,Notified C&L,74.0,H341:74;H361:36
14567,Benzyl mandelate,212-965-7,890-98-2,Acute Tox. 4,Notified C&L,38.0,H302:38
14572,"reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)",410-040-4,136213-76-8,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
14573,"Orange, sweet, ext.",232-433-8,8028-48-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3563.0,H411:1304;H304:3495;H317:3351;H226:2256;H315:3542;H410:1824;H225:1293;H400:1673;H319:108;H335:39;Not classified:8;H412:7;H314:1;H224:1;H336:1
14574,N-(4-chloro-2-methylphenyl)-3-(phosphonooxy)naphthalene-2-carboxamide,220-046-7,2616-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
14578,"1,5-anhydro-2-deoxy-D-lyxo-hex-1-enitol",244-264-7,21193-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:47;H315:48;H319:48;H301:7;H225:7;H311:7;H331:7
14579,"Peanut oil, hydrogenated",270-350-9,68425-36-5,Not Classified,Notified C&L,1.0,Not classified:1
14585,"3,3-dimethyl-4-phenylbutan-2-ol",266-902-3,67682-19-3,Eye Irrit. 2,Notified C&L,38.0,H319:38
14588,2-chloroethyl toluene-4-sulphonate,201-277-2,80-41-1,Acute Tox. 4,Notified C&L,50.0,H302:50;H319:1
14589,"2',4'-dichloro-5'-(4-(difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)-methanesulfonanilide",602-896-4,122836-35-5,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,127.0,H411:89;H332:127;H373:89
14593,Estradiol benzoate,200-043-7,50-50-0,Carc. 2;Repr. 1B,Notified C&L,60.0,H360:58;H351:57;H332:16;H312:16;H302:17;H334:1;H400:1;H362:1;H413:1;H411:1;H372:1;H350:1
14596,hexachloroplatinic acid,241-010-7,16941-12-1,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0.0,H301:0;H334:0;H314:0;H317:0
14598,2-methylpropene,204-066-3,115-11-7,Press. Gas;Flam. Gas 1,Harmonised C&L,0.0,H220:0;Not classified:0
14600,"Sage, Salvia officinalis, ext.",282-025-9,84082-79-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,1795.0,H371:372;H304:1666;H317:1667;H412:21;H226:1669;H315:1316;H410:1291;H373:1291;H400:1291;H332:276;H302:350;Not classified:126;H411:169;H318:14;H341:3;H319:3;H312:1
14601,"3-iodo-1,1'-biphenyl",243-826-9,20442-79-9,,Notified C&L,1.0,H335:1;H315:1;H319:1
14603,"Propanenitrile, 3,3’-[oxybis(2,1-ethanediyloxy)]bis-",607-062-3,22397-31-5,Skin Corr. 1B,Notified C&L,22.0,H314:22
14605,"1,1'-(hexane-1,6-diyl)bis-1H-pyrrole-2,5-dione",225-449-1,4856-87-5,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,16.0,H317:14;H319:16;H315:16;H311:14;H302:1;H330:1
14613,5-[p-(diethylamino)benzylidene]-2-thioxothiazolidin-4-one,252-723-8,35778-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
14614,"3,4-dihydroisoquinoline",221-769-0,3230-65-7,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40.0,H319:40;H302:40;H315:40;H310:40
14619,Nitralin,225-219-0,4726-14-1,Aquatic Acute 1,Notified C&L,41.0,H400:41;H302:3
14621,"N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine",429-670-6,105996-54-1,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H317:0
